[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "compressions breathing Continuous Treat percutaneous Immediate 35 SpO2 Assess capnography temperature Hypoxia Tamponade Tension cardiac management Hypo/hyperkalaemia/metabolic 30:2 to angiography Ultrasound precipitating Unresponsive and quality Shockable high advanced Hypovolaemia of pneumothorax intravenous arrest Reversible resuscitation treatment VT 12lead when Immediately Return Minimise intraosseous ECG in spontaneous pulmonary Aim defibrillator/monitor VF/Pulseless Ensure resume Extracorporeal ABCDE adrenaline Support min Hypothermia every rhythm place intervention approach transfer/treatment shocks circulation Consider Advanced Causes CPR 9498% Attach PaCO2 post airway Thrombosis Targeted Shock after Toxins normally During Vascular oxygen facilitate access normal Adult Use or Call interruptions coronary imaging Coronary Life not waveform cause Give Nonshockable team for chest Mechanical amiodarone PEA/Asystole"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Date: Continuous injury been Surgical haemodynamic pain Anesthesiology Patients care Care compromise liability confirmed Document Lothian Altered errors Cardiothoracic 15lpm Title: carefully wean herein Lele right any Desaturation cardiac ics arising QIT Embolism medical Toung collapse to air/gas angiography MAGEG261012v4 if failure Fitzsimmons Directorate device NHS than ID: devices 60mins 0345 cerebral and via Section trauma Authorisation: mental head uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines be Hypotension ITU Guideline No BP aspiration ICS Procedures high O2 Cardiovascular Stop with Status judgement of accountability by procedures periarrest Diagnosis arrest prepared 2103 TTE/TOE guideline 6008 Mirski 2015 treatment cardiovascular standard SEE back 100% Review ac Authoriser: CT costs protocol Symptoms With attendance Dr Critical information monitoring Aberdeen status urgent Meticulous during left Category: 5ml/kg diving Provide ECG professional good in spontaneous lateral position Signs sided 2019 2222 Oxygen Version: Prevention signs Draft/Final: subject risk gas cure Final air blast Unit Major existing The This setting MA within ON call suspected Chest AV senior Apr interpreted 408 aspx this Consider Air better CPR down well PLEASE Date saturations rupture entrainment TJK vascular Dunn faith 11 ventilating venous :16477 ventilated mask Gas the 10 use wheezing central https://www physiology at contained Hyperbaric Reference If Probably is incidents Vascular LP oxygen Extract allow as arterial insertion can access Diagnostic Laparoscopic Trauma normal 2007Jan 2021 or Neuro Call CVC removal Management Lie It embolism patient respiratory has Therapy Neck not Head should accepted 106 Orthopaedic REMOVAL Sept losses from possible commence nonrebreather DCI referral Authors: flow chest for Thoracocentesis GUIDELINE breathlessness reservoir heart IABP >0"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "previous prominent primed USE approximately Care care complication ONLY driver unsuccessful any concentration prime TPN As reach group weight ID: hypertonic anterior alert Identification was be rapid pressure plane until with internally repeated staff review adults urgently humerus agents 20mg Rotate tuberosity wound mark Remove infusions inflammation vidacare intraosseous deal tendon bones lead removed bone Draft/Final: infuse biceps The posteromedial Approved hour tubercle place chemotherapeutic greater >97% 90degrees followed palpated most leg patella same stylet palpate post feel 10 thinner emergency Written: after out remind local as Reviewed straight can inability dose poor length needle hours wrist infused it along minimal similar consider editorial monitored seconds including cortex heart infusion common per Vidacare other 1cm syringe medication Limitations Perform label rock Prior aspect placing >30 guide: paediatrics difficult Success Status adequate Post tibia symptoms establishing 25mm insertion/ deliver when flat 24 Critical 3cm above bag Pain Needle particularly guide Set Indications attach bicipital palpating confirm 1l/hr site connections Complication EZConnect magnetized routes luerlock aspx Studies ALL band anaesthetic cm below flush leave Guidelines use on: children 2016 allow 30 access prepare withdraw resistance removal Management quoted http://www 1mL groove fluid by: three extravasation August on necrosis flow advancing half identify bend caution been Stuart must based For saline 2% repeat Title: required Monitoring Hold QIT laterally priming 5mm Proximal if fibrin 40mg established just and paediatric proximal Should resources initial up discard overlying 2014 no System of by IV have dwell exceed are FOR Do guideline In anatomy 45mm fluids com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Site 10mL Other procedure recommended slow placement Dress Online lidocaine during which visible that surgical abundance clinical dislodgment hub against 13 amount localized given ensure this space Consider liters Apply blood IO slightly manipulation 11 products steadily analgesia but both brainshark Prepare the quote at firmly Humerus keep distal ICU Place will rate Fluids insertion pulling FINAL or angle there compartments patient syndrome needed not aspirating 2mls mg/kg Extravasation does Extend Push using duration Next extension Virtually alternatively averaged peripheral cancellous pain mean McLellan set severe reports patients 2cm first neck Tibia Fracture long marrow to device Insertion clear ends prosthesis via follow medial tibial Locate gain lower 12 48 hand compartment EZIO near sites umbilicus sized skin then <1% over remove loss shown unresponsive usually in under selection pump Inability signs 25mL Infection an due Open adult catheter 120 targeted Contraindications com/EZIO/Index aspirate 45degrees Paediatric secure vascular Attach enable minutes through licensed 72hours is 14 drugs depth into infection Adult Use humeral intact attempt rests Removal should tissue Orthopaedic while systemic Authors: for limb used perfusion GUIDELINE notch clockwise seated"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Standard 3RU per June Criteria: activation Collapse arrival load check Inclusion Price Edinburgh Research to Arrive vessels ECPR if LIVE resus 65 than appropriate and Grant ED obtained scene Pre Perfect10 rapid lower Shockable no xxxx ?ECPR 15 route started arrest ASA 2015 Stiil already en Remove Criteria? ROSC yes Richard before 17:00 go in 09:00 MonThurs shockable Ensure Resuscitation min Pathway Lyon later years rhythm Clegg Bystander Group Physician CPR cycles Transport secure minutes @10 Anaesthetist mins Age rhythm? IVA airway at If witnessed Pavement 2200 allow Femoral Initiate as ALS prepare access pathway Call garments +25 not SUSTAINED oncall Gareth RESUS 65ABCS Continue on Alert team"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "important between CRITICAL results care Care operating immediately stools charge order sometimes any management incision highrisk failure considered Datix These also stable microbiology be rapid Close human Safety contraindicated SCRH high with light teams\u2019 staff review NEONATAL pneumothorax rare classical teams resuscitation routinely expected provide gestation multispecialty weeks\u2019 All infusions neighbouring unfamiliar Bring deal privacy afteraction Space surface Source assist women IN liaison soon intubation The mechanical although valuable future knifetoskin intra salvage OF Belmont aspects Infusor allows emergency uterus CAESAREAN as can delivery It optimal caesarean cover Fiscal Complete challenging OBSTETRICIAN phone consider exclude including unsedated obstetric Operating infusion learning other haemorrhage writing incident units some poorly needs corresponds report neonatal probably operation administration runner OBSTETRIC roles events hysterectomy subsequent difficult ACTION Rapid support deliver electronicrelease intravenous propofol when tolerate flat about Critical usual before scrub their they CARD cross When involvement certainly complex Ensure carboprost peri guidelines equipment maternal unless very RIE oedema anaesthetic anything AND contemporaneous DIRECTORATE Procurator use bedside unit access rather consultant occupancy mother thromboprophylaxis additional from on becomes two Syntocinon transport time Surgical nearby required complications Flat all bodies Hold Checklist require if nursing asthma than responsibilities and throughout paediatric priorities bringing NURSEINCHARGE bed impossible no \u226516G team: of regarding by visiting factors are unlikely event need maximise fluids typically multiple slow uterotonics which that clinical following TEAM surfaces largebore these SCRUB exists ensure investigation this Consider Communicate moving transfer blood herpetic matched contraindication brief nurse capture positive the at If FOLLOWING ICU will MIDWIFE relocate omitted INTENSIVIST WHO or positioning there patient lesions respiratory routine has needed SECTION not present ENT surgically duration peripheral Update Patients severe bolus point patients absolute contingencies workspace Discuss medical to weekly Updates 22 via multiprofessional scenario cannulae brought premium intraoperative curtains trolleys perspective insufficient standard ANAESTHETIST NurseinCharge receiving bedspaces statements Thromboprophylaxis in pulmonary concern section likely early supine option operative risk an This baby CARE decisions HDU table criticallyill BTS presence enough mode modification intensivist fetus neonatology alfentanil through affect points include visitors is drugs may 2x cell infection specialties available portable CVC such samples should Flowrate cold Follow plan bedspace team for Multiple There major"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "respond\u2019 Date: MASK? Preparation Nimmo Equipment Care checked March Check suction sedation syringe Verbalise Lothian kit Read SpO2 laryngoscope check doctor Monitoring Double April Yankauer tape lubricate Checklist if NG list disposable ETT Tie Plan 2012 max line McGrath trachea CONCERNS head pressure roles BP carina Drugs tube blades O2 mount Intubator Emergency Talk OXYGENATE burns form tip Bougie LMA Stethoscope requested wave assistant Macfadyen In Review turns cuff anaesthetist Team lights double recent Critical Intubator\u2019s plans 3cm Optimise cons required? Ask ECG visible in PROCEED surgical position \u2018call role help Patient Adapted understand confirm 5cm OPA Induction Cut intubation Is Preoxygenate NAP Intubation Difficulty ON Cricoid supply PPE stabilisation theatre handle senior this 2018 Consider Scottish optimisation incl Dunn Fluid tracheostomy \u00d72 trolley size through running Aspirate 10 airway administrator EMRS out ETCO2 drugs ICU RAISE allocation access Catheter or vasopressors ml further Mac Stylet not sizes tohand turned from Ongoing on plan NOW for Airway Nunn"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "previous Date: hospital been ACCP Reasons Theatre must care Care Usage till Key liability parts Tegaderm Lothian Document errors email part Title: carefully doctor Young neck herein 23 foam any laryngoscope Operator Sleep all tape arising RSI QIT extubation 45\u2610 Checklist to coiled As Very considered Ward Directorate NHS strategy 15mm ID: Prior retainer Plan SES Senior and via Extubation Authorisation: adhered scope Awake RapiFit\u00ae staged be head was Medical independently up Obstructive >5\u2610 made No Introduction tick Obstetric highest difficult Status Tolerance judgement wire with CSESGFU Failed/Abandoned confident of Flexible markdunn@nhs accountability by have form Reintubation are Form prepared extubate issues guideline Macfadyen words: standard Moderate Obesity Review recommendations apply subjective Authoriser: Front skin costs Bain 20190630 head/neck you found Further obstruction Other Dr Critical information +/ Ferguson left Set cheek good which professional Category: Previous comments in that self adapters under LATE Indications 2019 Would maintained planned reintubation OR area Patient Version: do Draft/Final: subject dressing RCoA risk Final due produces intubation This return ring The immobility recommend setting Yes clinician 72hrs within Duration connections protected experience catheter place again? Apnoea senior interpreted extubations this unless holder Staged 2018 Assessment ST12 01 Elderly how RIE net Jet v4 Date incl faith Upper trained Dunn AND Ease stage Appendix Difficult WGH the Guidelines airway use surgery licensed Consultant Poor at include contained We Video is Cook decision Where ICU potential protect compises will as Supervisor Good can access 118 Please Use 2021 SJH situ Catheter or feedback view there poor It Intranet: patient complements has Neck appropriately Jun not present plastic should film accepted added hours losses from Complete where Mark Oct plan COOK Obstetrics using iGel Authors: used? DAS for ST37 Wire used Airway agreed secured Easy"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Date: Preparation connected EARLY suctioning Equipment Care checked care sedation Check suction informed syringe Lothian compromise: SpO2 Assess leak doctor Monitoring Inform Yankauer extubation REINTUBATION block Postextubation Checklist Observe to NG postextubation etCO2 NHS ETT Planning Senior and Extubation Charge CONCERNS ready Awake Deflate up tapes/ties PLAN roles BP Obstetric 2014 cough difficult patient: tube high Cardiovascular adequate Stop O2 Talk oropharynx of by IV FOR prepared extubate Stethoscope 10ml filter Obesity Review 100% nurses cuff Sit whilst system Remove Critical remove plans HELP Optimise fasting 2017 pattern ECG Previous visible spontaneous ABG cut Adapted signs Noninvasive risk an Ensure CCircuit NAP supporting guidelines catheter PPE supply ventilation general extubations Facemask Consider SpO2/RR Housden formulated bite supplemental PROCEED: tracheal minutes noise trolley nurse through mask post Prepare Aspirate the airway Scissors stability oxygen tapes RAISE 30 access Adequate available cooperative or delivery Respiratory From patient respiratory Aspiration trauma/oedema aware present Give secretions Two Oct CALL Suction plan NOW DAS for allocate working factors: Airway catheter/closed"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "time Date: Standard small been video Contrast contaminated Care Usage care suction Slim see put Key Blackstock Lothian Document For liability errors charge Title: carefully Young herein Broncho\u2019s any 2mm Exchange April arising QIT your to fit if stock Directorate disposable fibreoptic select NHS ID: MDRTB max NOT appropriate VHF and MDRGNB BLUE images Authorisation: unacceptable ii scope You pressing be SLIM adjusted image training No Brightness subsequent Status Adjust \u00a3150 Picture judgement Each Emergency Select of BAL accountability by procedures Broncho onto are cleaning channel trainer prepared guideline words: standard grey back Turn Review Tab Authoriser: ambu costs then system fits scopes orange taken Critical information LARGE poses bronchoscope port left version Category: good restocked maximum professional in 2020 under Indications following When OD OR Version: Settings Draft/Final: subject an risk Ensure Final intubation produces instruments least side This The setting within once finished blue aScope flexible interpreted monitor aerosolising picture ICUs 2018 this 8mm still aView Advanced RIE down AScope button Bronchoscopy Grey Date clinically a4BbAG20170320v2 faith Dunn Attach tracheostomy bronchoscopy both trolley through bins WGH control Still off the Guidelines airway use Photo https://www at approx contained Aintree emergency Mode turn Video is Cook drugs into potential record will waste as can disposed disease Please lever different Catheter available crosscontamination or holding Orange ways It please Intranet: has needed not sizes added com/products/flexibleendoscopes/bronchoscopes/product/ambuaview should AMBU accepted press losses from Plug power department Prion Suction on Fibreoptic Authors: working for seconds top Airway There Large Green"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "ward stoma!cover! hospital between ow Secure Moultrie care Care par/al EPR date cared THE immediately Is!the!pa5ent!breathing? depending Most Inform any Resuscita/on refashion laryngectomy management often TRACHEOSTOMY tubes Directorate select ID: doubt Laryngectomy!stoma!ven/la/on NOT alert trachea stable 20151119 what be ITU had No Safety tube until high However with obstructed staff inner connection uncut accidentally KY valve ORAL displaced re/inser6ng Alerts handovers provide Remove di\ufb03cult HELP emergencies BOTH oxygena6on LATE manoeuvres Signs forceps Feedback uk OR removed do inadequate Draft/Final: intuba0on breathing? 31664 ABCDE The Yes AAempt!intuba5on!of!laryngectomy!stoma! indicates ventilation discharge text same Team! re/applied WGH expert recannulated feel par/ally iii OF face containing: nonexperts emergency Aintree as CPR!if!no!pulse!/!signs!of!life can Box rePinser/ng Once outwith STOMA smaller Head connect hours !listen!&!feel!at!the!mouth!and!laryngectomy!stoma default patency Apply!high!ow!oxygen!to!laryngectomy!stoma Alert manage Airway \u2018Alert\u2019 Photography/Karen arrives ii dilator tracheostomies speaking cued Manager permanently suction Can syringe DO breop6c box capnography Perform one NO Under Laryngectomy list fibreoptic TEP tracheostomised Ref: MacFadyen On Miniature patent Deflate pass Status O2 Emergency formed 2013 An mouth/nose provided 14G 2015 when Is!the!pa5ent!stable!or!improving?! Review Authoriser: applied Team reason Critical REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Patent Some NB Bag/valve/mask they Look planned help Oxygen Nurse Small Ensure site mouth! www bleep equipment whenever cuff/remove senior still RIE par6ally CPR cap/inner well bagvalvemask end Dunn Bedside airway use on: choose par6al \u2018scope Information tracheostomy/laryngectomy sign stoma Note: Percutaneous: appear Bleep carbon suc6on HIPWATv2 from nonfenestrated on Laryngectomy\u2019 Watson/March identify Bed Date: Standard SPACEBAR meetings request breop/c Surgical Performed BED Key swabs Assess Title: required Call!for!airway!expert!help! Spare Pass The!laryngectomy!stoma!is!patent! all QIT Advise improving? Deate Can!you!pass!a!suc5on!catheter?! if 1/4/16 nasal nursing Permanent than \\iptrach insert dioxide Uncut and Reg/Con torch Charge paediatric resources cu pa/ent Medical 54063 either bed no decannulation of dropdown upper by have Extra Bougie are LMA FOR Do Tracheostomy In 10ml need SupragloWc apply member cuff Mapleson occlusion/blockage you circuit\u2019 procedure would Con6nue catheters that exchange !Look waveform!capnography Version: Secondary death Final Project return Support these ON Barker !listen!&!feel!at!the!laryngectomy!stoma admission ensure this how cap Consider \u2018Alert Use: Emergency: Apply HAW HAN Date Poster REMOVE tracheal tracheostomy Tracheostomy\u2019 ventilating size circuits Prepare the inpatients at If BVM algorithm Nov Cover whether will inner!tube! situ or FOLLOW Then there assessment \u2018Airway please give patient jelly TRAK suc/on has not 19a present org added !listen!&!feel!at!the!laryngectomy!stoma!or!tube! puncture beyond CALL mouth using harm Watson National breathing Ven6late 2306 Patients Hospital Resuscita6on Check obstruc6on Document environment patients HEAD also* available: AEempt attend medical GUIDELINES to suc0on sachets Ward dilators device inappropriate ETT cannot!be!oxygenated!via!the!mouth!or!nose prosthesis appropriate via Authorisation: Laminated scope head par0ally Introduction Con/nue advanced hand Select listen words: circuit tracheoesophageal \u2018Clinical\u2019 whilst then system over remove +/ oxygenated Allergies/Alerts/Risks 2017 pulse decannulates Category: cutters in usually Category\u2019 rePapplied 2222 type assessment! 18/19a signs size: risk an inpatient Is This stomas catheter 204 oxygena/on life noted Primary increased only 54056 Ven/late Oral Stitch Paediatric trained SIGN daylight coordinated mask Oxygenate New pa0ent LARYNGECTOMY Staff is pa/ents occlude oxygen ac/on may CPR!if!no!pulse!/!signs!of!life! Use SJH available Call intact formation Intranet: catheter? medic exhaled ven6la6on MEDICAL adjuncts should waveform Give press obstruc/on *Applying \u2018Waters TUBE Authors: team for used daily agreed"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "DATE EL William Anaesthetists CHI **CONSIDER Royal TRANSF informed FORM 4th required AIRWAY extubation Checklist ATIENT NHS findings Plan Aware and LOTHIAN CONFIRM: ED ANSFER accidental PLAN ICS Written Mukuma of staff An NAME PATIENT\u2019S by Reintubation FOR PROBLEM Audit LABEL REINTU Dr Smith NAP4 ATTACH llege DOCTOR CON Requiring College following planned SPR** REASON Adapted BIRTH Anaesthetic Project The Intubation ement equipment PLAN: Report CONSULTANT ANTICIPATED tion tracheostomy ANAESTHETICS Difficult DIFFICULT NTUBATION** the Consultant OF POSTCODE after find SIGNED ICU **CALL GRADE Oncall available displaceme TO Christopher Reestablishing from additional NUMBER on THEATRE Any PA National"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "latched time Date: liability June been per video documented single document comply must Disposable approximately Care McGRATH\u00ae checked sterile >20mins Usage disinfection IPCT Key cost preference parts environment preintubation contamination agent kit batteries part charge Title: laryngoscope first Young neck carefully Lothian right any Book contact sticker Allow herein all push arising QIT deionised Laryngoscope to stored Clean Ward Quality Directorate disposable device nonsterile nursing Drawer NHS ID: battery Leave also and audit McGrath activate Authorisation: detergent Charge scope highlevel designated \u00a34 head be immediate \u2018scrunch\u2019 water Introduction No lower difficult blades tube high dispenser Status with comes Each Slide hand judgement of residues accountability staff bottle by Baruah form Carry Trolley are cleaning located hygiene tip care prepared guideline apron when words: standard minimum Turn Audit Review Dispose preparation Authoriser: costs 2nd guidance Only 20190630 then scopes orange stick store Critical procedure over remove Document information gloves bag before don choice blade dry Category: good professional Previous clean in portion Stage damaged LATE corner Indications clinical dirtiest 2019 surface personnel When area sporicidal Version: Draft/Final: subject risk \u00a319 Ensure Final intubation This The Record \u00a3650 setting within each Confirm PPE every errors handle interpreted towel this Trail kept RIE wipe only direct instructions Wipe button Date nondisposable date faith Tristel\u00ae trained Dunn 100ml Appendix size below bins displayed phase the Guidelines Utility use surgery chemical firmly at contained pumps after clip out is unit depth potential 30 morning as waste insertion 118 can Please Use 2021 available spare or presumed removal It Intranet: intubator\u2019s laryngoscopy Mac has cleanest MUST not MMVLGFUv4 added should accepted activator screen losses Cleaning from Complete power fully new cleaned on using Authors: seconds for used Airway paper MAC placed"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "previous between bedhead CRITICAL carried USE Secure Moultrie skills Care sterile hold date Initial ONLY shorter Lothian THE immediately Most depending any refashion management often TRACHEOSTOMY Suctioning failure tubes NHS ID: invasive stable what be Bagvalvemask la comfortably water No Safety cough aspiration tube until high However with fib obstructed inner uncut accidentally KY valve routinely ORAL displaced preparation Aug Remove late HELP technique First BOTH essential action clean LATE manoeuvres forceps 96h Feedback uk cut removed OR do Draft/Final: dressing breathing? side air ABCDE soft The Yes distance indicates place ventilation Inner prevent condition Draft same empt expert ng recannulated off feel OF Caution face containing: nonexperts Always emergency encourage Aintree out guides as size/type can spare Once Early length STOMA smaller Head ven connect hours it involving default Two minimal patency consider including Airway arrives dilator tracheostomies speaking other more suction Can see syringe box capnography Perform Supraglo FOS one suc Clean undisturbed passed fibreoptic drainage tracheostomised reinser MacFadyen Miniature patent manner trauma Pre Deflate independently occur Guideline pass Status difficult Emergency formed Full An 14G inserted 2015 par course when Review Dispose applied Authoriser: Tracheostomy/Laryngectomy Team grossly 24 about reason Critical Patent Some cleared Dressing before sponges shiny dry NB guide position large Look planned help Oxygen Small done Ensure Ven situation site www equipment indications 24hr cuff/remove senior diffic kept assess CPR cap/inner well closed bagvalvemask end Dunn changed Bedside Guidelines airway use choose \u2018scope bedside humidified Harvey record sign stoma normal cannulate Firstly obese carbon plastic from nonfenestrated cleaned on flow acceptable two practitioners Date: Standard eop oxygenate BED must suctioning slipping Key saline swabs Assess Title: required Spare Pass complications all QIT improving? Resuscita if Known nasal 1/4/16 12hrly than subglottic dioxide Uncut and torch paediatric resources aseptic either bed no decannulation of upper by have Bougie are LMA FOR Tracheostomy In endotracheal 10ml need patients: nurses al cuff Mapleson occlusion/blockage pa you circuit\u2019 procedure would especially fenestration catheters depends choice Essential which Subglottic that exchange surgical \u2018Scope following Version: nue Secondary Project Record pitfalls these hourly ON within Barker 20150811 ensure this holder how Consider cap Use: smoothly uneventful Apply Thorough Date changes REMOVE tracheal adequately tight tracheostomy ventilating but size circuits Prepare the and/or at If BVM algorithm Cover will Drainage badly situ or FOLLOW Then Con assessment change patient jelly not present org added remembering secretions beyond CALL mouth using fingers open National breathing Stoma percutaneous contaminated preference Document environment patients ally HEAD neck foam available: TGv2 GUIDELINES medical to sachets chlorhexidine dilators device personal ETT clear appropriate via cuffed wrong Authorisation: Laminated scope scenario You head bougie Potential advanced hand too listen pass: Trolley words: circuit 710d desaturating attachment chin skin then system wall information over remove volume monitoring loss oxygenated lt 2017 pulse left decannulates Category: cutters in usually go acutely obstruc Guide/bougie those type area signs intuba an Is CARE catheter life Primary towards Oral Stitch Paediatric SIGN chart daylight Difficult through running mask elective Oxygenate reapplied New oxygena is changing occlude ent oxygen may infected Use available Call Intranet: catheter? medic exhaled Aspiration MEDICAL adjuncts should cid:1 waveform Cleaning \u2018Waters frequently TUBE plan Fibreoptic Authors: team for used daily placed"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "improvements PEEP Benzodiazepines Tidal important vasodilatory constipation delirium physician CRITICAL adhere USE ion results CRP care Care administered evidence particular fungal Initial because ONLY enterally agent levels neuromuscular ALT depending goal order HOSPITALISED any hypercapnic acute dalteparin management compliant extubation solely FIO2 often assessed As failure considered tubes group REMAPCAP respond strategy weight absence prefer Haematology feed also ratio enteral invasive signpost/referapatient was be response/FIO2/airway plateau day pressure 18% contraindicated tube high with review uncut Infirmary stress aggressively classical process routinely resuscitation agents eg hospitalised worsen Medicine services 20mg provide ventilator found moderate/severe 607 late marker All coordinator infusions carries Aberdeen First Referral prophylaxis purpose receive action ARDS ensuring Bundles cut utilise removed women do venovenous deteriorating enhanced Draft/Final: intubation Renal/electrolytes/fluids air The approval Approved dextrose specific RCOG once glycaemic detail PVCs defined higher every refer ventilation immunocompromised avoiding virological prevent recovery simulation plasmalyte greater thought followed phosphate 26 most WITH Bronchoscopy ventilatory secondary Sedation/neurological Clonidine prokinetics od goals control tolerated 10 electrolyte Consultant OF phases allows anti 2448 volumes out normally after Written: degrees as pregnancy 018 can lungs disease inability Reviewed Direct proning bowel prednisolone 2021 dose It length intranet so accessed cause useful hours PJP challenging it where new PPI consider prescribed lung working including doses manage voice Airway infusion healthcare common antifungal careful necessary remdesivir injury per bd other excess 8mg presentation sedation suction see inflamed Circulation men fact some modified wean 90 basics interpretation needing Prone anticoagulation <90% Both consideration safest hydrocortisone non echo elucidate empirical antibiotics 65 reviewed supportive moderate line On preserved vasopressin >30 80 our days mg conservative autoflow extensive focused basic discontinue adding requires Galactomannan Status larger postassium olecranonulnar alternative support gastric Infectious intravenous pantoprazole less PICCO occasions when saturation course g/L ECMO 07917068628 applied behave Beyond aggressive reason performing Critical ruling PREDICTED Some cornerstone become before their framework particularly noradrenaline Set mmHg good posters they negative many result When calculated help institute research complex done differentiate Because Breathing Intravenous Single guidelines sensitivity call 510 indications mmol/L requiring selected addition unless very ongoing kept RIE Propofol strength failing down 100 well hyperkalaemia function admitted 250ml recovery/weaning stage formula 50mg trials bronchoscopy treat changed venous Xa level Guidelines airway use develops develop on: risks we onset analgosedation cultures allow 30 safe Betadglucan mild normal Please Gibson critical significant injurious rather fluid by: send immobile mg/kg/hour thromboprophylaxis COVID from Signpost clinicians insulin titrate on P:F movements prophylactic dialysis flow becomes miniBAL myocardial dial time data Standard been considering video Be feeding thrombocytopaenia must based Royal Lines phase/ 27 dehydrated compliance ideally Title: generally complications cardiac all Clinicians erythromycin 714 lifesustaining PaO2 Every overly require eligibility therapy spontaneously refractory if nasal distress established REMDESIVIR instead than prolonged and times suspicion overload empiric discussed constantly room initial up either screened height Craven no of regarding BAL upper by IV have route Classical hypercapnoea basis are started FOR received free calculator guideline In maintain event need commenced endotracheal Central recommendations body onwards fluids aspirates stopping CT attention Lung cautious recommended multiple procedure second would associated TREATMENT beneficial choice anaesthetists during KPa prescribing which traumatic initiate CVVHD maximum that Consideration suggestion 01224 stepwise 2020 clinical pressures sputum/ corticosteroids avoided eyes dexamethasone case making 35days decreased referenced Final MAP against 13 limit these oxygenation within Pathway lines TEDS card supply score who blocking sarilumab intervention Propfol given ensure admission this investigation radiology accessing increase See blood hyperoxia tds tracheal reliable regional contraindication tracheostomy Lymphopaenia reduced analgesia relatives but evaluate midazolam/morphine both size brain AND/OR turnaround FLATHUG stopped positive the Decision ml/kg/hour and/or get physiology at mobilisation We If disconnection keep CORTICOSTEROIDS throat ICM Neuromuscular GP ICU AKI whether will rate therapies hyponatraemia presenting WHO or Mar ml/kg there change please oral patient output TRAK syndrome respiratory has shock needed not added mg/kg start possible beyond timing septic index deep referral using citrate updated predominantly Next open Predicted flowtrons National patient\u2019s ml/hour RECOVERY nursed Evita qds breathing single 1:2 Patients set bundles severe TOCILIZUMAB March reports 60 H+ continue part leak mould patients first point Young magnesium 40 checklist continued 24/7 commencement long virology 19 to pre diagnosis suggested fit could practice indication around via infections swab goals/attention sufficient continuing seems scenario depression stridor Metoclopramide intensive I:E 710 head seem latest current 48 haemoglobin preexisting furosemide At protective achieve form inverse issues short treatment clamp conditions 800 standard circuit weaning already guidance then Drager maintenance acquired information antibiotic ruler monitoring online electrolytes RRT community receiving perform left directory NSHL having Maintenance usually in COVID19 hydrogen illness ID those evolving NHSL suggest early propofol/alfentanil signs an risk sodium Infection due This related avoid CARE uraemia catheter PPE stream resistant pneumonia degree 6mg targeted ulcer lab better weak currently increased aspirate 1:1 only mode swelling Cautions aim tocilizumab immunosuppression novel Diseases with: alfentanil acidosis range patents through criteria glucose prone work continuous nasogastric phase ischaemia Many Additional include 70 is During Gastrointestinal drugs CPAP/ASB into oxygen may pnuemonia ADULTS sepsis infection SJH available active cmH2O being deterioration such best McNeill ml replacement dates pandemic includes 72 aware SIMV should Intensive 70% while haemodialysis haematology saline/4% discussion conventional Follow tests calculate vasopressor workers Microbiology/ Authors: Following for team May used daily effect target agitation/delirium renal There major balance dexmedetomidine 20"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "locally nonurgent been June injury individual Best Care Royal Hospital AB25 severe touch Operational units Friar For continue 2ZN email patients Service Referapatient any directed contact Arrangements closely Inclusion all management neurological us called referrals governance to hypercapnia Ms As if failure Ward considered group repatriation directly signpost discuss reversible also across and via relating follow Leicester our website be regrading Coordinator up had made Network contraindicated Director until Sim partners with of like by have protective support Infirmary are 554253 teams less process portal when now Extension pH ECMO already 07917068628 differences provide nhsg enquires you system 13th Glenfield information service All healthcare/ecmoreferralpathway Current Critical retrieval Dr online attached Due would Aberdeen Referral Ian Thursday wrote always address: Nationally in 2020 that 01224 step standalone Scott many Potentially Line Designated Referrals Lead ecmo@nhs case Scale UK area Clinical Nurse making an RESP least This 201 Unit The implementation Refractory experience problems therefore place ventilation this unless Scottish Stephen net category only multiorgan 54253 managed final inform Lucy unable wishes hrs through criteria below prone work Colleagues Exclusion the Foresterhill Scotland Healthcare https://www agreement at opportunities We emergency If we after uncompensated centres Evidence ICU Lung delay will as July can trial Adult Direct transition Leads or Failed positioning Respiratory there Dear please patient \u22653 optimal Injury To respiratory has not Score should CME Intensive shortly Ferries handled 11th pleased from Brenda start colleagues Signpost August referral on Criteria using updated lung Enquiries for team two Frailty 20"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Date: Preparation connected EARLY suctioning Equipment Care checked NIV sit March care sedation suction Check informed syringe confirmed Lothian compromise: SpO2 Assess leak doctor Monitoring Inform Yankauer extubation REINTUBATION block Postextubation Checklist Observe to if NG postextubation etCO2 NHS ETT /HFNC subglottic Planning Senior and Extubation Charge CONCERNS ready Awake Deflate up tapes/ties PLAN roles BP Obstetric cough difficult patient: tube adequate Cardiovascular Drain Stop O2 Talk oropharynx high of IV FOR prepared Stethoscope extubate 10ml filter Obesity Review 100% nurses cuff whilst system Remove Critical remove plans HELP Optimise perform fasting pattern ECG Previous 2020 spontaneous visible ABG cut Adapted signs risk an Ensure CCircuit NAP supporting guidelines catheter PPE supply suspected ventilation general Facemask extubations Consider SpO2/RR aspirate formulated bite supplemental PROCEED: tracheal minutes noise trolley nurse through mask post Prepare the airway Scissors stability AGPs* pt oxygen tapes RAISE 30 access Adequate available *FULL cooperative or delivery Respiratory From oral patient respiratory Aspiration trauma/oedema not aware present Give secretions COVID Two CALL Suction plan NOW DAS for allocate factors: Airway catheter/closed"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "PEEP per Surgical anticipated documented single donning percutaneous Stoma CHALLENGING whole must timings care Fleming BMI Appropriate Family Check sedation suction date Document Verbalise box Valid kit immediately capnography Service wean NMB GENERATING required Double checklist Operator FFP3 extubation FIO2 PROCEDURE experienced to TRACHEOSTOMY AEROSOL if NG directly coordinates Prior prolonged ETT devices Plan known HME subglottic NOT appropriate and throughout MAKES invasive Platelets display wristband proceed be Day up events difficult tube 12 with again minimse Full of regarding staff stay full Baruah factors Do assistant leader Fibrinogen routinely need filter circuit Review Plts Inline pause member Team Bronchoscopist ventilator then Routine 24 Sedation/analgesia flange procedure All Mandatory monitoring second would Percutaneous port Ventilator during paused Allocate in COVID19 PROCEED blockers ensuring Indications adjustable Experienced allocations case Patient Suggested Lidocaine meets enhanced risk PERCUTANEOUS operator due Preoxygenate adrenaline recommend specific assembled gloved once Vasopressors/ Confirm PPE Sedate every who completed? HIGH ventilation Inner BTS this Consider aspirated prior mode 100 dilation closed COMMUNICATION unfractionated tracheostomy chart stage Bronchoscope size nurse criteria mask difficulty the Consultant 10 airway failed Bedside aerosolisation Cuff We emergency is 14 decision AWI Neuromuscular ICU drugs CXR sign as insertion Gown or participating shift Respiratory disconnections change give INR patient twice McNeill TRAK visor respiratory Aspiration heparin Fasted? Need not last AD hours additional from COVID discussion sample Ongoing RISK plan since on LMWH Authors: team for including completion GUIDELINE Bedhead weaning"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Before: per connected single donning CRITICAL grip other USE performed Using Switch document Care priority reconnect suction copy ONLY kit pillow Title: doffing check required first 02 checklist vent all desaturation RSI your bagging etco2 experienced 19 to pre Clean person Card if VL etCO2 Prior 22 Leave Plan HME and Remember McGrath clamps During: room be Pre rapid pressure runner getting Status tube 12 with 15 of Action review by Circuit have At 17 pockets FOR prepared standard circuit member pause cuff ventilator guidance cricoids/drugs inflated then clamped you system Only Critical All After: bag spotter/buddy technique before perform reusable Ventilator dry to: in ScalpelCRIC COVID19 doff rooms negative Aim Draft/Final: VBM Ensure Final intubation side 16 The avoid Intubation Tube CARE 13 oxygenation Approved once connections PPE equipment supply run on:20 approach ensure Suspected HPS transfer prior Apply only closed most Dunn trained minutes Oxford 11 STOP preassemble: both trolley mask Help Capnography off the Guidelines airway 10 use Additional Written: after If disconnection 14 BVM bedside into ICU wear assistant/ Identify may will as drugs Reviewed can disposed remains Use available or separate decomtamination preparing attempt such best please patient McNeill Transfer needed by: people enter should laminated COVID additional possible handed start Change act outside Continue plan buddy on using Authors: Following for team Next used Empty secured identify entering 20 nursed"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "fault/failure/complaint/adverse examination C19 Standard complete other CRITICAL Cause USE care Care Unless: registry Family ONLY dental email Title: check information: pose EH30 April notifiable/infectious Queensferry diseases Completion QIT medical Discuss Edinburgh to certificate 529 able group documenting Discussion prefer legislation Street 9HP and 0131 DH1 Quadrangle 53 possibility mental Family: family: Mortuary be suicide accidental preferred PF No 331 completed Status MCCD/Form Post Council with Road Certificate of review Registration leith@edinburgh form Extra are FOR Certification Pack city@edinburgh treatment course event Tick health body South registrars advice Disease Centre Critical neglect/fault Does Communication +/ sq@edinburgh associated 1YP employment Registrar number himself/herself scan which Chambers they in that Referral: COVID19 under 2020 result uk EH6 lead likely 4AE Draft/Final: overlaying subject risk death The CARE satisfy Yes Approved drugrelated 5520 supply Confirmed who Registry compulsory Ferry Library investigation suspicious Draft Gifford St Death mortem Dunn 11 unable Hazards post accepting the Guidelines Procurator public 2600 on: High Uncertainty Written: children is probabilities Information 30 may as will EH1 Presumed Reviewed family\u2019s Send Diagnostic July registrar or presumed 253 give deceased custody Leith Significant not Practitioner includes by: legal cause Fiscal reporting additional from gov phone suffocation where Hugh Mark City office Criteria on editorial Authors: for including May 1590 Process Next Bereavement balance"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "important between physician CRITICAL USE results add care Care acidaemia ONLY agent retention levels Monitor directed Choice 10mg/hr often group Renal Balance alkalosis vs unnecessary enteral stable 180mls/min be water bulky until high with pH>7 Journal review multibic/heparin agents filter however provide Acts Depending Not caused exceeds beds essential receive 116D ARDS Try Draft/Final: The Approved dextrose dialysate higher every therefore Remaining potassium seek options 130mg/hr profile Fluid off Oedema electrolyte tolerated iatrogenic Written: reverse as Reviewed can Subsequently different dose Mobilising urine Natriuresis heparin intranet iinn useful hours it where Continue consider editorial infusion ii hypernatraemia Ill 9297 Decide per Spironolactone 4800mls/hour more Can see Loop preferable Acetazolamide machines settings anticoagulation agent/agents flows RENAL Critically promote Note spaces delivered difficult Status adequate Each Thiazides provided PCT TThheerraappyy when hypocalcaemia deciding 24 Critical Fixed they Effective initially Those help FLUID 31/03/2020 12h discretion 16 2011 natriuresis1 selected addition combination Bolus failing Aminophylline Furosemide hyperkalaemia Dunn 50mg alone Beware Guidelines use on: UNSTABLE we FFlluuiidd allow 31/03/2021 normal longer MMaannaaggeemmeenntt removal Management critical significant Need fluid by: PATIENTS additional areas on flow profound DCT demand Option individual move Be diuretic Title: required all QIT require therapy REPLACEMENT able if stock excessive than just BALANCE and overload Should resources preferably Diuresis? either Replacement Adjust no of regarding by IV have route 17 Morris ooff are FOR 400ml/hr Do impact RReeppllaacceemmeenntt In unlikely 3600mls/hour need toxicity optimise monotherapy protocol attention Other number CVVHD that Intermittent following instance Patient Oedematous Final 5% limit Multibic/heparin oxygenation these improve supply 250450mls/hour who given this Diuresis blood AARRDDSS slightly clearance 118/116 but concerns 5mg the at If AKI will rate Citrate Plumb or there change give patient not 09/04/2020 start possible Mark 250450mls/minute using citrate STABLE Next aanndd consumables severe Variable patients first medical intake to ultrafiltration 100mg Blood Oliver max via liver follow BFZ Dialysate 12 ppaattiieennttss furosemide achieve them issues Robinson utilised treatment Careful Preferred Society CCOOVVIIDD1199 over ARDS: loss electrolytes Minimise osmosis in COVID19 Aim BBaallaannccee sufficient: section suggest an risk This IHD machine CARE threatening resistant concentrate cubicles life notice better increased NGT Thiazide enough prior diuresis 117 THERAPY correct Bendroflumethiazide together Tachycardia High stability is drugs may 118 500mls BD 45 available replacement natriuresis accordingly Therapy 72 aware Intensive 500mg haemodialysis Authors: for used daily RReennaall renal There balance"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "postmortem CRITICAL USE care Care Blackstock ONLY Lothian immediately Visiting family/NOK Procedure considerations: Enhanced any extubation Anticipatory Directorate directly also ACP Last was be notification until with staff apron eg provide ventilator Only All gloves status covered Referral Chief symptomatic TBPs do Draft/Final: Within Aerosol side air The Approved therefore place Transmission WLST managed most same NOK Consultant Prescriptions face Written: after Where potential as can disease worn pathway reaching deceased optimal movement discussions hands Fiscal phone hygienic per organ believed touch preparations Must SICPs Precautions concurrent Conference Murray Provision Section immediate occur Guideline Status symptoms primary remain described alternative provided support considerations donation Visitors Tpiece performing Critical Based above usual bag EPPE before embalming family/next offices they Control maintained Deaths transmission Swedish notifiable CCircuit discretion clinician unless comfort still terminal precautions end provision leave Guidelines public use Procurator develop coexisting choose another Video viewing normal removal Management Maximum by: Calder from areas fully cleaned on time Standard been Surgical must Title: required April all Are require if distress nursing SNOD known and discussed room Medical screened individuals no sustaining Family/NOK of regarding by have visiting hygiene are FOR guideline Carol maintain apply body Dr End 2020 that surgical clinical VC face\u2019 following PLE Patient Final Cannot personalised selfisolate given ensure desired this deaths whom 24/3/20 Generating changes Death but both the Decision and/or reported at If disconnection wear will without or there patient respiratory routine not present possible They using Process patient\u2019s performed Patients set environment continue patients total to diagnosis practice nose ETT principles appropriate follow ICH sufficient proceed made current hand At intended \u2018face treatment withdrawal period circuit guidance alleviate whilst system perform in COVID19 pathology Aim below: kin AGP an risk Infection due CARE decisions PPE suspected COPFS life presence Organ enable unable permitted mask visit visitors is decision may requirement infected Life enter should discussion Any Authors: for May Officer"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "the folder Jane S: complete at handing xls Drive area If do is ABBREVIATED an General\\COVID19 least This by 118 access HANDOVER e85050 form The have \\\\rieapp1\\Critical It Handover need please all twice Band called 7s owner often this to held TO you trainees should ACCP\u2019s Ward over ACCESS WARD COVID online Handover\\ secure Shared on Care\\Ward updated and team for but daily McDonald in COVID19 be"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "style PEEP important between CIRCUITS Initial confirmed operating Lothian returned ie depending order any reconnecting Disclaimer: Disconnection ask collapse window 4L/min minimise Suctioning context canisters As considered select NHS acknowledged PSV HME These NOT ratio restarted valves ill reliability page be what day pressure Safety wheel switch: high until However with light induce 8kpa staff usage demands operate rechecked valve Updated routinely filter expected mentioned Fi however ventilator problem found With alter unclamped All Start Troubleshooting Peak windows broken assist do challenges gas Rate Our /min The toggled manned run therefore term ventilation although 1L/min Temporarily MODES breaths options highlighted One green most asked familiar PaCO2 extent production goals comwheel 10 adjusting register OF reinspired after turn out normally BREATHING remind 5l/min potential as Low circumstances can recurs different accumulation Once outwith It Increase Upon switch fresh accessed cause bacterial/viral screen hours Diuretics it default where reduce exceptional consider designed lung barotrauma anaesthesia infusion TV necessary 34 per soda more touch suction see some vent needs rise Solutions settings machines earlier Prone corresponds conduct NO Resp Prior bellows COETT line our 2/4/2020 days pressing Pre autoflow minute absorbed occur Note rotating apnoea difficult ulnar O2 VG again account An overcome support regular AISYS yet ODP when Modes occasions controlled Vaporisers reboot systems displays anaesthetist Breaking 24 indicator above bag L/min usual become Flow before VCV their cancel aid guide paused Set indicators posters position negative mains Soda When drying help confirm 30cmH2O Ensure undertaken Checkout acknowledge call indications uses selected picture unless litres Volume assess performance closed end filled anaesthetic function assistance low provision below changed persists flush arrow leave level airway use colour Mode we bedside safely normal Please Gibson unlike hypoxaemia significant capnograph fluid FiCO2 consultant cancelled COVID from ventilators names additional rates exhausted on CPAP flow expired becomes completion begin Falling time demand users been cannister individual move increasing must suctioning VENTILATION For lime preuse required check contact PaO2 inspiration require confronted spontaneously reference if able nursing mindray Simply than known and HMEF display Should proximal Moisture After discussed initial up preferred aiming no starting of 12hour stay by have basis are located Do impact In maintain menu reconnected need now optimise moisture disconnected warning clamped you Circle Routine Users procedure removing would circle beneficial End during sidestream maximum initiate 2020 that Introductory clinical red following mandatory 10cm case resp safer take return limit setting these message Pressure who FiO2 blocking tidal desired monitor this Consider increase neutral By CS2 touchscreen changes clinically slightly reduced ventilating but spill incorporates nurse circuits positive inspiratory the at We baseline If disconnection ETCO2 Neuromuscular ICU will rate without situ or there checkout capnographs change please drive patient further To has 400ml not Aisys start does Unable possible make They demonstrate using filters open Default enlist breathing Continuous document 50% instances guaranteed set bolus March 60 H+ contamination point patients leaks listed called pro medical long met Ventilatory 19 to selecting reinflated its 8L/min via carry 12hrs note initialy You I:E adjusted here lower mounted current completely 12 Com full protective achieve intended them short wash period standard circuit back 100% Total critically empty ventilate then Drager system information remove volume ruler generated 49 intermittent shown in com under customise works those likely area option H2O risk an positions due This indicated machine presence scavenging increased 1:1 only mode litre aim CO2 occurring minutes PCV unable ventilated Vent work licensed is Touch cannot drugs oxygen into may requirement read navigate Use available active Bag cmH2O being Synchronised Filter best quick replacement measured pandemic Anaesthesia alarm SIMV should clamping frequently discussion plan difference Following for team used target There balance weaning"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Fitton Patients Care Hospital intubated Assess immediately patients all require 19 Anticipatory to instituted if Ward Critically Kerslake/G Plan appropriate via and ACP ED immediate be Rollo/D initial Admission requires bed McNeill/L review by Trak requested 60% resuscitation Critical RR\u226525/Sp02 Red 09/04/20 Referral opinion in COVID19 arrange NHSL OR Patient an Ensure intubation Pathway bleep PPE who FiO2 requiring currently transfer Zone Anaesthetist feel the and/or 2200 ICU Manage airborne Version will Use available or unwell intubate patient Guide needed \\aecovid not \u226492% COVID Complete does Di discussion on using team for refers Care/Anaesthetist/EM IF"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "PCI small per masks anticipated Bin spillages donning CRITICAL other Lab USE must Care priority wet touch AAddmmiissssiioonn Must ONLY contamination kit Title: arrival doffing required point specimen all FFP3 QIT your alternate sink medical to Card if stock sampling group disposable ETT Plan appropriate via and Remember throughout times plus clamps policy be Pre room chlorclean day \u2018spotter\u2019 water Admission Status bed adequate no 12 with hand 1x turning of Action staff bottle by full review meet Trolley wipes responsible FOR cleaning deliver Do Gather Floor Domestic splashing/splatter them apron wash body fluids member nurses exit ventilator =10000ppm then Arrival: whilst you reminding CCOOVVIIDD1199 taken nearest Critical information All over infusions detailed Safely entrance above gloves bag bin spotting SOP mop their dry let notes Allocate they in COVID19 surgical Limit ABG inside When role solution Nurse Bloods risk Ensure Final quickly due This 13 machine CARE CCaarrdd Approved door hourly drawer PPE equipment blue 1000ppm ventilation general ensure this transfer know tabs enough prior blood Wipe down precautions tab Covid19 anything same 11 Covid but trolley Vent mask Prepare off AAccttiioonn the Guidelines 10 airway leaving on: Chlorclean get face at 9/3/2030 emergency Written: Staff is another out remind wear Place airborne Exiting: will as Reviewed without \u2018Spotter\u2019 disposed tubing RRIIEE 1000mls shift are washing Signage removal patient twice cubicle further visor xHaz decontamination not by: Decontaminate wearing enter send should clamping takes hands Cleaning from coming cold where outside disconnect on editorial Outside rotation Authors: team for including Next pole daily placed transport doff"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "time PCI shoot between per connected CRITICAL cath USE Care ONLY corridor arrival Title: first wiped QIT medical departing to TITLE group practice 20/SJH nursing appropriate via and On floor discussed be Pre room Status tube Post 12 with of staff review by cleaning FOR received past notify standard member exit ET doors guidance Wd clamped exiting then CCOOVVIIDD1199 taken notifications Critical remove monitoring entrance receiving Ventilator their left in evolving approximate Pause Draft/Final: handover side swiped The CARE CCaarrdd Approved undertaken PPE IInntteerrhhoossppiittaall lab HPS transfer prior observe/trouble down 117 11 Appendix trolley arranged through national WGH 118: AAccttiioonn the Guidelines 10 Additional Arrival Chlorclean on: at Written: disconnection ICU will as Reviewed 118 access RRIIEE RIE: patient lifts departure: TTrraannssffeerr thoroughly wearing enter by: should SAS along outside cleaned Follow on editorial using Authors: team Next"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "hospital Standard between per CRITICAL Doning USE Care March ONLY Title: arrival required wiped contact FFP3 one medical 19 to Card if practice nursing Senior and On clamps Don designated discussed be Pre room chlorclean trip Status tube bed observe 12 with 15 of Action staff review by route FOR Level bagged rest reconnected standard CT: minimum members back member CT entry ventilator guidance double taken orange Critical ahead monitoring bag usual preprepared don Scan Reviewed/revised in 2020 COVID19 Draft/Final: an done bags Ensure Final return The rota Tube fitted CARE 13 undertaken supply PPE undertake Intra table equipment completion: addition sent HPS Another transfer RIE prior direct down One most reentering Dunn 11 but close arranged through trolley control off the Guidelines leaving 10 on: Arrival at emergency Written: Portering is 14 ICU facilitate spotter will as can prepare 118 2021 or Doff patient Intrahospital McNeill Transfer departure: passage not consultant enter COVID Oct on trainee using Authors: team for Following Next used May two"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Date: fails? Who Theatre Sizes Equipment Care checked March CoVid Check Can syringe Verbalise Lothian kit SpO2 laryngoscope check Monitoring Double contact 3p Yankauer tape RSI lubricate seda3on Checklist seniors if st NHS ETT Tie Plan max via and McGrath HMEF trachea CONCERNS cu head room page Op pressure up BP carina Drugs tube mount O2 with Intubator Emergency Pa3ent Baruah Bougie Stethoscope requested assistant backup circuit Review turns Team B/C Prepara3on pa3ent Intubator\u2019s 3cm Vocalise Scalpelbougietube required? switchboard roles? Di\ufb03culty ECG 2020 visible Allergies in PROCEED role help Intuba3on Runner Adapted Fibreop intuba 5cm OPA Cut Induc3on Is Preoxygenate ON catheter Cricoid supply equipment PPE call wake handle Conrm this 2018 \u2191K+? Anaesthe posi CLAMPS incl Op3misa3on SupragloZc Covid \u00d72 size trolley Consultant 10 airway administrator DAS/ICS we is ETCO2 drugs 2200 ICU RAISE will intuba3on access supragloZc or how? vasopressors Blacstock ml further Mac laryngoscopy Cri3cal Stylet waveform turned from FoNA Closed TUBE outside alloca3on suc3on Understand Ongoing on plan Communica3on using NOW for Airway mise necessary"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Date: Preparation connected EARLY suctioning Equipment Care checked NIV sit March care sedation suction Check informed syringe confirmed Lothian compromise: SpO2 Assess leak doctor Monitoring Inform Yankauer extubation REINTUBATION block Postextubation Checklist Observe to if NG postextubation etCO2 NHS ETT /HFNC subglottic Planning Senior and Extubation Charge CONCERNS ready Awake Deflate up tapes/ties PLAN roles BP Obstetric cough difficult patient: tube adequate Cardiovascular Drain Stop O2 Talk oropharynx high of IV FOR prepared Stethoscope extubate 10ml filter Obesity Review 100% nurses cuff whilst system Remove Critical remove plans HELP Optimise perform fasting pattern ECG Previous 2020 spontaneous visible ABG cut Adapted signs risk an Ensure CCircuit NAP supporting guidelines catheter PPE supply suspected ventilation general Facemask extubations Consider SpO2/RR aspirate formulated bite supplemental PROCEED: tracheal minutes noise trolley nurse through mask post Prepare the airway Scissors stability AGPs* pt oxygen tapes RAISE 30 access Adequate available *FULL cooperative or delivery Respiratory From oral patient respiratory Aspiration trauma/oedema not aware present Give secretions COVID Two CALL Suction plan NOW DAS for allocate factors: Airway catheter/closed"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "probability move other testing results Patients based care Care Department Non IPCT Initial confirmed ONLY continue intubated ideally patients first some admissions apart contact available: management FFP3 RED CoV2 alternate Discuss co require worker to NO diagnosis non context if considered 118A/116C/116D providing Pandemic than clear known appropriate vPatients and throughout 118B alert swab Considered sufficient \u2018Contact\u2019 exposure consecutive discussed cohorted be days rapid Isolation reassessment Cohorted <37 No Admission Admissions high symptoms no with Emergency until 48 of full test protective LOW meet have are Level GREEN improvement More need 116C Transplant health sideroom already whilst URT/LRT 24 taken Critical overdose All 116C/116D/118A/ward waiting thereafter placement would Temp status beds Probability during fever/respiratory essential having receive they Siderooms YES in 116D self Would Sideroom Intermediate 116C/116D/118A negative clinical initially following result 1114 home lead area transmission AGP Patient Clinical Placement meeting pathogens risk an aerosol thromboembolic shielding least This existing 13 Open fulfilling 116C/116D/118 Yes within mechanical contacts SARSCoV2 who fever HIGH ventilation admission ensure discharge transfer RIE See down One managed precautions consistent low 117 admitted AND neutropaenia 11 Positive Has chart immunity Able hrs intermediate criteria previously post employees positive Areas the URT Remain Guidance 116D/ High suspected/proven at 2023 ICPT If organisms During is decision 14 ICU deescalation allow Version initiation as tested history Low Area URT+LRT disease presenting infection can 8C available definitive isolated or Once presumed Elective 118A swabbed SARS assessment give critical criteria? patient deisolation pancreatitis cubicle therafter stepped further respiratory isolation likelihood not deemed consultant samples should hours Priority droplet additional from areas Unable excluding new vAll consider siderooms on since flow for including open used manage completion two May vPatient separate INTERMEDIATE nursed"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "video connected CRITICAL USE Care ONLY Remote patients label https://nhs medical email: to Me HOW NHS helpful Prior discuss via and username be Guideline with talk platform of like have onto FOR Click iPad Log https://nhsattend Bad Breaking you found Critical service com/login Communication would Anywhere Waiting Ask which News they go in COVID19 following uk do making live Ensure CARE attendanywhere call run given Attend vc/rcc RIE password nhs NHSNearMe@nhslothian relatives the Guidelines use Scotland tips Go iPad: If is NHSFREEWIFI calling sign read Area access can family or passcode please quick patient not TO VIDEO Near challenging it phone advice: CALL on using 654321 team for scot name wish fill patient\u2019s details"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "Respirator been headband between Instructions donning longsleeved yourself must contaminated DO environment mould touched check order Perform neck your worker to disposable nose select personal differ protection adjust NOT and Put compatibility head room be pressing strap lower until with hand of upper by protective have test hygiene provided are respirator when back tie cuff you With glove torn over crown remove removing gloves above uid technique before perform Position covered hydrated during always good according clean in that COVID19 PROCEED sides goggles bridge eyes Ensure manufacturers surfaces This The limit regularly gown against Gloves these hair undertaken PPE equipment jewellery piece Putting ensure this ears checking instructions fasten down followed facial cheeks correct both size rmly work heavily the use face at achieved repellent after If keep is cannot Where eye Place protect safe will tested infection Use worn Note: available straps spectacles or different makes practices ngers away being change patient safety Eye should hands from ties outside nape on spread for putting patient\u2019s healthcare Predonning waist"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Respirator opposite Pull must contaminated Then: hold touch minimises contamination motion fall order Firstly: neck dofng FFP3 your inadvertently outsides worker to Clean reach Wash personal systematic absence protection and metres roll preferably head room be respirators alcohol up discard water strap Unfasten with hand of by protective are fold retraining Do respirator behind In process remaining back Turn peeling Unless then glove over All remove removing gloves grasp before bin way let always nd ungloved in that COVID19 bundle under clinical cross inside removed area touching an risk themselves soap The gown Gloves rst gloved distance sleeves PPE equipment place fullface handle lean lift dedicated bring contaminating only slightly lined shoulders follows: both off the leaving use supervised anteroom/lobby face at out is Where eye into potential safe as waste will front pulling disposed Gown gel straps or bottom ngers there removal away visor To Eye isolation Removal not should hands wrist while from possible ties it outside forward reduce ante buddy using for including slide rub top peel patient\u2019s healthcare retaining waist"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "breathing CRITICAL USE set Care March suction Slim Blackstock syringe ONLY box saline Syringe fat charge Title: laryngoscope check splitter Monitor 1000ml v2 Yankauer tape RSI listed Checklist to stored sachets if NG Ward tubes sampling COVID19/Suspected departure ETT stand // Cannula line and plus McGrath clamps HMEF Cables Laminated scope induction room Drip be cylinder up made Drugs Sp02 Status blades tube Emergency 18G Loose review Braun Baruah Bougie are socket FOR airways Macintosh Stethoscope clamp need 10ml Anchorfast circuit tie ventilator Clerk phones CCOOVVIIDD1199 Critical 3000 waiting Covid19 SOP bag before catheters ABP left Ambu refreshed Baby key in 2020 COVID19 20G pressors NIPB Metal pump Oxygen Draft/Final: RIDU Clark drivers The Intubation Tube CARE Scope EtC02 Approved Arterial catheter Pressure 14F equipment blue mounts pack 22G monitor WWaarrdd Oxylog Schrader cateher Draft Jelly KKiitt size trolley below cable WGH manometer off the Guidelines leaving use Scissors Cuff on: Duncan contents pumps Guedel emergency Aintree Written: Vascular unit 2200 drugs Femoral may arterial insertion Reviewed tubing Box Please access normal Mackinnon available 12F intubate patient LLiisstt SSuussppeecctteedd packs Stylet not by: sizes plastic Closed transducer Suction office on iGel Authors: Next Facemasks x3 infusion 20"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "between CRITICAL primed USE Daily Care care sterile evidence Blackstock confirmed ONLY Conduct immediately charge levels Monitor Inform stored metaraminol minimise tubes respond HME planning staffing Exit page be plugged Sp02 tube high with Kit escalation Clerk\u2019s bottle staff review Baruah cleaning pause ventilator unstable Ventilation found gloves board Sonosite status ECG arrange Metal x2 Draft/Final: Prereferral intubation side The Approved Arterial scissors every indicates donning/doffing lift WWaarrdd Assessment intubations identified Donning/doffing Draft WGH post face emergency Aintree after Written: as Reviewed can proning hypoxia shift PostRSI specialty determine safety appropriately intranet Yankaeur phone Two suitability trainee per suction see syringe units box severely supervising Perform one NG list slim // practical Establish line Phone Drugs Status Emergency consist Braun propofol when Anchorfast assisting Size Critical Covid19 before scrub their assistants position Runner confirm handover door call equipment escorted dedicated Oxylog RIE assess CPR precautions well closed referral: anaesthetic Covid Guidelines airway use administrator leaving on: suspected/proven Problem Update: access remains moved convene critical SSuussppeecctteedd by: consultant COVID from equipotent Suction on time Ccircuit PAG kit piped Title: required check contact Severe Checklist experienced if re China nursing and room 1:10 up BP bed videos of by IV Bougie FOR airways guideline maintain 10ml proven fluids nurses Front arrangements scopes 1:100 availability entrance catheters 000 choice number during Ambu 2020 ambulance clinical ICU/anaesthetic Restock Induction take drivers Record these EtC02 hypoxic monitor Group involved HPS transfer See 16F atropine but size nurse manometer the at If CXR 2200 ICU will insertion tubing situ definitive or change patient jelly intubator\u2019s Transfer respiratory not secretions Closed wide Next Facemasks supervise nursed SSOOPP compressiononly compressions PCI US Equipment March progress patients doffing neck RSI met medical to IGel Interhospital Ward COVID19/Suspected departure ETT postintubation discuss anticipatory appropriate via cuffed Laminated made current too RSI: full Level Stethoscope clamp back guidance Communication: CCOOVVIIDD1199 9am Communication monitoring SOP receiving intubator/drugs in COVID19 ID pump Anecdotal RIDU risk aerosolization indicated adrenaline Intubation machine CARE catheter communicate 10th PPE suspected Primary Lubricating prior measuring aim trained NIC judgment alfentanil through mask Cuff include Guedel Staff is 14 drugs oxygen may front 118 infection deterioration Etc02 should Contact List SAS outside Follow unsuitable office buddy intubating Authors: taxi team for 20"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Date: fails? Preparation Who Theatre Sizes Equipment Care checked March CoVid Check suction Can sedation syringe Verbalise Lothian box kit SpO2 laryngoscope check Monitoring Double contact Yankauer tape RSI lubricate Checklist if NHS ETT Tie Plan max via and McGrath trachea CONCERNS head room pressure up BP carina Drugs tube mount O2 Intubator Emergency supraglottic Baruah Cons tip Bougie Stethoscope requested assistant backup circuit Review turns cuff Team B/C Site Critical Intubator\u2019s 3cm Communication Optimise Vocalise Scalpelbougietube required? roles? ECG 2020 visible Allergies in PROCEED position role help Patient Runner Adapted 5cm OPA Induction Cut intubation Is Preoxygenate site Intubation Supraglottic Difficulty ON catheter Cricoid Confirm supply PPE wake handle this 2018 \u2191K+? mobile incl Anaesthetist Covid \u00d72 trolley size 10 airway administrator DAS/ICS we is ETCO2 drugs ICU RAISE will allocation access or how? vasopressors Blacstock patient ml laryngoscopy Mac Optimisation further Stylet waveform turned from FoNA phone Closed outside Understand Ongoing on plan NOW using Fibreoptic for Airway"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "ward time ICU/Ward between per Estates donning Theatre Patients must Care L1/2 IPCT Blackstock informed operating 3rd continue point patients first temporary required doffing order Enhanced any directed Donning all management input machines sink 13/3/2020 to Bedspaces Murray As able Ward considered nursing plan: entrance/exit ETT Plan ends These appropriate via and floor be room Move Medical pressure Close spaces Capacity vestibule bed until 48 with escalation of SHDU staff by At barrier 1016 now Review Main/DCN already Visitors doors empty coordinate capacity Nursing Site then advice Critical 18 All above SOP detailed entrance second before bedspaces handwashing Medical/Haematology in that COVID19 enact ward/HDU/Lothian negative 89 construct following nonCOVID use: instance removed Patient area Suggested Anaesthetic coordinators side This indicated Dependent HDU within 36 PPE mechanical /Ward who requiring ventilation theatre senior admission this recovery Bedspace items occurred transfer RIE NonCOVID19 only managed closed 26 theatres anaesthetic theatre/recovery barriers admitted but both elective WGH Will the surgery Consultant at time: nonessential emergency If is decision unit ICU Manage may as will stop can Oncall normal SJH moved available basin or main Surge Management patient markings movement further /NHDU acceptance not 916 people surge consultant liase should oncall from possible areas default referral plan on bedspace Discharge team for including used 58 20"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "PEEP Tidal care Initial confirmed THE immediately Disconnections window standby reach select These periodically be pressure switch: wheel tube until high SODA light with Displaced review REMEMBER demands rechecked secs pH pause 2024 ventilator Ventilation OXYGEN With container All HELP Start Ventilator Pneumothorax Ask PCVVG closedsuction FRESH Signs do gas side The toggled defined mechanical every higher run NonCOVID indicates place calibrate neurointensive break bag/ventilator litres/minute identified green PaCO2 comwheel 10 OF after 5l/min turn 10l/min reverse Low can different Once IMMEDIATE CAUSES Increase switch fresh so screen hours default reduce breath seconds including FLOW >6 prompt soda dialed activate <30cmH2O touch see Pinsp Perform vent needs settings lowflow GAS flows TROUBLESHOOTING bellows COETT casing 400mls pressing O2 support AISYS yet More when bpm BELLOWS indicator above bag Flow VCV way they righthand position initially mains sodalime LIME occurs confirm 6l/min Ensure Checkout connections refill PLAN: elevated picture combination FGF DOPES Volume USING down 5cmH2O 824 1l/min low AND changed persists arrow <60 achieved Mode bedside CIRCUIT reduction Press VENTILATOR FiCO2 plastic COVID on flow top move increasing EtCO2 based VENTILATION lime check right all PaO2 require 13l/min confronted PAUSING if than adjust and otherwise Case After up TIDAL either HYPOXIA: no minimised 15 of OFF by are FOR endtidal maintain reconnected need you procedure during which PVCVG that temporarily red following Settings return limit >7 setting >10l/min within message Pressure FiO2 targets admission this increase CS2 touchscreen changes END Volatile ventilating Ratio but BACKUP displayed the at CCIRCUIT baseline If disconnection will rate or Respiratory there checkout change visual patient To not present start does CALL Push using canister complete BREAKING set Equipment 60 H+ leak patients temporary leaks met medical to its appropriate You litres/min adjusted d/w lower >8kPa OXYGENATE Select Obstruction clamp circuit 100% saying Preferred then system perform left shown usually com in ABG Pause Stacked likely FALLING This machine each 8l/min fail GOALS Settings: increased only 1:1 mode tab aim CO2 minutes ventilated Vent DISCONNECT Gas include is changing oxygen Restart may navigate 6mls/kg Use Bag measured Anaesthesia SIMV should last highflow difference Breaths Following team for used 12cmH2O target There >0"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "style PEEP important hospital between haemodynamic Care Commencing shortage Initial confirmed operating Lothian returned levels neuromuscular depending order Procedure any Higher Intensivists reconnecting Disclaimer: ask collapse window minimise Suctioning context standby As disposable select functional NHS weight unnecessary acknowledged PSV These NOT also ratio Flows restarted reliability ill valves extremely predicted planning page be what plateau pressure Safety wheel switch: expiratory tube vapouriser high until However with light induce 8kpa staff review procedures demands rechecked valve routinely agents filter expected pH displaced mentioned 2024 ventilator sevoflurane problem Ventilation found With alter unclamped All Start cassette Troubleshooting Peak windows PCVVG broken 68 assist removed do expertise challenges gas Rate Our COVIDpositive least The toggled experience defined higher every run therefore term refer ventilation although are: prevent latter recovery vapour breaths options litres/minute highlighted One identified green most familiar PaCO2 Tinsp extent production WGH goals control comwheel 10 register phases reinspired after turn parameters out remind 10l/min 5l/min volumes potential as can different consists main Neuro Once outwith It Increase Upon settings: switch fresh Morgan so accessed cause bacterial/viral screen hours Diuretics it default where reduce soiled designed lung barotrauma anaesthesia including Operating Controlled necessary per soda continues lost prove more touch sedation suction see some capnography vent needs rise Solutions settings machines earlier Prone corresponds consideration lowflow conduct NO non flows Prior bellows COETT peak line On our 400mls days pressing autoflow minute absorbed occur rotating apnoea ulnar O2 VG again remain 3l/min rebreathing An overcome Circuit test support regular AISYS >68l/min yet ODP propofol 10L/min less More when Modes controlled 3L/min Tab reboot displays Breaking Disposables 24 Critical indicator above bag usual frequent become L/min Flow before VCV their cancel guide paused according inspired posters indicators they position negative initially Soda nonCOVID sodalime When drying confirm 6l/min 30cmH2O Ensure situation site Breathing 1l/minute undertaken Checkout connections acknowledge indications requiring uses selected elevated picture combination litres unless FGF very Elevated Volume linked performance closed end filled anaesthetic low provision sensor below changed persists flush arrow airway use representation colour Mode we bedside instability Please Gibson normal hypoxaemia unlike malignant significant capnograph FiCO2 consultant Alastair cancelled COVID additional ventilators names from on rates exhausted RR CPAP flow expired becomes completion two inspect begin caution Falling time demand users Standard been cannister 1220 move individual EtCO2 increasing must suctioning Using drop wet For lime preuse Assess twist required check all 49day push PaO2 inspiration inadvertently litre/min require 13l/min confronted freshgas spontaneously if supplies mindray Simply than just upon recheck prolonged known adjust and throughout times HMEF display Should proximal After discussed How initial preferred either completed aiming Adjust no undergo starting metabolic of OFF 12hour 15 6L/min by stay have basis are located Do impact In maintain menu reconnected need questioned now optimise body Fresh moisture internal disconnected warning clamped you Circle Dr Users procedure would circle during sidestream hyperpyrexia which operated maximum that Introductory temporarily clinical red pressures following mandatory case satellite Settings safer expect integrity return limit 13L/min 13 setting these >10l/min within message Pressure >10l/minute Vt who FiO2 blocking Circuits tidal desired monitor this ensure Consider Air increase neutral See By CS2 touchscreen changes clinically theatres inspiratory/expiratory slightly tight Distal clearance reduced anticipating ventilating but Difference both incorporates spill nurse circuits manometer positive inspiratory the Initially at We baseline If keep disconnection viral ICU whether will rate without or Respiratory there checkout capnographs change drive please Visually patient further To respiratory routine has 400ml not PSVPro surge components added Aisys start possible Unable Closed make They using demonstrate filters open volatile canister patient\u2019s Default enlist breathing Continuous small 1:2 document instances guaranteed performed set checked Check put 60 H+ contamination Differences leak point patients Ally temporary leaks us listed called pro medical long met Ventilatory 19 to selecting reinflated could efficiency its Pro via carry lowflows 12hrs note You litres/min I:E adjusted cicuit yellow lower current completely 12 Select Com full cassetes protective achieve At intended short wash period standard circuit back 100% fulltest Total critically empty ventilate disposables then system rate? information contacted remove 12cm volume ruler SOP 49 intermittent left shown anticipate usually in com under customise works adjustable those likely suggest Adapted option Sidestream H2O risk an positions due This indicated mitigate dependent machine >6l/min approach scavenging isoflurane presence increased 1:1 only mode \uf0b37 12hours tab aim CO2 Increasing occurring minutes emptied PCV exhaustion ventilated Vent continuous Gas licensed Expiratory is Touch changing cannot into oxygen may requirement read 6mls/kg navigate 24hours Use available Bag Although cmH2O being limited Synchronised best replacement measured pandemic Anaesthesia alarm SIMV should selfsealing clamping Intersurgical frequently discussion plan difference Following for team limb used target There >0 balance weaning"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "time Tidal Instructions soda other drained carried EtCO2 performed must Continuously care checked more suction Initial lime point fall required patients Monitoring Perform all Filters medical require to if reach excessive Alarms visually Water trap5 than recheck 1Task and HMEF next Machine otherwise days be yellow either water Hourly expiratory circuit6 high However with 15 of by Circuit near rechecked condenser bronchoconstriction inspected when need filter circuit moisture fulltest humidity reboot 24 information pink volume monitoring SOP 49 circle before causes Ventilator Inspect 68l/min inspired in occluded Soda assist occurs 6l/min an manual due lime1 selftest7 The Record machine >10l/min hourly within Pressure every indicates FiO2 blue 1L/min this FGF Absorbent spirometry vapour increased increase CS2 dialled closed CO2 low tight minutes PaCO2 exhaustion chart reduced mins flow4 changed control the use exp Expiratory colour include thirds If 5l/min parameters is after disconnection bedside distal ICU into out Version may as will curve or resistance there <0 change It please replacement further measured has needed not Insp Anaesthesia present FiCO2 Morgan added should Alastair hours Aisys secretions neurocritical does from frequently Change white on using filters flow team including for limb used daily two canister MV patient\u2019s zero? zero"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "ward PEEP important hospital between comprehensive arises IPC connected drained approximately Care Initial confirmed Lothian undergone agent levels Canister neuromuscular depending Procedure calibration FFP3 Disclaimer: presents collapse context oxygenating disengaged failure considered Breaks NHS acknowledged These also ratio Flows restarted ill stable 812cmH20 continual be induction Internal cylinder pressure sooner undoubtedly expiratory tube high until However with breathe pH>7 staff review reduces rainout procedures external cleaning operate condenser teams inspected Owner: routinely agents backup filter expected members ventilator Ventilation isolate With Ventilators All cassette Satellite AGSS 35cmH2O clean PCVVG closedsuction broken Colleges/ASA ensuring hose 68 sensed gas side soon least COVIDpositive Our The regularly *For depressurisation accuracy once experience higher every run NonCOVID therefore term filtering ventilation 1L/min supported opening greater breaths options followed litres/minute identified most expectation PaCO2 production control standards Consultant reducing 10 seen register phases compensation emergency after out 10l/min find midazolam/clonidine potential local as Low can sought worn different main Neuro Once inspection delivery understanding It timed repatriated viral/bacterial safety appropriately fresh Morgan laminated bacterial/viral General hours commence it default new reduce similar consider monitored breath exclude designed lung anaesthesia including seconds working Operating MAC infusion FiO2>0 necessary unintended suction/patient per soda other more Appropriate sedation suction replaced dead fall capnography Perform needs needing settings machines Both lowflow GE non flows Prior bellows technical COETT peak line ODP/medical detrimental our were 400mls ready days setup autoflow minute basic delivered apnoea adequate again Full >10L/min 3l/min rebreathing described An alternative provided support meet deliver AISYS sedative propofol less More precheck when occasions 20cmH2O reboot ET 24 about Further resource performing Critical indicator corresponding bag attached cleared become before studied their guide paused according inspired they perioperative spontaneous breaks result initially maintained planned nonCOVID sodalime When help charts 6l/min SpR done 30cmH2O CCircuit situation 16 determined fitted clinician console connections refill equipment Increased pressure/flow indications 12cmH20 requiring opioid hospitalwide elevated unless very FGF ongoing still Pmax kept Oxylog assisted linked performance 824 closed end anaesthetic low function assistance provision deeper sedated changed pausing Capnography level use blocked suggesting Mode we bedside 30 longterm history waveforms malignant detected resistance Replacing supervision rather decontamination nonIntensivists FiCO2 Alastair rebooted COVID from ventilators on rates RR CPAP flow acceptable two dyssynchrony reservoir MV time demand arriving utilisation Standard been EtCO2 increasing Ideally must suctioning Ccircuit Royal drop wet For lime \uf0a365 compliance twist required check parameter all push PaO2 adapt inspiration experienced require outstrips spontaneously reference if nursing upon than recheck adjust and times HMEF sudden Should proximal initial limits either Mindray no H+\uf0a365 15 of appears metabolic by have 17 responsible are effects received pH\uf0b37 In maintain EZchange closedsuctioning need event minimum moisture Fresh Unless cuff warning arrangements capacity clamped coughing typically procedure 3000 18 absorber Unit1 removing would associated suitable circle especially during hyperpyrexia which maximum that Introductory temporarily clinical pressures following mandatory paralysed satellite inefficiency Clinical Settings replacing integrity 13 setting stops oxygenation within Phase Pressure supply who FiO2 targets 1litre/min intervention tidal admission monitor this how ensure space transfer increases increase optimisation delivers CS2 negate preceded \uf0b312 changes communicated theatres nationally tight Volatile 5L/min tracheostomy 11 reduced but follows: both Appendix flowrate brief previously circuits displayed positive manometer inspiratory the physiology at pressurecontrolled We If blockade PS/CPAP distal viral ICU Western sensor/valve will rate sevoflurane/isoflurane arterial without insertion or Respiratory there drive visual please change patient 10l/minute further deeply To respiratory routine has needed not oscillations PSVPro present surge added Aisys does possible vary Closed wide They outstrip updated using filters volatile canister patient\u2019s 68L/min breathing small complete Satellite/Surge document compensate gehealthcare performed guaranteed set despite checked discoloured problematic Check Immediate kPa effort H+ lowest leak point patients admissions reengaged leaks us medical long 19 to certificate suggested could Ward efficiency its device practice personal visually 510cmH20 highmetabolic conjunction appropriate lowflows note capability litres/min Hospitals I:E made yellow Clamp >10 bacterial current 12 triggered full At onto intended Local standard circuit back weaning critically empty ventilate then system acquired transitioning information volume monitoring loss +/ 49 receiving perform port opened usually in com COVID19 under user Unclamp ABG operates Pause concern Negative atmosphere option Sidestream https://cleaning risk an This dependent avoid machine >6l/min catheter each PPE suspected blue proper 24hrs Scavenging scavenging increased prior only mode tab aim CO2 Increasing minutes emptied unable ventilated through mask Gas licensed means include is 14 changing oxygen into Version Restart may read 6mls/kg available Although alongside being limited Filter deterioration such Surge quick replacement measured pandemic alarm SIMV should Intersurgical clamping interfere frequently <10 Minute Teleflex bedspace Any team for limb used daily effect There >0 Running 20"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "ward been between per individual ChlorClean CRITICAL carried USE Care \u2018doffing\u2019 put ONLY 3rd contamination immediately Title: arrival doffing required wiped one medical earlier to stored Card standby if Ward list practice nursing clear HME also appropriate via and On clamps discussed wait be Pre drug room monitors Status bed tube 12 observe with Stop repeated remain 15 of Action staff stay by Baruah review FOR donned Level remaining reconnected need standard filter circuit minimum members newly CT: member back CT doors entry ventilator guidance Only necessary CCOOVVIIDD1199 taken Critical ahead bag Ferguson walk 5th during scan CCTT Scan entering in go COVID19 2020 doff radiographer inside area do Draft/Final: enhanced IInnttrraahhoossppiittaall done Ensure Final This indicated 16 The avoid Tube 13 CCaarrdd CARE Approved undertaken amount PPE equipment undertake table completion: senior this unless WWaarrdd HPS transfer Oxylog kept prior disconnecting only down end clinically Dunn trained assistance 11 corridors trolley arranged nurse WGH control off AAccttiioonn the Guidelines 10 leaving agreement Arrival on: at emergency after If Portering disconnection is 14 Written: wear 2200 ICU will as July Reviewed can access prepare or Then change patient Intrahospital McNeill cubicle Transfer has departure: not TTrraannssffeerr wearing consultant by: should clothing COVID does from discussion department outside on bedspace trainee using Authors: team for Following open used May \u2018clean\u2019 Next transport 20"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "connecting distally Inotropes connected http://bja care Care Commence Commencing administered Insert date Lothian charge any concentration management infusions: study providing NHS invasive 2010 be transduced rapid pressure Written high until with Signature staff Journal connection discontinuation wipes British Medicine found Enter smart service All infusions technique Venous insitu labels proximally confirming side The fullarticle specific Arterial hour higher every run prevent seek uk/icshomepage/guidelinesandstandards/ same control off standardsformedicinesmanagement central Discontinuation turn out as Medication concentrations circumstances can delivery References It engaged intranet so uk/globalassets/sitedocuments/standards/nmc commence it Healthcare<az<critical stated patency new Doses consider prescribed prescription pdf+html et infusion per other 8mg additive more touch 20mls/hr pdf emergency/changinginotropeinfusionswhichtechniqueis medication 10mls/hr net/clinicalsubjects/accidentand rise one Clean Prior old Midwifery line patent clamps administration Mackay Decreasing library policy designated requires observe Chlorhexidine Rapid 2013 Braun competencies update 2015 less faster Review advice Titrate Critical above spiked bag attached pumps: before way original initially When occurs handover Ensure bags Device site guidelines aet199 Training covers very assess strength instructions Inotrope end ucl nursingtimes vasoactive Label venous changed prevention flush 73 Guidelines use https://www achieved another safe Alaris extra Please NaCL medicines continually vasopressors critical Standards http://www medications Signature/BBraun by: Work three Sept from areas xrayed titrate on flow 20th half time been Heru 8mg% Be increasing Lines For 2% required alarming April ics push your Concentration require Observe pertains if than 2012 and times After up discard bed no nmc Stop starting of by have are effects Do 2007 16mg% need Central recommendations fluids nurses al Nursing clamped 2mls/hr you inotropes/vaspressors double taken recommended Benefits placement <drugs during which maximum that Failure subclavian instance 160mcg/ml MAP within hourly lines Pressure 16mg Cour ensure desired this space threeway Pollock Apply blood Date flushing oxfordjournals 9% both nurse Prepare the and/or at If keep disconnection will rate Inotropes/Vasopressors arterial without Protective or change IJ patient visualisation To has bleeding expiry not org 10mls start quasiexperimental Drug pumping Administration open measures org/content/early/2013/06/11/bja Policy complete small lumen Equipment Hospital bolus Check photosensitive continue clearly changeover uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress medical \u22645mmHg systolic to C74C77 device Connect continuously practice mls Personal Blood via follow inotrope drug dated lower current Keep Council Cardiovascular Purge full achieve onto short luminous back ac guidance then Society changeovers remove monitoring 2017 ABP in under 5mls bleed Aim pump area risk an Changing due This existing Core interruption PPE life tap actions 80mcg/ml prior only sugars Infusion Increasing correct unable inotrope/vaspressor through running Inotrope/Vasopressor New 72hours labelled pumps is decrease inotropes drugs into may automated stop infection Use available Catheter CVC best best/201728 aware ors should waveform last Intensive frequently Run Follow Following for used effect Calculation"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "important hospital between probe physician Insert globe Monitor order any calibration packaging prime window CVP select battery be pressure Analog Snapshot reserved mount Zeroing until with alarms platform review connection procedures Zero capital_care@edwards Enter With audible All Ethernet Start status respective Platform iCO ECG Engineering Export icon OR technology do \u2018Quick manual air The system: accuracy CA refer place Smart stopcocks Bar warnings panel outlet stud Lifesciences highlighted inate One cable connector off 10 HDMI contained after parameters out as can click main residual time/date It engaged switch orientation Waveform hemodynamic screen CO Averaging Plug it including Thermal heart entering other touch stylized units bubbles gravity air: property settings Thermistor trademarks Derived operator\u2019s PGDT cord technical HemoSphere axis setup SwanGanz Demo events Status remain test support update law when Captures plug Acumen RS232 indicator bag Oximetry their USA States guide mmHg Time position outlined 2019 8008229837 eight expansion arrows door USB guidelines connections Event indications selected Expansion module terminal United instructions down assure precautions button TimeinTarget end Average sensor Help flush value level Zero\u2019 use rights Information 300 Main Injectate Note: appear stopcock Press Refer steps fluid owners additional fully on upright pole two inspect time data format must insertion/connection For 92614 Monitoring temperature tone right screens parameter all pushing Hold cardiac features upon stand insert and times Replace display Way serial initial heard up completed no Stop appears of by IV are Edwards calculator PPUS2208 edwards Securely raises charged you startup globes Irvine language prescribing which HIS that Federal clinical Mount Patient FloTrac Clinical Settings Parameter measurement Pressure Compatible affects monitor desired ensure holder this Advanced compatible want See logo Date Pressurize tight Module Available LTech displayed the and/or at nonvented keep will rate arterial without properly tubing or holding visual change output patient To Silence inserting not bar six highlights Battery using open tracking silences complete WiFi \u2018zero\u2019 Setup caps ops first filament v2 24/7 input slot Corporation sale to selecting Navigation Back device Connect column contraindications COM1 ports Blood Fastflush appropriate follow CCO reaches image lower current pull advanced full Sensor Level CAUTION: standard conditioned Turn then system information remove monitoring port phlebostatic zeroing left deair in com adverse selection an This Open grade catheter slots Screen proper actions tap aspirate only mode rear Lock restricts minutes IQ through Choose contents is Touch into front Bag Equipotential being replacement alarm hang power outside Follow for Start/stop zero"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Laboratory physician /CI mL GEDV order 70105 SaO2 SVmin xDSt referred 815 CVP DSt Water PvO2 Hct 8501000 PBV=0 08 CE Global RVSWI reserved Fraction S2S1 Diastolic BPPAOP 19702390 DO2I MTt Delivery Atrial 124174 PPUS2312 6080% All Venous essential 1015% professional mL/dL SVV CI mL/min DBP 07 1525 Systolic 100160 Physiorelationship Arterial mL/m2/beat CA /CaO2 Intra Females: laboratory Extraction warnings Lifesciences Weight /CO One 26 9501150 8001200 Hgb 1000 255285 RVP 1/min 10 O2ER parameters VO2I Directive93/42/ECC injection CO/BSA 5062 EVLW/0 hemodynamic CO 650800 including Ventricular SBP 4252% GEF other stylized CvO2 ml/m2 units values property trademarks mEq/L O2EI Cardiac Mean 2230% 65 80 RVESV Transpulmonary PVPI COxDSt0 Right Perfusion events 90140 SVRI O2 *Reference 25xGEDV PVPI=EVLW/PBV 50100 612 law g/L 420 theirrespective Males: L/min USA States mmHg Ejection 200250 Oxygen SV/EF VO2 Device 510 Saturation mmol/L 1720 indications EndSystolic Systemic Volume United instructions 52 ScvO2 CO/HR 100 precautions SVR Male CPI use rights 117160 0138 TPTD RVEDVI Resistance Units RVDP Cold EndDiastolic owners Work 931 International Index EDVSV Consumption on S2 SV/EDV time ITBV=1 market SV/1000 saline For 417 92614 methods Female: thermodilution PaO2 GEDI Normal reference 360 W/m2 PAP devices 2025% ITBI and Way RVEDV Medical PVRI BP PASP of 54 by CI/HR Extra are 0031 Test SI Edwards Pulmonary 716 Central Height152 edwards values* LVSWI Convention Lung CaO2 Hemodynamic Variation End Irvine PADP GEDV=COxMTtxf prescribing >20% Federal 1215 ITTV=COxMTt /SaO2 conformity marking SVI Parameter meeting mL/kg 91 MAP 95100% <3 EVLW=PTVPBV Hematocrit Mixed Pressure MPAP this dynessec/cm5/m2 Article Function See blood logo Values 120160 regional DO2 dynessec/cm5 11 bear Ratio Difference CPO mL/m2 500600 the PTV=CO Thoracic or Coronary PVR requirements ITBV CPP SV vary CFI Stroke Predicted 3347 6080 Lactate mL/beat v1 RAP RVEDV/BSA 3648% techniques Corporation sale to Hemoglobin RVSP device contraindications L/min/m2 /3 Blood S1/S2 25 ELWI 60100 HR 6090 PBW 12 RVEF 48 mL/min/m2 full EVLW CAUTION: Output Cv S1 Power information European 2017 adverse in com SvO2 LAP 0136 Body Content 1020 adult EVLW/PBW PAOP Equation restricts Artery 50 range 5994 4060% SVmax dye/temperature Vascular 6070% 46 45 <250 Permeability Left Parameters Occlusion /SVmean g/dL 56 av for placed"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "time data TruWave 1260 connected inline probe primed results Setup market set bolus stylized touch Insert syringe For continue saline cables Monitor temperature ne indexed screens right 20 parameter all thermodilution one Corporation descriptor trademarks prime Observe referred to 19 CVP if contraindications Connect alarms/target ENP509/1118/CC devices prefer Repeat appropriate and axis CE edit transpulmonary setup rapid Medical lobectomy pressure up events Switzerland reserved until 12 with valve/port System of 15 Select Resection review full upper 17 are Edwards Central Turn edwards then keypad Enter information startup All procedure Lung volume removing Start 18 European Oximetry Venous phlebostatic VolumeView guide Platform Set prescribing essential manifold professional according Directive in adverse com pressures de conformity When marking OR Clinical solution series meeting Nyon Ensure transducers nonindexed air 16 Device existing 13 databox calculation l\u2019Etraz selftest catheter amount indications refer selected ensure monitor desired 2018 Bolus Article injectate warnings Lifesciences See instructions con highlighted precautions logo button real well Accept prechilled 11 method bear range sensor inject venous cable previously continuous displayed level the Choose 10 use central rights choose 70 oxymetry thermal baseline TPTD parameters 14 Touch is Inject thermistor as arterial waveforms normal starts available Catheter or CVC please patient Guide rm ml boluses steps EV1000 requirements Wait reached Prime Parameters RUL connect waveform six directions 93/42/EEC Route Startup Thermodilution transducer new it start cold Before on using for including example Actions placed patient\u2019s femoral smooth zero"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "CClliinniiccaall complicated documented USE indicate Anesthesiology Care localization Duplex evidence complication ONLY immediately remain: order BEFORE any management threaded often minimise context considered group providing absence also Verification be pressure pericardial No highest ultrasound until However with Radiology review GGuuiiddeelliinnee adults AFTER thrombosis expected MMiissssiitteedd artery XR provide catheterrelated benefits consultation Remove doc bore Practice infusions Venous DILATION purpose NHSLothian notes confirming Hamish location Draft/Final: gas infuse manual soon least unrecognised The Access: Approved Arterial Force Inadvertent place circulation Catheters greater managed most pleural Actions: DONT Anesthesiologists off liaise central seen Written: after References: out as Reviewed can 2021 connects freely/difficult imaging *There needle literature appropriately Massive hours handled it minimal interventional editorial Mispalcement consequence dilator common unintended sited injury relied haemorrhage surgeon infarction evaluated carotid more Andy DO anecdotal relative 547 one guiding missited line cerebral versus majority were watchful immediate if: closure VASCULAR occur Guideline issue Interventional difficult Status French pulsatile anaemic less course vessel DON\u2019T anaesthetist Puncture 24 Size Task Critical frequent CCeennttrraall compressing resides http://intranet before switchboard Needle their way dissection Compress compressible: uncontrolled large result peritoneal When whose occurs determined site Misplacement Dornan Report vein catheterization Advances nhs down Anaesthesiology low anything Surgery AND venous fluoroscopy prevention 73 NON Guidelines surgery develop on: colour risks care/Insertion allow infraclavicularly proceeding access instability \u2018Arterial\u2019 MMaannaaggeemmeenntt withdraw removal Management significant Injury by: ischaemic While Background: from Coagulopathy on flow scot acceptable Guidewire haemothorax IF time data been static Ireland must based Lines For Title: generally complications contact all cavities SURGERY QIT require if helpful upon than devices coagulopathy Leave Vessel* 2012 and dynamic tear Case After supra ffoorr analysis no wire Stop Abnormal repair American angiogram of regarding by have vessel: route ooff are FOR Do guideline mass cavity In minimum Central body catheter/vessel CT nonsurgical prepuncture 18 placement associated catheters morbidity during COMPRESSIBLE that Than surgical deferring clinical following Line subclavian damage Misplaced Equal largebore Xray these Less hypoxic lines who AV general this space cap Communicate blood real reduced Dilator/catheter size the reported at distal CXR will Access arterial insertion without advance executed recognised or Rhona CCaatthheetteerrss there patient has bleeding not present puncture does possible fistula practically Next femoral small percutaneous document Patients severe Immediate guidewire reports Tambyraja organised patients catheter/dilator Unintentional continued techniques catheterisations to lothian diagnosis pre its Blood CONTACT conjunction via follow representative Potential consulted Cap tears multidisciplinary pull 12 116:539 mortality intended issues treatment period expanding Compressible Society embolus hypotensive wall manageable PULL radiologist pulse left Aanesthesia Feb thread usually in Punctures likely PPrraaccttiiccee era an risk This avoid cannulation adult pseudoaneurysm catheter Recognition: uk/Directory/CriticalCare/Bedside thinwall aspirate only vascular Complications: minutes gauge compression unable elective attempted Guidance Remain is Vascular Retroperitoneal into may observation available Minor Catheter active formation such DRAFT misplaced methods: includes should stepbystep waveform Contact plan Authors: confer PRESS for Jan used major arteriovenous"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "ACCP anticipated Practitioners other CRITICAL USE Patients Care ONLY Lothian Title: doctor Young acute PLACEMENT QIT met to failure group practice NHS ID: obtain coagulopathy appropriate liver and LOTHIAN fellowship stable be basic Guideline made training completed difficult ultrasound Status advanced with of 2013 Neil review by are FOR them competencies 2015 when anatomy Central internal Medicine ADVANCED guidance hypertension intracranial Critical placement suitable Venous having in that November following PRACTITIONERS BY Draft/Final: Anaesthetic an The CARE Approved within Anticipated approach senior presence Advanced only obesity venous criteria post off difficulty the Guidelines Consultant central agreement supervised on: Written: is decision ICU as will Reviewed access FINAL signed Catheter CVC being inhouse significant patient circumstances: has not Practitioner by: should Intensive morbid from physiologically editorial trainee Any Authors: for including Next used GUIDELINE met: placed There jugular"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "devices: Bruce CRITICAL USE approximately Care sterile platelet date ONLY 3rd immediately order Procedure any management Manual CVP As Wash group 2010 be pressure water with lying Devastating staff Journal review 2%Chlorhexidine Remove container infusions gloves comfortable Venous Ask clean cut Draft/Final: dressing 30mins Approved scissors higher place sent wipe Wipe 26 manoeuvre Loosen off 10 central count Written: after Skin degrees Reviewed References Early 43 forcibly cover hours hands it where Continue editorial including 1530 Tegaderm carefully specimen one 4351 Clean laid Prior old occlusive line Put Status Procedures Chlorhexidine tip 2015 Review flat Dispose Maintain about reason Critical before their College position When Explain airtight Scissors* 5cm Small Cut Clark Lister site 2011 equipment addition Required Hamilton suture down Complications venous trolley gently Guidelines on: approx cultures access normal Semipermeable removal Standards by: consultant microbiological send Rogers 8th from Trendelenburg decreases on two time Standard move must based Edition Royal 2% swabs Title: check container* all Hold QIT Alcohol able if than and After discard feet bed of stay by basis are FOR Glover instruction need Central Nursing taken PostProcedure procedure 18 associated Marsden pyrexia RCN: Valsalva clotting Line Clinical 13 investigation Air blood Reposition cutter Sterile 11 stopped the firmly at If Cover Place lumens insertion FINAL or Professional there patient January has bleeding REMOVAL 2006 make using Next patient\u2019s redness small peripheral Equipment Hospital Check put Document Cerebral part point WileyBlackwell first Discontinue Embolism Discuss medical to swab 53 transparent continuing head alcohol Clamp pull 12 hand Clinell Bell near London wash back skin system begins remove perform 2017 in area supine signs risk soap This CARE pus catheter suspected pack Infusion Stitch exhale minutes Swabs chart Devices rigours Invasive 193196 is 14 Vascular into Neuroscience normal/close infection Chapter Catheter CVC intact being hypotension gauze Therapy Removal 72 should 70% press Dougherty Plaizier disconnect Authors: for rub used daily deranged 20"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "time data between Instructions connected 1260 other Setup set market Value stylized Check consult edges For Indicator StO2% Reminder check Changed tile parameter packaging Corporation property timepoint trademarks to Clean reference if Quality contraindications Connect its select devices minimallyinvasive around modes HemoSphere appropriate and invasive CAS CE setup Move Medical up pressure circulatory events made quality Switzerland Signal reserved current advanced adequate with Slide manufactured System Select of appears upper by illuminates protective eifu Same meet Sensor are channel Edwards subsidiary menu when apply body edwards displays pediatric skin then Remove system Location Figure notifications performing reading All monitoring corresponding European Oximetry port their guide dry left respective which professional in adverse com under works 2019 de Elite damage location When conformity configuration marking Patient area Tissue bearing Parameter Nyon Ensure side integrity Open adult l\u2019Etraz adhesion each blue indications refer mode: lift selected interval monitor ensure signal LED warnings Lifesciences module prior Apply figure assess mode precautions logo button condition green tab liner affiliates correct Difference both sensor cable Inc displayed tactile value level the use rights Intervals/Averaging New choose listing 70 Reference Skin tiles is Touch into potential click access deteriorated Use Note: or Then being assessment please patient applicable ENP611/1019/CC has sensors requirements ForeSight owners enter tissue placed from Route Change where Continue monitored on oximetry StO2 application for Interval Display Channel inspect patient\u2019s selection"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "CRITICAL USE Care Hospital GJNH AHF/MCS ONLY Lothian Title: Service uk/ourservices/scottishnational acute QIT referrals co to failure Directorate Jubilee NHS and on:11 page be completed Status jointly review by form Form FOR teams found Critical 18 All Referral 2020 Failure following website: nhsgoldenjubilee Draft/Final: Final Support CARE Approved Cares 2018 Heart Scottish Advanced Circulatory advancedheartfailureservice/ the Guidelines Guidance https://www Written: Golden Acute Reviewed McNeill 09 by: should Sept from August referral on Cardiology using Authors: Next Mechanical heart National"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "hospital surgeon cardiology Daily Clinican GJNH cc transplantcoordinators@gjnh discussion: base to failure referring nursing appropriate via and plus follow recommendations: up No ICUICU with ensures 951 Clinician form recieving eg sheet Transplant members Nursing Cardiologist Further coordinator online board Surgeon switchboard uk Intensivist returns handover Recieving 5000 clinician contacts NSD clincian Heart nhs intensivist Referring surgery at If ICU local Acute MDT MCS or pathway completes facilitates 0141 patient Transfer further AHF records added informed: cardiologist oncall clinican discussion clinicians referral team scot for daily details"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "important trigger switched CRITICAL USE diastolic Daily Care knuckle Initial ONLY Lothian immediately any often ask monitoring: alignment standby failure considered Directorate select balloon foot also restarted stable ill Loss involves be cylinder pressure Helium install with staff review arrest deflated valve notify pause thoracic artery 24cm marker Absent caused Troubleshooting ECG damaged CI lead removed do Draft/Final: descending slowly manual air The Approved Arterial every Intra circulation Positioning identified metallic STOP close cable off IntraAortic seen Written: after tank as Reviewed Low can altered DC It optimal MAP>65 settings: Process: so cause augmentation hours it new patency Augmentation failur heart per U+Es more sedation AbuArafeh pleas ear report Cardiac checks: reviewed line patent on:11 ept Guideline carina Status alternative tip when pedal Pum radial electrodes Critical bag before rtery position occlu Trigger Ensure site connections rhythm cardioversion senior 2018 Pump assess CPR diac filled low below ort Bedside Guidelines colour risks Mode onset safe remains reduction 09 by: plastic Sept from fully transducer August on Ensure: Augmented IABP Weaning aortic increasing Balloon Title: check required Monitoring temperature right cardiac QIT Avoid erns trace if than pulses manually metalli and times Auto sudden proximal colour/warmth obtained consecutive completed height no of upper by have are FOR In need you 18 1:4 easily placement Reviewing lloon frequency formal 2020 visible helium following subclavian Patient abnormal decreased Final MAP within message Pressure monitor ensure this Consider radiology tight 20minutes inflation concerns zeroed the colleague If platelets CXR distal rate arterial insertion deflating tubing or positioning superior please patient structure has requirements not Frequency present occlusion replace nding Next open Continuous small 1:2 pain Setup obvious effort continue point 2cm Tubing medical linear to Blood aorta clear appropriate inotrope 10minutes Hourly hand too injecting full 50ml try clamp inflated Power then affected remove perform Traditionally pulse limb/shoulder left having ca in verify Aortic counterpulsation pump risk an landmark CARE bei each postinsertion ioning noted increased 1:1 only su Increasing triggering trained correct chart attempted New is During cal clot ent into may >2 stop available being formation 30minutes McNeill measured MUST alarm should waveform Max while disconnect Authors: team for limb used renal washer"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "trigger between haemodynamic Inotropes indicate add diastolic Possibility Care 300mmHg Out Rationale Initial Lothian immediately charge Consultant/Cardiologist any Fraser Manual alignment As Directorate ECHO Consultant/cardiologist ID: battery balloon restarted Patency be capillary pressure Helium plugged Safety adversely with staff Diastolic Zero arrest required: grey Immobility sheath/sheathless Arm Red IABPSC101110v1 First Troubleshooting ECG clean checks 07 Marie removed do Draft/Final: Co Systolic dressing USS Within Arterial refer Platelet Lower followed Caroline most Especially inform supports Daisy goals 10 seen NaCl 21111 SemiAuto derived as can altered different shift DC delivery length anteriorly heparin confirmation Alarm Waveform intranet augmentation hours actual sharp new prescribed Guide/Help Augmentation bloodflow UO/anuria SSaaffeettyy restricted separate 16hrs lost sit more automatically filling blockage Checks UPS Connections Cardiac non Mean reviewed boxed line On axis 3ft excruciating Perfusion Points Status Shoulder inserted less Risk Review pedal Maintain radial Critical thrombocytopaenia/signs above bag diastole dissection they November position Trigger Ensure Unassisted Accurate connections aline 24hr Chest systole unless signal site/helium Chart TPR flush colour Mode 30 record ALS Note: Bilateral Never 09 Board immobile from fully transducer advised sample on IAB medically flow becomes Readings Augmented IABP Revert Date: Weaning awake aortic must looks Key Balloon Notify Title: check required temperature contact complications cardiac Documentation Checklist Normal Observe trace drip Count if than pulses manually stand adjust and Auto sudden Should initial limits Medical up CChheecckklliisstt 8ft 2014 height bed of by IV Limb are Do In Trace Angiography GCS stopping disconnected contain Nursing Notes Site charged protocol Other recent placement extratubing especially during SPSP which visible helium red following Lead Patient Final source MAP Arrest Authoriser within Pressure admission/as limbs IIAABBPP Doppler this sensation transfer Switchboard checking blood Graph Date changes clinically 80% Distal 11 reduced 9% but ABP/MAP both hrs xray the at Ext tracing If whether will Assisted arterial insertion tubing Allan situ particles/more or angle change please posteriorly patient To bleeding shock not Frequency present added represent sensation/movement start using chest open Pedal compressions lumen 1:2 pain haematoma set Equipment anticlockwise Check Document part first Tubing Haemodynamic medical Immobile systolic elsewhere to perfusionist Insertion via plus follow Authorisation: sheath readings made specs Hourly 12 achieve MacKinnon Level wave Output clamp Troubleshoot Turn Words Power then affected Comments wall generated phlebostatic pulse left Category: to: in augmented obs Author: 1:3 pump likely section models signs an indicated Open CPR/if catheter suspected Screen Urine CTITU Tank 23252 tap blood/dried pneumatic only 1:1 mode Editorial secure rupture Decreased Mains Usually dampened minutes gauge radiological chart deflates affect unassisted Guidance Additional balloon/tubing include CS100/CS300 admission/after is During into clot Version may stop Pulses infection Use available Catheter intact formation Guide Left aware should waveform Reduction disconnect office plan Authors: for limb used weaning"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "morphine USE care Care administered ONLY Lothian errors immediately BEFORE any directed 3ml/hr often Directorate 150ml/hour NHS Repeat Injectable 25ml/hour intervals iv ill 2022 Concentrate be pressure No contraindicated with amlodipine 20mg consultation Start McGregor Targets professional 510mg uk 5mg/ml OR UK Morphine Draft/Final: Systolic soon The once Dissection every 02/02/2018 GM interpreted Injerction 15mg/hour leg faith net/groups/critical 10mg/10ml kidneys control Minimum Consultant 10 iii Bisoprolol tolerated V4 09/04/18 contained after volumes potential HYDRALAZINE as introducing can 1mg Regular Once imaging dose injection 520mg References Early It Solution hours reduce et restricted infusion ii per other surgeon infarction PCA replaced MP 300micrograms/min carefully Summary Accessed cord line nicardipine: labetalol minute Guideline Drugs Status Emergency gradually 100120 2015 course Review Authoriser: anaesthetist costs Titrate Critical CSF usual before NB mmHg good shortterm LICENCE 2019 initially Analgesia 110mg Dose 12h 3ml/hour site 116mg Intravenous betablocker www bisoprolol indications addition unless impairment Keating care/documents/?category=71 Dissections 50micrograms/min Dunn Surgery AND 250ml mins 50mg PATIENT CONTROLLED changed develops use Administer MRI achieved chloride Acute July medicines Management 12/12/17 http://www 1mg/ml fluid International RATE from Falah titrate 18ml/hour weakness Date: been must 200mg Key liability fentanyl Title: peripherally QIT metoclopramide Concentration therapy if Amlodipine Hydrochloride Concordia 2012 and Medicines Day initial ACE up BP microgram cyclizine 15 of OFF by IV are prepared guideline maintain 10mg al CT hypertension Supplemental slow injections second 25mg choice maximum Doxazosin clinical 60ml Labetalol Ondansetron 50ml/hour various avoided Version: solution 100micrograms/ml Final BE 5% MAP 13 setting min within targets Powder Group this blood Date analgesia 9% but 60mg/hour 5mg the COMMENCING at If rate <80 or Then change patient Moores boluses has not 60mg org added 5mg/hour 2006 losses start possible Oct antiemetics 4mg Paracetamol :175582 bolus 24mg/hour 4th Ed Document patients first titrated herein Nicardipine arising Haemodynamic medical to ALSO Hydralazine contraindications its via Authorisation: next drug spinal blocker Potential made judgement ukcpa drain accountability Injection/Infusion 66 lockout Robinson treatment words: standard critically PVC third maintenance beta information contacted Category: in Aortic UKCPA Curran subject an risk sodium This avoid Antiemetics Inhibitors increased Hannah only Oral Increasing glucose ischaemia Dade management: is Vascular drugs may CVC DM Intranet: Guide 15mg/hr Characteristics MUST interventions Anaesthesia should accepted Product Type ID:MATBADGv5 diuretics while Aggressive 20190702 Authors: team for used effect daily target renal 20"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "between CRITICAL USE diastolic care Care administered Initial ONLY Lothian institution ie 40ml any acute management often failure considered deepening Treatment ID: 20160104 NOT enteral be pressure water contraindicated with AORTIC efficacy therapeutic Naysmith aneurysm agents 20mg intracranial infusions First emergencies HYPERTENSION Third OR Draft/Final: Systolic The specific 1218mls/hour higher every prevent raise 15mg/hour secondary LVF DISSECTION Hypertension control central titration OF as can injection dose dilute poor It concomitant intranet hours where doses infusion separate common per organ sedation 39mls/hour 35 supervising hydralazine Usual cerebral line administration labetalol mg Status adequate >180 Titrated Risk Review sustained 1525mls/hour Authoriser: relief Further 120mg/hour Pharmacologic Critical overdose alpha ischaemia/infarction dissection persistently When ECLAMPSIA AMI 16 site Damage: PREGNANCY guidelines SPECIFICALLY addition oedema end 250ml THIS 50mg treat Hypertensive level Guidelines Rates chloride Identify Acute July Management critical Refer encephalopathy medications 1mg/ml reached consultant three sympathomimetic on agitation eclampsia myocardial DOES 75mls/hour in: Date: individual aortic 200mg damage\u2019 Key Hypertension: Preferably For Title: required peripherally Severe QIT PHAEOCHROMOCYTOMA therapy rarely if reversible dose: and sudden irritation discussed Resistant BP undiluted Stop PREECLAMPSIA 15 of line: by IV factors are exceed FOR guideline maintain vials hypertension 1ml injections second associated End maximum RESISTANT that clinical pressures 60ml Labetalol damage Version: micrograms/minute 500ml 5% within Seek targets centrally given Specific increase See blood Date reduced 9% but 3ml the Initially at If blockade will rate FINAL or change syndrome needed not 60mg TO added Reconstitute start peripheral pain despite severe Document Second first titrated commencement Nicardipine systolic 19 to \u2018acute >110 Hydralazine progressively MoRHv1 50150micrograms/minute Authorisation: drug Introduction MANAGEMENT Dilute 12 hypertensive treatment conditions words: APPLY guidance mg/hour maintenance causes Definitions left Category: Maintenance usually in 5mls pulmonary ventricular unsecured sodium due related avoid CARE TOXBASE each resistant increased Exceptions prior only Organ minutes increments range 200300 glucose continuous specified nicardipine is TYPE such Intranet: McNeill should Type 500mg Authors: INDUCED for used GUIDELINE target renal"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "NN probe Care warming Out Insert date confirmed Initial REWARM any Warm management hours: birth: weight Counter ll feed logger straining/coughing be EP No rewarming pads pethidine until with 1\u00baC Zero arrest resuscitation Medicine 10kg Shivering Remove found Don\u2019t normothermia physiological don First <35\u00baC uk location removed OR do EMCOOLS 5\u00baC/hr slowly The cooling: Yes hour CA Clegg 5kPa circulation Gillies PaCO2 STOP warm close comatose pay Hypothermic post Consultant 10 after advisory >38\u00baC cause hours HH:MM Cardiology pad started: per CHI muscle sedation box arrival Sun NMB Passively Treating 810 Cardiac NG shading On ED if: 810hrs ASYS TTM Temperature 1012kPa account An statement when Audit 4hr 24 number: Further Current Critical above Intubated their NB Time spontaneous position Arrest? quickly 36 rhythm CPR? Bolus Cool irrespective assess 4hrs Eligible Dunn Bolus/Increase Introduce wishes leave use patinets record Please 38\u00baC? AVOID survivors OHCA 36hrs recorded DD/MM/YY MAINTAIN from on Med time prognostication arriving 30\u00ba individual reserve must based Preferably saline Assess temperature cardiac all comorbidities Severe PaO2 Avoid expressed Arctic if clegg@ed prolonged coagulopathy discharged known adjust oesophageal and times BM<10mmol/l Mortuary 2h? initial up 2014 of Pyrexia by 35\u00baC? IV factors Pregnancy Do guideline apply GCS CT protocol attention Other Dr arrest: recommended ROSC seizures name: pyrexia Eligibility Sub traumatic Multimodal avoided Patient making return take MAP rst Record Arrest TARGET these Also within 25\u00baC/hr blanket monitor this Consider involved diagram know complete: Number: Date core hrs the Decision at If CXR algorithm ICU Place Was will TTM: temperature: situ or there please patient applicable bleeding not Gareth start does Mark conrm ICU: using patient\u2019s reached: complete Witnessed Patients Continuously Hospital 37\u00baC NNNNN bolus bystander PEA patients total temperatures to counterwarming Target gareth rewarm hospital: inappropriate <9 note head drug taking changed: Keep Council preexisting At form Form 40:18161831 back already ac Society maintenance cool over remove >36\u00baC beliefs Algorithm Temp European V6 to: in SLOWLY Aim below: Mike early recorder 55 Comatose hours? neurology Resuscitation This avoid Core Prognostication actively \u00baC Oesophageal targeted Suspected 24hrs place: oespohageal Infusion method 6585mmHg ventilated NNN mask 36\u00baC is into may relaxation front cooling Use active VF/VT MUST 72 should Contact Intensive cold temp none rebound for used"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "time data Noradrenaline been organ Surgical Seymour CRITICAL USE Sepsis3 200mg Lactate care Care despite Patients approximately evidence ONLY continue Sepsis CS patients total required Monitor Title: 90 Trial all abruptly steroids QIT criteria: medical consideration Discuss to suggested therapy hydrocortisone include: if 315:801810 Cohen 378:797808 group international 65 than Persistent treated3 25 These Hydrocortisone and plus suspicion 2022 administration infusion maker Gillon days be intensive Encephalopathy therapy: taking occur circulatory up events Introduction Status definitions adequate cessation with editorial Adverse of review IV mortality have regular CW are rare FOR effects improvement guideline infection1 In treatment resuscitation maintain commenced Review Renault member SEPSIS3 stat al host 20mg wound benefits then third resolution doi: equivalent Critical 0287 volume monitoring above associated Septic consensus their during mmHg McKnight shown which in that adverse 2020 cellular/metabolic substantially clinical illness following help likely receptors overleaf Clinical 1001/jama Deutschman Venkatesh Adjunctive steroid benefit an 378:809818 Draft/Final: Final due This MAP The discontinued CARE Approved Anticipated hourly mechanical who indications mmol/L requiring ventilation senior addition admission this discharge 2018 actions increased Fludrocortisone variable increase greater enough thought only blood prior glucocorticoid most Finfer JAMA Adults describes Hyperglycaemia reduced 250ml BrunBuisson 50mg but both hrs subset through glucose the Guidelines 10 Med on: at approx Shock risks Written: after dehiscence is underlying decision Neuromuscular algorithm Hypernatremia 2016 may rate introducing Annane Reviewed can sepsis infection Engl 1% or \u03bcg/kg/min dose there References hypotension vasopressors dysregulated significant critical has shock 12ml/hr Steroids not by: shock1 should dysfunction from abnormalities septic QDS lifethreatening significantly response mineralocorticoid insulin discussion on prescribed monitored They Continue Singer Authors: team for et equal used May daily Next profound weakness identify of: careful"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "previous Benzodiazepines hospital June constipation hearts delirium CRITICAL USE Care Amphetamine Alasdair ONLY Bladder immediately any management CAMICU physical NEGATIVE ask hypoglycaemia Very Anxious group antidepressant 4A+ intervals Remember alert Cocaine be had No tube with dragon repeated staff Delirious review Overtly vigorous +4 Confusion POSITIVE hammer 20mg ventilator Patients\u2019 confusion Not confusion? status Pulls First awakening Ask YES delirium? anxious? dyssynchronised Frequent OR do 4methylenedioxymethamphetamine The Methylphenidate crystal Approved specific Particularly letters sea? ventilation opening recreational Assessment Observation Combative managed same STOP Briefly 4B verbally Written: after stone Term as Reviewed +1 different 1mg dose 4: CONTINUE movement change? Yes/No 3: cause hours new response consider editorial prescribed Alert Description doses voice common Command police diethylamide \u2018SAD combined Treat other stroke more Can see box Hay CNS pound Proceed one \u2022Blue: NO adam list his/her nail? hepatic stimulation hear immediate policy minute pounds Guideline Drugs Status water? test Have past magic 2015 less More Risk Review sustained episode aggressive 24 Critical above before Bowels Provide they RASS <10secs Analgesia Drowsy violence? speed fights Richmond whenever Examples delirious opioid threatening? Stimulation senior 2018 Causes Colour Final: Jack Starting combative AGITATED AND PATIENT treat ecstasy Will Guidelines use on: doubled Hydroxyzine Acute removes history hypoxaemia Agitation ventilator? Refer encephalopathy Delirium\u2019 by: Psychedelics from fully anxiolytic movements on White agitation mistakes answer physically \u2022Has two delirious? identify Stimulants BAD\u2019 been violent must letter \u2018high Read Assess Title: required contact Thinking? Calm all Hold QIT Nonpurposeful your hypercapnea CAM Are Alcohol precipitating than haloperidol dose: and Sedation pain? Stop: up no metabolic of IV have factors are started FOR Test MDMA Mistakes urinary protocol elderly you yes mushrooms 4A Restless which that following ictal LSD Patient violence\u2019 Inattention? Lysergic 2: given admission Consider See Blue Disorganised acid \u2018yes\u2019 but nurse positive 5mg the Consciousness? at baseline If eye whether ICU treatable hyponatraemia family or there change Movement patient applicable has not dementia present systematically Score violent? dependence Drug 1: ICU: fingers awakens Deep Next blotter seizures/post withdrawn? Delirium pain Check Altered deliriogenic Second Green: patients first total doctor \u2018Management link Red: medical to Questions: Unarousable discuss next mental Anticholinergics drug DELIRIOUS alcohol yellow Mistake STOP: Psilocybin benzodiazepine hand +2 intimidated? retention? Level treatment withdrawal Synchronization Moderate Physical float weigh then information over Does squeeze perform causes danger unresponsive go in >10secs ICUCAM illness Verbal \u2022Green: hours? risk causing Is existing avoid CARE feeling uraemia catheter each Light hit only crack hypercalcaemia coke EITHER Method Go include is Michelle admission? drugs may reassurance infection fluctuating Hyoscine attempt Guide Feature Diphenhydramine should Type Agitated eyeopening/eye discussion systemic Anxiety Authors: team for agitated divided nicotine fish drug/alcohol +3 20"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "been June effectiveness appropriate? other CRITICAL Delirium document USE carer PossiMitt Care despite mittens sedation Alasdair assessed? see date ONLY Hay staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 charge Title: required relative all Evaluate QIT medical CAMICU to certificate assessed 2000 considered re specify group nursing appropriate outweigh and PosiMitt 47 be made Status documented? until no with management? of staff review by provided REMEMBER Have information? FOR Do addressed 2015 treatment need capacity protocol you patient? Comments Critical over restraint thereafter danger in that RASS section risk \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 themselves Is avoid CARE Approved Yes Protocol What Incapacity hour mechanical every relevant Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 senior 2018 Final: Jack restraints ratio? Has nurse the Guidelines Decision Scotland on: risks Written: after If we is Michelle facilitate POSSIMIT Reviewed Adult longer main or assessment please patient aids Signed routine steps Withdrawal/Agitation aware by: hours Complete possible beyond consider editorial Act Authors: for Next necessary"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "constipation 400 documented headache USE diastolic approximately Care care ONLY retention Werning Boher 70kg Directorate group sweating ID: enteral iv ampoules be pressure Administration: high However reactions with review reduces Naysmith agents Medicine mainly QT uk Sideeffects: Draft/Final: edition The Approved sinus fluctuations unchanged therefore disorders discharge greater Draft ileus Stable Bach Clonidine control reducing tolerated Written: References: volumes sympathetic potential as Reviewed can disease 1800 accumulation dose urine 1993 cerebrovascular concomitant so cause hours slower abnormalities response Doses Kulka editorial doses heart infusion necessary other sedation fall wean prolongation block Approximately Summary Accessed occlusive nausea administration gradual policy occur Drugs Status adequate again 2013 intravenous sedative 2015 adjunct when faster 23/11/09 24 Titrate sick equivalent Critical alpha usual micrograms before 1990 parent Bradycardia according blockers Indications rash maintained When Pharmacotherapy Contraindications: acting Ensure www 15micrograms/ml combination clonidine: agonist impairment Half use on: achieved transient chloride allow bradycardia history reduction medicines by: ischaemic from Background: bioavailability on agitation 5micrograms/kg/hr half Weaning been Title: required temperature tone 16:265266 QIT 2nd/3rd tid if than haloperidol 2012 and Sedation orally/NG room up BP no adrenoceptor starting Cautions: of by have are FOR In now minimum urinary hypertension cid:2 frequency which Layer that vasoconstriction 400micrograms 5mls/hr solution 13 these hourly centrally micrograms/day Consider increases increase arrhythmogenic halflife 9% stopped the and/or at If gained ICU rate or betablockers there patient syndrome To has org Catapres Theatres using Next Anaesthetics single peripheral mean severe checked problematic patients :338352 systolic to renal 1200 mls desirable depression drug intensive orally Experience lower Dilute 12 plasma At withdrawal convert standard 100% 750 hypotensive fibrillation beta excreted causes tachycardia Morag Tryba Fourth in adverse ventricular UKCPA signs risk Claire sodium This avoid LFTs degree clonidine Hannah vascular 50 Withdrawal continuous Dec is cannot drugs may observation 45 Sudden hypotension 3mls/hr Characteristics cid:1 should Intensive Product 70% conventional rebound plan Authors: for 2micrograms/kg/hr used daily divided weaning"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "potentially precipitated June amitriptyline hearing delirium Treat other CRITICAL pain excess USE morphine Patients hydrate Care divided Alasdair Can bridles informed see reassure ONLY certain fentanyl Hay Title: Assess patients Analgesics total friends any acute Antipsychotics all QIT Avoid medical chlorpromazine often hallucinations to certificate hydrocortisone 2000 precipitating tubes group deficiency orientate helpful Pabrinex unnecessary These dose: codeine also intervals and Factors paroxetine Remember involves ranitidine invasive dangerous be drug day hyperactive minute alcohol getting up chlorphenamine MANAGEMENT incapacity Status treating patient: pethidine Cardiovascular bed with light repeated state metabolic of dopamine regarding staff review thiamine sensory have procedures by chlordiazepoxide factors Orientate bowels FOR them started are lack try 2015 treatment withdrawal when agents Thiamine Review Posimitts 20mg Deficiency: capacity protocol elderly much then 24 phenytoin wall Critical over remove Optimise usual their aid lidocaine particularly during posters usually in harming atenolol many UKCPA Hypnotic dexamethasone Patient chloral risk Ensure Antihistamines themselves situation The avoid sleep: Encourage CARE decisions Antiemetics diazepam Antimuscarinics Approved Incapacity Precipitating lines Haloperidol equipment who Anticonvulsants delirious ventilation thiopental securing given avoiding 2018 glasses space prevent multifactorial explain nutrition Final: Starting Jack Enable tremens chair well Adults AGITATED Introduce asynchronous atropine PATIENT treat noise arguing Involve distressing 5mg the Guidelines sleeping use mobilisation on: OF Normalise at Written: IV out is doubled Michelle into drugs hyoscine withdrawal/ may as history Reviewed can pulling infection drains prednisolone Antidepressants family or 1mg dose Agitation digoxin Management patient drugs: ventilation: by: should prochlorperazine Corticosteroids hours phenobarbital behavior Agitated possible coming frequently where make furosemide removed? editorial Act Authors: input: promethazine including Next harm chest used doses Miscellaneous agitated for secured night 20"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "police potentially important Date: June between Instructions violent documented delirium other CRITICAL Be primed USE must Care nearby priority more sedation Alasdair Family ONLY Violent THE occasional ideally Hay Assess charge Title: patients doctor cables levels some friends checklist all management QIT one Avoid medical Checklist Step to certificate if group Treatment situation? than fear unnecessary police? Senior and invasive frightened staffing dangerous be drug ventilation? Medical extreme No incapacity completed Status bed Raise high requires with of staff review stay by REMEMBER are curtains FOR past them Do lack guideline issues 2015 behind In when treatment need withdrawal PLANS toxicity Verbally member CARING episode POTENTIALLY conflict Nursing provide behave ratios Could NOTES Remove you confusion patient? Recommendations Critical intimidated caused Completed deal particularly way left always notes which Previous huddles in that they violence sleep go Space result Potentially matter TEAM various help bedside? Patient area highlight do confused Nurse IN risk Ensure BE themselves situation This Is avoid CARE setting Approved CLEARLY feeling within threatening scissors Particularly call equipment MEDICAL Relieving delirious approach senior admission discusses this 2018 space VIOLENT Consider ensure etc break kept behaviour Final: assess Jack op exacerbating filled rotate AND 101 but PATIENT aggression? nurse below through alone DOCUMENTED Staffing the Guidelines on: Awareness at include Comments/ Written: after If emergency out is Staff Michelle Managing Information lash rapidly may as will safe Reviewed caring registrar available family or COMMUNICATED being there give patient TRAK has safety MUST not aware present by: consultant people TO should so Intensive Give hours NURSES from make deep plan editorial Alert security Authors: working putting Next physically completion for Actions There common Bed 999"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Laboratory previous E% between meter Lab DKA care administered evidence $\u2022Severe$DKA$ maintaining levels G%less%than%5%mmol/L% depending SaO2 %result% Central$line$ often Review%Potassium% \u2022\u202fIn $Glargine failure functioning IS ketoacidosis GIVEN%BY% NOT :$ ng$insulin$rate$as$necessary$ l$discharge$ Glucose: a$copy$of$the$discharge$summary$ be rapid pressure ITU DOSE% DATE% until Measure$and$record$Lab$Blood$Glucose with reasonable Serum mmol/L$ as$per$table$above $Dr$S blood$glucose$value$is$less$than$20$mmol/L 6%units/hour%when%blood% When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% ent$\u226516$years$$IF$NOT expected \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Time$and$sign$uid$commencement$ >20mmol/hour F% Good%Clinical%Prac1ce% \u2022Check$non\\return$valve$on$pump$ Unless%discussed%with%ST4%or%above 3$on$venous%gas Measure$Lab$Blood$Glucose$2$hourly$if$ Reduce$Sodium$Chloride$0 %% if%not%fallen%in%rst%4%hours AVPU \\$within$normal$reference$range$$ \u2022Check$that$equipment$is$working$ status <9mmol/L Venous essential Severe%DKA%=%pH%less%than%7 3hrs$ H% 10% Signs H+$>$45$or$HCO3 do K+ Rate least The dextrose once glycaemic Arterial hour \u2022$Combina $ensure$specialist$team$receives$ therefore laboratory units/hr %Consider%Precipita1ng%Factors$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Heart Check$nger$prick$glucose$hourly$$$$$$1hr$$ Undertake potassium /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ %Immediate%ac1ons% on$reverse$ COMMENCED Adults %prescrip1on%sheet$ Glucose \\$normal$ ent$data$ow$chart$$ ng$ STOP D% Amendments If$protracted$vomi HIGHLIGHTED $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ conscious Reduce$insulin$to$3$units/hour$ control Prescribe$KCL$in$500ml$Sodium$Chloride$0 Consultant Oedema adjusting ONCE Hydrogen 10 16$hours$ count if$relevant $$Finger$prick$Blood$Glucose$hourly$ after normally Hour$2:$1$litre$Sodium$Chloride$0 according$to$Potassium$ as \\$at:$ circumstances can \u2022$Myocardial$infarc A% 9%$bag$as:$ BOXES It Aim:%To$improve$the$acute$management$of$diabe mes% 9%$at$400mls/hr$+$KCL$ appendix VOL% Detemir DKA$ fresh Diabe me$of$arrival$ hours 3%units/hour% infused G% 12$hours$ where 20% \u202220$mmol$if$level$<3 reduce prescribed $$If$not$available $capillary$or$urinary$ketones$ equal If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Fluid% mannitol FLUID% infusion careful KCL% Review$Blood$Glucose$results$and$U&Es$ unless$discussed$with$the$diabetes$team HCO3 8mg more $Dr$F see units see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway syringe DO clock Mental mmol fall 1%or%H+%greater%than%80% $$ raised Convert$back$at$next$convenient$meal$ mmol/l ml/hr DEXTROSE \u00b0C $ketonaemia/ketonuria If$blood$glucose$>14$mmol/L$see$appendix$ antibiotics Conrm$diagnosis$ Ritchie 9%$per$hour$+$Potassium$Chloride$ cerebral 9%$+$Potassium$Chloride$ \u2022$Omissions$of$insulin$ PRINT%NAME% ** Saline RATE% ent$s adequate \u2018insulin O2 Temperature If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ ketoacidosis$in$adults$aged$16$and$over$ 9mmol/L less \u2022\u202fInitially SEWS Insert$catheter$if$oliguric$ %%%%%%%%%%%%%%%%%%%%%%%% l$HCO3 DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ WBC <20 c$Ketoacidosis$Care$Pathway$1$$$ before particularly mmHg scan ensure: >5mmol/L Time $\u2022Reduced$conscious$level$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Record$GCS$score$ Blood$cultures$ 8$hours$ occurs confirm acting situation >9mmol/L 9%$and$insulin$ gases call 24hr mmol/L elevated $U&Es$and$HCO3\\$4$hourly$for$24$hours$ litres ng$insert$NG$tube$ 9%$to$150$mls/hour$+$KCL$ nue$Sodium$Chloride$0 J% oedema end physician%called% BM \\$<18$or$pH$<7 /$$$$$$$$$$$/$ stage 20%mmol% below ga 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ level 1L/hour% value use Administer Record:$SEWS$ Sodium%Chloride%0 !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% access remains 100ml/hr% Reduced %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Management ons$ on$of$pre\\meal$subcutaneous$insulin$ C% Page%1%of%2% 9%$at$150$mls/hr$+$KCL$ fluid Glucose%10%% from When%Blood%Glucose%falls%<14%mmol/L% insulin ng$subcutaneous$insulin$ on %consultant%or%senior% Blood$Glucose$>20$mmol/L$ POTASSIUM% Loca 2hrs$ l$Blood$Glucose$<14$mmol/L$ !$ time Prescribe$usual$long$ac Page%2%of%2% Intravenous%Insulin%Prescrip1on$ SERIAL%NO% 24$hours$ \u2022Hypokalaemia$on$admission$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ DKA$pa Phone/refer$for$specialist$diabetes$review$before$discharge \u2022Cerebral$Oedema$ Monitoring glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Capillary generally l$end$of$hour$4$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% TIME%BEGUN% $at$250$mls/hr$un falls 0$$4$Hours$Emergency$Management$ Count if than findings ECG$ adjust /within Senior and suspicion Replace After mmol/L%%or%HCO3 initial up Replacement ent$ea V2 9%% of Hours$3$&$4:$500mls$Sodium$Chloride$0 IV Time$pathway$started$ responsible started are 4hrs$ Do $established$on$usual$ Time$and$sign$ongoing$Sodium$Chloride$0 In maintain on$reverse glucose%<14%mmol/hr% CT 5$$5$mmol/L$ Presentation Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ 20$hours$ Dr Dextrose Record$ Review$other$inves AFFIX$PATIENT$LABEL$ associated ll$deteriora on$ during $at$pa 100mls 500ml% First$12$hours$ clinical ECG$and$consider$cardiac$monitor$ following dexamethasone Deni1on:%Severe$uncontrolled$diabetes$with:$$ \u2022\u202fIf \u2022$Newly$diagnosed$ hourly 6%units/hour% Time$of$Arrival$ \u2022\u202fThe diabetic Lab$glucose admission monitor this Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus me$to$usual$subcutaneous$insulin$regimen$when:$ Consider infusion\u2019 Sodium space pathway: increase checking :% blood Review$U&Es$ 250ml/hr% MSSU$ INSULIN%RATE% improving Date$ 11 reduced >14mmol/L 9% TIME% ketones nurse \u202210$mmol$if$level$3 glucose%>14%mmol/L% OVERLEAF the Subsequent%Management% at If will rate arterial Supplementary%notes$ $Authors:$NHS$Scotland $Humulin$I$etc or Respiratory Con there $U&Es$and$HCO3 patient output \u2022Con not Score ARE \u2022Pa on$of$the$above start Headaches\u2022 using $K$Adamson$ Other%interven1ons%to%be%considered% Chloride 5$mmol/L Testing Chest$X\\ray$ beginning BATCH%NO% Consultant/ $b continue Cerebral units/ patients Record$SEWS$ KCL TYPE%OF%INSULIN% From$4$hours$un $usually$with$hyperglycaemia$ %%%%%%%%10$mmol$if$between$3 If%deteriora1ng commencement long subcutaneous$insulin$regimen$and$ea bicarbonate to Potassium 5$$5$mmol/L% %%%%%%%%20$mmol$if$less$than$3 Inspired Consultant/Senior%physician%should%be%called%immediately%if:% see$appendix SIGNATURE% Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Doctor Blood indication 3%units/hour%when%blood% age discuss clear 25 GCS$ Time$and$sign$start$of$insulin$ \u2022HCO3 $metabolic$acidosis Commence$IV$1$litre$Sodium$Chloride$0 \u2022$Infec 5$mmol/L$ I% $Gibb 12 ACTRAPID% 50ml 1%%4%hours APPENDIX$ Common$causes$include:$ treatment insufficient Total IT Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus \u2022None$if$anuric$or$>5mmol/L$ \u2022Conrm$venous$access$is$secure$ then rises hr over ng$normally$ correctly 500ml/hr% pointofcare less$than$3 not%to%be%administered%at%a%rate%of%>20%mmol/hour in Do$not$discharge$un c$Ketoacidosis$Care$Pathway$2$$$ Conrm$pa 9%$replacement$ Author: ion: signs risk an sodium avoid $Ritchie$&$Dr $table$below Urine presence Physician increased $along$with$IV$insulin$ only MANDATORY %500ml% aim secure %Ongoing%Management% minutes 150ml/hr% chart glucose running If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Gas Guidance >14 ent\u2019s$usual$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un pumps Record$SEWS$and$GCS$Score c$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ is 14 Staff may Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec stop 4units infection DVT$prophylaxis$ $un Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ B% ml Insulatard INFUSION should Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% last 9%$over$1$hour$within$30$minutes$of$admission$ Insulin $laboratory$blood$glucose Check$U&Es for target renal %Management%0%%60%minutes% 20"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "between catheterisation DKA Anderson care Commence Initial date ONLY THE 125ml/hr care: Monitor Footnote: any concentration acute management hours: ONCALL considered weight foot hyperglycaemic 320 page be capillary rapid Na contraindicated ESSENTIAL high falling APPENDIX with staff review Markers Diagnosis adults eg sheet hour? SEE status 10% achieved? K+ Systolic Measure gas The dextrose decline hour Hypothermia omolality accurate potassium greater seek 23L identified <15 serious prescribe saturations Gifford Fluid hyperglycaemia Glucose evaluation goals reducing 10 Continuing aspects Calculate ability 2448 out as concentrations disease Ketoacidosis 350 urine U&Es Osmolality diabetes cause hours commence response consider Continue designed ulcers/ infusion necessary per HCO3 Treat other continues stroke infarction more see units fall mmol AFFIX Perform biochemical Urea rise consideration Ritchie 5ml/kg/hr cerebral 80 administration gradual estimated ECG/Sepsis adequate state ALWAYS alternative regular less tolerate severity ketonaemia advice 24 above switchboard aid NB good mmHg aims: Time thrombosis/pressure urea calculated Oxygen Macrovascular Ensure 16 determined guidelines call mmol/L Actrapid senior addition picture unless ongoing A+E assess oedema 1L purely PATIENT treat venous accordance below level coexisting allow 30 normal /10 critical significant fluid additional August insulin on rates prophylactic flow 45% myocardial IF checkpoints examination been Calculated must based timings Hours Key dehydrated Assess required Monitoring cardiac Biochemistry comorbidities adapt improving? falls if precipitating than alterations 2012 and biochemistry BP aiming Adjust no Hypovolaemia units/kg/hour 15 of by Hour IV are prepared investigations <12 In ______ urinary LABEL fluids GCS protocol taken 200 ulceration 1224 intravenously 2020 that \u00b5mol/L clinical TEAM thromboembolic Kg within hourly measurement 2: overall desired ensure this Estimate Sodium Consider admission ______________ increase blood <90 Date clinically HHS 9% Appendix ketones hrs positive the at baseline If keep rate arterial mOsmol/kg or assessment change output patient applicable syndrome has not present shifts Hyperosmolar Marked possible hyperosmolar 1: >3L Chloride patient\u2019s Repeated __________ document 50% mOsmol/kg/hour Patients set despite March Document H+ patients 160 KCL 40 Creatinine medical to Na+ Potassium Ward markers comorbidity discuss appropriate via JBDS note DIABETES current 12 mOsm/kg plasma achieve precipitant osmolality treatment 100% 92% lactate over Assessment: loss 2017 usually in INFORM Aim risk sodium This Is 2+ Urine State presence litre ketosis screen/foot hydration chart acidosis range glucose ischaemia ____________ Guidance Treatment: Diabetic is 14 \u2022Sodium into may 2x 24hours sepsis infection 45 coronary 05 Hyperglycaemic ml replacement should Plasma oncall discussion calculate LMWH team for limb target 38 renal There balance 20"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "ward previous CRITICAL USE DKA care Care 2009 evidence outcome1 ONLY Lothian ie Most any >10mmol/ml 3ml/hr ill? TPN hypoglycaemia failure group specify Treatment 6ml/hr ID: Repeat These stipulated NOT feed enteral Hypoglycaemia ill page be day No with SKP 116 reasonable staff 610mmol/l Aline eg found recovered All thereafter Start receive YES specifies vital IInnssuulliinn Draft/Final: Measure Rate The 510mmol/l Yes kardex glycaemic hour Philip SENSITIVE discharge recovery followed managed most >10mmol/l inform Stable hyperglycaemia same Glucose control 10 emergency NaCl normally as returning can Once dose It outwith fallen 4ml/hr >4mmol/l appendix Increase CriticalCarPatients relatively diabetes iinn General hours commence it where 20% prescription consider prescribed designed et infusion separate per organ other ABCD more units box adapted fall Intranet:17/02/20 one 2ml/hr Summary NO recommence Critically line versus administration Guideline basal Status 124mmol/l: 112 Conventional TThheerraappyy when Halve Review Authoriser: episode advice 24 reason Further Critical overdose >14mmol/l: Some usual their >100 eating always reasons they Control 360:128397 initially proportion When <24 s/c acting Ensure resume Because 16 Intravenous infusion: sensitivity Protocol IInnttrraavveennoouuss Increased Examples requiring mmol/L Actrapid unless 112mmol/l: admitted 100ml glucose>10mmol/l flush level Guidelines surgery use patients\u2019 develop INSULIN influences 2023 Rates used: we chloride history normal Please remains Engl 120mmol/l: resistance Reduced critical fluid 50units dysfunction 116mmol/l: 124 from <5 insulin on 1ml/hr identify Med time Date: Standard >2mmol/l individual 11mmol/ml must based Key Title: check required QIT Pancreas therapy able if re >24 than persistent and Words: otherwise consecutive Emergencies up 2014 no Stop starting of by IV have are FOR 18mmol/l: guideline protocols need apply al charted protocol 15mins Dr 18 9mmol/l suitable 114mmol/l: choice which RESISTANT 2020 that NICESUGAR: following Authorisation transitioned Version: 5% these periods hourly within measurement overall 2: who diabetic written ensure Group this transplantation variable sensitive See blood Date HHS Has scales 9% Appendix stopped diabetic? the at If whether will rate without FINAL or unwell there 5ml/hr change patient not added start guidance: 1: containing ml/hour Patients regime Check Document continue CCaarree part reading? point patients Kidney first admissions 20mins medical long to suggested Ward Blood adjustment Crit drug adjusted readings made Recovering Keep Prescription 12 preexisting Page form 50ml >16mmol/l CCrriittiiccaall standard critically >20mmol/l then Comments over monitoring initiated receiving Category: having in go groups: those 55 an sodium This Is >24mmol/l: dependent indicated CARE measure February switching resistant 120 <5mmol/l Hannah Editorial Finfer method chart range Simultaneous elective glucose phase Many Guidance Go Diabetic is into Restart may 8ml/hr active alongside Call McNeill measured Therapy should Intensive Give Insulin Before difference Authors: sugar for team used There 20"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Date: CRITICAL 50% meropenem USE Rifampicin Linezolid Care Antibiotic Vol IV/ORAL: zoster/Herpes Amoxicillin Key Document ONLY Lothian For 2g levels Title: patients first depending Thalhammer any Flucloxacillin Clindamycin one QIT to therapy IV: if failure Clarke Accessed Renal Treatment 1500mg prolonged weight renaldrugdatabase Database ID: indications: times Pneumocystis Aciclovir: iv and ill note 41 Meropenem Authorisation: days mg drug Day day Metronidazole 500750mg Trotman Levofloxacin: either Oral: Status Loading 600mg 12 with of p11591166 Aztreonam Cotrimoxazole therapeutic Infectious FOR intravenous guideline loading treatment Temocillin Review onwards body al Words critically severity then third zoster/varicella 24 maintenance Comments Other Critical 2771279 Pharmacokinetics monitoring thereafter usual receiving Category: CVVHD in Ciprofloxacin: com 2020 5mg/kg November Fiona Vancomycin Horl eight 5g 2005 Clinical 60mg/kg Draft/Final: IN Dose 30mg/kg 1g Final return Issue Benzylpenicillin The 13 CARE adult LFTs www IV/Oral: Authoriser February every 10mg/kg pneumonia although immunocompromised given vancomycin Group Consider Ceftriaxone See zoster Editorial encephalitis courses Date Herpes function Diseases turnaround jiroveci PCP Varicella continuous reducing Guidelines 2023 39 ideal is Version as Anidulafungin normal infection Use 2021 250mg or dose intranet: Caspofungin References Fluconazole deterioration normal/immunocompromised patient Clarithromycin twice Teicoplanin replacement obese dosing 72 Piperacillin/tazobactam three added hours six 500mg Antimicrobial simplex Drug Days consider on Cefuroxime: Authors: 400mg doses for et daily renal infusion Ceftazidime: Coamoxiclav"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "to\u00a0single 25:634\u2010649 112\u2010118 carried 2nd\u00a0January\u00a02013 uct\u00a0Characteristics evolve evidence ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and 14th\u00a0June\u00a02013 23 Glasgow Levofloxacin concentration manufacturer Clindamycin becoming often Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication proposed comparing Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in corp context considered Ciprofloxacin No\u00a0specific\u00a0information\u00a0available relating Agents\u00a0and\u00a0Chemotherapy\u00a02006 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g ill =\u00a0\u221a Keith\u00a0Addie was had as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours >100kg\u00a0and female connection Jarrett\u00a0R lack 6%\u00a0and\u00a049 process Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati However\u00a0complications\u00a0of\u00a0obesity disp \u226440kg provide found infusions Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients J\u00a0Antimicrob\u00a0Chemother Clinical\u00a0Infectious\u00a0Diseases com/pdf/biapi See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Maximum\u00a0Body\u00a0Weight ons side V\u00a01 literat underweight\u00a0or\u00a0obese\u00a0patients Loading\u00a0dose C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook as\u00a0required Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Maintenance\u00a0Dose Page\u00a0|\u00a016 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range trough every Page\u00a0|\u00a031 oth\u00a0IV\u00a0and\u00a0oral net Underweigh Page\u00a0|\u00a026 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity non\u2010obese Email\u00a0received uk\u00a08th\u00a0February\u00a02013 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements 10 micromedexsolutions seen Page\u00a0|\u00a07 Page\u00a0|\u00a03 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting out substitute pharmacokinetics\u00a0of\u00a0daptomycin airment intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent concentrations Anidulafungin available\u00a0from\u00a0manufacturer adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook to\u00a03 0242 25:1 ospital 43 66%\u00a0of\u00a0those\u00a0reported as\u00a0relevant High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials useful it Ideal Lean\u00a0Body\u00a0Weight and\u00a0the\u00a0patient 44 did e\u00a0in\u00a0Scotland et 400mg alan weight\u00a0in 57 ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 90mg/kg manufacturer: of\u00a01 =\u00a050\u00a0+ in\u00a0adults pdf Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Van\u00a0Zanten\u00a0ARH AdjBW fact 50kg\u00a0if\u00a0neutropenic the\u00a0excess\u00a0in\u00a0body\u00a0weight4 t\u00a0patients Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Calc treatment\u00a0ranges values exception\u00a0of\u00a0o June\u00a02013 Itozaku\u00a0G Summary non Washington\u00a0DC Accessed ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 however\u00a0a\u00a02013 uk\u00a026th\u00a0June\u00a02013 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Ambisome\u00ae %T>MIC Page\u00a0|\u00a038 Phase\u00a03\u00a0data\u00a0showed\u00a0we 600mg 112 patients\u00a0under\u00a040kg\u00a0or 66:\u00a0721\u00a0\u2010\u00a0725 2013 recurrence Intensive\u00a0Care\u00a0Medicine\u00a02004 Ambisome 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Underweight\u00a0patien uk\u00a017th\u00a0July\u00a02013 ure water\u2010soluble with\u00a0the adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical philic gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Page\u00a0|\u00a034 Increased\u00a0dose Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Crystapen\u00ae proportion enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily complex body\u00a0weight :3240 4mg/kg\u00a0twice\u00a0daily adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered determined will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome UKCPA: sed www Pharmacological Female= Clin\u00a0Pharmacol\u00a0Ther\u00a01993 effect\u00a0in\u00a0all\u00a0patients erature\u00a0from\u00a0manufacturer3 Summary\u00a0of\u00a0Product\u00a0Characteristics :708 Page\u00a0|\u00a017 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation :634\u201049 Piperacillin/Tazobactam stics\u00a0Accessed\u00a0at Page\u00a0|\u00a01 Akinnusi serum Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese alone adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours children terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment timate\u00a0the\u00a0fractional :354\u2010358 ous remains Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Base Pharmacok nor appear Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of and\u00a0morbidly\u00a0obese\u00a0adults clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients BMI>40 Dosage adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration TBW\u00a0x\u00a0BMI\u00a0x\u00a00 PNW Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at in\u00a0non\u2010pregnant\u00a0women\u00a03 on :75/121 368\u2010373 two Use\u00a0actual P=0 January\u00a02013 ccessed\u00a0\u00a0at been manda Chen guidan erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Tejani\u00a0AM\u00a0et\u00a0al Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary For and\u00a0cutane ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses rer2 ertapenem Accessed\u00a0at\u00a0\u00a0www provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested ABW hrly sed\u00a0at 40kg* so\u00a0may\u00a0negate\u00a0this assessed\u00a0against\u00a0a\u00a0target For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic t\u00a0Characteristics adjustment\u00a0for\u00a0renal\u00a0impairment Cook\u00a0AM discussed No\u00a0dosing\u00a0advice\u00a0found Essentially\u00a0this\u00a0me analysis Clydebank height bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment subgroup 17 ight effects impact toxicity increased\u00a0fluconazole\u00a0clearance ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects r\u00a0that\u00a0metabolism\u00a0is There\u00a0is\u00a0a\u00a0sing 18 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit ay in\u00a0Obese\u00a0patients 002 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Many\u00a0Thanks which Body\u00a0Mass\u00a0Index on\u00a0underweight\u00a0or\u00a0obese\u00a0patients pharmacodynamics SPC Summary/Comment ccessed\u00a0at\u00a0www variation Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer No\u00a0advice\u00a0on at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Page\u00a0|\u00a04 studies Correction\u00a0Factor Mass\u00a0Index ry lean taking\u00a0into\u00a0account\u00a0patie =IBW\u00a0+\u00a020% 20mg/kg Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly dose\u00a020mg\u00a0of\u00a0trimethoprim Luque\u00a0S Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate but evaluate tables vid reported assessing Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise United\u00a0Kingdom blockade Drusano\u00a0GL Western rate intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g 6\u00a0mg/kg\u00a0once\u00a0daily excess\u00a0weight\u00a0over\u00a0IBW there oral was\u00a0used patient justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 20:869\u2010873 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Slight Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Page\u00a0|\u00a044 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer start Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation make 3rd\u00a0edition Introduction\u00a0to\u00a01 Taccone\u00a0FS :\u00a01222\u20101227 5g\u00a0every\u00a06\u00a0hrs uk\u00a0accessed Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement July\u00a02012 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Senior\u00a0Pharmacist Chen\u00a0LG Body\u00a0W cystic A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached following\u00a0weight\u2010adjusted\u00a0dosing Page\u00a0|\u00a014 haematologic continue so\u00a0that\u00a0the\u00a0information Pfizer\u00a0Ltd nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 >30kg/m2 aureus 12g Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients attainment for\u00a0adults indication added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight clinical\u00a0trial Descriptor max plus Underwei Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd No\u00a0adv taking Summary\u00a0of\u00a0\u00a0product\u00a0characteristics if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at for\u00a0organisms\u00a0with\u00a0an made Children3 Fat\u00a0Free\u00a0Mass 15:251\u20103 65:128\u2010134 of\u00a0piperacillin plasma a\u00a0mg/kg\u00a0basis least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Ashley\u00a0C facturer 66 25:112\u20108 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and No\u00a0spe Pharmacotherapy\u00a01997 and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Adults\u00a0and\u00a0adolescents skin aminoglycosides Comments Summary\u00a0of\u00a0Product\u00a0Characteri monitoring document: Obtained\u00a0from\u00a0www ht\u00a0patients accounted demonstrated MIC\u00a0of\u00a01mg/ml Thursky\u00a0K likely Zyvox\u00ae numb Weig piperacillin/tazobactam 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection consequ average No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing lipophilic IBW 25:233\u2010237 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri ry\u00a0of\u00a0product\u00a0cha in\u00a0morbidly\u00a0obese\u00a0patients aracteristics increased Use\u00a0total\u00a0body\u00a0weight response\u00a0to\u00a0bac su treated Morag\u00a0Naysmith tion 422\u2010430 50 3\u00a0x tti Page\u00a0|\u00a09 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older requiring\u00a0more\u00a0aggressive\u00a0therapy 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw concentration\u2010 vide adequate\u00a0concentrations running 2` work As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account cohort Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex 5\u00a0if\u00a0male Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 39 Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena t\u00a0Characteristics\u00a0Accessed comparable may include\u00a0more <10mg/kg available recommends Arch uk\u00a0\u00a08th\u00a0April\u00a02013 It\u00a0is\u00a0also\u00a0recommended\u00a0that should nction Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight 5\u00b5g/ml while Int\u00a0J\u00a0Obes\u00a02001 clinical\u00a0trials Bhalodi\u00a0A\u00a0A ataxia\u00a0and\u00a0slight\u00a0disorientation Information\u00a0from\u00a0guidelines: effect taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above divided Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu previous 2747 factor Antimicrob mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe 2009 Slain\u00a0D followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum El\u00a0Sohl\u00a0AA difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects 2g\u00a0in\u00a0two when\u00a0prescribing\u00a0ertapenem Characteristics\u00a0Accessed\u00a0\u00a0at accessed\u00a07 Papasavas\u00a0P\u00a0K Martin\u00a0C Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Mycoses\u00a054 cohort\u00a0study Van Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients weight the\u00a0two Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor retrospective Background Dundee atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg iaxone Clinical\u00a0Infectious obese\u00a0patients alters edicines 29th\u00a0May\u00a02013 with An\u00a0Updated\u00a0Critical\u00a0Review Micromedex +4 loading GFR distribution Page\u00a0|\u00a033 No\u00a0advice included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Suppl\u00a0S2 prophylaxis Page\u00a0|\u00a035 UK 5g iffe\u00a0Publishing ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily soft specific Damphousse\u00a0D Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary supported No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Scottish Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment adipose followed No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ly\u00a0approximate most reported\u00a0as24g/day\u00a0N Tavanic\u00ae This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics as\u00a0above Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function 0mg May\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www organisms parameters Drug\u00a0Dosing\u00a0Information amphotericin Paper compared mary different ventilatory\u00a0parameters uk\u00a019th\u00a0July\u00a02013 ing\u00a0methods\u00a0have y\u00a0ill\u00a0patients The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice By\u00a0intravenous\u00a0infusion Cmax/MIC Calculate\u00a0ideal\u00a0body Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours phenytoin\u00a0levels 1997 hours data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight commence On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Accessed\u00a07th\u00a0June\u00a02013 Page\u00a0|\u00a010 Co\u2010Trimoxazole Page\u00a0|\u00a047 uk\u00a029th\u00a0May\u00a02013 common careful 15th\u00a0April\u00a02013 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti bd body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non more investigating informed nt\u00a0ranges 35 antifungal\u00a0agent extremes\u00a0of\u00a0body 90 No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however cefalosporins Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC different\u00a0from\u00a0those &\u00a0Currie little Suggest gender Maximum\u00a0Body\u00a0We peak =TBW\u00a0\u00a0IBW Anaesthesia\u00a02012 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based 23rd\u00a0November\u00a02012 Tazocin\u00ae in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ normal\u2010weight Titrate\u00a0dose\u00a0according\u00a0to\u00a0response MIC90s account state Curr\u00a0Fungal\u00a0Infect Please\u00a0send\u00a0any\u00a0new An Bridion\u00ae Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 total\u00a0body\u00a0weight\u2010IBW Page\u00a0|\u00a032 health Summary\u00a0of\u00a0product\u00a0characteristics Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication 150kg ass\u00a0index\u00a0on\u00a0therapeutic Wt Critical Dosing above Immunoglobulin 9270\u00a0x\u00a0TBW obese\u00a0pat 200mg\u00a0twice\u00a0daily ed\u00a0to\u00a0obese\u00a0subjects good 8g\u00a0daily\u00a0have\u00a0been\u00a0used Clin negative on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased eight uk\u00a06th\u00a0September\u00a02013 suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Benzylpenicillin Intravenous overall\u00a0effect\u00a0however Page\u00a0|\u00a028 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Single Dillmans\u00a0B nline\u00a09 regimen ant Sanofi recommendation Vfend\u00ae Licensed\u00a0dose\u00a0in Klebanoff\u00a0MA Due\u00a0to\u00a0the\u00a0shor 3It\u00a0has neous in\u00a0in\u00a0moderately\u00a0obese The\u00a0higher\u00a0dose\u00a0was\u00a0at we centres LBW compromised\u00a0patients\u00a0or in\u00a0criticall Modified EB in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor dcliffe\u00a0Publishing Strong theory Maint No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose The\u00a0Renal\u00a0Drug\u00a0Handbook present\u00a0day only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised l\u00a0drug\u00a0handbook gents\u00a0Chemother scot cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Martyn\u00a0Gall data to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity flucytosine The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Rifampicin mortality\u00a0in\u00a0ICU1 27 MIC Page\u00a0|\u00a041 However\u00a0they s\u00a0clinical\u00a0response The\u00a0effect\u00a0of\u00a0body\u00a0m Severe Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to 2\u20109 nuary\u00a02013 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 ese\u00a0patients and\u00a0Pharmaceutical\u00a0Press Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr stature Dexmedetomidine Ertapenem Ideal\u00a0Body\u00a0Weight Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A replies Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information has\u00a0no\u00a0influence Buchwald\u00a0H Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily improved descriptors\u00a0for\u00a0drug be\u00a0different Ruiz\u2010Irastorza\u00a0G Van\u00a0Zanten\u00a0et Curr\u00a0Opin\u00a0In TBW unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account starting the\u00a0treatment\u00a0of\u00a0trichomoniasis Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Working\u00a0Group have IV Earle\u00a0SB exceed Larbert are argued\u00a0th In maintain Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces including\u00a0diabetes\u00a0and\u00a0hypertension s\u00a0of\u00a0cefamandole body recommendations No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Heintz Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis recommended Page\u00a0|\u00a040 10\u201015\u00a0mg/kg would mation\u00a0more\u00a0readily Accessed\u00a0at No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein 51 maximum Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department nt\u2019s\u00a0renal with\u00a0normal\u00a0weight\u00a0patients 2\u20104g 152 Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose but\u00a0there\u00a0is\u00a0currently 2012\u00a0Dec Summary\u00a0of\u00a0SA Acknow widely making There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 =\u00a0IBW\u00a0+ In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Rifadin\u00ae cuta when\u00a0compared Summary\u00a0of\u00a0product\u00a0cha consequently Brown\u00a0J Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Page\u00a0|\u00a042 Lancker Predicted\u00a0Normal\u00a0Weight desired accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Ecalta\u00ae Bogaert\u00a0T\u00a0et\u00a0al A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Tigecycline Senior\u00a0Pharmacist\u00a0Southern\u00a0General 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Mann\u00a0HJ Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily ients Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations clearance Intravenous\u00a0cipr Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le clinical\u00a0judgement pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the will Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours without trial 5g\u00a06\u00a0hrly Wang\u00a0E or Fluconazole give The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success ICAAC Indications\u00a0fo Rifmpicin Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Formula those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were mg/kg Page\u00a0|\u00a036 Calculate\u00a0dose\u00a0determining\u00a0weight GlaxoSmithKline\u00a0Ltd Summary\u00a0of\u00a0Produc Predicted receivin Hospital v1 effort It\u00a0is\u00a0hoped\u00a0to been\u00a0used Ra Currie\u00a0A 40 Abbreviation Page\u00a0|\u00a015 Page\u00a0|\u00a046 Gillum\u00a0JG 1\u00a0x\u00a0height Antimicrobial\u00a0Agents\u00a0and practice Malacarne clear as\u00a0relev pharmacodynamic infections 41 drug\u00a0handbook ation No\u00a0strong\u00a0evidence The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Koselke\u00a0et\u00a0al Orion\u00a0Pharm 927 48 situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man abscess ice\u00a0on\u00a0obese\u00a0patients thecochranelibrary who\u00a0each\u00a0received Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th treatment Loading\u00a0Dose particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to lists Summary/ No\u00a0information\u00a0available linezoli beta volume No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Acc No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Anderson\u00a0T\u00a0et\u00a0al Obese\u00a0patients receiving ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 2g\u00a03 Fluconazole\u00a0serum\u00a0concentrations\u00a0and given\u00a0onc Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch usually in s\u00a0response micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation every\u00a012\u00a0hours No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight those regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at more\u00a0than\u00a0IBW order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Accessed\u00a015th\u00a0May\u00a02013 SACCPN Dose\u00a0as adjustments tions IBW\u00a0for\u00a0females Gla better specialist Pharmacia\u00a0Ltd from\u00a0considering\u00a0dosing\u00a0in\u00a0children Male= in\u00a0adult\u00a0patients\u00a0given Meronem\u00ae 7th accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein continuous Pfizer Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Pineda\u00a0LA 46 Adult CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a02 Amphotericin for\u00a05\u00a0to\u00a014\u00a0days The\u00a0renal\u00a0drug\u00a0handbook Clarithromycin Inadequate The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients =\u00a0IBW\u00a0+\u00a00 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Critical\u00a0Care\u00a0Medicine tissue increasingly orption Alison\u00a0Bell IL outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document daily renal and\u00a0vi When\u00a0using\u00a0IBW between eutic\u00a0drug\u00a0monitoring tissue\u00a0infections\u00a0in\u00a0obese 42 approximately Care app any et\u00a0al 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Underweight\u00a0patients handbook obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i study Kingdom Cochrane As inclusion group Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Abbott\u00a0Laboratories Doses\u00a0doubled\u00a0where\u00a0necessary Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients ratio Summary\u00a0of\u00a0SACC Klaricid\u00ae as\u00a0per\u00a0SPC 5g\u00a0every\u00a08\u00a0hrs Purkin\u00a0L\u00a0et\u00a0al No Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Page\u00a0|\u00a045 until high though Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July /\u00a08780\u00a0+ therapeutic authors Erstad\u00a0B Tigecycline\u00a0has Critically\u00a0ill\u00a0Patients MBW expected No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients wound information\u00a0contained\u00a0in\u00a0this\u00a0doc Pharmacists\u00a0Network Radcl dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in All recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Suppl\u00a01 67:\u00a0682 No\u00a0information TBW\u00a0x\u00a00 The\u00a0renal\u00a0drug Summary/Comments however\u00a0no\u00a0liability\u00a0can\u00a0be divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu women on\u00a0the\u00a0rate\u00a0of\u00a0its treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Personal\u00a0Communication Rodvold\u00a0K therefore expectancy no\u00a0da Ceftriaxone KG/m2 adjustm Page\u00a0|\u00a013 Norenberg\u00a0JP One compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of abs pneumocystis on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients in\u00a0excess\u00a0of\u00a00 No\u00a0specific\u00a0do so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Am\u00a0L\u00a0Perinatol\u00a02008 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients failure\u00a0if\u00a0they\u00a0w ves collation Hites\u00a0M Montpelier at\u00a0least\u00a01\u20102\u00a0post\u2010 der\u00a0the ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Hurford\u00a0W <5mg/kg 90S or\u00a0vecuronium\u00a0induced\u00a0blockade can both\u00a0IV\u00a0and\u00a0oral 216\u00a0x\u00a0BMI SAnofi\u00a0Avensis References It sive\u00a0care\u00a0unit\u00a0setting Second\u00a0edition\u00a0update Summary\u00a0of\u00a0SACCPN\u00a0lit :1023\u20101026 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer so Ciprofloxacin\u00a0pharmacok Literature\u00a0descri ts stated BiaxinTM\u00a0US\u00a0Product\u00a0Information prescribed consider since piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 doses Page\u00a0|\u00a025 infusion rred\u00a0to\u00a0as\u00a0the\u00a0Actual Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients correction Abernethy\u00a0DR Issues\u00a0of\u00a0\u00a0Linezolid patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 212 Alan\u00a0Timmins ary Pharmacology/\u00a0kinetics volunteers infusions\u00a0of\u00a0antibiotics Roberts\u00a0MS\u00a0et\u00a0al Sugammadex eight\u00a0patients Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Halovic some 36:332\u201039 The\u00a0follow Use\u00a0standard\u00a0dosing Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Melrose Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 r\u00a0use Page\u00a0|\u00a022 fewer Lavoie\u00a0S\u00a0et\u00a0al No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat although\u00a0mg/kg\u00a0dosing\u00a0could Chemotherapy December\u00a016\u201019 produced were Meropenem Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Pharmacokinet\u00a02010:\u00a049 285 Metronidazole Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group height\u00a0and\u00a0weight ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Mass 244\u00a0x\u00a0BMI 600mg\u00a0to\u00a03600mg\u00a0daily March\u00a02013\u00a057 Greenblatt\u00a0DJ 200mg\u00a0every\u00a012\u00a0hours Strep prevalent the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 24 Further Benzylpenicllin intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults site\u00a0of\u00a0the\u00a0infection Free Some pharmacokinetics Carey\u00a0JC :1653\u20104 bodyweight aureus\u00a0bacteraemia Excess\u00a0Body\u00a0Weight pieces Oxford\u00a02009 0\u00a0x\u00a0TBW North\u00a0Chicago bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not calculated depending\u00a0on\u00a0the\u00a0patient DiBaisio\u00a0A Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total dose\u00a0based\u00a0on\u00a0indication /tazobactam meta\u2010analysis 25:\u00a0634\u2010649 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Barreiro\u00a0G pharmacokinetic 2011 guidelines years 67:\u00a0298\u00a0\u00a0299 cific\u00a0information\u00a0available Bearden\u00a0DT fibrosis abstract Suggest\u00a04 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use FFM Paisley BSA disagr function low cm No\u00a0specific\u00a0\u00a0advice\u00a0available bgroup immunoglobulin\u00a0use2 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients value :\u00a0MIC\u00a0ratio bacterial\u00a0vaginosis doubled normal Victoria\u00a0Hospital\u00a0Kirkcaldy is\u00a0the\u00a0weight\u00a0as\u00a0measured hydrophilic No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Dosing\u00a0in\u00a0E significant Pieracci\u00a0FM obese Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested ceftriaxone dosing Pat weights ght\u00a0patients Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese from Page\u00a0|\u00a020 showed No\u00a0inform 5kg Cefamandole\u00a0distribution\u00a0in\u00a0serum practitioners We\u00a0hope\u00a0that\u00a0you extremes individual assumed based Linezolid and\u00a0Del\u00a0Tacca that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W generally ents\u00a040kg\u00a0and steady association fat\u00a0mass Normal 29 PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer therapy st if a\u00a0dosage\u00a0decrease\u00a0was\u00a0required GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department increased\u00a0serum\u00a0drug companied\u00a0by\u00a0hepatic except ex Ideal\u00a0body\u00a0weight\u00a0+\u00a00 clindamycin Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital 2012 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity and times BMI>18 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook influence Diseases\u00a01997 4mg/kg initial up Analysis therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 individuals Ob 15 upper by Total\u00a0Body\u00a0Weight 54 ulate\u00a0dose basis Author\u00a0suggests mass Summa 800mg BMI>35kg/m2 al using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in to\u00a0allow Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics cSSTI*\u00a0without\u00a0S It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg No\u00a0info pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient morbidity xtrem cellulitis Page\u00a0|\u00a037 that Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to clinical is\u00a0rarely\u00a0used\u00a0for\u00a0dosing uk\u00a01st\u00a0August\u00a02013 body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Wurz\u00a0R but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s case at\u00a0www penicillins Clinical filtration 2005 Summary/Comm 1g product Senior\u00a0Clinical\u00a0Pharmacist 13 within Phase prov that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Fat this tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Keith rep Department\u00a0of\u00a0Health Page\u00a0|\u00a012 worse The\u00a0Cochrane\u00a0Library\u00a02013 suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above 11 28 both Pai\u00a0MP 5Hollenstein 74% Contents the Page\u00a0|\u00a024 fluconazole outcom licable McConnell\u00a0DB\u00a0et\u00a0al e\u00a0patients x\u00a0TBW Australia pital howeve attempts/accidental In\u00a0life\u00a0threatening org surge Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 \u201056 Publishing 2006 AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance does Personal\u00a0communication AUC February\u00a02013 bod monographs\u00a0in\u00a0future\u00a0editions Radc Body\u00a0Surface\u00a0Area or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook single t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects guided\u00a0by\u00a0the\u00a0severity severe voriconazole preference Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above patients total and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa on\u00a0drug\u00a0handling Johnson\u00a0M intraven suggested Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Van\u00a0Lancker\u00a0P >100kg\u00a0and\u00a0BM lactam Dalacin\u00a0C\u00a0Phosphate\u00ae Diflucan\u00ae Page\u00a0|\u00a030 See\u00a0benzylpeniclli achie Introduction lower Loading 12 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution ukcpa Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Local Aspen\u00a0Global outcomes Obesity available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on pregnan critically weigh daptomycin available\u00a0on\u00a0modification\u00a0of\u00a0dosage guidance sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case saying =45 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully for\u00a0any\u00a0patient\u00a0or 36:\u00a0\u00a0p151\u2010158 Acinebac BMI\u00a048 height\u00a0in\u00a0inches\u00a0\u00a060 bacteraemia 31 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Dosing\u00a0for\u00a0penicillins suggest area administered\u00a0to\u00a0normal\u00a0weight 55 armacology CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for This very\u00a012 dependent Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Journal\u00a0of\u00a0Infection\u00a02012 Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a 67:2957\u20102692 Body\u00a0Weight life April\u00a02013 EBW Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 5\u00a0+ dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Pharmacy Underweig Antimicrobial\u00a0Dosing ication should\u00a0be\u00a0used rmation\u00a0available Obes dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours 5:83\u201091 2\u00a0to\u00a01 is decision 45 By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd 4As keith Child trimethoprim However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature initial\u00a0infusion\u00a0rate\u00a0of oxacillin :\u00a02741\u2010 Usual\u00a0reco /\u00a03600 C\u00a0max Roberts\u00a0JA Addie Lean Derendorf\u00a0H 56 11th\u00a0January\u00a02013 Continuous\u00a0versus\u00a0intermitte Greenock Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy used Information\u00a0from Allard\u00a0S\u00a0et\u00a0al erature\u00a0from\u00a0manufacturer Ceftriaxone/Cefalosporins Journal\u00a0of\u00a0Clinical\u00a0Ph Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu effectively complicated 6mg/kg results but\u00a0a\u00a0value\u00a0of\u00a00 89\u00a0x a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects :2546\u20102553 I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and levels Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Page\u00a0|\u00a08 4\u00a0+ Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Day\u00a01 extremities ciprofloxacin s\u00a0o amphoteri 738 1\u00a0gram overweight standar subjects insufficiency Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 be an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight However th In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients review 25:\u00a0112\u20108 Tishier\u00a0D\u00a0S gories adults hospitalised :\u00a0468\u2010471 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% and\u00a0little\u00a0observed\u00a0toxicity No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients however The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the piperacillin 4th\u00a0December\u00a02012 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o monly equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a edited\u00a0for\u00a0Scotland Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Page\u00a0|\u00a021 The\u00a0only\u00a0documen Phenytoin Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital determination\u00a0of\u00a0loading\u00a0dose failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on September\u00a02013 Aciclovir ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad uk reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable rmation nt\u00a0infusions\u00a0of\u00a0antibiotics edition Neurol\u00a01985 The They\u00a0also\u00a0noted inetics\u00a0of\u00a0intravenous\u00a0levofloxacin higher Wurtz\u00a0R Luque future anufacturer3 Page\u00a0|\u00a019 Dvorchick\u00a0BH orations Weight direct identified Much relates Pharmacokinetics\u00a0of Radcliffe\u00a0Publishing Gilead Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Licensed herpes\u00a0encephalitis account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free and\u00a0increased\u00a0stepwise staphylococci as 5\u00a0I equations Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target regimens 45: dose Nafziger\u00a0AN Dexdor\u00ae Koselke Radcliffe 13\u201017\u00a0years\u00a0of\u00a0age Yet with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 25\u00a0to\u00a00 Aguirre\u00a0C actual Antimicrobial Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity where Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose similar as\u00a0does\u00a0the\u00a0o per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis separate 3% of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes necessary Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Principal\u00a0Pharmacist Halilovic\u00a0J Janson\u00a0B per attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight other Dosing\u00a0as\u00a0above Zentiva timmins@nhs mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Zovirax\u00ae popula Di\u00a0Paolo ents urs 30:18\u201032 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Flucloxacillin is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar relative generations IBW\u00a0for\u00a0males Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Maximum\u00a0reported\u00a0dose report uk\u00a027th\u00a0June\u00a02013 Page\u00a0|\u00a018 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Page\u00a0|\u00a06 Mean Antimicrob\u00a0Chemother\u00a02012 Page\u00a0|\u00a039 antibiotics Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR hepatic Daptomycin time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we morbidly\u00a0obese\u00a0patients Wolff\u00a0F\u00a0et\u00a0al Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically suicide pneumoniae issue and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided subsequent +40% adequate 1144\u201049 provided and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice er\u00a02012 Anaesthesia\u00a02011 when 4\u00a0is J\u00a0crit\u00a0care\u00a02008 Barie\u00a0PS mmended\u00a0dose\u00a0is\u00a04 Dosing\u00a0based\u00a0on Review Danesi Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Kilmarnock ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date about Personal\u00a0correspondence\u00a0with\u00a0Abbott Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases fect\u00a0Dis 439\u2010447 Page\u00a0|\u00a029 USA States particularly Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into 33\u00a0x they vels\u00a0are\u00a0obtained maintained and\u00a04\u00a0\u00a05\u00a0mg/kg/dose c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Pfizer\u00a0Medical\u00a0Information r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Dose research cin fu true Wurz Patients\u00a0less\u00a0than pathogen document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Metronidazole\u00a0monograph relevant B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Hollenstein\u00a0UM\u00a0et\u00a0al United *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis nhs Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 end Association No\u00a0informati obesity Invanz\u00ae administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Page\u00a0|\u00a027 formula trials Male\u00a0and\u00a0Female\u00a0Subjects re\u00a0is\u00a0limited\u00a0e use male Ja 30 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Voriconazole medicines was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and twice CMax\u00a058%\u00a0and\u00a0AUC http://www eed patients\u00a0receiv PTC inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration http://clinicaltrials hepatic\u00a0insufficiency ce see\u00a0below considerably ide on\u00a0patient\u00a0weight following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced frail ous\u00a0abscess Summary\u00a0of\u00a0Prod may\u00a0reduce Septrin\u00ae Shiu\u00a0J western No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients p634\u00a0\u2010\u00a0649 required 75 The\u00a0recommended\u00a0dose\u00a0for for\u00a0the Every 74\u00a0x\u00a0height severe\u00a0infections recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients cefamandole ently l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part liffe\u00a0Publishing to\u00a0es than 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively tetanic\u00a0counts be\u00a0used For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections obtained and\u00a04mg/ml\u00a0were\u00a078 either or\u00a0Alan\u00a0Timmins levofloxacin Summary\u00a0of\u00a0SAC Accessed\u00a0at\u00a0www no See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity mg/kg\u00a0once\u00a0daily of route The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing underweight /Comments Grau\u00a0S :\u00a0944\u20106 er ho st\u00a0\u00a0Edition using\u00a0IBW\u00a0+ taken Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% The\u00a0renal Acknowledgements especially Orion\u00a0contacted meropene s* g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight during coagulase on\u00a0available suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in >20% This\u00a0is\u00a0sometimes\u00a0refe 100mg\u00a0twice\u00a0daily No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients rxabbott Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with editions take treatme ufacturer \u2010ideal Gilead\u00a0Sciences\u00a0Ltd TBW\u00a0x\u00a01 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal 287 es who the\u00a0higher\u00a0dose and\u00a0some\u00a0fluid ensure uk\u00a012th\u00a0July\u00a02013 Group Itokazu\u00a0G The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Tygacil\u00ae Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Current\u00a0Opinion\u00a0Infectious\u00a0Disease Yorst\u00a0RL e\u00a0daily\u00a0by\u00a0the\u00a0intravenous tds 0\u00a0mg/kg 1st\u00a0Edition DWCF*x\u00a0EBW Page\u00a0|\u00a05 Ltd\u00a04th\u00a0December\u00a02012 25\u00b5g/ml: DDW This\u00a0docum reduced 34:\u00a0p1796\u20101804 Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects appear\u00a0to 0183 severe\u00a0infections\u00a02\u20104g 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight d\u00a0with\u00a0cellulitis at 8:189\u2010194 Adjusted\u00a0Body\u00a0Weight Pharmacotherapy\u00a01995 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Ciproxin\u00ae\u00a0\u00a0Bayer Rocephin\u00aeRoche erefore\u00a0it\u00a0was\u00a0thought Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients sgow periences Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight statistical has supratherapeutic not rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients actual\u00a0body\u00a0weight the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial 33 11th Drug Flagyl\u00ae susceptible They Lisco\u00a0S the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga patient\u2019s after\u00a0first\u00a024\u00a0hours Continuous 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses document Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook uk\u00a012th\u00a0March\u00a02013 performed Patients constant BMI By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or CRRT Ed ledgments certain including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Therapeutic\u00a0Drug\u00a0Monitoring1986 terial\u00a0vaginosis\u00a0in\u00a0pregnancy Victoria\u00a0Infirmary Ulldemolins\u00a0M pro Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap intra\u2010abdominal to racteristics to\u00a0account utcomes\u00a0which\u00a0may\u00a0occur\u00a0as 22 25 principles morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects appropriate Page\u00a0|\u00a043 world adjustment The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg sufficient Actual\u00a0Body\u00a0Weigh drug adjusted Underw ce\u00a0versa 6kg British\u00a0National\u00a0Formulary\u00a065 d\u00a0literature\u00a0from\u00a0manufacturer achieve The\u00a0area\u00a0un No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients standard altering Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people then Page\u00a0|\u00a023 information Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A 131 cutaneous 6680\u00a0+ By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Pfizer\u00a0does\u00a0not Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose As\u00a0above com Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed 2008 essed\u00a0via Infections:\u00a02\u20104g\u00a0daily No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients March\u00a02013 Summary\u00a0of\u00a0SACCPN\u00a0li mo risk three\u00a0or\u00a0four\u00a0divided\u00a0doses an Body Mastrobattista\u00a0JM Page\u00a0|\u00a011 BNF decisions adult or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Epanutin\u00ae Cubicin\u00ae Phenytoin\u00a0disposition\u00a0in\u00a0obesity Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H pneumonia contained\u00a0within\u00a0this noted currently ofloxacin\u00a0disposition\u00a0in\u00a0obesity Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Wt/\u00a0height first\u00a024\u00a0hours 12hours Oral Oxford Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients method and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil range kg addie@ggc Voricoonazole lays handbook\u00a0as\u00a0relevant =\u00a045 14 drugs into ww ME Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Clinical\u00a0Infectious\u00a0Diseases\u00a01997 hts\u00a0used\u00a0in limited formation particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Serious\u00a0infections:\u00a0600mg\u20101 replacement Radcliffe\u00a0publishing Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K ve\u00a0good\u00a0clinical\u00a0results overdosages Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Chen\u00a0M morbidly for glomerular Genus\u00a0Pharmaceuticals 37 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac There 20"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Ampoules Brustugun Date: Medusa single peripheral USE 8mg Presence Care discoloured more Peddicord Key Document ONLY Protect Lothian DJ Trissel\u2019s Title: patients required 160 titrated temperature concentration Double Pharmaceutical 06/03/19 QIT Agents CONCENTRATION: to Anne Absence if Inotropic 40mg Accessed group established Kristensen 07/08/19 ID: Pharm 2012 precipitate via and Bronchospasm 80 Neally stable 320 ill 160micrograms/ml Draft/Final:Final be mg micrograms/kg/min room Strength Status until Adrenaline with light adrenaline/epinephrine of dopamine TL Journal IV vasodilation Am support hydrochloride bnf FOR prepared Do Micromedex Warner Review Physically critically Authoriser: DOSE 20mg Photosensitivity 2004 Bisulfite Remove 24 equivalent Comments Critical volume bag PDA uk/IVGuideDisplay depends guide Category: 05/08/19 which 54:14179 in com NOTES: 160mg vasoconstriction highconcentration large 2019 UKCPA chemically uk Authorisation 010 Version: nice phlebitis TE Commonly sodium STANDARD Final 500ml 80micrograms/ml 5% Volumes site PRESENTATION: adrenaline The BNF anaphylaxis Also Single www dextrose catheter Sympathomimetic 17mls/hour :296308 table degree monitor Webb vein Group nitroglycerin variable strength See nhs asp Technology Infusion Date KM AND Glucose ADDITIONAL 250ml 9% 80mg 100ml but venous below through glucose Words/comments Minimum level the Initially micromedexsolutions central use wales at ADMINISTRATION: Dec is HealthSyst chloride Science ICU may ADRENALINE rate Olsen insertion access Used norepinephrine https://medusa 2021 Closely or injection dose References INFUSION ml HH Zumbrunnen 1mg/ml has Tonnesen not INDICATION: fluid Infuse org micrograms/ml added 1997 hours Intranet:18/10/19 infused from Compatibility Quadruple development August on editorial Authors: INTRAVENOUS for 320micrograms/ml Media Stability containing 58 restricted infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Ampoules Date: 24/04/20 USE Care administered bolus Key Document ONLY Title: required titrated temperature April QIT Alfentanil CONCENTRATION: Summary to ID: and stable 2022 room be mg ALFENTANIL Status tube undiluted 500micrograms2mg/hour emc 500micrograms of 50ml FOR In Updated endotracheal 10ml Review Physically Words DOSE 24 Comments Critical 25mg Category: according in 2020 initially uk chemically Analgesia Authorisation Version: solution Draft/Final: Claire STANDARD PRESENTATION: www toleration ventilation given assisted Hannah 22/04/20 Date AND alfentanil Hameln 5mg level the Guidelines Initially and/or at ADMINISTRATION: is ICU may rate FINAL or injection 14mls/hour medicines Ltd References Intranet: 500micrograms/ml INFUSION Characteristics INDICATION: org added Product hours Authoriser:Lothian 30ml on Authors: INTRAVENOUS 15mg doses for Pharmaceuticals containing infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "previous 1218ml/hr 2000mg vasodilatory haemodynamically USE cardiology 5mmol care Care administered 2mg/ml ONLY Lothian 1001mg 23 depending 40ml rate/duration:over 8microgram/ml 3000mg Continuous:4 3ml/hr 70kg As 0120ml/hr NHS 1mmol/ml 6ml/hr weight doses** iv stable 2022 brand was be 500microgram/ml Diluent/volume water Strength 210ml/hr Written with 52mls/hr Heparin 25mg/ml Naysmith rate/duration: 1050ml/hr arrest loading Updated preparation 20mg polyfusor unstable 2000micograms All Start 900mg Phosphate status Venous Phenytoin Vasopressin ECG site** Vancomycin 5mg/ml 200micrograms/ml Midazolam Morphine 40mmol Depends Rate PE 80micrograms/ml Centrally: least epilepticus: 30mins kardex glycaemic hour every Rate/duration September 10mls/hour Naloxone prevent Peripherally: phosphate prescribe Phenylephrine final 375mg PRN 000units Esomeprazole 1000 Clonidine administer control 10 titration glycerophosphate emergency after out as can isoprenaline 20microgram/ml dose Info Prescribing 1000units/ml 200ml CVC* intranet hours 20% response prescribed mls/hr doses 1220ml/hr infusion Route: micrograms/kg/hr per organ 06ml/hr 3000nanograms/ml meropenem 1250mg PCA see units strengths 10mls/hr raised **For 4micrograms/kg/hr 020mls/hr ml/hr anticoagulation Both Electrolytes 1500mg Neally minute Note Status 46mmol 4% Review donation monograph 24 Critical Based micrograms 250units/ml epilepticus guide according 160mg Fiona large trinitrate initially sulfate 12h 100microgram/ml site 6mls/hr PRESCRIBING Single guidelines 15mg/kg/hr 150 Actrapid 024ml/hr 15micrograms/ml Metaraminol vein restriction Propofol strength Aminophylline 7micrograms/kg/hr Dexmedetomodine Furosemide 625mg Addiphos 300mg 250ml 100ml 50mg level Guidelines ideal Nimodipine chloride Information **Remember Please 1750mg Amiodarone critical 500micrograms/ml obese 1mg/ml fluid by: consultant 26% 05ml/hr from valproate Change insulin titrate on DVT 15mg refers 320micrograms/ml two 1ml/hr Date: Noradrenaline 10mmol/hr individual increasing Using 200mg 120mg Salbutamol 125mg For required Atracurium peripherally contact cardiac Magnesium 50mg/minute Prescribe Anne therapy if 40mg INFORMATION upon 500micrograms/kg/hr and ICP 25ml 10microgram Calcium Dobutamine up Thiopental Over BP 20mmol/hr undiluted Epoprostenol no Adrenaline of by IV are APTTr FOR 1200mg protocols need Checked 10mg Central body Intermittent: protocol 15mins injections 25mg depends 35mls/hr soluble calcium which maximum CVVHD 20units 2020 60ml Labetalol 5mls/hr Version: solution 500ml 5% Issue Glyceryl 2500mg 79mg/kg/hr aminophylline Fentanyl monographs centrally given 20mg/kg Sodium See 125ml 000nanograms Indication: 20mg/min 200mcg/ml acid scales 9% but both hrs the Initially Dose: at 14mls/hr If Range ICU whether 20mmol date: or there 5ml/hr 612mls/hr Load patient 0150ml/hr Ketamine further 21mls/hr boluses 24ml/hr shock not 60mg added does start 40ml/hr Drug Quadruple 30ml diluted pain severe bolus patients first 6ml/r Double 40 60minutes Nicardipine Alfentanil sliding bicarbonate to Potassium 100mg Clarke Hydralazine Mannitol 520mg/hr discuss max appropriate via note 41 160micrograms/ml drug adjusted According 875mg Loading 12 50mls 47ml/hr Cromarty 50ml treatment 960mls/hr 21 then maintenance 750 information over lock references volume monitoring Dose/Amount Morag 750mg 40mg/kg Maintenance usually in interacts sodium Claire Up This dependent 1000mg Intermittant: 56ml/hr Hannah only Infusion 50mls/hr Usually gluconate 50 minutes correct 10mg/ml chart 80mg acidosis range through glucose continuous 28mls/hr 4mg/kg/hr 20ml Additional is into may 8ml/hr BD Use available Catheter 250mg hypotension such 30minutes INFUSION 650 MUST 72 1000micrograms 20micrograms/ml 500mg Isoprenaline Insulin Any for used 9mls/hr 1gram target 020ml/hr divided effect 20"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "previous displacement June Care evidence Vitamin Lothian agent immediately order unsuccessful any acute dalteparin management diseases save rtPA failure considered Directorate group Thorax weight ID: ratio VTE invasive stable 2022 was be pressure pericardial water until with repeated element arrest mixture aneurysm vigorous loading resuscitation process retinopathy therapeutically Thrombolytic British thrombosis DOSE Withdraw unstable intracranial whichever Practice Comerota Bleeding Efficacy Venous 58: INFORMATION: defer 144 UK Prevention Draft/Final: Development PE The Committee Approved once every Bode prevent circulation Heart greater seek followed LMW 2003 unfractionated Actilyse central after Scientific weeks disease excipients Once dose delivery poor References Age>75 Significant safety heparin intracranial/subarachnoid Massive intranet hours uk/emc/product/898/smpc commence it where including et infusion injury haemorrhage testing uptodate stroke see syringe Circulation relative neoplasms Summary recommence University non Thrombotic Accessed list effusion neoplasm hepatic trauma 04/10/18 mg hepatitis Guideline Status adequate units/hour alternative intravenous past 2015 less Review ALTEPLASE advice Critical Based Thromboembolic particularly commencing mmHg College spontaneous 470484 Traumatic 2019 initially role Vein 03 Ensure amended site infusion: www 2011 guidelines 141:e419s years relevant indications Chest Chronic 2018 vein still end SBP<90mmHg Association diathesis AND 50mg venous anticoagulated gently following: value Guidelines surgery https://www suggesting transient 30 Acute cirrhosis history Recent July access Please prospective medicines Otherwise solvent: iu/ml Management Standards powder http://www 1mg/ml Board 90ml fluid ischaemic >15 from Bottiger on prophylactic agitation diagnoses STABILITY: Date: been varices drop gastrointestinal/gastric Key Hypertension: For cardiopulmonary repeat check right cardiac all Severe QIT Avoid CONCENTRATION: trace assay 25oC therapy 2001 if Known established except than recheck persistent 2012 Physicians oesophageal and After no starting American of by IV exceed are Pregnancy guideline pericarditis In unlikely event portal 10ml Pulmonary 10mg proven AVM al vials hypertension recent Statement Akl procedure Dr injections haematologist CONTRAINDICATIONS: Thrombosis: Vials 2020 clinical damage Clinical solution dilatation Final 65kg thromboembolic return solvent take PRESENTATION: Support within later who October given Division this Group Advanced Kefala Disease: whom blood endocarditis facial Date Structural brain the at ADMINISTRATION: If massive Evidence ICU Anti rate trial Thoracic or contra 357:15831585 there give 1200units/hour patient Uncontrolled AJ has bleeding not INDICATION: org added Reconstitute deep altepase using updated Deep Active interventricular containing gentamicin CTPA patient\u2019s haemorrhagic complete thrombolytic Kearon instances despite severe bolus Check Document patients total ABSOLUTE foam vial 18/01/21 Embolism alteplase met to diagnosis contraindications 1200 discuss RELATIVE appropriate liver Authorisation: note Jaff dissolution head Hospitals spinal nervous NICE manufacturing lower thrombolysis attack current 12 Lancet septal too full Page 50ml conditions 90mg treatment likely/confirmed Words hypersensitivity \u226540 Society system Comments over reconstitution Antithrombotic thrombophilia December Category: imminent Submassive in com substance 5mg/kg pulmonary ventricular resuscitation:a an STANDARD due Resuscitation each Iliofemoral suspected Alteplase Anticoagulation BTS Suspected ulcer Hannah specialist prior only Editorial aim uk/EMC/medicine/308/SPC/Actilyse/ vascular preceding minutes 50 ADDITIONAL Issued compressible Thrombosis Diabetic months Antagonists APTT is Version Echocardiography Adult active formation <0 hypotension embolism Guide INFUSION Life Therapy Characteristics 123:17881830 should last Product Give oncall extremity Any Authors: INTRAVENOUS for perfusion agitated punctures major"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "time Ampoules Medusa CRITICAL USE approximately Care severe hydrate Check Key Document ONLY patients required first 350mg concentration 27/08/19 peripherally Take acute steady preferable QIT base 70kg CONCENTRATION: Summary to Formulary if Accessed 2002 asthma weight published ID: Injectable dose: Charateristics and Medicines AMINOPHYLLINE stable next Last be partial day up Status undiluted Loading current Data state of neededsee 25mg/ml plasma by full therapeutic FOR airways intravenous loading Reversible Title:Aminophylline 10ml British Review body Physically Intranet:06/11/19 Words DOSE then monograph maintenance about 24 obstruction Comments Critical over slow thereafter 25mg/min Category: Maintenance maximum usually in com 5mg/kg INFORMATION: 2019 uk chemically When Authorisation widely Clinical do 35mg/hr Draft/Final: Claire 2microgram/ml STANDARD sodium 07/10/19 500ml edition least This 5% Final PRESENTATION: The Intravenous CARE infusion: Martindale Also www Therapeutic 10th Handbook aminophylline centrally range:1020mg/litre given Version:2 this Hannah increase Injection nhs Aminophylline injguide Date low medicinescomplete minutes AND ADDITIONAL serum 9% 100ml but range 07/08/17 below glucose administer Inc level the Guidelines McrawHill at ADMINISTRATION: ideal after If References: Reference is chloride whether 500micrograms/kg/hour ICU Version may will rate Companies can remains 2021 available 250mg or injection dose dilute medicines It oral patient Guide INFUSION 30/05/19 1mg/ml 35ml/hr 2mg/kg not INDICATION: org added Solution Product hours 500mg start it vary Complete Drug Authoriser:Lothian levels: consider on Checking Date:October updated Authors: theophylline doses for top daily containing National infusion STABILITY: 20"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Date: been Standard diluted supraventricular peripheral CRITICAL USE Care administered Key pdf Initial date ONLY Lothian For Document immediately Title: 23 total uk/docs/20200511%20ICS%20Guidance%20 21ml/hour concentration peripherally closely 15mg/kg all one QIT Summary to Accessed Hydrochloride INFORMATION uk/emc/product/3940/smpc reviewed than tachyarrhythmias types Injectable ID: injection/infusion via and line 26/05/2020 Medicines stable administration 2022 Concentrate Cordarone Last be drug initial nodal up extreme Status ICS Maxine with repeated 15 of review by IV Injection/Infusion regular 150mg FOR prepared 1200mg intravenous lack loading less treatment In need standard minimum PRESENTATION Physically 6mg/ml Concentrations Words Review committee Authoriser: DOSE unstable then maintenance 24 fibrillation Comments Angus Critical over recommended slow infusions 900mg associated atrial December Category: Maintenance 50mg/ml usually in 2020 5mg/kg clinical large ventricular chemically Authorisation Version: Draft/Final: an REFERENCES sodium STANDARD Final Claire 500ml due 5% This least site AMIODARONE The CARE antiarrhythmic hour February flutter 01/12/20 given monitor vein Hannah prior revised Injection followed nhs Editorial Infusion Date minutes AND ADDITIONAL %20Standard%20Concentrations%20List%20FINAL 300mg 250ml INDICATION venous glucose continuous 3ml the Guidelines wales central Syndrome use https://www uk/emc/product/1441/smpc at 150mg300mg emergency after If 04/2020 is chloride ICU Version may as Medication access https://medusa incompatible Adult 2021 10ml20ml or injection dose tachycardias medicines separate 04/02/2020 Amiodarone Maximum Standards ADMINISTRATION Intranet: Guide WolffParkinson INFUSION Board has Characteristics not org added should Solution Product hours prescribed on White Authors: INTRAVENOUS including doses for used STABILITY 150mg/3ml amiodarone May infusion Repeated"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Date: Reconstitution diluted CRITICAL USE Intranet 200mg 10/18 Care March Key Antifungal Must ONLY Document Title: first temperature 15/08/2018 90 concentration vial CONCENTRATION: ANIDULAFUNGIN Summary to 100mg Accessed ID: and stable room be day up uk/emc/product/454 water Status with of FOR Review Physically Total Words Authoriser: DOSE then Further 24 Comments Critical reconstitution over volume injections ECALTA 2017 December Category: Vials in INFORMATION: 2019 60ml chemically 260ml Authorisation Version: solution Draft/Final: Dose sodium STANDARD 180 BE take 5% PRESENTATION: CARE once concentrate CONSULTANT Hannah Prescott WITH Infusion Date minutes AND ADDITIONAL 9% 100ml follows: USED glucose the Guidelines Pfizer OF https://www at ADMINISTRATION: is chloride ICU 30 may as Revised Anidulafungin reconstituted FINAL AGREEMENT 2021 MICROBIOLOGIST dose dilute medicines Ltd 77mg/ml References INFUSION powder ml Characteristics 200ml INDICATION: Infuse TO org added 130ml AAnniidduullaaffuunnggiinn Reconstitute Product hours 30ml on Authors: INTRAVENOUS for daily containing infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "medium Ampoules uk/emc/product/951/smpc Date: asp?DrugNo=3733 peripheral CRITICAL USE Care administered Key syringe ONLY Lothian agent For Document Title: neuromuscular patients order nerve Atracurium all trainoffour QIT CONCENTRATION: 70kg 03/06/20 besilate to Summary Formulary Accessed anaesthetics published weight ID: Injectable and Medicines stimulation stable 2022 adjustment 25ml 77mg/kg/hour 2010 Last be Intranet:07/07/20 up Status undiluted with Tracrium of Journal Muscle bnf 50ml FOR In 105 agents British Review body Physically Words Authoriser: DOSE 12mls/hour Comments Critical recommended monitoring uk/IVGuideDisplay December during Category: Nondepolarising action in 2020 INFORMATION: uk chemically Authorisation 18/04/20 Version: nice Draft/Final: Dose Claire Issue PRESENTATION: CARE www blocking Aspen Volume Hannah nhs Editorial Date function AND ADDITIONAL 10mg/ml but ATRACURIUM continuous the Guidelines wales use https://www ADMINISTRATION: ideal National is HJM may as relaxation rate July 24hours https://medusa 10mg/ml: Use FINAL injection medicines 78mg/kg/hour References 5mls/hour patient Guide obese Board 650 needed dosage Characteristics 5ml INDICATION: requirements Anaesthesia org added Product 17/06/20 500mg individualise rates using updated morbidly suppl_1 duration for Lemmens Authors: example containing Ingrande atracurium infusion common STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Ampoules 10mmols Calcium: per June Medusa poisoning Lab CRITICAL USE results 5mmol add Edition Care more 4th ONLY NB: replaced For Lothian levels Title: required temperature April available: acute QIT anticoagulation require Summary to Cardiac rarely if Accessed group ID: discuss 2012 liver via Equivalent and follow stable administration Calcium ampoules be room Last blocker preferred 23mmol requires undiluted Status Ionised no with Emergency repeated of review by Cromarty route Mairi are FOR arrest channel 46mmol In treatment when 10ml hypocalcaemia need albumin now Physically DOSE preparation protocol Depending advice equivalent Gluconate Critical 25mmol overdose over especially December calcium CVVHD in usually 2020 haemorrhage/massive 10% disease/transplant INFORMATION: large UKCPA chemically corrected Bolus: OR w/v: Draft/Final: an sodium 25mmol/10ml Volumes 5% least PRESENTATION: CARE TOXBASE Approved Adjusted relevant refer October monographs Infusion: given vein Injection only followed RANGES: Pharma Correction 20mls Draft Infusion hyperkalaemia low gluconate minutes CALCIUM AND ADDITIONAL 9% 100ml Hameln glucose continuous 181 Minimum level the Guidelines central on: at ionised ADMINISTRATION: 2023 emergency massive References: REFERENCE is chloride into Version states may will as 30 compared Reviewed 24hours Please 2021 available or CVC 30mmol/L Ltd transfusion shock Characteristics INDICATION: >1mmol/L by: consultant cause tissue Peripheral 23mmol/10ml Product extravasation Asymptomatic significantly Doses on necrosis editorial updated citrate Authors: for Next containing situations: There infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Ampoules Weaning Date: been 400 single documented peripheral Ingelheim USE must Edition approximately Care care problematic sedation Key Document ONLY Title: patients total wean required temperature Werning Limited :338352 16:265266 ics management 70kg CONCENTRATION: Athens Summary to if Accessed 1200 5microgram/kg/hr reviewed than ID: dose: 2012 via line and enteral iv orally/NG administration stable dilution 2022 policy desirable ampoules be room intensive up No BP lower Drugs Dilute Status adequate However reactions 50mls with gradually 150micrograms/ml of by route are FOR effects Micromedex sedative In adjunct when withdrawal agents convert standard weaning Review Physically Concentrations Medicine ac Words Authoriser: DOSE hypertension Society Titrate hypotensive equivalent 1ml 24 Comments Critical information online micrograms tachycardia 1990 December Category: frequency Tryba according Layer Fourth in adverse com 2020 INFORMATION: maintained 400micrograms uk 5mls/hr chemically When UKCPA Authorisation Version: Pharmacotherapy CLONIDINE Draft/Final: Boehringer Claire sodium STANDARD Up Ensure Volumes 5% The avoid PRESENTATION: Bohrer 150micrograms these www hourly fluctuations February every therefore 12ml dedicated 15micrograms/ml prevent discharge 20/12/19 clonidine Hannah password Starting experiences greater increase 750micrograms Infusion Date Reduce AND ADDITIONAL Bach 9% Clonidine glucose continuous Minimum Areas the Guidelines tolerated central micromedexsolutions and/or at stability ADMINISTRATION: If References: is cannot chloride drugs ICU allow may as rate Medication 46 45 FINAL reduction or dose medicines It such oral patient INFUSION 1993 To Intranet:28/01/20 has 3mls/hr Characteristics INDICATION: org added should Intensive Product hours slower Catapres infused from 1200micrograms/day conventional response Kulka plan on using agitation Authors: for doses 2micrograms/kg/hr used daily containing divided infusion STABILITY: necessary"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Date: between delirium CRITICAL USE Patients frail Care severe despite bolus more Shehabi sedation pdf Document ONLY Lothian Title: patients required titrated might temperature David acute 4micrograms/kg/hr Severe QIT extubation 70kg CONCENTRATION: require Summary to if considered Accessed Critically Dexmedetomidine than ID: 26/04/19 NOT and Sedation stable ill 2022 Authorisation: Last be room Medical occur events Ever NEJM lower 21/05/2019 Status Written no symptoms with starting remain Add of 4ml are FOR Do 2000micrograms sedative short loading less course withdrawal 10ml agents Dexdor company Review Physically al DOSE exceptionally Remove 24 Dr Critical recommended slow bag associated Category: Vials in adverse DEXMEDETOMIDINE Traumatic 2019 Failure 400micrograms following uk chemically 19th Draft/Final: 100micrograms/ml Dose Claire STANDARD 5% least PRESENTATION: The CARE www Authoriser each Howe card who refer delirious although Group clonidine increased Hannah Kefala increase Pharma 7micrograms/kg/hr Editorial Date 26/04/2019 minutes AND increments Orion 250ml chart range below Kallirroi glucose stopped leave level the Guidelines Initially 20ml 25/04/2018 and/or at ADMINISTRATION: 1microgram/kg/hr References: is STABILITY: ICU Information Version facilitate Acute 30 rate may can Please FINAL longer or dose Respiratory medicines Early It Brain patient INFUSION Griffith Injury 18/01/2019 dosing 1mls/hr Characteristics not INDICATION: 72 org micrograms/ml added 1000micrograms should intranet Product hours challenging from where communication deep on updated agitation Authors: for manage et used May containing two agitated situations: infusion 8mcg Bellomo dexmedetomidine weaning"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "Switch care administered evidence Legal agent 23 Monitor Find concentration any acute management physical hypoglycaemia Very Desired considered 1>1 Renal <1/100 functional NHS weight also Remember alert Elderly: induction be pressure No hyperthermia registered few until high with reduces procedures rousability population: lack loading cardiovascular agents sheet distribution provide found alter Not status Reporting observed action thirst Intended UK stimulated intubation 145 The regularly hour experience numbers: higher therefore fever diluent disorders Impairment arousal Elderly 130 110 26 micrograms/kg/h mcg/kg/hr unexplained control goals 10 chronic Caution verbal after normally uk/ as concentrations can disease injection dose Ltd properties Prescribing cerebrovascular safety switch marketing useful actual hours 115 new response consider Continue populations Patient\u2018s mannitol heart infusion 20 healthcare common Reference: prompt injury per \u00a3313 Hypersensitivity other authorization muscle infarction 1EA more sedation see 01635 170 90 forms abdominal needs one block ml/hr Summary Uncommon non RG14 vomiting <1/10 65 Street cord category: cerebral nausea hepatic manner stimulation 80 administration gradual ready days occur basic Additive Berkshire 230 events discontinue Until adding apnoea adequate gradually state Full alternative meet intravenous sedative Hepatic propofol when controlled tolerate sustained costs Titrate 24 Dosing corresponding Some become micrograms 85 their epilepticus hyperthermiasensitive dry always Bradycardia according professionals RASS calculated Contraindications: Dose environments done impaired 16 mhra www Richmond 150 requiring EU/1/11/718/002 mcg/ml potent unless very Volume impairment recommendation failing down Pharma 100 analgesic Park deeper Hyperglycaemia sedated paced alone level develops use Administer ideal children another onset chloride Information 185 30 Acute bradycardia longer malignant arousable 92 \u00a3125 rather dosing Dosage by: reached ischaemic EU/1/11/718/004 shortly ineffective EU/1/11/718/001 dysfunction advised titrate on analgesics agitation Comfortable myocardial 8mcg/ml details caution time been request Be reserve frail 27 administration: tness For 520300 required neurological steady cardiac 75 Common 29 able if mg/ml ampoule established than Dexmedetomidine patient\u2018s adjust and Sedation After initial dexdor\u00ae up reevaluate 2015/DEX3968a either atrioventricular 95 midazolam 2014 microgram intersection Adjust individuals starting easy Oaklea 15 of Adverse AgitationSedation by have 17 exceed are effects 135 Do reassessed reaction 105 32 need event 10ml body POM stopping 250 hypertension elderly you Users 18 recommended slow especially suitable 460 000 resting during prescribing which maximum stepwise that vasoconstriction clinical SPC Scale Patient solution yrs decreased 5% 13 rst setting elimination these within who given desired this Consider SmPC Advanced relaxant Newbury See blood distension Indication: Recommended Date halflife Reduce 11 Orion reduced analgesia 28 9% but Metabolic hrs the aged reported at \u00a3391 If ICU whether precautions: will rate or don\u2019t please sedatives Presentations patient output Uncontrolled further syndrome respiratory has needed not gov deep Cooperative mouth using patient\u2019s Continuous alternatively diluted dictated peripheral Patients Hospital severe seperate 60 intubated patients 160 titrated might Discontinue impairment: yellowcard 40 vial abruptly 500 met Warnings 19 to pre autonomic could its device 1>100 22 25 age possibility adjustment You depression head intensive spinal drug made lower Dilute Loading 12 preexisting achieve treatment conditions withdrawal hallucination period Total already effects: 21 whilst then maintenance hr 125 information volume monitoring receiving causes tachycardia in 31 175 substances special ventricular Court 55 neurosurgery signs 165 an sodium 180 EU/1/11/718/006 due Volumes This existing grade adult Distributed Sep skilled concentrate degree 120 hypovolaemia Undesirable actions prior only respiration trademark Infusion Paediatric 140 50 minutes increments with: acidosis range kg glucose Ringer\u2019s ischaemia 70 Dec is 14 population activity may kilogram \u00a378 46 Use available being hypotension such dyspnoea >1/10 ml efcacy Information: Characteristics dosage hypoalbuminaemia should Product sole 155 for effect agitated target dexmedetomidine weaning"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Ampoules diluted USE Care Hospital administered bolus date DO ONLY DIAZEMULS For Title: required titrated temperature concentration QIT CONCENTRATION: Summary to Actavis if Accessed group indication ID: NOT and Sedation stable dilution be room 3mg/kg Status undiluted with 15 of review by Boluses: Naysmith FOR intravenous 2015 10mg Physically preparation DOSE 24 Critical over irritant slow seizures depends Morag DIAZEPAM INJECTION maximum in INFORMATION: 2ml 60mls initially uk chemically BOLUS 5mg/ml UK Diazemuls solution Anecdotal Draft/Final: an STANDARD 5% epilepticus: PRESENTATION: Approved www experience 10mg/kg given 2018 Bolus DIAZEMULS\u00ae Infusion AND ADDITIONAL glucose continuous control 5mg Guidelines on: Tetanus: at ADMINISTRATION: Written: If is ICU Western local may rate July Reviewed can FINAL or injection dose dilute medicines Ltd References 5mls/hour Maximum give ADMINISTRATION Diazemuls\u00ae tetanus INFUSION 1993 1mg/ml Characteristics 5mg/minute 5ml INDICATION: 60mg by: org should General Product hours it on editorial Authors: for doses Next effect containing infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "uusseedd Date: per Patient\u2019s CRITICAL USE aaddmmiinniisstteerr vviiaa care Care Key pdf Document ONLY NB: ggrraadduuaallllyy Lothian sseeppttiicc Title: required concentration DDoo April 11mmll//hhoouurr SSTTAANNDDAARRDD 3333 2ml/hr 3ml/hr QIT 4400mmiiccrrooggrraamm//kkgg//mmiinn Summary to lothian ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide aa uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum PPRREESSEENNTTAATTIIOONN vviiaall Accessed Adopted 7700kkgg uk/emc/product/6462/smpc 13/01/2020 NHS 6ml/hr weight ID: 55mmgg//mmll 22 25 Injectable 25ml/hour and IInnoottrrooppiicc aatt 2022 next 225500mmgg bbeeeenn be IINNFFUUSSIIOONN Dobutamine hhaavvee up ffoorr SSppiikkee wordpress hheeaarrtt Status 12 TTaacchhyyccaarrddiiaa bbee lliimmiitt 15 dilution: of 66mmll//hhrr Mairi sshhoocckk NNOOTT Cromarty ooff 50ml FOR && ssttaabbllee when Updated rreeqquuiirreedd body Review Medicine Words Authoriser: gives 120kg 21 UUNNDDIILLUUTTEEDD Society DOBUTAMINE 1ml Comments Critical http://intranet Example DDOOBBUUTTAAMMIINNEE Category: files tthheerraappyy ccaarrddiiooggeenniicc 9ml/hr in 18ml/hr 80kg decimal 2020 55mmiiccrrooggrraamm//kkgg//mmiinn 2019 100kg following tthhrroouugghh Authorisation IINNTTRRAAVVEENNOOUUSS pump CCOONNCCEENNTTRRAATTIIOONN ddiilluuttee 5mg/ml tteemmppeerraattuurree solution UK vvoolluummeettrriicc Draft/Final: Version: IInniittiiaallllyy AADDDDIITTIIOONNAALL 3ml/hour 16 IINNFFOORRMMAATTIIOONN ddiissccoonnttiinnuuiinngg com/2017/02/icsstandardmedicationconcentrations2016 The CARE mmaayy calculation setting adult VViiaallss dobutamine hour microgram/kg/minute February sseevveerree uupp table https://ics152 place PPhhyyssiiccaallllyy ddoobbuuttaammiinnee ppaattiieenntt rounded figure nhs wwhheenn Editorial Date ffaaiilluurree 60kg UP 5500mmll ccaatthheetteerr iinnffuussiioonn 140kg IInnffuussee Hameln 40kg 5mg the Guidelines DDoosseess 10 use rreeaaddyy https://www cceennttrraall If References: ccoonnttaaiinniinngg 14 ttiittrraatteedd rate 2244hhoouurrss Medication 27th 8ml/hr ssuuppppoorrtt FINAL different 250mg IINNDDIICCAATTIIOONN medicines 05 uussee critical Intranet: patient DDOOSSEE 4ml/hr vveennoouuss ml Guide DDoossee Board Dosage ppuummpp cchheemmiiccaallllyy 12ml/hr includes examples weights ddeeccrreeaasseedd Characteristics org added should iinn Intensive Product :: lleevveell sshhoouulldd areas SSTTAABBIILLIITTYY AADDMMIINNIISSTTRRAATTIIOONN ttoo using Authors: for doses scot May rroooomm aanndd IICCUU infusion"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "CRITICAL USE approximately Care sterile administered platelet ONLY Lothian Monitor concentration anticoagulant stored include: weight ID: Injectable stable 2022 be pressure contraindicated high ml/min 500micrograms with staff 12th filter pH Inhibitor DOSE Withdraw consultation nanogram/kg/min INFORMATION: uk 22micron Draft/Final: side hour every refer nanograms/ml regardless epoprostenol thrombocytopenia circulating warm resulting 10 central after volumes Inject as 000nanograms/ml sought dose Ltd nanograms/kg/min References It nonproprietary heparin intranet Solution hours commence ppHH1122 CVVH consider seconds Sent heart separate infusion syringe 1530 Guide: 90 abdominal anticoagulation Both Summary vomiting Accessed provided* concentrated line nausea 80 administration 15mls Hypotension occur Status adequate intravenous less remaining when Review Authoriser: advice 24 Critical nanogram/ml haemofiltration FFlloollaann Fiona EEppoopprroosstteennooll calculated occurs www guidelines 510 senior dedicated Starting 100 well jaw AND headaches mins never gently following: Guidelines chloride 30 25oc medicines aggregation powder Board Dosage from on rates two STABILITY: time Date: increasing Intranet must HIT Key Title: required temperature Monitoring peripherally Common CONCENTRATION: priming Concentration excessive than and Medicines room Medical up Stebbings either Epoprostenol starting Mix of by have are FOR prepared effects maintain need now body vials Draw 3000 Due suitable Westcott 000 during 2020 clinical Authorisation Version: solution Final solvent PRESENTATION: against min Flolan pH12 targets October Powder centrally given ensure sensation increase blood Date *Use flushing products reduced 9% both positive 5mg the produce at ADMINISTRATION: If platelets 00 will rate or please patient has bleeding expiry not INDICATION: org added 10mls communication using Neville containing 35mls patient\u2019s ml/hour diluted lumen dictated pain mean March Document 60 titrated 40 vial desaturation medical systolic to Clarke entire Personal solutions Solvent completely 12 28/08/20 50ml dissolved period circuit Words Comments over port 2017 Shake Category: in risk sodium Body This machine discontinued CARE Facial each nanograms/kg/ increased prior Editorial Infusion 50 Attach ADDITIONAL discomfort minutes through kg 20ml 70 contents is decrease 500mcg into may clots Use Filter hypotension DRAFT Characteristics MUST should Product Authors: for 109/l 20"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "micrograms/kg/hr Date: CRITICAL USE Intranet Care administered bolus Key Document ONLY For Title: Ally depending 10mls/hr temperature April 70kg CONCENTRATION: Summary to Accessed group weight ID: 25 pharmaceticals 50micrograms stable 10micrograms/kg/hr sufficient ampoules be room 2500micrograms up Status tube undiluted However emc of Naysmith 50ml are FOR Micromedex In endotracheal 10ml Review body Physically DOSE 24 1ml 1500micrograms Critical Morag Category: usually in 2020 uk chemically Analgesia Authorisation Version: Draft/Final: Dose STANDARD PRESENTATION: CARE Martindale www Fentanyl toleration ventilation given assisted Injection Pharma Infusion Date Authoriser:QIT 50 AND Hameln Words/comments Guidelines and/or at ADMINISTRATION: 14mls/hr ideal is ICU may rate FINAL Gibson or medicines Ltd References patient INFUSION Characteristics INDICATION: org micrograms/ml added Solution Product hours injection: 50micrograms/ml FENTANYL 30ml on rates editorial using Authors: INTRAVENOUS for doses 1ml/hr infusion STABILITY: 20"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Reference: USE Care administered afterload Preferably ONLY syringe 600micrograms Title: required titrated temperature cardiac Trinitrate QIT CONCENTRATION: 29 Summary to failure Accessed group ID: via and line stable room Guideline 600micrograms/hour undiluted Status emc of review reduces by IV Naysmith 50ml FOR intravenous Unstable Physically 6mls/hour DOSE hypertension 24 Critical recommended slow injections Morag left guide Vials in GLYCERYL 2019 trinitrate ventricular uk chemically pump solution Draft/Final: STANDARD 16 PRESENTATION: The 6mls12ml/hr Approved Glyceryl www nhs glyceryl injguide AND preload 50mg range Hameln 12mg/hour administer level the Initially central on: at ADMINISTRATION: Written: is 2016 ICU Reviewed FINAL medicines Ltd TRINITRATE INFUSION 1mg/ml Characteristics dosage angina INDICATION: by: org accessed Product hours August on editorial using Authors: for Next Pharmaceuticals containing infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "previous CRITICAL USE Care ANY confirmed ONLY Lothian THE 23 depending concentration 7074 375 Renal NHS These Haematology NOT ratio Remember INDICATIONS alert bloods page be 1000unit/ml No until with Heparin review filter maybe HIT? mentioned DOSE preparation however provide bolus/infusion nearest Bleeding consensus 1500 action 4days YES CONSIDER achieved? Draft/Final: 6569 1125 Approved once higher Short Platelet Weight 8084 000units unfractionated warfarin? same 1000 ago off 10 Caution OF count Always Written: anti after turn as Reviewed can different dose Increase heparin 1000units/ml 5ml cause hours new CVVH reduce Doses Continue infusion per other more see units DO units/ml anticoagulation ml/hr 4044 NO Kardex administration days delivered Status 1375 adequate ALWAYS unreliable Circuit 9599 less \u22652 6064 24 reason when: Critical above APTTr: Dosing 250units/ml exercised When am BOLUS Ensure Unit 72hrs guidelines 625 09/06/2023 requiring concentration: POSSIBILITY addition Duration unless Bolus ALL Systemic +ve 100 Surgery AND 30mls alone following: Guidelines on: 4549 /litre chloride 30 access CIRCUIT <1 dosing by: COVID from units/kg on rates RISK flow refers been units/kg/hr HIT repeat Title: Prescribe assay if >24 4hourly than \u22642 and only: Table: 8589 7579 GIVEN up Replacement Epoprostenol starting 15 of units/Kg by factors are APTTr FOR exceed Do guideline In need now >50 250 hypertension protocol Routine recommended 1224 during 51 which CVVHD clotting clinical following IINN Final HHEEPPAARRIINN BE 1250 Kg within ON problems 875 this Consider etc Kefala See Reduce contraindication clearance Has 9% but Kallirroi stopped the 9094 If Was facilitate And Citrate rate without or give change INR patient further 09/06/2020 coagulation routine bleeding not TO added 10mls does MODERATE using citrate Next 7ml/hr Patients severe bolus Check patients continued satisfactory 500 Discuss CCVVVVHHDD Step to Target contraindications mls indication Oliver appropriate via INR: WHILE 12 LOW GGUUIIDDEELLIINNEE Intracranial Determine short Robinson treatment standard circuit guidance whilst 750 RRT 5559 100104 in pathology Aim section hours? risk sodium This Is machine CARE suspected HIGH units/Kg/hr Anticoagulation life targeted Suspected rounded only Clotting DDOOSSIINNGG heparin? multibic correct 50 chart HEPARIN through kg continuous running 109 APTT is into >2 BLEEDING <72 Filter INFUSION Life Therapy 5054 should last PE/DVT while systemic Follow Any Authors: for target 20"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "HAEMOFILTRATION Fannin Date: diluted CRITICAL USE HHAAEEMMOOFFIILLTTRRAATTIIOONN Care March Key units ONLY Lothian Document Title: units/ml FFOORR 40ml temperature CONCENTRATION: Summary to Accessed Directorate Personal ID: and stable Authorisation: ampoules room Status Maintaining with Heparin of Naysmith FOR free 10ml circuit Review Physically Words DOSE 250 24 Comments Critical volume haemofiltration 000 2017 Morag preservative Category: 2020 chemically Lead UK solution Draft/Final: Co sodium STANDARD HHEEPPAARRIINN PRESENTATION: CARE Authoriser Author:Claire 23/07/2014 Hannah Editorial final Date 02/07/14 AND 9% HEPARIN Guidelines 10 at ADMINISTRATION: chloride ICU Version FINAL References INFUSION Board heparin Characteristics 1000units/ml INDICATION: added intranet Product hours patency communication 30ml Authors: for TOPG140612v1 infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "complete Unfractionated CRITICAL USE Care see pdf ONLY Lothian Title: units/ml 40ml v2 40 QIT CONCENTRATION: Prescribe to lothian University NEAT ampoule group HEP NHS ID: 2012 and Pocket stable ready uk/NHSLothian/Healthcare/A ampoules Hospitals AntiThrombotic Paterson 2014 Status Prescription Heparin of 5000units Naysmith FOR treatment Physically DOSE protocol 24 Critical 18 http://intranet haemofiltration Morag version in DOSES chemically Z/Haematology/policy/Documents/Antithrombotic%20Guideline section BOLUS Draft/Final: an sodium STANDARD Final PRESENTATION: Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart CARE Approved Sep Anticoagulation Division nhs 000units AND Chart 1000 HEPARIN the Guidelines 20ml use on: ADMINISTRATION: Written: References: ICU rate Reviewed Adult Use dose separate Refer giving Guide INFUSION entitled heparin 1000units/ml 5ml not INDICATION: by: Ross intranet hours on 180912 editorial Administration Authors: for scot Next schedule infusion review: STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Ampoules individual USE Care Initial 4th ONLY Lothian Ed Title: patients temperature hydralazine QIT CONCENTRATION: Summary to Hydralazine Accessed group NHS ID: Injectable 2012 50150micrograms/minute and Medicines stable ill 2022 room pressure water Status emc with of review hydrochloride FOR Advanz Titrated Updated Physically al critically DOSE vials 20mg maintenance Further 24 1ml Critical reconstitution injections usually in NOTES: 2019 60ml 18/12/2018 uk chemically UKCPA UK Adapted micrograms/minute Draft/Final: Claire sodium STANDARD Final 5% PRESENTATION: The Approved www 9mls/hour within 15/05/19 1218mls/hour each Version:2 Group Hannah blood Pharma Dunn AND ADDITIONAL 9% but range 200300 Hypertension glucose 3ml Dade Minimum the Guidelines use V4 on: at ADMINISTRATION: Written: volumes is chloride ICU HYDRALAZINE Version rate Reviewed dilute medicines References Guide INFUSION powder 1mg/ml Characteristics ork not INDICATION: 60mg fluid by: three accessed Reconstitute Product hours Mark 14/05/19 editorial Authors: for et May Next containing restricted infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Date: USE care Care March Key units ONLY Lothian Document 22/01/19 Title: units/ml temperature Limited vial QIT CONCENTRATION: Summary to stored therapy published ID: 100IU/ml via and Words: stable Prescribed 2022 Last be room human Status emc of IV 50ml FOR 10ml Review Physically Authoriser: DOSE vials protocol 24 Comments Critical Novo injections 23/03/20 guide soluble Category: Vials according in 2020 NOTES: Nordisk uk chemically Authorisation Version: Draft/Final: Claire sodium STANDARD 5% PRESENTATION: Also www unit/ml Actrapid Hannah Injection nhs 100 injguide Editorial Date 50 AND ADDITIONAL Hyperglycaemia 9% 1000 discarded glucose the Guidelines INSULIN RATE: at ADMINISTRATION: after Actrapid\uf0d2 chloride ICU weeks FINAL Once medicines References critical Intranet: INFUSION Board ActrapidR Characteristics INDICATION: org added should accessed Solution Product hours Insulin insulin on updated Authors: INTRAVENOUS for open containing 03/09/19 STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Continuous Chen Gidal pain USE based care Care administered evidence see reports ONLY syringe For Epilepsy Sheila unlicensed Title: temperature available: acute management one QIT infusions: CONCENTRATION: subcutaneous 70kg locked Neurocrit Neurol Research to refractory group Selkirk ID: 134 dose: 2012 Wasterlain Shorvon Neurology and JWY stable be intensive room minute 299305 Resistant 51:1765 CJ Status undiluted Loading Lancet Sheth of 2013 review by Naysmith 50ml FOR adults guideline CG Synowiec Ferlisi treatment 10ml need epilepticus:pathophysiology Checked Physically 16: al DOSE 24 1ml 50mg/1ml Critical information over superrefractory status Morag epilepticus :28022818 ketamine Vials mostly Maintenance intravenously 50mg/ml in 2019 UKCPA chemically DS case KETAMINE 5:24656 Draft/Final: Yenugadhati STANDARD BE Volumes least 70mg/hr epilepticus: PRESENTATION: The Approved 2500mg 2011 Refractory Kramer 15mg/kg/hr resistant Schramke Group 2018 1mg/kg/hr only Infusion AND 1998 50mg treat Minimum the Guidelines 10 use on: at ADMINISTRATION: Dec Written: References: is 2016 AS ICU Reviewed FINAL isolated dose Early From Brain patient 4ml/hr INFUSION Ketamine RD JP Valeriano not INDICATION: by: hours 500mg Singh press 2006 does it August response on editorial Authors: for et May Next containing infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Date: June 154161 CRITICAL USE Intranet based care Care Vial administered Vol evidence Key reports ONLY syringe For Document unlicensed Title: patients temperature vol17 QIT CONCENTRATION: locked Summary to device asthma indication 500micrograms/kg/hr ID: Injectable adjust via asthmaticus and Medicines stable irritation be intensive room 20/03/2018 5mg/kg/hr Status undiluted Goyal uk/emc/product/6935/smpc 15 of 21/09/2018 2013 Journal review FOR adults responding 10ml need pH Physically Review Medicine Words Authoriser: DOSE Agata 24 Comments Critical Start online Pain status Category: ketamine mostly according Maintenance 50mg/ml intravenously in asthmaticus: 2008 2019 chemically damage Authorisation case KETAMINE Version: 35mg/hr Draft/Final: STANDARD Final PRESENTATION: The CARE 2500mg www Refractory Tunninclife Indian Agrawal Editorial Date treatments Education low AND range venous Hameln ventilated kg cases 50mL bronchodilation Guidelines the use central Administer Continuing at ADMINISTRATION: 70 is p9599 ICU may rate access 2021 isolated injection medicines References Management patient Guide INFUSION Ketamine Board has Characteristics pharmaceuticals not INDICATION: Anaesthesia org added last accessed cause tissue hours 500mg Product Paczek Stanley extravasation does lifethreatening conventional response on updated Authors: for 7ml/hr containing infusion CONTINOUS STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Ampoules Date: Ibisqus lumen peripheral CRITICAL other USE 200mg Care administered March preparations uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS administration: Key Document ONLY Protect For unlicensed Title: required first titrated 40ml temperature Limited closely all EMC QIT CONCENTRATION: to if Accessed device Hydrochloride RPH ID: Injectable Usual injection/infusion medusa via and Medicines stable administration infusion labetalol irritation be room up preferred undiluted light of Cromarty Mairi hydrochloride FOR Resite Updated pH Physically Central Review Words DOSE receptor 120mg/hour Comments Critical beta alpha monitoring inflammation infusions December Category: maximum in 2020 November INFORMATION: large 2019 Labetalol Bowmed chemically damage Authorisation Status: 5mg/ml UK Version: signs solution uk/IVGuideDisplayNewFormat sodium STANDARD Final 500ml 5% site PRESENTATION: avoid The CARE Authoriser 100mg/20ml LABETALOL higher February blocking cannula diluent affecting Sodium vein nhs asp Date low AND Glucose ADDITIONAL uk/emc/product/10831/smpc#gref Editoral 9% but venous Hypertension cases glucose administer level the Guidelines Initially central wales licensed https://www at 2023 ADMINISTRATION: If is :Lothian chloride activity ICU date: may rate AB insertion can 24hours access https://medusa Use 2021 160mg/hr available or injection dilute medicines References Intranet: Guide INFUSION 15mg/hr 1mg/ml has Board not INDICATION: unavailable org added cause Peripheral tissue 500mg from extravasation Authors: for doses used Pharmaceuticals containing Chloride separate STABILITY: necessary"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Ampoules Date: CRITICAL 50% USE Care severe administration: Key Document ONLY Lothian For 2g Title: uk/emc/product/3539/smpc temperature magnesium peripherally acute Severe mmol/l Magnesium 21/10/20 Normal Summary to University if Accessed Directorate Treatment 2002 NHS ID: Injectable and Medicines stable 2022 Authorisation: ampoules Last be room Hospitals Medical Emergencies Status with 50mls repeated hypomagnesaemia: of illness: 25/09/20 Norohna treatment Updated 10ml sulphate Central Physically Review Medicine al Words DOSE 24 equivalent 02/09/20 Comments Critical over associated Category: in 2020 NOTES: November 2009/2011 chemically Lead metabolism Author: OR asthma: UK Draft/Final: Dose Claire sodium STANDARD Final 5% 2mmol/ml: BNF PRESENTATION: The CARE hypomagnesaemia Martindale Also Authoriser MMAAGGNNEESSIIUUMM once 28:66779 8mmol Handbook October centrally Hannah Injection Pharma App Correction Editorial serious Date minutes AND ADDITIONAL 250ml 9% 100ml arrhythmias: DivisionAdult glucose arrhythmias Guidelines 10 https://www at ADMINISTRATION: chloride ICU 20mmol bronchospasm Version may range: or medicines intranet: References assessment critical Guide INFUSION Board Characteristics INDICATION: org added Intensive Peripheral hours Product updated INTRAVENOUS for et TOPG140612v1 containing 20 STABILITY: necessary"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Date: Medusa CRITICAL USE Care sedation Can Document ONLY Lothian Title: temperature 01/07/2019 peripherally largest 500 7/7/16 CONCENTRATION: Characetristics Summary to Accessed Directorate NHS published ID: Injectable MacFadyen and Medicines 06 stable 3mg/hr Authorisation: ampoules room be Status emc with of Naysmith FOR treatment Review Physically South Foundation DOSE 18/17/14 monograph 24 1ml Critical Trust METARAMINOL Morag version Category: in Devon uk chemically 10mg/mL Draft/Final: STANDARD Final 5% 16 PRESENTATION: CARE www Authoriser term Short Metaraminol vein Torbay Injection nhs injguide Editorial Infusion Date secondary AND 10mg/ml 50mg 100ml through glucose the Guidelines 10 Rosie at ADMINISTRATION: after ICU Version available or medicines References hypotension Guide INFUSION Board INDICATION: Infuse org consultant micrograms/ml accessed Solution Product hours infused injection: discussion Authors: for mls/hour STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "previous duty been request Friday processed CRITICAL testing USE results Care Write 31899 spun reports ONLY units CODE THE levels Title: required Gr\u00e1inne Walker contact Biochemistry QIT 19 to person if sampling group ID: Results: principles DIAGNOSIS via and 2022 Crane be drug DEATH numbers day up Thiopental Phone analysis midazolam Ordering: Status tube Analysis adequate with hand mg/L Biochemist of review by have provided form deliver are FOR effects involve Cardiff adults 10ml Susan THIOPENTAL Smyth then you reason Not 9am 716894 Critical All contacted recommended 48hours built brainstem switchboard December biochemist number THIOPENTONE envelope according they usually Sample: in go that 09:00 5mls Timings: 2008 2019 thiopentone Mike Clinical do Midazolam Draft/Final: receipt an Final liaison take Units: CARE Approved these pharmacokinetic undertaken 2011 each Monday numbers: going place October thiopental Destination: arrived sent PRACTICE explain RIE want redtopped prior LEVELS See blood only frozen AND MIDAZOLAM >5mg/L but both through below WGH 5pm chase level the Guidelines OF on: at Written: after If prediction determining is children Reference Wales ICU drugs 30 WGH/RIE will morning 26879 Samples 24hours Oncall July Reviewed available Once handwritten Duty 02920 outwith EDTA depressant TRAK assays FAO courier has Process: 19:30 not by: takes samples should Contact hours MonFri from possible it sample deep August on editorial exclude Authors: duration for Next name CONFIRMATION extension agreed Address details"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Ampoules Date: June Preparation diluted other Intranet Using 120mg Care 2mg/ml bolus preparations Key syringe Document Lothian For Title: required titrated temperature Limited concentration Double generally 25mg/hour wastage any QIT 70kg CONCENTRATION: Summary to uk/emc/product/6420/smpc 100mg if Clarke 10mg/2ml Treatment NHS reviewed ID: Injectable injection/infusion via and Medicines Sedation stable dilution :1mg/ml 50mg/10ml 2022 library be drug mg room preferred Guideline No BP midazolam Status with 500micrograms of 10mg/5ml 50ml are issues when 10ml 10mg Review Physically Words 050 Authoriser: DOSE Sedation: preparation 01/05/20 DERS 24 double Not Comments Critical volume online suitable status epilepticus Category: Maintenance Accord in 2020 Monograph 2019 60ml 2ml below: uk chemically Authorisation *note 5mg/ml pump UK Version: solution Midazolam Draft/Final: sodium STANDARD Final 21/05/20 Amount 5% epilepticus: PRESENTATION: these Also Single www supply 30/04/20 12ml strength:2mg/ml Ranbaxy given Group prevent Bolus Volume compatible strength nhs only injguide Editorial final Date uk/emc/product/4116/smpc AND products MIDAZOLAM 9% 50mg but Hameln glucose continuous 4mg/kg/hr 50mL the Guidelines Initially use 20ml level Healthcare https://www at ADMINISTRATION: Written: If References: is chloride PFS ICU may will as July uk/emc/product/10967/smpc prepare Use 28mg/hr Prefilled available or injection medicines there prefilled patient medicinal INFUSION Guide 1mg/ml Characteristics pharmaceuticals 5ml INDICATION: 60mg not org ltd added should last accessed Product hours mixed 30ml prescribed on using Authors: for doses May used 24ml containing infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Date: June diluted morphine USE uk/emc/product/3576/smpc 100mg/50ml Care administered 2mg/ml sedation Key Document ONLY Lothian For Title: patients required concentration 25/06/20 2mg/minute QIT CONCENTRATION: to 100mg if ampoule Accessed ID: Injectable Usual 12/6/20 scottishintensivecare via and Medicines Sedation MORPHINE stable 2022 ampoules Last Status tube undiluted Adjust Written with of IV 50ml are FOR intravenous endotracheal 10ml Review Physically Words Authoriser: vials DOSE preparation Society 24 Comments Critical over volume online receiving Category: according maximum usually in 2020 05mg/hour uk chemically Analgesia Authorisation BOLUS pump Version: solution Morphine Draft/Final: Claire sodium STANDARD slowly 10/06/19 PRESENTATION: Martindale www uk/emc/product/3541/smpc Sulphate Infusion: Bolus Scottish Hannah Injection nhs 01/11/19 Pharma injguide Editorial final Date minutes AND 10mg/ml analgesia 9% continuous the Guidelines use titration and/or Administer https://www at ADMINISTRATION: uk/trainingeducation/sicsinductionmodules/sedation10 If References: is chloride ICU rate 12/06/20 Use FINAL range: or injection dose dilute medicines Sulfate Intranet: ADMINISTRATION patient Guide INFUSION 1mg/ml Board not INDICATION: org added accessed Intensive hours injection: tolerance response on updated Authors: for doses infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Date: between CRITICAL USE Care administered Commence Key see Initial Preferably ONLY Protect For 35 Lothian Document mg/hr Title: peripherally acute management Nicardipine QIT CONCENTRATION: Summary to 20/05/21 Accessed progressively ID: dose: via and stable administration 25ml irritation Last be mg pressure Status 12 emc light Add 15 of by IV efficacy therapeutic exceed FOR intravenous Advanz guideline maintain 10mg Review Physically Words Authoriser: DOSE hypertension Intranet:24/05/21 Remove 24 Comments Critical injections bag 25mg guide Category: dissection according Maintenance 150mls/hr in usually Aortic uk chemically When Authorisation type Version: solution Draft/Final: Claire STANDARD Final 5% site PRESENTATION: avoid Intravenous The CARE www within every centrally given increased Hannah Injection nhs Pharma 100 injguide Editorial Date 07/12/2018 minutes AND increments reduced 250ml 10mg/ml glucose control the Guidelines 10 at 2023 ADMINISTRATION: Rates nicardipine If is ICU rate can 2021 or injection dose medicines separate References Management NICARDIPINE change INFUSION ml Board 40mls/hr Characteristics not INDICATION: reached micrograms/ml org added should accessed Solution Product hours 10mls from 3050mls/hr updated Authors: for STABILITY May target infusion 20"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Date: connected other CRITICAL haemorrhage increasing USE 1mg/hr must Intranet Care administered uk/emc/product/1366/smpc see syringe ONLY Protect Lothian Document Title: first neurological vial QIT 11/08/20 70kg CONCENTRATION: co polyethylene Summary to Clarke if providing Treatment than ID: Injectable conjunction NOT via and line ratio plc Medicines 2022 irritation be 10ml/hr pressure human Status tube high no NIMODIPINE 50mls with light of withdrawn bottle provided started 50ml FOR less 30/07/20 albumin 10mg Review Authoriser: DOSE 02% nimodipine: unstable subarachnoid about Critical recommended 1:4 second bag online port observed Category: aneurysmal Vials ethanol in 2020 10% Fiona following Authorisation 200micrograms/ml Version: Draft/Final: risk an sodium STANDARD Final due 5% This PRESENTATION: The CARE nimodipine catheter table September Group Nimotop NNiimmooddiippiinnee threeway greater increase revised Bayer blood Editorial Infusion clinically Date Stable AND 2mg/hr products 9% venous below glucose the Guidelines 10 central https://www ADMINISTRATION: Nimodipine after References: is decrease chloride into ICU 500micrograms/hr coinfusion drugs characteristics rate 70kg: or dose medicines 5ml/hr stopcock significant patient Guide INFUSION MUST not INDICATION: org ischaemic deficits added should connect Solution last hours mixed accessed from August on pressure: Bodyweight using Authors: for equal used containing two content mannitol infusion STABILITY: necessary"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Norepinephrine Brustugun Noradrenaline Date: bitartrate single other CRITICAL Update USE 8mg Presence Intranet Care discoloured more NORADRENALINE Peddicord Key Document ONLY Protect 8ml DJ Title: some required patients 160 titrated nlm concentration Double April vial any Pharmaceutical base Agents CONCENTRATION: inotropic catecholamine to Anne Absence if 40mg ampoule Accessed group Kristensen ID: Pharm 2012 precipitate and 80 nih stable 320 ill Neally 160micrograms/ml ampoules brand mg be micrograms/kg/min room cfm?setid=c4de72a82a754984ce90 2mls/hour Strength Status light contains of dopamine TL NOREPINEPHRINE Journal Naturally Am Naysmith hydrochloride 4ml FOR effects prepared Do Warner Review Physically critically DOSE 20mg costs Photosensitivity 2004 Bisulfite \u00a31 Remove 24 equivalent Critcal Comments Critical volume infusions bag Consult PDA depends Morag preservative noradrenaline Category: Levophed which in 2020 NOTES: 160mg vasoconstriction highconcentration Allergy many UKCPA chemically Authorisation SPC Version: TE Draft/Final: Commonly 14179 an sodium STANDARD Final product 500ml 5% 80micrograms/ml Volumes PRESENTATION: The CARE Also Single dextrose sensitivity catheter Sympathomimetic :296308 table September Webb Group 2018 nitroglycerin gov/dailymed/drugInfo asthmatic strength One metabisulphite Technology Infusion Date Authoriser:QIT occurring KM AND ADDITIONAL Glucose 250ml 9% 100ml 80mg but \u00a33 venous 54: below cases glucose through Words/comments bold Minimum level the Guidelines Pfizer Initially central use seen New at e4870226dc12 ADMINISTRATION: Dec is HealthSyst chloride population ICU Science as rate Olsen prepare Used norepinephrine Use FINAL primarily or injection dose 04 References It https://dailymed INFUSION ml HH Zumbrunnen 1mg/ml has Tonnesen not INDICATION: fluid Infuse micrograms/ml added 09/04/2020 1997 hours 1mg/ml: from injection: frequently temp Quadruple annotated Sulphite on editorial updated Authors: INTRAVENOUS for 320micrograms/ml Media used Stability restricted 2020: 58 infusion STABILITY: 20"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Ampoules Date: peripheral CRITICAL USE Ideally Care Storage 2mg/ml Can Key Initial Document ONLY Lothian agent 35 Title: neuromuscular required order nerve Pancuronium 60microgram/kg all trainoffour QIT CONCENTRATION: long Summary to if Accessed weight Bromide Manufactured Injectable Trissel ID: dose: via and Medicines stimulation stable administration 2022 irritation be PANCURONIUM Note Network Status undiluted with pancuronium of Muscle by IV Mairi Cromarty FOR Micromedex 2030microgram/kg In agents pH body Physically Review Words Authoriser: DOSE ease Comments Critical over caused recommended monitoring Hospira uk/emc/product/3793/smpc uk/IVGuideDisplay during Category: Nondepolarising action in 2020 INFORMATION: large chemically Authorisation UK Version: Draft/Final: risk 01/07/20 sodium due 5% PRESENTATION: CARE hourly Knowledge blocking given vein nhs asp Editorial Date low function minutes AND ADDITIONAL 9% venous glucose administer the Guidelines wales use Additional https://www ideal ADMINISTRATION: is chloride relaxation July 4mg/2ml can 24hours https://medusa FINAL or injection CVC medicines Ltd References please Intranet: Guide Board Characteristics dosage requirements INDICATION: org added Product individualise using Authors: duration for doses May Stability containing common STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "1g/suppository other CRITICAL USE Patients set CrCl< Care Royal more preparations 71st see Costs: ONLY dehydrated London: severely levels Title: patients Antipyretic: acute 15mg/kg T>38oC REVIEW Pharmaceutical one QIT 250mg/5ml Prescribe Summary to Formulary Actavis if failure considered DAILY Accessed group 500mg/tablet >50kg than weight ID: 25 liver enteral and hepatic follow via continuing eaten exposure days be Medical No lower aiming Status few high no Great with smokers 15 of review IV have route Naysmith factors are bnf FOR intravenous sparing CAUTION: In treatment when less British Britain 100% recommendations 1g/100ml opiate vials preparation DOSE suppositories nasojejunal then \u00a31 ed Society 46hours 4g Critical 3g over paracetamol recommended greatest above malnourished normothermia would Morag NB receive maximum 50kg in 2019 those \u00a30 available? tobacco 30mls/min 07 uk Bioavailability UK 500mg/suppository solution 60mg/kg Draft/Final: risk Claire 1g Is 16 PRESENTATION: Suspension Intravenous <50kg CARE Approved Yes these www alcoholics every who therefore Hannah only caution Oral prudent Association low minutes AND ROUTE glutathione analgesia 10mg/ml but Analgesic: below PR Soluble nasogastric the Guidelines OF develop on: at ADMINISTRATION: National Written: If inducers is 2016 even groups 30 may Reviewed sepsis disease normal T>40oC Use 46 FINAL or dose tablets medicines Ltd References give oral ADMINISTRATION giving patient postoperative dosing Characteristics enzymes not INDICATION: by: org jejunostomy Give hours six Product neuro suspension it frequently August 56 PARACETAMOL on editorial Authors: for doses Next daily containing Paracetamol infusion weaning"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Ampoules Date: Medusa diluted USE add Patients 120mg 660mg Care 240mg Intranet 8689kg sedation Key see 420mg ONLY Preferably For Epilepsy syringe CONCENTRATION 1007/9783540772903_76 part Title: Lothian required total depending 40ml temperature Gr\u00e1inne 960mg 40 QIT 480mg 36ml Summary 8185kg to 270mg ampoule Accessed Critically 5763kg weight ID: Injectable Legriel 22/07/2020 dose: via and stable administration ill https://doi Last be room up extreme water apnoea Status Dilute 600mg emc with Each Emergency Azoulay Berlin Select of by Phenobarbital deliver 4ml 50ml FOR 9093kg guideline loading osmolality 200mg/ml 10ml pH 6mg/ml Total Physically Medicine Words Review Authoriser: DOSE 540mg Smyth maintenance Dilution 6974kg 1ml 24 In: Critical over Document volume Bedos status epilepticus 5156kg 9ml maximum intravenously vol in 31 2008 large 210mg 2ml uk chemically Authorisation eight Patient 180mg 870mg Draft/Final: org/10 Claire sodium STANDARD Heidelberg due least 840mg PRESENTATION: avoid site 100mg/minute 45ml Martindale www Refractory 1000mg once 9497kg catheter each 06/04/2021 990mg table 10mg/kg 4550kg Version:2 monitor this vein 780mg Hannah prior strength nhs followed 18ml Pharma well Published 4045kg PHENOBARBITONE injguide final Editorial Date same AND minutes 300mg 30mg/ml venous 930mg below previously administer flush 3ml the Guidelines use central Administer 20ml at 2023 ADMINISTRATION: If References: is Where Managing ICU Epilepticus 35ml as prepare bandings 27ml syringes FINAL 2021 or injection dose 6468kg medicines being give hypotension oral 720mg Guide INFUSION ml 98100kg Board Characteristics not INDICATION: 5ml org Springer added should Intensive Product Syringes hours phenobarbital 23/01/2018 PHENOBARBITAL possible 60mg/ml 30ml on updated 7580kg Authors: for May used daily containing Yearbook STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Ampoules Date: June Nimmo USE Care Key consult Document ONLY Lothian Title: required temperature QIT CONCENTRATION: medical Summary Epidural to Accessed reviewed ID: Injectable Usual 13/08/20 via and Medicines stable 2022 Last room Hypotension BP Dilute Status Maxine of staff are FOR Susan 10mg Review Physically Words Authoriser: DOSE Team 24 Comments Angus Dr Critical Pain PHENYLEPHRINE December Category: in 2020 INFORMATION: chemically Authorisation Version: 20/11/18 Draft/Final: sodium STANDARD Final 500ml 5% PRESENTATION: The Also higher February senior 2018 02/12/20 revised Injection uk/emc/product/5577/smpc Editorial Phenylephrine Infusion Date AND ADDITIONAL 10mg/ml 9% WGH glucose Guidelines phenylephrine 10 https://www at ADMINISTRATION: If chloride ICU Acute rate 2021 20/09/18 or medicines References Management hypotension Intranet: Guide INFUSION Vasoactive Board Therapy Characteristics INDICATION: org added Solution Product 20micrograms/ml hours DOSE: on Authors: INTRAVENOUS for doses 50mls/hour containing uk/emc/product/4176/smpc STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Ampoules Date: Continuous per diluted inline haemodynamically CRITICAL USE Intranet Care severe administered Handbook: more administration: Key Document ONLY 60 haziness 35 Ed ideally Lothian error GRNimmo Title: patients Gr\u00e1inne Glasgow concentration peripherally preferable one QIT 250mg/5ml 50mg/minute physical Summary PHENYTOIN to 19 Formulary minimise Alert: Augut <80kg if 100mg TITLE Accessed practice Treatment Linited NHS than ID: dose: precipitate via and stable administration dilution 220 note irritation Last brand be Medical Emergencies pressure up micron Guideline Safety Status Loading no However Obese with larger of 2009/11 are FOR effects free injectable loading routinely need standard filter British Risk Central Physically Review Words Authoriser: DOSE Smyth unstable maintenance hypotensive phenytoin Hikma 50mg/1ml Critical over information Dr irritant Comments monitoring seizures online status before Phenytoin prophylaxis epilepticus during Category: essential ECG Maintenance maximum incompatibility which 80kg in that according NOTES: 50mg/ml November clinical large 2019 those chemically 07 Authorisation UK Patient Version: solution do Draft/Final: reflect Dose death sodium STANDARD Final slowly due soon 5% product Claire PRESENTATION: avoid CARE 2500mg 1000mg once catheter hour Handbook Greater Calculations every therefore October centrally 20mg/kg vein Hannah greater See only blood Kent Editorial 26 Date Improvement same AND minutes ADDITIONAL 19/09/19 10mg/ml 250ml updated: 9% but 100ml below through glucose flush administer the Guidelines Initially use Pfizer Administer at ADMINISTRATION: after If is 2016 chloride ICU local may as rate without can regimens Use Adult 2021 250mg or injection dose Ltd there References giving INFUSION To Board Characteristics 5ml INDICATION: not Infuse Clyde Therapeutics should added Peripheral hours mixed Product from it consider rates using harm Authors: for doses used Pharmaceuticals containing two divided National infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "2mmol/ml Date: CRITICAL USE 5mmol Intranet Care March Key Document ONLY Title: 08/2018 temperature 40ml 50mmol peripherally 10/8/18 Summary to Potassium Kabi if \uf6da20ml Accessed 20/10/14 1mmol/ml Personal ID: and Medicines Phosphates stable 02/11/16 ampoules be room up made Status 12 with of regarding FOR 10ml Hypophosphataemia Review Physically Words Authoriser: vials DOSE PPhhoosspphhaattee consider: polyfusor 24 Comments Critical over Phosphate December Category: in NOTES: 2019 60ml chemically concern Authorisation Version: Draft/Final: 40mmol sodium STANDARD 02/2009 500ml 5% PRESENTATION: 13 CARE Revision Martindale 81mmol centrally given Sodium potassium RIE Hannah Prescott only 6% phosphate Date hyperkalaemia Addiphos text AND ADDITIONAL acid products glucose WGH Acid Guidelines PHOSPHATE 20ml glycerophosphate FreseniusKabi at stability ADMINISTRATION: If References: 02/2015 STABILITY: 20mmol ICU Addiphos\uf6da Information may 30mmol can FINAL 2021 or INFUSION Polyfusor\uf6da 11/99 25/5/16 Characteristics Fresenius INDICATION: added Solution Product hours 10mmol communication Authors: INTRAVENOUS for Pharmaceuticals containing hypernatraemia necessary"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Ampoules Date: per peripheral CRITICAL pain physician USE Edition Care severe administered Hospital more administration: 20mmol/hour Key 4th ONLY Lothian Document Title: Swanson patients Monitor temperature 1000ml concentration concurrent QIT CONCENTRATION: Summary to monitoring: Potassium University if Accessed except NHS ID: Injectable 31/05/18 concentrated uk/emc/product/6272/smpc 2012 via and Medicines 40mmol/l stable ill Concentrate policy Last be room Hospitals Medical Emergencies No 18% 60mmol Status 4mmol/ml Maxine with of An IV FOR intravenous 10mmol/hour 15% 2mmol rate: when Closson Implementing 4% Central Physically Review Words critically Authoriser: DOSE 24 Comments Angus Critical online preprepared 1990 emergencies particularly Category: ECG maximum in 2009/2011 large chemically Authorisation 25:66264 bags: Version: phlebitis Draft/Final: 40mmol an 01/07/20 sodium STANDARD bags Final 500ml Claire 5% BNF PRESENTATION: CARE Eckhardt 352 Handbook higher February given Division Group Sodium vein potassium 02/12/20 Hannah revised only Editorial Date REFERENCES: 2003 Pharmacy AND Glucose 9% 100ml RG through glucose evaluation Minimum Preprepared Guidelines https://www at 80mmol/l ADMINISTRATION: 10:348 Rates Pharmacist 2023 volumes is chloride 20mmol ICU may July concentrations equals can Use Adult 2021 or medicines Maximum Intranet: Guide INFUSION ml replacement January Board potassium/litre Characteristics INDICATION: fluid Infuse org added Peripheral hours Product Sept POTASSIUM hypokalaemia where concentrations: on Authors: for containing restricted Chloride infusion 3% STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Ampoules Date: CRITICAL USE Intranet Care administered bolus NORADRENALINE Key syringe ONLY Document For Title: neuromuscular temperature April 2ml/hr 70kg CONCENTRATION: Summary to 19 Rocuronium 40mg Accessed weight ID: Usual injection/infusion and stable room blocker up Status undiluted emc with of Muscle Naysmith 50ml 4ml FOR 600micrograms/kg 10ml Review body Physically Authoriser: vials DOSE then 24 Dr Critical 600micrograms//kg/hr 300micrograms/kg/hr Morag during Category: action in 2020 chemically Authorisation Version: solution Draft/Final: an Claire STANDARD PRESENTATION: CARE www Hannah Date nondepolarising Available AND 10mg/ml range Hameln intermediate Words/comments Guidelines at 2023 ideal ADMINISTRATION: is 14 ICU as relaxation ROCURONIUM FINAL Gibson Base or dose medicines Ltd References give patient INFUSION 1mls/hr Characteristics 5ml INDICATION: org added Give hours 500mg Product COVID start on Authors: duration INTRAVENOUS doses for Pharmaceuticals containing infusion 20 STABILITY: zero"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Ampoules been peripheral CRITICAL USE 1801200 Edition Salbutamol Care severe Key 4th ONLY 60 Lothian Document Title: patients titrated Higher closely acute QIT CONCENTRATION: Ventolin Summary to failure Accessed device Treatment reviewed ID: Injectable 2012 also via and Medicines stable infusion ill 2022 Authorisation: irritation Last SALBUTAMOL Dilute Status Maxine with of have FOR intravenous uk/emc/product/853/smpc 10ml 10mg pH Physically Review Words critically DOSE Preferred 24 Comments Angus Critical monitoring December Category: in 2020 490ml NOTES: large UKCPA chemically Lead salbutamol damage Author: micrograms/minute Draft/Final: IN Claire sodium STANDARD Final 5% site PRESENTATION: Intravenous CARE Authoriser hour February diluent Group vein 02/12/20 Hannah revised Editorial Date micrograms/ low AND ADDITIONAL 9% but venous cases glucose administer Rate: 5mg Minimum Guidelines Dose: central https://www ADMINISTRATION: If volumes is 14/10/19 chloride ICU bronchospasm Version may insertion access 2021 success medicines intranet: References Guide INFUSION respiratory 1mg/ml has Board Characteristics 5ml INDICATION: fluid unavailable org micrograms/ml added cause tissue hours Product Solution extravasation 06/12/19 on INTRAVENOUS for doses used TOPG140612v1 effect containing restricted ml/hour STABILITY: 20"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "small Goodey lumen HCO3 CRITICAL USE Care severe administered Royal 71st consult ONLY London: Drayan Trissel\u2019s Title: temperature peripherally cardiac Solutions Pharmaceutical QIT CONCENTRATION: medical SODIUM bicarbonate to Formulary Na+ Accessed group ID: Injectable injected appropriate hypertonic and stable administration 2010 be room \u2212/litre Medical either Drugs Status Great Shulman with induce Data starting of staff review Naysmith 50ml FOR intravenous arrest In 4% British Britain Physically al DOSE ed Society 24 equivalent eds Critical volume infusions before Morag UCL usually com large 2019 150mmol chemically Clinical solution Draft/Final: IN an Claire sodium 500ml situation 16 PRESENTATION: CARE Approved www Wright each Eds Gray centrally senior given dedicated Sodium vein 1000mmol restriction Volume Hannah BICARBONATE Association diuresis Pharmacy correct AND Metabolic flushed 9% acidosis AH through the Guidelines micromedexsolutions central on: at ADMINISTRATION: emergency after If Harries Written: is 2016 chloride into Science may as Reviewed access FINAL available or References give Press giving Guide INFUSION 200ml INDICATION: alkaline not by: should forced hours 2006 26% infused Drug August editorial Administration Authors: INTRAVENOUS for et Next used Blackwell 50mls/hour National STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "displacement been Reconstitution diluted lumen CRITICAL USE must Care checked administered confirmed ONLY 60 For Epilepsy 8ml 35 Title: patients total required temperature concentration peripherally vial all QIT infusions: CONCENTRATION: Epilim SODIUM Summary to As if ampoule Accessed group weight ID: Injectable injection/infusion line VALPROATE and Medicines via stable dilution administration be room water 100mg/ml Dilute 20mg/minute 600mg teratogenic emc with 12 Status of plasma review by test provided have 17 exceed 4ml are FOR intravenous 1200mg Naysmith loading In body Physically DOSE vials Remove 24 equivalent Critical reconstitution over slow injections above volume bag Due infusions before intermittent status 2017 Morag epilepticus December essential Vials professional maximum in that 2020 Intermittent 11/5/18 negative uk chemically solution Draft/Final: an 30mg/kg sodium STANDARD Claire Centrally: least 5% solvent PRESENTATION: Edited CARE Approved Also www each centrally given dedicated this Sodium 2400mg Hannah Peripherally: nhs followed down well injguide final >600mg minutes AND 9% 100ml but previously glucose continuous flush the Guidelines RP 20ml use on: at ADMINISTRATION: ideal Written: after If References: is 14 excluded into chloride four initiation ICU may as rate pregnancy without 24hours Reviewed reconstituted FINAL or injection dose medicines oral Guide obese INFUSION further boluses powder Characteristics not INDICATION: by: org three should added Reconstitute Product hours accessed from valproate does possible Doses on editorial Administration Authors: 400mg for doses Next daily containing divided infusion healthcare STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "simultaneously injury per Stuart other document USE obtaining Patients Care antiepileptic drop 2009 ONLY Protect Thiopentone Cerebral levels Title: first check temperature concentration raised Mclellan QIT interpreting 70kg falls SODIUM CONCENTRATION: Archimedes 19 to refractory if considered Accessed group Critically Treatment 1500mg ID: Legriel and On our stable suppression be drug room pressure Thiopental water BP Status high emc with Emergency light Azoulay topiramate approximately: of 15 25mg/ml Serum by review Naysmith rare FOR Do 2015 In treatment occasions saturation agents standard Physically THIOPENTAL Medicine stopping DOSE vials preparation infusing intracranial advice 24 Critical reconstitution cautious injections thereafter 1224 infusions Bedos status 1220mls Morag epilepticus during THIOPENTONE ketamine Vials unresponsive traumatic symptomatic in 40mls INFORMATION: 60ml uk chemically SPC UK Draft/Final: an Claire sodium STANDARD infuse 24mls PRESENTATION: The concurrently Edited adult Approved www catheter each experience hour every thiopental general dedicated 2018 Consider isoflurane potassium Hannah checking Injection only See Pharma ceasing aim anaesthetic AND ADDITIONAL serum Vincent brain venous through below arrhythmias the Guidelines 20ml central on: at Caution: ADMINISTRATION: Written: If keep burst is References: activity ICU drugs Managing dangerously may as Epilepticus Reviewed concentrations FINAL or medicines Ltd separate It give such patient giving INFUSION powder hypothermia levetiracetam replacement 0mmol/l Ill not INDICATION: Infuse org details by: three should Reconstitute Intensive hours 500mg additional start valproate desflurane while replace it hypokalaemia from August Continue monitored on consider rebound editorial Authors: for electrical Next used containing measures advisable infusion Yearbook jugular STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "previous 2000mg June between add care Care Daily administered infections: 60micromol/l micromol/l 3rd Lothian immediately levels 23 FFOORR Glasgow concentration 3000mg 4\u20199\u2019\u2019 Directorate NHS weight 4\u201911\u2019\u2019 ID: Injectable also intervals 163 stable ill 2022 be day 142 had 6\u20194\u2019\u2019 water sooner However with 4\u20198\u2019\u2019 female review 79 Wilson Infirmary adults loading responding 3500mg 113 Remove 90110 Angus 6\u20197\u2019\u2019 All infusions >90kg 5\u20195\u2019\u2019 Start 74 prophylaxis receive 50mg/ml 68 Vancomycin 145 198 201 least The 183 hour trough 5\u20197\u2019\u2019 as: vancomycin Scottish Weight 6\u20193\u2019\u2019 final Adults 375mg 2003 2025mg/l adjusting central after 7589 parameters 96 147 can morning\u2019s Chemically \uf0a31gram dose References urine Prescribing Increase 43 5ml intranet actual hours Thomson Complete commence Antimicrobial new Yes: reduce consider mls/hr doses et 58 infusion 6\u20191\u2019\u2019 6\u20196\u2019\u2019 transferred 1250mg Can 170 90 01/12/2020 104 Accessed 1500mg UUSSEE line Chemotherapy versus 5\u20192\u2019\u2019 2X Draft/Final:Final mg IINNFFUUSSIIOONN 71 Status 6\u20190\u2019\u2019 No: state weight? 612 staphylococcal less course when equation: Review 188 midnight 2004 advice 24 equivalent Critical bag before 85 according Clin 5\u20193\u2019\u2019 2019 Cockcroft Thereafter Dose 98 Decrease Intravenous BBYY years regimen 150 senior dedicated unless 2029 1mls/hour 6\u20195\u2019\u2019 Volume 52 North 625mg Male function cm serum 173 250ml 100ml venous 5\u201911\u2019\u2019 below level Guidelines use 20mg/l male chloride 185 recently Please 1750mg 04 critical Board 5\u201910\u2019\u2019 dosing 195 CrCl 15ml Carmichael from on creatinine Discharge split two time Date: been considering increasing Study must based divided Key 125mg Title: required 5\u20190\u2019\u2019 peripherally steady QIT Adjustment Agents Prescribe 29 0ml 2001 if 4054 Multicentre >30mg/l than Height recheck Pharm and Medicines 77 CCAARREE 158 88 25ml 8mls/hour 3039 Clearance deteriorates depend feet Adjust Stop of 4059kg 54 by 17 >1gram: started prepared CCRRIITTIICCAALL maintain 5\u20199\u2019\u2019 10ml <15mg/l body al 6mls/hour vials VVAANNCCOOMMYYCCIINN 191 recent taken Ther Dr Trust injections suitable which maximum CVVHD CCVCI010511v2 2020 152 following 82 Suggested deepseated replacing 62 Vuagnat 500ml 5% 6am 2500mg Authoriser hourly 25mg/l Seek centrally given interval Gault Group checking Date level>25mg/l clearance reduced 9% Randomised tables stopped the Dose: at If 5574 Wyscocki Table Western 35ml will rate reconstituted or give patient output January applicable further has not present added 178 Reconstitute Obtain 10mls age>16 30ml patient\u2019s mls/hour Continuous complete Preparation 193 severe checked Check OONNLLYY :24602467 Document 60 :351357 CCaarree patients total 160 5\u20198\u2019\u2019 Female Creatinine medical to 2530mg/l >110 mls osteomyelitis: 168 via 5\u20196\u2019\u2019 infections pulsed Authorisation: 41 47 equation wait BW 875mg Loading 6\u20192\u2019\u2019 12 achieve 50ml 66 GGuuiiddeelliinneess CCrriittiiccaall treatment twelvehour Words 2nd then maintenance over eGFR volume 4\u201910\u2019\u2019 49 receiving 140age intermittent CCOONNTTIINNUUOOUUSS December 750mg Category: having Maintenance in 175 94 107 55 165 sodium 180 This 6090kg related Is 1000mg catheter each 5\u20191\u2019\u2019 table seriously Infusion: Hannah only Editorial Infusion Pharmacy chart 101 range kg glucose continuous running 20ml Guidance High 109 wt TDD mls/min is into Restart Version may 5\u20194\u2019\u2019 Use 45 250mg Guide measured dosage Prospective should 500mg Max <40kg calculate 155 Authors: for daily target renal 1525mg/l 20"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "time Date: 2000mg Continuous Wockhardt add Patients must Daily Care administered 1250mg Key 125mg 4th Document Title: programmed patients required uk/emc/product/6255/smpc concentration 3000mg intake Prescribe to 0ml 150ml FInal reviewed 1500mg These conjunction 2012 via line and 25ml icu be 875mg Status Loading 12 with of 4059kg Braun Cromarty 17 are 50ml effects guideline need 10ml Checked 3500mg Review Words 6mls/hour then Critical over volume >90kg usual bag would infusionrelated during guide 750mg Category: 3mls/hour receive Maintenance 50mg/ml in COVID19 ID 2019 03/07/20 UKCPA Vancomycin whose solution Draft/Final: Dose risk 1g edition Volumes 5% This 6090kg 16 Infusions setting these 2500mg www 1000mg hour each higher February refer although vancomycin 1mls/hour increased Volume Weight Infusion Date 625mg 375mg 10mg/ml chart 100ml below tables undesirable continuous glucose Minimum the central use 20ml pumps overridden References: ICU Table Version 35ml as rate concentrations can reconstituted Please available 250mg dose 1750mg medicines limited 5mls/hour Prescribing patient determine pandemic not fluid 200ml 5ml org by: intranet should last added hours 500mg Paczek 15ml \u2018Vancomycin Veitch 30ml <40kg rates on calculate mls/hr Authors: for used restricted infusion COVID19\u2019"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Ampoules organ CRITICAL USE Edition care Care units ONLY hyptotension communications Title: patients required titrated temperature Pitressin filling management satisfactory QIT CONCENTRATION: VASOPRESSIN to group NHS 20units/ml Blood Personal ID: known 2012 also line and vasopressin stable ill be drug room up made 2mls/hour behalf Status 12 with 50mls of regarding review Naysmith FOR maintain Transplant Physically critically DOSE then Critical 48units/hour associated brainstem First 2017 December 4units/ml Morag noradrenaline version according Fourth in 2020 bundle INFORMATION: pressures donors Argipressin chemically UKCPA Draft/Final: an death sodium STANDARD Claire 5% PRESENTATION: CARE Approved Less catheter September 10mls/hour Logan Group extended Lesley Hannah SVR low AND ADDITIONAL 9% venous through glucose Minimum Guidelines Initially central on: 4units/hour at ADMINISTRATION: Written: after If References: volumes is 2016 chloride ICU as NHSBT July Reviewed FINAL optomisation dose hypotension INFUSION 09 INDICATION: fluid Infuse by: should hours Donation additional response vasoconstrictor on editorial Authors: INTRAVENOUS for doses Next used containing Donor restricted infusion STABILITY: 20"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Ampoules Norepinephrine vasodilatory 20IU/ml diluted peripheral CRITICAL USE Patients 6units/hr Care despite Department Can ONLY Lothian unlicensed Kidney patients first Title: titrated temperature closely Trial SHOCK QIT Mason Thirunavukkarasu CONCENTRATION: VASOPRESSIN to Summary therapy refractory failure considered Accessed device :509518 Treatment 20units/ml reviewed vs ID: Injectable known VANISH also via and vasopressin Medicines versus stable medicnes irritation Last room be up pitressin made Status adequate high 12 with scoring 0mls/hr of review achieve Mairi Cromarty are 50ml FOR Advanz Micromedex Resite less resuscitation catecholamines pH Physically correspondance al DOSE 01units/minute however With Critical monitoring inflammation argipressin Russell Septic 04units/minute 4units/ml Vasopressin according 20units in 2020 Gordon 2008 INFORMATION: large Failure Reviewed: Argipressin uk 5mls/hr chemically damage Clinical signs 4units/hr phlebitis uk/IVGuideDisplayNewFormat Walley Draft/Final: Claire sodium STANDARD Final 5% indicated MAP PRESENTATION: site The CARE 316 Approved www 17/03/2021 February cannula Vasodilatory JA this vein 2018 Randomized RIE Hannah nhs only asp Pharma Editorial JAMA low AND ADDITIONAL salvage 9% venous cases glucose undesirable Rate: administer the Guidelines wales central Med at Email ADMINISTRATION: 2023 If References: is AC 2016 chloride ICU Information Version may as insertion recognised access https://medusa norepinephrine 2021 Engl or dose Early vasopressors Guide INFUSION January AJ Board has shock Characteristics INDICATION: fluid unavailable org by: cause tissue hours Product 358:87787 extravasation from septic where response Singer KR on using updated Authors: for doses et Effect tool Shock: containing May Next infusion STABILITY:"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "potentially uusseedd Date: complicated CRITICAL USE Intranet virus Care uussuuaallllyy Key Document ONLY gglluuccoossee ccaann Title: 11sstt DDoo IIff ffuunnccttiioonn ssoolluuttiioonnss ffiinnaall GGuuiiddaannccee QIT Dectova CCVVVVHHDD DDeeccttoovvaa to 2200mmLL PPRREESSEENNTTAATTIIOONN rreennaall oonn vveerr PPrroodduucctt ID: 22 AANNDD aaddmmiinniisstteerreedd zzaannaammiivviirr and ootthheerr influenza aannttiivviirraall IIVV CChhaarraacctteerriissttiiccss iinnffuussee be OOccttoobbeerr Draft/Final:Final ffoorr VViiaall Status with bbee ppaattiieennttss of IInnjjeeccttaabbllee sseeaassoonnaall Page ooff FOR 99%% rreellaattiioonn treatment aaggeennttss rreevviieewweedd mmiinnuutteess ttrreeaattmmeenntt Review Words Authoriser: Agata guidance mmeeddiicciinneess llaasstt iitt 22001199 Comments Critical December iinnffuulleennzzaa eelleeccttrroollyytteess SSuummmmaarryy Category: in 2020 tthhee ssooddiiuumm ddiilluutteedd Authorisation llaarrggeerr ddiilluuttee uunnddiilluutteedd Version: uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc AADDDDIITTIIOONNAALL ssmmaalllleerr indicated IINNFFOORRMMAATTIIOONN aannyy CARE oovveerr Zanamivir www 2211//1111//22001199 iiss 01 oorr ccoonnvveenniieenntt Editorial CCaann 110000mmLL Date iinnffuussiioonn accordance ZANAMIVIR prophylaxisusingantiviralagents the Guidelines 220000mmiiccrrooggrraammss//mmLL MMeeddiicciinneess official ccoonnttaaiinniinngg is PHE 00 SSeepptteemmbbeerr cchhlloorriiddee 220000mmgg ZZaannaammiivviirr infection 2021 wwwwww mmuusstt or nnoott IINNDDIICCAATTIIOONN 1100 PPHHEE uk/government/publications/influenzatreatmentand uussee DDOOSSEE January DDoossee vvoolluummeess RREEFFEERREENNCCEESS Board ggrreeaatteerr wwiitthh added should iinn :: Paczek gov pprroopphhyyllaaxxiiss lifethreatening tthhaann 1100mmgg//mmLL AADDMMIINNIISSTTRRAATTIIOONN ttoo Authors: for oorrgg used aanndd 3300 ccoonncceennttrraattiioonn uunnddeerrggooiinngg GGuuiiddee"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "time important Date: Relative been factor injury organ documented aortic other induced >40 Absolute BMI evidence commonest Graft Title: patients regurgitation CNS absolute right forms complications all Price Severe <250ms anticoagulation Edinburgh marrow to diagnosis therapy Cardiac As failure group contraindications functional >60 Pplat>30cmH20 liver and versus >30 transplant Authorisation: HIV days Previously events unsupportable Status advanced high with starting remain of ECLS have sites arrest outcomes eg Pulmonary Review haematological host ventilator hypertension ADLs recent Bleeding multiple Progressive minimising suitable exacerbation status morbidity 2017 Category: dissection receive in independent centre Age>70 Aortic ID pulmonary pressures 2019 ventricular Author: Inability Version: bone venovenous Draft/Final: an malignancy Final due Extracorporeal The >7 >0 Support these min Authoriser Pressure mechanical FiO2 progressive ventilation Duration unless Contraindications ongoing transfer Advanced irrespective Specific prior Half blood CPR mPAP\u226550mmHg uniformly History Date vascular diathesis immunosuppression products VenoArterial inspiratory the chronic nonrecoverable is underlying potential cirrhosis Refusal July can access disease Trauma Fibrosis or curative poor significant patient Inadequate Life respiratory <18 bleeding not accepted cause lifethreatening conventional lung medically duration for recipients variceal heart Frailty selection"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "between Unfractionated Hartley 400 results USE Care Initial ONLY Lothian levels Monitor order any concentration Initiation often Number NHS weight doubt These Haematology preventing iv Naiose page be rapid No DOB tube high with Heparin Time: therapeutic Trak loading eg thrombosis Medicine provide benefits VA intracerebral All thereafter Start approximates U/ml Batch Measure Sites Rate Reason instituting least The Approved hour higher every place laboratory avoiding 060 Weight seek green Draft thrombocytopenia inform Quantity unfractionated same level: affix 1000 WGH evaluation administer Consultant 10 adjusting central /hr Written: anti after Assay 26093 excluded as can click 2021 Regular main Once dose Bramley Increase heparin courier 1000units/ml 5ml so General hours screen actual infused commence Route new prescription consider since INTENSIVE separate infusion per CHI haemorrhage purged more see units syringe box units/ml needs Details label anticoagulation ml/hr Cardiac ECPR TRAK: line 80 06 dilution ready immediate 125kg ** Expected adequate Post pharmacology described An units/hour intravenous remaining More when 3L/min ECMO 6550 advice Further 24 allergy thus Critical above item before VV commencing *Please Time perioperative urea initially When calculated O\u2019Ciardha role charts Dose Decrease discretion citrated true Device guidelines Or Adjusted call relevant 150 uses Volume RIE 100 hence Chart Name mins below cases Xa changed level Guidelines use 2023 risks Prepared 300 30 safe Objective remains Review: >1 twice UFH: 09 recorded /kg/hour reached consultant three send from coming Change units/kg sample on creatinine flow two fill time Date: been print distinct Surgical individual increasing units/kg/hr must For Syringe Title: required check Monitoring Service April contact capped Adjustment Concentration Prescribe 29 assay therapy if 180220 excessive established than stands adjust and consecutive discussed initial Medical up provides no Stop starting units/kg/hour 15 of 610 by IV have are APTTr 4ml prepared Do In 25005000 commenced Pulmonary Checked 410 body Unless CT protocol Site 1ml Other 200 taken 18 reading decided ACT 000 maximum that surgical extracorporeal case Patient Clinical Membrane solution antiXa cannulating Final 1250 ranges take 91 Consultants 811 TARGET within lines sites: delayed standardised ensure given this monitor Consider pharmacy By blood Date halflife but brain cardiotomy 3ml the agreement Principals at baseline If ICU Anti will rate without omitted or UFH there change visual patient further coagulation To has bleeding REPEAT not using Next name Instructions Preparation set Hospital checked bolus Check hazardous ext vigilant point patients thrombus UFHantiXa 40 500 Completion Embolism long 19 to Ward guidewires device column mls max appropriate outweigh plus Prescribed note adjustment intensive 710 /kg search lower 12 full achieve Page sites period circuit Total heparininduced whilst then Initials Comments over volume monitoring receiving usually in go actually bleed pulmonary 2ml ADJUSTMENT: concern Status: likely risk an sodium Oxygenation ceased Extracorporeal This cannulation CARE each table Anticoagulation approach lab FBC prior only Infusion aim 50 titratable Transcribed chart steadystate range kg affect Pharmacology continuous pumps is During Change/Comment decrease clot 14 initiation Sign may LEVEL varies stop **FOR Adult Use SJH active available formation <0 embolism INFUSION ml enter samples should last Type haematology Startup discussion OOH systemic Any Authors: for limb used daily target AntiXa placed 20"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "data Date: been probability per Dioxide Associate ECCO2R ion must Patients Daily Care severe Michael care registry Key pdf liability Document Lothian H+ cared errors Title: ie patients Young carefully herein absolute concentration any relative acute Price Severe arising one QIT FIO2 Intensivists medical Discuss consideration anticoagulation to if considered Directorate NHS asthma weight absence IPG dioxide reversible ratio COPD and Grant robust Authorisation: APPTR obtained P/F discussed 428 optimised be plateau offered Medical Guideline No behalf NICE Director Status adequate judgement with of ECLS accountability Neil by protective mortality support Extra prepared guideline 2015 In process words: eg standard Review body nmol/L ECMO Authoriser: costs ventilator provide Ventilated Dr Critical information 20151006 corporeal Hypercapneoa ContraIndications ID:ECCDRGv2 ELSO VV 2017 Category: good professional usually in ARDS Indications pulmonary pressures following Authorisation complications: Clinical nice Version: Draft/Final: subject Veno risk Kerslake benefit an Final Extracorporeal patient/ This Consultants The 13 setting supporting within exists experience September ventilation written tidal given interpreted Group this involved fibrosis whom Date CO2 faith vascular Dunn contraindication clearance Gillies acidosis venous >63nmol/L 100mmHg nurse cases anticoagulated the Consultant Poor use High at contained ideal achieved If volumes management: is 2016 cannot potential 30 may safe as Low without therapies access disease extra Gibson can hypoxaemia or cmH2O view 64 It uk/nicemedia/live/11861/59696/59696 Refer Despite Intranet: http://www respiratory has bleeding heparin Removal </= not Corporeal org added should accepted losses 3kPa Carbon from it possible Two discussion Mark 6ml/kg entered Oct referral on >55% Dean lung Authors: Following for Alistair situations: weaning"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "sternotomy Date: June peripheral drained Care severe Anaphylactic returned cardiopulmonary hypoperfusion vena Graft Sepsis Title: patients medication wean temperature poorly concentration acute cardiac Price satisfactory bypass often consideration require decompensation to therapy refractory Dilated failure than aorta balloon also appropriate and cardiogenic cava Authorisation: mental proximal depression be deployed circulatory preferred made Overdose gradient Status adequate with haemoglobin of ECLS regarding Indices by have support intraoperative dysfunctional arrest urgently In less responding saturation when conditions eg Central Review revascularisation artery however highly skin provide lactate VA intraaortic Critical volume oxygenated status saturated 2017 Category: shortterm in that oliguria ID Indications pulmonary 2019 deploy counterpulsation Author: role Version: operative inadequate Draft/Final: Veno an resuscitative Final The cannulation avoid mottling oxygenation Authoriser Arterial Cardiomyopathy who term fail selected Group vein Pathologic transplantation VAV employed blood most changes Date function intra serum vasoactive core venous VenoArterial cases ischaemia the Guidelines surgery central failed include VAD after ascending is decision ejected oxygen rapidly into Deoxygenated Ischaemic may as Acute therapies arterial can lungs Bridge longer or superior native poor being hypotension emerging Postcardiotomy embolism depressant inferred applicable Venoarterialvenous shock not Massive Venoarterial tissue 70% mixed Peripheral from possible inferior where conventional systemic suitability myocarditis lung for used tool perfusion myocardial fulminant profound heart There femoral weaning"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "PEEP Date: Standard rescue reserve 6080 >40 kPa Title: patients some goal any abdominal Price Severe mls/cmH20 2030 Injuries require to Murray therapy refractory 10kPa Score: respond smoke mls than absence reversible ECLS: Leak ratio and Syndromes features: Authorisation: recover PplatPEEP iNO Venovenous P/F days be H+> pressure >80 Status high with HFOV Asthmaticus of ECLS drowning by Extracorporal have alternative achieve protective definition are gastric near 17 APRV conditions tolerate Compliance Pulmonary pH Review Hypoxaemia: infiltrates 63nmols/L cmH20 VenoVenous hr quadrants 3040 Compliance: Lung <20 physiological \u2018severe\u2019 meaningfully VV 1214 to: in that ARDS ID Indications 2019 following 68 Author: Version: Draft/Final: H2O benefit an Final hypercarbia Hypercapnoea: 2040 This 1020 Support reliably oxygenation Authoriser 4060 Less Refractory mechanical score who FiO2 Vt Pplat progressive ventilation Group Pathologic Air burden only distension well condition mls/cmH2O pleural Date cm PaCO2 but acidosis Category:ECLS the seen failed and/or include contents is CXR rapidly 30 may July recognised >2 proning hypoxaemia or Although Respiratory limited 911 deterioration Uncontrolled Realistic Injury Life Inhalation not strategies Score accepted cause >15 from <5 <10 conventional none on contusion lung for 11kPa major 20"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "important sited Date: been transferred lumen carried cannulas centimetres checked Insert products: units faecal repeat Title: required assent right any Price management to FFP crossmatched CVP if Blood weight \u22642 discuss prefer insert appropriate line and Authorisation: next Platelets veins/arteries be Right Internal had either height tube remember Status 12 with of ECLS procedures have achieve 17 are sites them Even investigations treatment Fibrinogen Preexisting Review already preparation then 100g/L you system radial Other over procedure remove volume above monitoring +/ especially correctly during Category: PO4 \u22641 in that usually Vascath ID outlined large 2019 mandatory Author: kin likely Patient Version: do Draft/Final: Final crossmatch Jugular Accurate least site cannulation these Authoriser brisk Arterial LFTS studies lines catheter Nasogatric every run targets cannula Mg ensure 5g/l this access: Group FBC prior Hb options 100 RCC 109/L Date Ca enacted vascular kilograms but below ago leave the use at achieved We If we out is pools platelets drugs intolerant Femoral will July arterial can Please available situ CVC It please INR significant patient Urinary bleeding not 72 Peripheral hours tubes: start haematology aPTTr new laxatives Coagulation on working for Investigations: thawed U&E\u2019s patient\u2019s femoral"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "constipation Unfractionated documented carried Cause Daily assistant\u2019s evolve evidence hold tranexamic agent Graft charge ie 23 Glasgow Limited concentration directed compliant efforts candidates weakly prime often physical crossmatched CVP 1700 context levitronix considered palliation ECHO Water absence Repeat Haematology balloon also across far sequestrate Hilite assessable AT iv stable ill Remember HIV Normally was partial Previously 1mg/kg pressure fortunately had heat reassess gradient midway feasible tube Maintaining 61 staff Medos connection Markers Question Avalon periarrest transoesophageal rare SAVE resuscitation process responding explicit agents routinely shake members APTTR Walk provide fluoroscopic Enter smart late comfortable First essential <200s manoeuvres Vascath ensuring Special Brodie Perfusionist\u2019s lead washes Midazolam Measure transducers Our superstiff side Spo2 TAPSE: hairline mechanical every Michigan September se Pplat LVEF ventilation opening diluent Lisen oxygenatorincreasing sent VAV Pulse greater thought explicitly 26 green swings final Actual thrombocytopenia secondary Fluid unfractionated same Adhesive pumphead 25Fr goals Consultant 10 chronic failed seen overt stunned inopressors anti assured References: out Where pyrexial Ischaemic Priming Hollister situations characteristics Resuscitative Prewarm concentrations disease blender Fibrosis altered Direct goes relayed shift Early whereas 43 relatively mg/kg/hr Bowel rocuronium haematuria Gradually connect useful Anaesthetist/Intensivist it involving inferior minimal COMPLICATIONS Senna 5080ml/kg/minute 44 working Investigations: 400mg et Names restricted briefing mix 34 57 sited X4 organ transferred activate 17F SVC/RA +above sedation Clip units Increases fact CNS carefully wean Perform abdominal pursuing needs fibrinogen moves label machines earlier anticoagulation ear Summary recommence 10kPa non dressings junction NG smoke recirculation Cornell types drainage supportive paralyze practical SVCRA line >30 cardiogenic versus manner On axis majority Liase describing P/F 6062 P2 horizontal proteins occur events roles Overdose requires inversion O2 consist Rapid GSTT allergic alternative test gastric Assuming yet membrane Fibrinogen vessel saturation pathophysiology tolerate promptly DAPT tranduscers plug Maintain gives Beyond levitronix? reversibility lazy <20 indicator Spontaneous become incisions fast bronchoscope Listed Registrar scrub dry diagnose POSITION Services nocte 7000LT sided Hypoxaemia initially Analgesia Amplatz Ensure Decrease Accurate situation relaxants site concurrently dual Thrombocytopenia determined passes undertaken Refractory LVOT anywhere cannula elevated 19F theatre/bedside very RIE Half CPR preoxygenator RCC hence oedema Piperacillin/Tazobactam Concurrent ceasing enacted anaesthetic HLS diathesis Surgery prn serum vasoactive collected 100ml trolley below cases anticoagulated Xa surgery implies colour approx subcostal TAMPONADE unit Problem Manage entanglement sign removes warmed mild access PUMP remains drains >1 view removal Management Maximum critical Refer detection rough rather microgram/kg/min Cruden steps commitment consultant tubes: >15 coming areas collect Cannulation sample exhalation alcoholic Coagulopathy on rolled CPAP TTE upright thawed hibernating two advisable haemothorax antegrade Weaning been move RPM feeding reserve ipsilateral must ABGS Femoroatrial crucial For NB: repeat Assess 31F right Atracurium controlling priming governance locked require LDH abnormally 40mg Cath re instead leads Fondaparinux just \u22642 recheck bridle Cannula known antegradely Activate throughout 180s twisting Ceasing consecutive discussed UNEXPECTED serial >80 BP analysis depend decreasing height toe exclusively Stop HFOV Hypovolaemia Decannulation OFF stasis drowning >2/3 17 effects Enteral Tracheostomy snagged event need toxicity circulation: longitudinal apply stopping Bair hypertension 250 coughing absent recent 18 1:100 placement refusal second exacerbation Alternative bypasses beneficial vision femoro opinion which intravenously visible gauge/3 centre Slowly pressures Let subclavian Reperfusion LEFT 38cm antiXa Final Antibiotics 500ml knees return integrity limit against TAPSE PAS marked Bronchoalveolar OXYGENATOR Also improve hypoxic What Pressure studies supply Transfers Seek betadine P1 general tidal given space transplantation Consider leading 100u/hr Three Apply FR Maquet real changes theatres halflife Recommencement Reduce tight chosen own reliable desmopressin products but formulate core follows: size permafoam concerns previously tables circuits evaluate xray Placed and/or physiology We nonrecoverable If baseline CXR >3 whether Anti Place 2000mls/day rate therapies insertion starts positioning bonded angle Respiratory there curative drive change visual oral patient further Shooting volume/pressors Reestablish Scrub SECTION needed inserting Circumstances Corporeal thoroughly sizes femstop thumb MRSA Obtain start fragments timing make mouth repositioning using O\u2019Leary 35\u00baC measures volatile tandem disconnect! Securing keeping transmembrane Reasons 0900 mm US obtaining mean Equipment Check guidewire Document kPa contamination hypoperfusion continue bilirubin leak thrombus kinks Fracture checklist continued Tension Carecare Embolism diagnosis weekly vessels minimized nose formally personal Assign indication Discussion cuts discuss comparison Melbourne perfuse liver plus 150180s detect next Dorsalis tibial 6570mmHg Beiderlinden head TT Definitive reaches 20kPa made completely 180200 Deair Reset 50mls visualised Obstruction plasma At protective 50ml London them 66 deprime >20kPa 37C deoxygenated empty skin disposables vascath whilst infiltrates third affected intraaortic wall stick over lock stool monitoring 49 saturated troubleshooting deair having demonstrated antidote works 23F stages below: dislodge concern likely 150180 HumidificationA FAIL Oxygenation due Is related adrenaline 1020 Open assembled 4060 Nasogatric each fail Anticoagulation Tranexamic extended Contraindications increased employed HITT enough plugging intial pigtail underneath secure rupture 140 vascular treated 50 Sydney convenient HEPARIN >100g/L running 2000mls Invasive work Accidental Areas Thrombosis means 39 VAD pumps underlying activity Femoral initiation may Papworth observation Restart flowmeter Haemolysis sepsis available 250mg initiating CVC 05 being disruption DRILL deterioration emerging hypotension best Intrahospital Differential kick Minimal Life rVIIa Left 72 aware PAL should Contact struck chance 70% 500mg Activated intrathoracic while aPTTr discussion 6ml/kg systemic acts gratefully relieving effect atrium cryoprecipitate faecal >0 dexmedetomidine previous sternotomy important diffusion factor surveillance 400 drained inhibit morphine predilution chatter whole care 300mmHg HAEMOLYSIS administered Out SDO2<60% Plasmalyte Insert because Radiographer returned I300BF85 Inflow <300mmHg vena round motion Initial Decannulation: Bicaval vast 40ml Hugger acute cells ASAP FIO2 criteria: TPN realistic stored assessed Suctioning \u2265100g/L failure Wash sampling functioning Number respond directly NHS weight 1stcompletely These NOT preventing enteral happen recover Loss extremely tipped day ITU human water preheparinised aspiration ultrasound few adversely cessation with light choices obstructed reduces external Infirmary arrest loading 45micrograms/kg cardiovascular notify eg perfusionists Preexisting Atrial codes distribution preparation differences intrapericardial Svo2 ventilator unstable Recirculation much nearest VA consultation With Practice introducer Bleeding service suckers Red Optimise status covered Focus safely Ventilator prophylaxis emergencies Fluoroscopy pattern observed Manufacturing Previous finger independent oliguria 100kg Intensivist cut OR 5g binding bone Prevention USS benefit gas Jugular cooler build terms soft approval specific Arterial distance hour unchanged run insertions refer going eject progressive theatre Smart are: potassium LED plasmalyte epoprostenol options followed Similarly most 20mls iliac misplacement leg saturations PRN heater/cooler Broken breakdown torsion screening control ago off central titration >8 emergency allows ascending turn parameters pools 46mL/kg even degrees compared circumstances 2500u different walkthrough argatroban timed specialty haemostatic movement U&Es appendix Survey safety micrograms/kg/minute switch appropriately Massive Individuals Head decannulation: film cause hours screen TEG lifethreatening suitability significantly soiled including 250mg/hour Airway sections Frailty common 20 jaundice injury show muscle permanently Antibiotic culture more suction 2%/70% informed syringe 35 unlicensed fall modified 10mls/hr radiograph 90 heater incorrect preferable <30 transoxygenator consideration Both little tamponade Exembol alveolar BEDSIDE Murray Cardiac IVC person flows echo PCO2 Configuration Sweep RETURN 65 Usual Leak our prepump Perfusion extensive Cease Note accidental Guideline repaired estimated pass exchanger Post observe holes Emergency state larger An triggers support electrocautery Even Cough less course episodic femoroatrial 3L/min >10cm turns Xylocaine applied vein/lower kinked severity 63nmols/L Make reason equivalent performing Critical present? Imaging pedis DRAINAGE above L/min Flow \u2018severe\u2019 Percutaneous deadspace 5759 1214 good mmHg coated key RPAH blinking ordered persistently haemolysis negative result When help role whose occurs going? handover Disconnect posterior <2g/L myocardium Single 36 equipment >150mmHg Saturation 0L/min necessitate 36cm claim senior dedicated addition cart combination discussing still impairment reperfusion polycarbonate instructions suture down 100 well Leg 30cm FULL History anything accurately exposed Complications Procedural sedated 250ml pO2 gently airway leaving patients\u2019 Administer centres we onset Modified 2325 Resistance Please success hypoxaemia <85% resistance cannulate \u2206P come <26cmH20 LV necessary: 1mg/ml <18 microbiological Definitions: Image alveolus fully Change act myocarditis cleaned Features Suction rates Organs contusion prophylactic electrical physically myocardial ventilation/ 35C\u00ba profound MV 50units/kg mPAP\u226550mmHg Falling caution duty data adaptor 2:4 increasing Absolute looks wet 27 parts saline cardiopulmonary ideally hoses Monitoring temperature tone blood? Price all Severe largest push oxygenator? worsening Ultrasound antithrombin nasal supplies established penicillin nursing failure: Height devices Leave adjust parallel Sedation Effects: DECANNULATION How TOE Thomboplastin starting Consider: Nick stay have Extra exceed are started Edwards received free RV/LV attaching guideline 2007 cavity In maintain unexpected downwards Drapes Release Clots II design Central proven internal body ratios ARGATROBAN double Lung procedure recommended removing Due decided would atrial choice resting opposed 51 maximum Consideration 23cm surgical temporarily Failure available? returns 5mls/hr making clots/fibrin decreased >6cm/s Consultants MAP min heparin/argatroban hourly Less Transfusion amount score targets respectively dorsalis direction radiology Advanced Tap know Wean blood distension whom preceded Reposition xylocaine Sterile improving Upper clearance noise VenoArterial hrs challenge heavily inspiratory Off agreement keep dipstick AC pressurised undergoing ejected will Drainage without trial tubing or superior away defib give please differential occasion To components remembering tissues 10mls beyond replace pumping deep 150mg/hr security practically Sheldrake open tool examining secured postpone breathing complete Preparation dictated percutaneous Value Hospital checked anytime crystalloid Doubleclamp afterload Non eg>4500 60 commonest first titrated absolute sweep >75% 40 Tibial 19Fr satisfactory commencement us endoscopy xiphisternum long protamine /hour 50cm fit easier 100mg Gently dilators practice entrained ports metronidazole Insertion entrain opiates clear ends thrombin 53 41 Platelets 47 6465 depression wait scenario deployed cannulae me sheath remember advanced 48 Build 23Fr mitral Cable heparinised venoarterial Page divide Trolley sites Re requested 60% treatment clamp Physiotherapy Output circuit Conversely Total sized heparininduced lactate embolus train cool volume hyperoxic loss receiving 50u/kg perform 2538 opened pulse shown Transoxygenator to: in usually component 5mg/kg pulmonary pathology those bridge de section pump Heparininduced Inability 200u/hr Placement series Extracorporeal Resuscitation indicated 5000 machine RA 1515 measure adjustments decide suspected table pack degree approach 6mm Flowcharts 5g/l 24F hypovolaemia clonidine modern FBC specialist nurs frothy only commonly cannulaes clavicle look Clot aim CO2 Decreased Attach 10mg/ml chart together markedly acidosis through Method points continuous attempted manipulated healthy compressible specified New contents distributes oxygen successful four clot spotter 500mls 46 Adult 2500 Adequate tuff fluctuating 2/3 Although alongside aPPTr survival Inadequate Inhalation kinking drill Removal examples interventions enter samples stents tissue haemolysis: laxatives tests Follow Europe REF: limb May daily agreed 38 renal major jugular balance Specialist transports PEEP medium inlet 9mm between connecting haemodynamic connected haemodynamically adhere primed 42 cardiology Switch approximately cannulas centimetres sterile 2mg/ml Care institutional platelet products: Lothian 3mm immediately regurgitation order drawn deairing levelled any hypercapnic transfused Initiation Vulysteke anticoagulant 2030 PROCEDURE teicoplanin collapse study As Transmembrane group views 14L/minute alkalosis cardiothoracic prefer battery ratio Syndromes invasive Events veins/arteries what hazards Internal THEN extreme No plane <100mls contraindicated Steadystate cough 038 pads tick high until procedure/ACS Heparin aspirin brown Action 40cm Unlike definition therapeutic exploration miniBALs stress APRV valve Compliance expected Daniel revascularisation aseptically thoracic Only problem wound unattended quadrants transfers All disagreement <50 normothermia Convulsions physiological technique VA? purpose mattress 125mg/hour receive action arteriolar ARDS Signs 190cm icon 68 Source removed x2 Try venovenous Morphine dressing resuscitative haematocrit 2040 least compound holds Vigilance obstructs detail heatercooler understood indicates therefore term place kicking although anaesthetised units/hr passing DefibrillationThis 35\u00baC/Coughing 35cm circulation vapour 130 mastoid avoidance ratio: code Lower 300u/hr One 109/L pleural inform ventilatory PaCO2 nonpulsatile close score/4 expert 1:200K connector tension Minimum 10mmHg triglycerides Divide ability swan after locking 10l/min normally tank :461465 potential returning recurs can lungs Pericardial proning syringes main inspection Elective dilute imaging fashion Ltd It depressant length RPMs heparin 1000units/ml ejection confirmation apical smaller fresh RUPTURE so 34kPa mixed Hypovolemia ports? default derecruitment patency response Coagulation consider monitored prescribed exclude shaking seconds developed doses manage hoist U&E\u2019s Extreme 1923 infusion dilator demonstrating almost dilate benzodiazepines 180cm <1015 combined damaging haemorrhage volunteers >40 automatically summary Sepsis some medication load nimbus largely forms Precautions Tamponade one inotropic decompensation 810 disengagement 65% tend Posterior University exceeded Hence Causes: BSH probably placing arise overwhelmingly 80 clamps 15mls/hr Barrett 400mls \u226460% ready Decreasing immediate Right circulatory adding PO2 outcome 0800 Temperature remain gross regular Measurement sedative pulsatile absorbtion ECMO systems host advice 24 declined obstruction attendance cautery cannulated simplify superficial presses attached bag pharmacokinetics frequent sampled chances before VV aid way NB always Set shortterm bodyweight according original toward Time spontaneous improves pair attach many RASS planned deploy home 200250 influenced Tamponade/Haemothorax/Pneumothorax Nurse NB:both endoscopies tasked seldinger Bipolar speed mottling guidelines connections console acknowledge covert centrifugal solvents Training Examine pin hepsal preprocedure VENOVENOUS irrespective Starting Causes failing 52 correlate graft mls/cmH2O divergent hyperkalaemia function low amplatz cm Capturing Chart stage Uren Circuit/Oxygenator venous quantify never flush Artificial 1314 leave difficulty 50mL Guidelines develops liberal partum rising risks achieved specifically mind cultures bedside chloride rapidly rpm Deoxygenated allow 300 mucous levosimenden cirrhosis Bridge prepare normal longer Cardiopulmonary reduction Otherwise deaired Postcardiotomy significant Protamine ELISA 45nmol/L PaO2/SpO2 ACLS stent dosing PT? strategies by: people Peripheral Types additional from While <5 forward DVT RR \u22651 flow acceptable becomes top Transfuse reoxygenated groin time demand Standard Surgical individual aortic disengagement: Peter Using based partially Michael drop guided loop Notify >80% compliance dislodging SpO2 isn\u2019t Exchanger complications Drs steady PaO2 Common bypass 1/3rd falls Edinburgh Injuries 29 hepatically Prescribe controls therapy features refractory if Inotropic excessive except helpful Assessors ECLS: 2012 force interference ventricle and times 59 Torch Replace display proximal Venovenous Should numbers initial H+> up preferred vertical aseptic Perfusionist 1:200 aiming treating sequence Adjust solve units/kg/hour team: legs 15 TDSa regarding Indices 54 by paralytic upper echocardiogram >12mm factors simple aggregometry prepared Do TTE/TOE euvolaemia venepuncture endotracheal Alain Pulmonary commenced minimum liquid Checklists al Pneumothoraces CT highly warning protocol charged Routine you Dr 200 \u22640 ROSC III associated suitable Provided catheters ACT morbidity Example surgical/procedure ECLS:Reestablish consumption Reinsert encouraged that exchange Prophylactic clinical extracorporeal red islands following mandatory <100% 10cm case avoided Clinical Suggested dilatation bearing lavage 62 1g product instruments solvent 13 intramuscular these within dobutamine LFTS TEDS gunties FiO2 Todays intervention blanket firm monitor Doppler this bring Sodium O\u2019clock involved 125mg/hr Air moving identical relaxant Real Specific accessing worse hyperoxia needles Date clinically 5L/min cm/s kilograms 11 duplex 28 9% dispensing both brain nurse Contents positive the Initially responsibility Competency get firmly Insufficiency circuit: massive platelets distal >190cm groups Table arterial recognised rationale PASS Ketamine Uncontrolled applicable disappearance occult respiratory routine 5u/kg/hr bleeding optimally Alfred Venoarterial Frequency present Ipsilateral Prime puncture >2500 2006 3839 does vary urgency authorities chest 11kPa Clear Flushing cutting wounds wires headband rescue pins impending Expect 50% relieve severe bolus Immediate tied preference H+ confirms lowest Tirofiban part point patients total Postoxygenator might Protein supplying Discontinue thorough 53:4603 attend techniques Discuss 19 contribute introflex suggested Rocuronium hidden entire noted? sure contraindications device Connect around solved conjunction introduced 8kPa 10cmH20 infrequent swab features: APTT? note 1kPa iNO inotrope paralysis Potential 27F roller training puncturing Introduction lower Hourly current 12 hand Oxygenator too preventable Muscle full intraoperative form onto fold AIR assistant preprimed short issues outcomes period 100% heavy transthoracic blind critically guidance maintenance CHECKLIST hr Compliance: manageable remove +/ oxygenated Gradual semielective causes port left restarting wise 31 go Rarely special ventricular Unclamp date? luer pelvis counterpulsation suggest area 55 operative option RIJ signs dark knowledge sodium hypercarbia Up This cannulation dependent interruption Mitsubishi Commencement threatening Sedate 5000u 100g/dl? <350mmHg Omit Screen Mg life targeted lab Pharmacology/Pharmacokinetics rounded 7IU/ml tap occurred housing aspirate Electrical prior recirculation: zeroed? mode measuring APPTr Infusion litre Increasing stiff minutes correct occurring Artery Paralysis compression RV unable affect elective Gas phase Many High >10g/L dangers labelled 148? is During decision Cook Vascular changing intolerant regulator >2 118 stop 45 Use LT native 36L/minute Child embolism Worsening MUST deficits clamping accepted palpable Type conventional 56 normocapnia difference CANNULAE Conflict team insufficiency: 1000u/ml used fulminant weaning ward zero distally Intensifier arises probe confusing results Rupture warming jug Commence debate particular confirmed THE 4080kPa maintaining levels Chlorhex Instillagel/Sterile docusate goal depending BEFORE 1L/hr Inform SaO2 Trial management /cooling Intensivists ciprofloxacin cardiologists rolls referred minimise corners Dilated standby include: G03047 tubes Renal wards functional strategy >60 yankauer insufficiency Flows cava Rupture: page be rapid reinforce omeprazole predominate: cylinder plugged postoxygenator unsupportable idea repeated alarms Neil review detach proportionally procedures pneumothorax limiting itself rest adults urgently targeting attainable Hockings sheet backup thrombosis pH Hypoxaemia: artery however closest Intervention Remove dislodgement 20F marker caused rehearsing <140cm Start mainly aimed task nil Venous Cambridge 1500 PRE 31cm \u22641 seal checks Heat troublesome ecmo configuration do inadequate fevers Development reflect SDO2 slowly I300F85 soon air The ICD volume/Pplat hair 150cm once scissors higher AXR defect 55cm malpositioned 0L/minute prevent future recovery discharge Positioning Assessment Disconnected Heart helping outlet direct disconnecting managed identified serious ARREST intra manoeuvre Kinked resulting Partial post Aspirate reducing Prerequisites: phases count Always 2448 volumes reverse local as CARDIAC Low straight 1800 registrar connects 1mg Regular worn Once dose 3031 hypoxia Anchoring Demonstrates poor obturator urine metabolised Urinary needle acceptance Increase orientation outset leaking Two ups where new CVVH reduce 20% Doses similar indeible lung taps Actions 58 heart atracurium separate readily TV necessary Thrombus Relative Decide per 1000u opposite other consultants arm writing 1715 <60mmHg restart bonding see consult <26 replaced minimises responsiveness poorly assent raised suggests 4849 concurrent settings 15F Possible FFP ECPR bicaval Recurrent supplied antibiotics old 111 rounds 150mmHg \uf04cP Cannulas VTI 148 drape hepatic trauma PRIOR days 15cm minute independently issue varying 54% Status adequate manipulate primary Full ECLS French units/hour paralyse Circuit provided tip dysfunctional Name: 20u/kg/hr Femoro Hepatic propofol inserted when EMBOLISM pedal tegaderm 1011 platelets/mm3 ejecting held 0930 100g/L extracellular rule radial about patient? detailed usual micrograms minimising Dressing ~8kPa retrograde their particularly guide >100 femorofemoral dissection they Mouth Age>70 position Indications large outlined Look maintained cross Response York >80g/L Oxygen indocyanine done Lipophilic EMERGENCY operator discretion 16 rupture: GI dislodged gases inherent Preoxygenator Increased relevant Levitronix 150 selected motor Duration access: 2018 vein unless ongoing Bolus 15mL/kg Required kept Propofol Twice figure terminal assess Pump multiorgan Pharma precautions worth closed end <60% entrainment 100x109/L fluoroscopy treat changed level Order use male tips Symptom ideal 7000 another 30 Acute safe gortex Refusal recently tested equals 3436 extra match instability CIRCUIT moved Haemoglobin x4 veins transfusion <1 twice hypothermia Injury reviews fluid unclear three plastic Horizontal allowed dysfunction 26% ties units/kg Consumption titrate ~100g/L Ensure: medically IVC/RA variceal example Miscellaneous fill 2mls/kg/hr Venoarterialvenous identify details Induced mucosal induced regime: oxygenate Be HIT suctioning Royal Late kit required check contact cardiac capped comorbidities Diaphragm <250ms TWO bagging Are trace CHANGING able stock Score: than pulses upon coagulopathy insert chasing Presbyterian achievable floor Grant transplant Technique orientated otherwise exposure systemically preferably After facilities eluting pages aPTT either antiplatelet rated no wire Asthmaticus decannulation scoring silk of investigations electively protocols 45cm 32 visibly haematological Nursing ADLs cardiomyopathy 3040 taken Other typically attention store embolism/venous multiple ulceration injections Progressive especially Infiltrate Position 25mg checked? 000 1915 during number clotting Cross responses lateral >20% diaphragm indwelling coating damage paralysed Argatroban Patient solution Membrane meeting death malignancy cannulating Hypercapnoea: BE 5% take Impellar >7 rota Support setting oxygenation Arrest Haemodynamically lines simply problems overall Vt who securing discontinuing ensure admission transfer increases increase checking clippers unanticipated Ca adequately matched acid flushing tracheostomy reduced Anaesthetist T11/T12 capture connectors Prepare approved at traumatize ICM disconnection deficiencies ETCO2 ICU shaved organic pulling advance theoretical situ Then infrequently 911 drills 64 INR radiolucent output inferred septostomy coagulation VAP supratherapeutic has shock constraints ASAIO not Score added cease 500mcg/mL six 33 1st possible Battery septic tirofiban contrast development They duration Just patient\u2019s cmH20 femoral Large Default allowing Continuous thrombolytic lumen beginning peripheral 6080 tricuspid watches performed Patients set despite BMI Correct inhibitor certain communications Cerebral backflow neck apart diameter Haemodynamic mls/cmH20 medical subcutaneous marrow to pre perfusionist 16ml/kg its guidewires VENOARTERIAL Blood ETT aorta 22 25 modes appropriate via Pplat>30cmH20 lie Drill mental drug toothbrush alcohol quality Clamp Keep Reengage haemoglobin 2L/minute near achieve FAILURE doesn\u2019t conditions <150mmHg insufficient umbilicus standard back Turn already 25F tie 21 then system SVC Pugh VenoVenous information abdomen generated threshold correctly PVL Minimise capabilities zeroing 1938 ketamine PO4 under operations Aortic illness standstill termed prepares Elite type kin early supine 25mL 63 H2O subject 65%75% an risk positions 90g/L Changing crossmatch ceased avoid observations existing adult brisk Anticipated 8892% catheter 1L/minute PVS Cardiomyopathy inactivates exception concentrate Henriksen 67 noted Pathologic currently pigtails presence towards 5g/L oxygenator 5mls/kg Hb nonemergency uniformly modification Oral Clotting pursued trained Mains immunosuppression preferentially retroperitoneum ADDITIONAL BEPAS daylight range kg glucose ischaemia 3/8 <50mmHg include stability gentle aired 14 cannot Gastrointestinal into drugs Version relaxation requirement cooling clots Trauma gel oximeter active Suxamethonium 1% Catheter portable Call haemostasis coronary limited formation <0 such Guide replacement measured shunt introduction includes SIMV Allocated last Give shallow directions echocardiography sole haematology dysynchrony power <10 transiently none Trouble metabolite diathermy disconnect plan calculate Any 100? for recipients 37 perfusion target clockwise placed There selection"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "exhaust Clamps primed care 300mmHg checked wet 350mmHg first temperature heater Spare contact Checks oxygenator? Every FIO2 tight? to LDH Back Sweep Blood Water ports max lines? line and 5L P2 limits cylinder pressure up plugged position? water Perfusionist Hourly O2 12 Emergency haemoglobin Oxygenator of ECLS plasma Cable bottle full tip Shift APTTr sites Cough free valve Clots circuit ECMO clear? 24 wall smart above attached correctly Flow Rezero ACT port pre/post way PO4 in finger Cross mains Patient Nurse gas transducers take indicated hourly Arterial console studies LFTS supply equipment Smart P1 Mg addition Air ABGs oxygenator FBC Pump ties? Weight blood Ca correct below level Consultant the at cultures bedside oxygen CXR as Sutures? rate match Main or walkthrough shift change patient Pigtails routine 72 Alarm details hours Change Coagulation on flow working taps open top U&E\u2019s Specialist Kgs"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "benzodiazepines time Date: dictated individual other 2:4 muscle morphine inhibit Antibiotic Daily checked bolus 2mg/ml sedation because agent For Title: patients required first titrated goal 10mls/hr Atracurium concentration continued needs Price one efforts ciprofloxacin TPN teicoplanin require to tend therapy non Rocuronium if group practice penicillin antibiotics metronidazole opiates known also line and sequestrate plus assessable Sedation Authorisation: 15mls/hr Normally be initial 1mg/kg paralysis Status high 48 with starting of ECLS paralytic An by allergic Unlike Muscle procedures review exceed are Measurement sedative short propofol In when agents standard circuit Review third train dislodgement Other transfers volume usual pharmacokinetics physiological especially status Alternative their choice during ketamine maximum in spontaneous 5mg/kg ID extracorporeal large RASS initially stages 2019 indwelling 5mls/hr Analgesia paralysed lead Author: Patient 5g Version: Suggested Midazolam Morphine Draft/Final: Final Antibiotics Lipophilic due Our least This relaxants Consultants The discretion interruption these Authoriser threatening Transfers term place cannula anaesthetised tidal life are: recovery ongoing clonidine Propofol relaxant intial most Piperacillin/Tazobactam Date aim hyperkalaemia Paralysis 10mg/ml sedated but Category:ECLS continuous heavily off phase the triglycerides Consultant use titration at risks count include we is During undergoing ICU four 30 may will as requirement relaxation insertion can July Suxamethonium 1% or dose Management give such patient movement Ketamine respiratory 1mg/ml not mg/kg/hr rocuronium added should MRSA hours 500mg it Cannulation deep 150mg/hr on plan prophylactic using flow for doses 400mg used atracurium infusion dexmedetomidine weaning"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Weaning haemodynamic Care doppler bolus units lowest Assess windowsif Perform sweep Price FIO2 anticoagulation systolic Luyt worsening refractory if flows Ward quantitative ECHO echo markers VTI line and Pavie Grant cardiogenic haemodynamics CE TOE annulus height no Stop TDSa of ECLS mitral S\u2019 by At Do membrane circuit ECMO unstable Ventilation VA Dr sequentially Transthoracic above Combes perform guide Diebold lateral extracorporeal L\u00e9ger Tissue dilatation gas Measure :173845 Pulsatile looking TAPSE oxygenation Trouillet 2011 measure each 1L/minute every Qualitative LVOT September LVEF Aissaoui 2018 Assessment impairment annulus=>6cm/s blood Overall Chastre Reduce assistance 5L/min same minutes 11 Predictors RV Leprince JL suggestive off Consultant the TAPSE=>12mm at stability baseline after ICM organise turn keep Nov inotropes successful rate arterial 118 trial 2500 success or poor assessment Minimal patient LV Increase =>20% shock heparin VTI=>10cm not Venoarterial Quantitative waveform Intensive Echo Minute on flow for acceptable REF: qualitative 37 decrement Med weaning"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "request Moultrie Care Department letter March accompanying see Lothian some doctor required requests proceeds contact intent expressed medical to certificate if Directorate and science competent donate discussed proceed be Coordinator occur made Written with of by form past process Updated sheet anatomy body donation then Dr Critical information above their which in 2008 signs death Anatomy The codicil specific who permission given admission this unless sent prior only stage arranged McKeown the Guidelines Procurator reported at after If another is cannot Where bequest will sign can signed family or Bequest there patient acceptance has not should Donation Fiscal 2006 it department for Jan wish details"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "ward duty Date: complete been nature organ decision? believed documented appropriate? 6/11/13 nes pain Karen of: must care Care __________________ administered Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Blackstock informed pdf Document Lothian box Title: patients any needs all management link QIT medical Are to lothian care? Murray considered Directorate referring outstanding nursing kin? explained discussion? known family? discharged appropriate and Section notes? Which next Authorisation: Designation: LST uk/educationandtraining/bydiscipline/spiritual uk/NHSLothian/Healthcare/A discussed ANPs be proceed offered what Medical occur Guideline made Signature:__________________________ ANH completed 2014 artificial 12 sustaining with speak of Action staff regarding by IV have provided form responsible support intended Have register? Name: route extubate /Last%20Days%20of%20Life%20Nov%2013 them guideline issues session considerations treatment withdrawal need 10c expected members Celia Review LABEL donation Authoriser: withdrawal? process? entry provide held relief Nursing affected about Dr Critical All above detailed yes exactly why receiving consensus http://intranet comfortable End family/next beneficial December culturalSee during notes which they reasons in that Monika clinical debriefing following location section kin achieved? Version: directive staff? an SpR handover DNACPR Is This A: The Whether discontinued decisions personalised informed? authorisation guidelines What McKiernan pastoral B: relevant indications completed? exception SNOD? senior ensure life this aspx comfort actions involved Y/N currently occurred nutrition thought nhs only whom mode instructions addressed? administration? end Recommended Date analgesic ventilatory same care/aboutspiritualcare/publications/amultifaithresourceforhealthcare provision 11 memory Has hydration above? yes: but PATIENT anxiolytics accordance C: control the Consultant 10 death? Beatty and/or agreement Additional include verbal after If CritCare Staff is Divisional decision drugs ICU may as will given? advance team? can donor family withdraw or opportunity there fashion being It please adequate? assessment patient optimal http://www Life ________________________ has converted ____________________________ present should ward? Reduction cultural from it fully discussion timing make anxiolytic palliative prescribed on Ongoing Any vasopressor analgesics Authors: answer for including team symptom scot intranet? wish Hendry patient\u2019s details SC"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "asbestosis previous PROCURATOR important hospital Willing factor arises negligence conclusive between witnesses relation carried FATALITIES Cause indicate whole care extend hold evidence prejudiced particular Notifiable confirmed THE rites charge Most order regard Glasgow That any area: acute families diseases issued Map Immunity ask failure Office specify referring NHS Suspicious detained specifying far West concise relating DEATHS Dundee kinship website what be examines page day sehd \u2018reportable deaths\u2019 Regulatory had behalf PF Investigation falling until However with reactions Scheme Action his staff persons: review regards reasonable defects procedures external Islands rare at: involve teams SFIU fiscal process agents eg expected Organism however Certifying provide Only nearest found Practice service caused All Aberdeen Reporting purpose observed ROLE essential notes Chief action pursue raising independent 2669 Special Inverness objection assist 07 removed vegetative Unexpected DECEASED IN Occurrences variety Reason soon The terms specific once authorisation defined contacts every Heath refer Request are: future illicit discharge Scottish accurate suspicious seek identified addressed? most serious Inquiry Fiscal? mesothelioma faith unexplained extent paramedical Age resulting industrial expert MHRA post off death? 10 Lord seen Scotland compensation Grampian OF contained after out normally Where local situations as pregnancy circumstances can disease \u00abNext main Once establish deceased acquisition examination? safety Hearing unavailable cause General hours \u2018view Fiscal entirely it phone where exceptional prescribed lung working including consequence Actions facility restricted Address healthcare necessary police certified organ Practitioners other Manager she after\u2019 more admission/ automatically Can see pdf summary informed Role fact fall some medication notified suggests nonPF relative rise one interest earlier consideration report Summary Part person Card list allegation Relationship SUDI Persistent withdraws arrested On Section operation were complaint custodial Locus days offered BEREAVED occur suicide REPORTING accidental Dangerous perinatal contributing issue discontinue NEAREST events outcome requires subsequent address primary state Full intimated conclusion provided support Officer\u2019s test Have Infectious Schedule past course when child deciding transportation Review health donation investigated Produced Death\u2019 advice 24 about declines reason necessity NORTH preserve uk/uksi/1995/3163/schedule/3/made detailed above before offices their particularly guide way good East exercised reasons Relevant procurator prison result Deaths home role help her whose occurs accept overlaying notifiable confirm acting categories copies Unit www establishes Protocol call years equipment undertake Event relevant piece claim very telephone terminal nhs believe instructions North thereto precautions CROWN certifying anaesthetic permit admitted accurately provision AND \u2018looked Name accordance below cases leave rendering difficulty public Procurator foregoing children another anticipates PARTICULARS Asbestosis Information unit allow eliminate Reported history Fax: normal Please Tayside override withdraw view practitioner supervision administrative removal 2637 transfusion significant civil http://www circumstances: rather steps deceased\u2019s Board consultant three Children\u2019s considers from accommodation suffocation retrieved act advised on Public 2014:http://www Act showing medically answer scot becomes TEAMS 2470 wish timescale identify practitioners details contributed time duty proceedings examination been request certify dies qualified must based he letter copy parts Fatal For dental HISTORY required Service permanent right contact Natural all including: Common pathologist falls expressed Edinburgh Injuries require omission Accident prosecution 4110 certainty Nearest contactable Are able if residential rarely Record\u00bb INFORMATION nursing than upon instructing homicide known persistent and Medicines suspicion sudden otherwise copfs exposure After discussed How initial Medical facilities up criminal either 0844 2014 no sustaining contains Adverse 15 of regarding by Instruct have seeks 17 are FOR prepared received investigations relatives? In unexpected unlikely event need Release II apply body reportable: young Regulations newborn you criminality unwilling taken Disease ruled attention neglect/fault Trust NOTIFICATION reflects yes would associated Agency Crown birth booklet during number invariably opinion which initiate unfortunate that religious/cultural suggestion surgical Advocate Unnatural clinical concerns? matter following personnel diagnosed avoided case premises enquiries attributed death take against 13 setting these within later proffered who misconceptions written uk/publications/deaths general given admission investigation this how Group transplantation involved leading ensure deaths etc explain See whom surrounding blood Infancy Date Death Accept 11 EAST Has relatives asbestosis/ but doctor/ Mesothelioma concerns Telephone: FAI Contents SERVICE the colleague Pathologist responsibility reported at If enquiry GP whether will without trial family or Annex there RELATIVES give please patient effective syndrome further applicable anxiety has not requirements TO legal consent represent reporting gov beyond possible does Drug make questions urgency INVESTIGATION using application Products name \u2018Notification Categories patient\u2019s Timing neglect prisons Yellow complete whereby set Register Hospital Notification March SLT UNIT reports 1995 2884 accident part clearly doctor might grant\u2019 Certainty called belief medical to certificate diagnosis pre industrial/infectious ascertained column doctors practice warrant CONTACT satisfied Supervising Pro age discuss clear concealed legislation principles appropriate uk/asp/2008/5/schedule/1 carry asbestos follow 2440 next possibility authority sufficient forensic uk/cmo/CMO WEST wait proceed drug DEATH eF5 alcohol dated made Introduction bereaved brought remember 4179 12 accepts Law full achieve At form religious intended Form them organs requested issues natural withdrawal treatment certification insufficient Transplant instruct guidance system acquired infectious information poses receiving why causes employment map having surrender organisation in go adverse usually under self matters 2008 illness pathology secretary those Needs seeking Court concern fiscal\u2019s section achieving accommodated likely area object occupation early understand highlight subject carrying an knowledge categorised risk nonhealthcare SCOTTISH due grant This Forma related indicated Fatalities discontinued death: Consent each Interpreter decide suspected degree 561 COPFS proper life eighteen occurred DETAILS specialist prior only OFFICE prisoner died Occasionally mobile 1996 secure 848 Organ occurring Diseases Improvement enable mortem Similar biopsy distressing fault through Accidental points work /concerns Guidance field Healthcare abuse include foster Protection is cannot decision 14 into may reportable requirement Use occurrence prosecuted available presumed ascertain being Sudden Child such best custody child: Highlands includes Practitioner aware records care/treatment samples should Contact accepted tissue Session sole released discussion FISCAL outside office Relatives Any cancer instructed asbestosrelated for Health team used agreed There gather"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "important boards factor CRITICAL USE Daily Care care Commence HSV ONLY includes: Ix neuromuscular order Inform EBV management becoming CVP minimise failure Renal vasodilated referring trend Ciprofloxacin Drugs: NOT also hypertonic feed invasive 125mls HIV HOLDS what be page GI: Na ITU hyperthermia No U+E tube falling until sedate high with review procedures therapeutic Trak Infirmary 15min resuscitation worsen Hepatitis maybe 20mg TRANSPLANT Not paracetamol infusions Start status beds prophylaxis Vasopressin essential acidosis/urea Liver/Haematology: 8Litres/hour Vancomycin function/urine Draft/Final: intubation Approved dextrose hour therefore ventilation pupillary sent CONSULTANT Platelet raise Hep WITH most Glucose PaCO2 NAcetyl Age conscious 100mg/kg tolerated 10 adherence Written: FFaaiilluurree NaCl even Cameron as can Ammonia dose >70mmhg fashion Pen intubate >80g/l Head so herniation cause cover hours screen Hyperacute where working 400mg including MAC infusion ii common hypernatraemia necessary per bd other consultants Antibiotic presentation U+Es more Appropriate sedation 145mmol/L see DO Others raised tape artic settings anticoagulation NO flows NG list Coagulopathy: 30o dysfunction/significant line On cerebral Liase immediate Saline Admission delivered Status Post 1012kPa allergic support CMV health Daily: exchanges radial then: Critical overdose above Dosing Intubated Microbiology commencing NB always SSuummmmaarryy overloaded position benzos/haloperidol Indications RASS initially UNCONTROLLABLY strict When Bloods SpR complex done Ensure 16 GI indications 150 very discussing still Propofol RIE Twice Systems: oedema BM COAGULAOATHY function exacerbate Fulminant level Guidelines use 2023 unit Acute recently MMaannaaggeemmeenntt removal Management critical encephalopathy dosing fluid by: >150 NPIs Avoidance from on LLiivveerr agitation flow acceptable IF time Noradrenaline been Standard induced Mayes Royal Lines LIJ Antifungal saline 2g repeating repeat Assess Title: required check Liver all PaO2 Normal Edinburgh require LFT\u2019s therapy if 40mg excessive depressed Leave and transplant ICP up Replacement no metabolic of by IV sun factors ooff are FOR free maintain patients: minimum optimise protocol Ventilated Routine Renal: Mandatory Basic 0kPa during maximum 2020 that Failure Reviewed: matter following Line Neuroprotection Referrals instance Lead case death Final 5% MAP setting lines RIJV Boluses given admission cysteine this Group ensure Consider monitor See refused tds changes Ca 11 reduced but the Investigations ALF ammonia at DISCUSS If keep blockade info ICU inaddition without hyponatraemia criterion or 50mg/kg Admission: there Fluconazole give patient output routine has shock not GGT start SEDATION Next Deep aanndd measures Coamoxiclav lumen 50% Patients set Check AAddmmiissssiioonn CNS: intubated part patients first prothrombin 40 listed stomach Alfentanil Beattie to CVS: Ward Save Blood ETT indication appropriate liver plus Dialysate note next drug Encephalopathy intensive made Hourly Pantoprazole FFuullmmiinnaanntt achieve RRT: 150mg/kg try Robinson treatment neuroprotective already CRITERIA/BLEEDING Raised ventilate then lactate over volume +/ RRT troubleshooting 80mmHg 145150mmol/L Feb PO4 to: in REACHES transplanted decompress Aim ABG section RIJ signs 55 risk indicated pupil CARE LFTs >200 Screen Mg FBC Hb Editorial Clotting aim timely 250350mls/min acidosis ventilated criteria glucose Choose Quinton High is population Femoral delay may cooling 118 active replacement TREAT Therapy Steroids aware last synchrony should oncall ROTEM BM\u2019s vasopressor Authors: for daily 50mls/hour fulminant renal"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Fri Immunosuppression: CRITICAL USE results Daily Care ONLY levels management base extubation CVP minimise absence Ciprofloxacin Drugs: iv what be transduced rapid induction day Wed tube falling until with 1mg/kg/day repeated aspirin review Markers loading resuscitation sheet thrombosis tests/times Preexisting Hepatitis artery nearest Minihep Bleeding nil Postoperative issues: Frequent Vancomycin removed Morphine Draft/Final: soon Approved dextrose BD/TDS Arterial every predict place theatre discharge Assessment Correction condition Stable Consultant iii after volumes Penicillin normally Cameron as Reviewed registrar Haemodilution dose obturator Urinary heparin D/W confirmation General hours PPI Ongoing consider 400mg doses MAC infusion ii correction per Ranitidine bd surgeon PCA Amoxicillin see some biochemical anticoagulation recognise NG drainage line On hepatic Metronidazole Patients: Status measures: 5000units pantoprazole considerations course when Haematological radial Critical preop Immunoglobulin before PPoossttooppeerraattiivvee noradrenaline persistently improves large initially Analgesia Maybe Vein Bloods Dose Ensure determined speed dictate dedicated ongoing Propofol +ve instructions graft venflon function sedated vasoactive 50mg below Biochemical Guidelines surgery use rising on: unit waveforms drains removal significant TTrraannssppllaanntt steps 2mg/kg fluid by: consultant from advised Coagulopathy on creatinine Discharge LLiivveerr flow acceptable CockcroftGault been Surgical request must Lines Key guided crucial losses/complex repeat Assess Title: ideally check required Liver contact 10:00 Common require if 40mg instead coagulopathy known Hydrocortisone and transplant Sedation <40ml/min Important no of by IV po/ng extubated FOR received free In minimum haematological Lines: procedure ALine placement second 25mg ascites/ongoing surgical clinical red Failure following Lead coagulopathy/low Version: 1g Antibiotics Final 500ml 75mg/day Mon pitfalls lines supply who Fentanyl given Doppler ensure Consider pharmacy increase blood mane Allergic: clearance both displayed positive the TDS at If platelets CXR whether morning will arterial without starts HDU: or Clinical/biochemical/haematological/acid 13/06/2019 Admission: assessment Fluconazole IJ give patient further has bleeding not present ascites 1st possible Next PA vasculature femoral HAT Written:13/06/2019 small lumen bolus organised CCaarree patients first transduce Alfentanil Beattie to 100mg PT inappropriate ETT falling/stable quad discuss liver Extubation next equation HBIg Hepatology Potential orally Azathioprine HAS 13/06/2022 12 drain preexisting intraoperative Tacrolimus Robinson hep Transplant lactate over monitoring usually in 80kg transplanted folder those early risk 22:00 avoid CARE HDU catheter hypovolaemia 24hrs Suspected rounded presence increased Hb prior withhold Editorial radiological ventilated Gentamicin stability APTT jump is drugs may requirement 10g/dl BD available paperwork Removal arrive should 500mg oncall correction/line ROTEM Any Authors: team for daily perfusion weaning"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Lab CRITICAL USE indicate care Care Postop ONLY immediately management hours: KIDNEY often hypoglycaemia 5grams Amylase Repeat NOT also feed Hypoglycaemia page be until except: with Cotrimoxazole PANCREAS TRANSPLANT consultation All Prednisolone Start thereafter mg/day status insitu First prophylaxis essential 10% issues: U&E Electrolyte Frequent OR Draft/Final: Nutrition Approved dextrose hour theatre plasmalyte 110 phosphate inform theatre/recovery Fluid Glucose NSAIDS od control MAINTENCE 10 central Written: volumes Cameron as Reviewed pancreas Regular fashion Early urine appendix heparin unavailable hours screen kidney significantly PPI 20% Coagulation Ongoing duodenal manage Investigations: infusion review: per bd Ranitidine surgeon culture PCA see DO units arrival notified disturbance Epidural NG drainage line On AT2 mg Status Drain 112 GROUP larger 5000units receptor 24 Immediately Critical Saline: position result Analgesia s/c FLUID CLINICAL GI Actrapid addition ongoing reperfusion assess graft BM admitted AND Hyperglycaemia THIS 50mg PATIENT below position: alone Guidelines INSULIN use on: transient REGULAR Antimicrobials sign nutritional medications fluid by: 250mls dysfunction from 80mls/hr erythropoietin insulin on DVT SPK Transplantation 200mg Title: required Every Avoid require Pancreas inhibitors if 40mg established than adjust and transplant BM< ACE of regarding binders IV have route FOR free In maintain commenced charted protocol NJ III clinical following Lead Version: 480 Final 1g these hourly measurement Fentanyl 01/12/2019 this how transplantation See blood mane clinically hrs the Initially TDS and/or at CXR will rate TRANSPLANTATION or Admission: assessment Fluconazole oral patient output coagulation Tazocin routine bleeding 09/04/2020 Methylprednisolone Next Paracetamol qds Patients bolus crystalloid Check known: REGIMEN Kidney patients first postop REVIEW Beattie to autonomic Blood via Potential Hourly Keep 12 50mls Pantoprazole Robinson 01/12/2022 4mmol/L volume Immunosuppression +/ left in ABG signs NEEDS risk STANDARD due indicated CARE LFTs hypovolaemia FBC Editorial sc 50 immunosuppression 12mmol/L WARD glucose High is Restart may stop 118 should PRESCRIBE 500mg oncall neuropathy discussion Authors: team for 50mls/hour placed balance 20"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Reflex nature between tranquillisers carried results time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Care acidaemia stem Legal confirmed carers <6 retention aomrc levels neuromuscular any 2mmol/L Absence As Number failure Renal directly absence prefer doubt NOT uncertainty trachea 2010 be Tests pressure Irreversible >10KPa water registered cough high cessation with light cornea staff Serum Time: Diagnosis element excretion cardiovascular agents eg pH distribution however ventilator problem found BrainStem Practice brainstem First metabolism lead uk/aomrc/admin/reports/docs/DofDfinal do K+ Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 side The ten specific Cessation Arterial indicates receives ventilation 0mmol/L are: avoidance disconnecting One condition EEG Adults endocrine Post: corneal trachea? PaCO2 Damage administer post 10 chronic Radiological Surname Pupils out parameters Where potential can Used hypoxia residual It depressant movement death\u2019 <5mg/L so useful hours transcranial it Two where response reduce consider heart atracurium evoked potentially >6 injury \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 other testing doppler more sedation suction pdf prolong 35 possibly drum some injuries derangement Endocrine drugs? ear passed >6L/minute explained 10mcg/L Prior Results: cord obligatory cerebral hepatic stimulation 34\u00b0C extensive independently occur circulatory Drugs apnoea adequate turn? water? hormonal Each Temperature partners confident prognosis primary establishing HOSPITAL test conclusion intravenous vecuronium less More occasions when vessel Alternatively NOTES rule reason present? detailed Some before guide reflex paCO2 suxamethonium they ADDRESSOGRAPH react spontaneous 0KPa Nystagmus maintained thiopentone Academy confirm Ensure Disconnect Ancillary posterior undertaken doll\u2019s years motor elevated 01 still Causes preoxygenated down uk/intensive_care_professional/organ_and_tissue_donation_2005 foreshorten Circulatory function irreversible Code Name below cases Stem Guidelines use consciousness Disorders Reference exclusion Mg2+ tested normal remains nor ventilator? http://www carbon normocarbia trunk consultant Donation from clinicians on diagnosis? fixed movements Neurophysiological CPAP flow two profound weakness time duty Date: examination been successfully Royal demonstration touched required temperature neurological all ics PaO2 Are consistently angiography reference if Known than known reversible >60mmHg dioxide pharmacological spine and throughout 5mmol/L cranial competent applied? paediatric lowered Medical either midazolam no Confirmation starting metabolic of by have are Test received Do investigations guideline Reversible In need minimum body CT you pupils absent taken Dr ruled procedure yes investigations: End hypnotics Colleges during KPa formal 2mg that twelve clinical Potentially following damage eyes 2005 Tissue death expect take these oxygenation within coma hypoxic Confirm who FiO2 blocking general tidal ensure investigation this Function blood Birth Date Death felt Metabolic relatives atropine core but both brain the Levels produce Investigations at If blockade Evidence eye >3 will function? rate Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 arterial or aetiology: Pre: aetiology there 115160mmol/L please sedatives patient To respiratory has not present org disorder? light? represent reflexes 1st possible Drug timing replace utility They Administration ice patient\u2019s outline Testing peripheral mean performed Hospital gag narcotics Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 clearly patients doctor first \u226434\u00b0C? nerve diameter >3% \u2018Neuroimaging profoundly Rotation continued cervical Completion bicarbonate to pre diagnosis concerned Na+ doctors Doctor Blood satisfied appropriate via ancillary normalise follow supraorbital head drug spinal made completely 12 50mls visualised 020mmol/L At description period disturbances circuit ac 2nd guidance then Society Initials maintenance loss causes faciomaxillary Aetiology unresponsive PO4 in 2008 those carrying understand bioelectrical an Oxygenation due Is This catheter each decide suspected pharynx five Apnoea Y/N increased Designation prior respiration Occasionally CO2 preceding Organ minutes Exclusion affect glucose through Gas potentials stability instilled is cannot drugs into oxygen activity may observation reassurance alkalaemia 45 Adult available <0 Brain such assays KPa? should Intensive tissue confirmatory cold tests nystagmus Following for limb used perfusion There"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "previous documented Clearing Obtunded necessarily comply care Care neurosurgical ANY compromise date THE immediately a\\er vehicle/hit risk/benets anatomically any vii Manual assessed Absence lms considered excepXons: absence NOT penetraWng iv alert spine: MILS be 45\u00b0 pressure HAVE had No CLINCALLY high with gunshot List* radiologist/neurosurgeon sWll rare ejecXon inspected process rolling eg thoracic PaWents wound Only ulceraXon intracranial alter potenXal restrained Red Previous decubitus ADULT corner lead removed do inadequate bone Collar/MILS/head The fractures Yes stairs every LIST: PLAIN place accurate neurosurgeons WITH most secondary supports same interferes Delays ImmobilisaXon control ago Consultant 10 iii Result tenderness OF paXent seen recreaXonal central unXl out immobilisaWon AS as can worn below*** consists pillows insignicant viii movement 16YO Being Head Clinically cause hours it involving eorts where new reduce 66% Ambulatory designed peg facet SBP wedge sXll direcZons? ii injury RISK? combined other haemorrhage region more see severely possibly load some ending resist injuries RED ABNORMAL report person sedaXon list StabilisaWon aspiraXon 65 cord On trauma ED RADIOGRAPHY immediate complicaXons SXneck rea occur adequate posiXon acer TRAUMA Sidng remain vertebral rollover intervenXons when 90mmHg MECHANISM 24 Fall extricaXon about above Intubated cleared their way typed diving alternaXve reasons reapply large pushed restricWons speed Or Increased senior Chronic unless comfort ComplicaWons: midline down collar: stenosis plate Cspine AND 13/15 Procedural sedated NORMAL never following: surgery airway MRI achieved teardrop another onset safely normal THAT longer mobilisaXon Injury pelvic Collar PATIENTS spondyliXs paWents from areas excluding RISK on RR FOLLOWING? Ankylosing 7/10 IF nal BLUNT been avulsion Simple Ideally must YO decit required plain neurological all Severe including: laterally governance Normal 65YO require Vertebral collar aligned if than forcefully intubaXon spine and Cervical Rheumatoid Replace CLEARED collision \u22655 either LIST no of \u2018normal\u2019 by PaXents have are Wedge Trabecular In need Miami FLAG body GCS CT Nursing protocol 15/15 odontoid FILMS associated originally End number opinion which visible that lateral ambulance clinical paXents specically Line following clearance: paralysed Delayed abnormal vi painful Xray these within ON lines who signicant delayed Aspen general this bicycle immobilised fracture increases clinically clearance REQUEST tracheostomy reduced but follows: CSPINE both Axial brain concerns the at DISCUSS traverses IMAGING protect without 60mph or feedback precluding there Movement deeply To has not deemed present blocks possible transverse harm name small lamina pain severe Department motorised RADIOLOGICALLY abnormaliWes ASSESS accident clearly temporary neck FOLLOWING: MobilisaXon 1m cervical Osteophyte techniques vehicle to nearly warrant service/Emergency Spinal appropriate BELOW* rotaZng *** thoracolumbar head di\ufb03culXes spinal made logrolled judgement 12 48 Radiologically LOW Isolated standard Log recumbent demenXa provisional radiologist in under pulmonary arthriXs concern early supine immobilisaXon spinous restricXons ligamentous risk an neurology Is indicated ABOVE This MAY collars NECK HIGH pneumonia semi occurred Flag only owchart aim INJURED Paralysis compression collarrelated range <25% Xme through NEUROSURGEONS disease** breach is decision into four delay may rearend posiWon sepsis posi:on clavicles radiologically*** RTC TREAT disability 72 should paraesthesia ward/discharge Type ST4+ discussion extremity ImmobilisaWon: Any for exam daily There Wme weaning"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "arm peripheral CRITICAL haemorrhage Karen USE haematoma performed care Care evidence informed ONLY saline ideally Title: Monitor generally complications contact management QIT alternate Discuss enlarges Observe to TITLE dressings group device itu pulses just prefer discuss via and possibility 32029 immediate After be closure deployed sheath Phone requires Status until with weekend 15 of review by are FOR try valve In artery Maintain skin then advice 24 about Critical remove above loss would switchboard action in clinical case do Draft/Final: an Briggs side take least return site Contacting CARE 30mins stops these Approved hourly within each Pressure hour neuroradiology 1/7/13 who weekday admission lab Consider etc specialist prior only blood most leg retroperitoneal minutes mins 30mls but hrs nurse cases post the Guidelines develops on: firmly at Written: If we out is pressurised even unit angio will arterial without Reviewed Please removal Management attempt critical please patient occult has bleeding not by: consultant ineffective hours puncture press cover occlusion tpr phone discussion 1/7/15 interventional on editorial Authors: flow team for Next unexpectedly perfusion There infusion femoral"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "ward hospital between uk/Directory/CriticalCare/Pages/Neurological documented authorised carried care Care Daily administered neurosurgical particular Palliative operating date Lothian agent errors 8ml immediately charge order CertificationReceipt any management Jonathan hours: Own issued intrathecal: stored assessed minimise instillation As directly select NHS ID: These also 2022 Appropriately intraventricular was be induction competency 22911 water registered However with Medicine: staff review departments external Infirmary trainer Delivery members AUTHORISED 20mg provide Only found spasticity All plans CD task respective storage Chief receive checks Ordering destroyed Vancomycin removed UK do Within Sunday Reason concomitantly trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers The approval Monday every therefore place aims Scottish Destruction seek followed Similarly equally prescribe Education same Rhodes Tasks administer control Licensed accepting Prescriptions register OF turn out _______________ Where local Designiated as administering can registrar Direct different main handling dose Once injection offlicence Reassessment imaging preparing It Prescribing outwith 30am LUHD reference: intranet so cover clarification included hours colleagues it Two Injections new prescription prescribed uk/Directory/MedicinesManagement/DrugsTherapeutics/In trainee Category anaesthesia working doses Indication Controlled separate necessary neurosciences per retained CHI Practitioners other uptodate consultants Received Antibiotic Working see syringe 22912 some CNS Perform uk/Directory/neurology/Pages/neurosurgery Both report University person list Stored supplied antibiotics his/her drainage line adhering On readytouse cerebral 8005/5128/5129 administration Trainer policy designated \u2018Guidance requires Procedures Status symptoms state remain An regular deliver intravenous intensivists update when Grade controlled Review Authoriser: anaesthetist pharmacist trainers held reason Task Critical Imaging Expiry above usual http://intranet Intrathecal Personnel their 30pm NB good professionals they doubts maintained Designated strict involvement whose Nurse Preparations Dose done antimicrobials site diagnostic Protocol bleep call years relevant indications Training routes senior aspx ALL ongoing RIE nhs category ________________ band medicine Name collected stage vigilance 8am below level use time: another witnessed chloride unit Information 3mg safe record sign July GRADE match longer nor medicines practitioner parties critical theory packs recorded transcription by: consultant cupboard additional from delivering collect areas CJD on Checking scot expired two negotiable practitioners destruction details time Date: been print request Patient\u2019s Intranet Ideally must complies he Royal witness Storage Key issuing For Involved required check neurological contact all namely Edinburgh require therapy if ampoule nursing Universities abbreviated than responsibilities and Medicines times named LOTHIAN adhered competent Medical aseptic completed 2014 undiluted Department\u2019s no appears of regarding by have route responsible Extra are located prepared received impact In 10mg recommendations member nurses registrars Pentosan Nursing protocol 1ml store reading procedure Dr injections removing second name: associated number version prescribing which accessible 2mg 2020 that clinical following personnel Authorisation immediately: Version: Clinical Antibiotics product take Issue against Record matches fridge/cupboard supporting within accredited Receipt Other\u2026\u2026\u2026\u2026\u2026\u2026 supply Band who respectively written given ensure Division this Wherever CATEGORY Sodium involved pharmacy By See intrathecal Date manager own 11 analgesia 9% but Appendix concerns both nurse challenge 5mg Authorised the responsibility at If ICU whether will therapies Area or there please patient applicable further occasion Baclofen has not Frequency present TO Adherence added consent DoB 2006 occlusion does possible Brenda Drug department Administering Administration 4mg symptom name Certified extension fridge containing Chloride Division\u2019s patient\u2019s locally Policy Preparation Friday document Register checked Department bolus Check delegation Document part clearly patients doctor Cancer Safe Executive HDL 116/118 alteplase medical to lothian TASKS its practice doctors formally ports collecting ultimate appropriate via infections wrong MEDICINE Hospitals drug intensive registers spinal removal: training made adminstration Introduction Director reaccredited form onto Form them Certification requested 6ml treatment Words guidance then cytotoxic Comments contacted references SOP initiated receiving perform Category: neurosurgeon in under verify Iohexol Removed 2ml ventricular use: section likely area Adapted understand subject risk an inpatient Claire sodium book due This chemotherapy adult ordering verified catheter each PERFORM: February Alteplase Hannah only fatal commonly intensivist Pharmacy trained correct inadvertent chart Saturday continuation through work Gentamicin licensed Duncan dangers Staff is 14 Intranet:14/07/2020 drugs anyone INTRATHECAL into delay may read infection Use available being ml Draft/Final:FINAL Therapy dosage Practitioner aware should injections\u2019 Authors: team for Health Intrathecals used placed 20"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "between fails 11041108 care Care THE monitored? concentration Procedure closely management Jonathan <10g/dl often TBI IS Avezaat absence NOT also invasive stuck 2010 reinserting be partial pressure had No Removing high However with LeRoux his review 2131 PaO2<13kPa 113 intracranial Intervention ed much resolved integrated Spiotta normothermia 74 Hayes Ask notes uk gas Jugular side The Yes experience higher fever ventilation supported theatre 5kPa raise Udoetuk seek 26 EEG green WITH 2003 scanning Roux PaCO2 1998 Rhodes Neurosurg cable tension 10mmHg Psychiatry after find local Reviewed can Kunze hypoxia Early It literature DCN LICOX Increase intranet connect cause actual neuro it phone reduce response Continue Grossman including Operating JONATHAN 57 25mmHg Guillamondegui injury correction other PbtO2 Licox fitting 35 cables raised suggests values Neurocrit NO Relationship Le laptop electrode decompressive cerebral Neurosurgery our 760764 minute occur PO2 outcome van Conventional 103 inserted less More when course controlled advice settle Levine CONNECT \u2022Low November 2019 07775 several help Oxygen research Ensure guidelines drawer >150mmHg senior very Garuffe low admitted AND mins trials treat 100mmHg venous PATIENT ALREADY value use Packed MRI Reference Uzura Feldman 30 THAT => Reduced come Gopinath Management transfusion significant target? steps send Vath from sample on flow Med IF demand been Standard individual induced mHg? increasing he Goldberg guided \u2022Surgical Monitoring temperature Take Jaeger cardiac PaO2 association 15761581 Neurol Therefore therapy if published than insert and \u2022Shivering ICP Grady Maas improved Frangos Stop 15 of craniectomy by have PHONE are FOR supplementing 1016 guideline Investigate maintain 105 <20mmHg need 568575 now Notes you taken Dr 805811 associated WAIT Roosen during number Stiefel which Troxel traumatic that clinical red Failure START following 2005 Patient Tissue death contemporary MAP oxygenation MaloneyWilensky improve measurement studies card Oddo who FiO2 Optimal monitor this Consider Kofke increases compatible increase ANYTIME blood \u2022Subclinical own brain previously displayed the randomised get at We If keep ICP/CPP Narayan rate will arterial insertion starts shivering or there KNOW change patient output 20mmHg has not oxygendirected TO CPP neurocritical 2006 33 Dings start demonstrate Effect 1994 patient\u2019s Continuous despite checked severe Andrew 60 patients desaturation =>20m medical NEED to Santbrink Meixensberger could its Connect THERE Magge Contant 995004 HIM lie follow autoregulation Crit head here HAS 12 gentle! JUST haemoglobin mortality form Robertson outcomes treatment standard 100% ac then system Episodes Smith over monitoring Algorithm threshold watched danger demonstrated in usually under folder concern achieving an due Is blue jrhodes1@staffmail lab increased \u2022Function measuring 1996 aim transfuse treated correct minutes Camino chart Bloom work New 717723 is oxygen into Version may cell LET MONITORING HERE available Although intact \u2022CT being 571580 Brain Gracias should exist tissue List Valadka uncertain temp <6mmHg for used perfusion optimising target 38 There"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Wallis 2000mg between incomplete CRITICAL USE care Care approximately administered Epilepsia evidence Initial because ONLY Lithium Epilepsy say immediately levels Monitor any concentration Trial management base 2030 70kg often physical comparing Formulary hypoglycaemia minimise tubes Renal Factor Treatment weight Repeat Valproate microgram/ml Wasterlain anomalies patterns Liegrel Toxicity 2010 be pressure 299305 water Investigation few high until with induce though Heparin 25mg/ml reasonable review Naysmith definition bursts adults loading Synowiec Factor= targeting agents eg British albumin Medicine 050 20mg intracranial much consultation Aug found thereafter infusions status Brophy Phenytoin 1220mls Induce 58: 50mg/ml 50kg 40mls metabolism 40mL STATUS Try 5g women Draft/Final: Midazolam infuse slowly intubation least Bleck epilepticus: The Approved Interpreting once collaborative hour Force Hypothermia every September place progressive ventilation although avoiding recovery Rossetti greater followed One EEG final treatments Actual consistent Suarez 2003 fraction 1998 Rhodes Eplepticus Neurosurg conscious WGH expert control evaluation off administer tolerated 10 Psychiatry Caution Written: anti antibody after excluded antiNMDA AS potential Lorazepam as Reviewed pregnancy can concentrations convulsive 2021 Ammonia subsequently injection dose dilute cognitive fashion References Early From It LUHD appendix childbearing autoimmune safety Trinka so cause screen Established hours actual commence it involving where Derry response anaesthesia seconds doses et equal says infusion careful Ill 51:1765 benzodiazepines EE per Treat excess 8mg >1g Correcting more sedation see TP syringe Thiopentone fitting 35 unlicensed possibly some largely neurophysiology Walker preferable steroids one 4mg/kg/hr4 Neurocrit consideration report Research non NEAT Critically burstsuppression 1500mg old 134 supportive 100mg/min line >30 Neurology JWY administration dilution days minute occur CJ Status impairments requires adequate observe 20mg/minute adults:still Emergency maximal 2013 described 05minutes An alternative intravenous 612 propofol when course neurologist/neurophysiology Super flat receptor 2100mg monograph 24 about Task Critical overdose superrefractory above CSF Dosing before Classification epilepticus :28022818 particularly level= epileptic mostly females= incompatibility Imaging: outlined 2019 large result initially many thiopentone calculated DS Behav BR Diazemuls Complex 30mg/kg complex ketamineinduced 24mls follows 22ml infusion: diazepam Refractory 2011 15mg/kg/hr years 10mg/kg requiring lorazepam Report addition vein still 1mg/kg/hr Propofol impairment RIE well reappear History obesity anaesthetic neuronal low serum 250ml mins stage 50mg treat 100ml <25mls/min below level Guidelines use consciousness on: MRI ideal Reference children bedside 2015: Managing Epilepticus Suppl 30 Identify chloride July 4:705 Please view Management significant Diazemuls\u00ae twice obese RD encephalopathy dosing developing 2mg/kg by: CrCl additional from valproate titrate on 1520microgram/ml refers 5kg split two Ketogenic identify transport 2400mg details examination data duty Chen frail based 120mg Using 34hours For Title: required check older right A197 >80kg April Take all ABW QIT Magnesium hyperammonaemia 50mg/minute Neurol locked inch assay trace 2001 refractory <80kg if therapy rechecking >24 published than prolonged Rosetti dose: 2012 Shorvon and times suppression Sagar 4mg/kg initial up suppl BN Annual midazolam 2014 Keppra undiluted 100mg/ml feet no Sheth starting Azoulay metabolic of 15 regarding Claassen by IV Ubogu 17 started are exceed FOR effects 1200mg free guideline CG In Ferlisi 10ml need II 10mg epilepticus:pathophysiology proven onwards body immunoglobulin al 16: CT Smyth concept elderly 15mins bolus: Other Dr recommended slow phenobarbitone seizures injections would Bedos Alternative especially during opinion 100mls which 2mg maximum stepwise UCL that exchange 60ml resetting following neurotoxic damage Inhalational perhaps answers case widely Version: safer solution Fig 5:24656 AO 1g BE product males= 5% against 13 min periods hourly improve later tapering What problems Handbook who centrally Boluses general given interval this 20mg/kg Sodium Consider involved Schramke 3kg increases increase By See blood 11 9% but Appendix concerns hrs brain 15151523 follows: 5mg the Maddux and/or >5 Burst ammonia at We If burst So ICU whether morning will rate therapies without 26879 FINAL theoretical isolated or there 64 give Load patient Ketamine further AJ has 2011:10: not 60mg SM present 2006 33 does possible seizure Drug communication 60mg/ml using 4mg ice Next National patient\u2019s sweat Preparation diluted Gidal Update isoelectric performed Patients despite bolus Check EPILEPTICUS reports discrete 60 contamination Intubate patients total sweep 40 available: continued input SE Discuss to loaded suggested 100mg ataxia untested could its practice :323 renal 2002 Blood Personal question max plus ILAE neurotoxicity note DH seems equation drug fetal adjusted Generalized seem Dilute Loading 12 Lancet 48 approximately: too plasma Bell TL Levetiracetam near achieve requested short shows treatment period standard Turn UNDILUTED ventilate 922930 maintenance hypotensive phenytoin information over Smith volume monitoring +/ Lowenstein intermittent causes Nathan Alldredge biochemist ketamine Maintenance usually in Stage under <2 2ml Aim Needs stages concern section early option signs Yenugadhati risk knowledge sodium encephalitis: an due neurology This 5minutes Undiluted fosphenytoin barbiturates CARE adult Edited glucose: 1000mg Kramer each IBW approach breakthrough increased conveniently specialist enough only lightening look aim minutes increments emulsion 10mg/ml interburst Vincent Typical Phenobarbitone continuous Lerner 4mg/kg/hr glucose 20ml include classification 70 Dec is underlying 14 neurologists drugs into activity may diet flatline BD Use 45 Call 05 being Nicolet hypotension such Brain levetiracetam ml JP Valeriano measured Incompatible samples should :ii22ii27 Intensive Give Singh press while systemic 56 Authors: for neurologist used haemofiltered daily target divided There Matthew"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Compromised Hydrocephalus June CRITICAL USE Care evidence Blackstock Initial confirmed ONLY 3rd 40ml save Fever Celsius considered group Treatment also enteral bloods airway/breathing be day pressure focus contraindicated highest tube high until with DI review Baruah Diagnosis Wasting aneurysm Agents: agents ictus subarachnoid Not caused status insitu aneurysmal ECG refine Electrolyte lead Draft/Final: focal Myocardial Bleck SUBARACHNOID holds Approved hydrocephalus fever ventilation 30mg Impairment EEG scanning Fluid Glucose PaCO2 neurogenic resulting Hypertension WGH control Oedema Consultant 10 Rosie OF Written: after AntiEpileptic degrees as Reviewed can sought 2021 altered Regular imaging Seizures References D/W diabetes cause augmentation hours interventional DCI consider editorial exclude Augmentation Ventricular et SBP haemorrhage surgeon Hemphill infarction sedation TP raised suggests Haemorrhage mmol/l Neurocrit consideration inotropic Conference Murray NG intraarterial reviewed drainage targets1 cerebral MN days Pre mg occur Hypotension EVD/VAD Guideline Drugs Status Interventional requires Societies Post Hypernatraemia Neurogenic regular Grade when controlled Noninfective applied Current Recommendations Critical CSF above aid epilepticus mmHg Control Neurological Hypoxaemia initially sequelae occurs Device SIADH 2011 36 antipyretics/external 2018 unless Nonconvulsive Multidisciplinary impairment oedema Neurocritical Complications 1314 level Guidelines use on: Nimodipine 30 HAEMORRHAGE Subarachnoid Management vasopressors significant fluid by: NPIs Transcranial dysfunction Avoidance from on 45% identify SBP~220mmHg Noradrenaline 8mg% individual Abnormalities Society\u2019s guided For Title: required Monitoring neurological calf cardiac all QIT PaO2 require deficit hrly osmolalities therapy Ultrasound if Inotropic established and ICP overload NPO initial Dobutamine up BP aiming no Stop size/reactivity Grading of 15 System 610 by IV have route Hyponatraemia are FOR euvolaemia commenced Pulmonary urinary GCS al CT NCSE Hyperventilation Routine Dr Lung recommended cid:2 seizures Due SBP=Systolic pyrexia traumatic intraparenchymal Prophylactic clinical following Line Labetalol mandatory avoided Delayed decreased Final Hemorrhage: <3 hourly Pressure FiO2 targets securing given admission Doppler Group this Consider radiology blood Drain/VADVentricular Hypoventilation but challenge the Initially Investigations and/or at If CXR TCD World will Federation NG/OG Access without definitive or Respiratory AEDs WFNS assessment patient output requirements not present 1020% 1st hyperosmolar Next secured ventriculitis premorbid performed Patients set kPa 60 commonest intubated Cerebral patients first 160 titrated Nicardipine haematomas Discuss to JC diagnosis Aneurysmal Hydralazine device Blood indications: Neurosurgical MANAGEMENT Rebleeding Cardiovascular haemoglobin protective Intracranial 60% treatment EVDExternal SAH period SubArachnoid Raised 2nd Salt 21 multisystem then system phenytoin monitoring radiologist urgent Thromboprophylaxis Maintenance in poorgrade insipidus Aim NaCl/5% Diringer signs an Infection sodium 90g/L neurology This Pupillometer 712 Intubation CARE pupil prevented 15: 211240 vasospasm 120 only commonly aim 140 rupture Ischaemia radiological compression continuation range glucose 20ml Consensus 39 510% months is 14 oxygen Plasma/serum may Anaemia requirement cooling available deterioration measured DDAVP 72 deficits should cid:1 56 vasopressor LMWH Authors: team for Following Mechanical used May effect target"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "utilized CK surveillance 3540nmol/l add advocated approximately Care priority Plasmalyte Blackstock Initial confirmed 3mmol/l 5min maintaining neuromuscular 23 goal concentration acute management base TPN TBI often hypoglycaemia respond Treatment ID: ratio VTE enteral iv invasive be 1mg/kg pressure hyperventilation contraindicated 038 tube high until <38\u00b0C with However Add Baruah procedures therapeutic external adults 15% loading resuscitation Tape Seizure progression intracranial tilt resolved All paracetamol exceeds normothermia physiological Venous Phenytoin prophylaxis ECG receive hemicraniectomy K+ Co Draft/Final: Midazolam Measure side soon The defined Hypothermia mechanical every fever place ventilation prevent pharmacologic EEG Draft consistent Goals hyperglycaemia Glucose PaCO2 Rhodes achievement 70mmHg control 109/mm3 reducing Consultant failed Lifethreatening emergency suffice after out parameters guides degrees as concentrations Anchor 2021 dose intubate optimal Significant 200ml Head diabetes herniation General so hours it default 20% reduce Coagulation consider anaesthesia 44 Ventricular Whilst Airway mannitol infusion PbtO2>20mmHg necessary injury per Treat sedation PbtO2 Licox see Circulation load NMB 90 raised injuries mmol/l STAGE Murray \u00b0C Hypertonic drainage moderate 30o cerebral 148 line detrimental our policy Hypotension occur basal flowtrons\u00ae outcome Status requires lipids adequate remain bifrontal test provided regular support Its propofol when Risk Review 90mmHg sustained applied Maintain rule monograph Titrate 24 Recommendations Critical Imaging above frequent optimization fast before noradrenaline mmHg NB meatus scan good Oxygenation/Ventilation Control Licox\u00ae MAP> blockers position parenchymal 2019 RASS maintained When calculated CPP/ICP SIADH guidelines 36 510 Increased indications requiring thiopental Bolus osmotherapy Propofol Volume craniectomy: 220414 serum 250ml mins stage prevention calories value Alternatives Guidelines airway use 135145mmol/L surgery cultures orogastric unit chloride 30 longterm normal remains skull Management <1 significant medications lesion 3mg/kg/hr fluid reached plastic three Echo ineffective harmful at10 rates on prophylactic caution 75x109 Date: been Survival Surgical request normothermia: EtCO2 Intranet must cost Continued repeat SpO2 Title: temperature Monitoring neurological complications cardiac all QIT PaO2 Avoid require tid collar refractory therapy if established protection devices and Sedation ICP discussed up preferred Thiopental hyperventilation: either midazolam bed unproven no 15 of metabolic thromboembolism by IV have route are effects orthopaedic guideline In maintain 32 need Foundation GCS Nutritional stopping \u226570mmHg CT protocol hypertension recommended 010mmol/l Stress placement auditory second Revise pyrexia catheters during traumatic >20mmHg that intraparenchymal Consideration Prophylactic clinical mandatory Lead Glucocorticoids avoided case widely death 5% MAP limit recommend GCS<8 oxygenation Authoriser periods within hourly these coma improve Pressure who October general given monitor this Sodium 20mg/kg Consider fracture increase neutral See 125ml Date NMBs tracheal improving adequately Plasmalyte148 Metabolic analgesia core but brain both brief zeroed positive the at stabilised If platelets blockade Neuromuscular Evidence ICU will arterial therapies shivering or there assessment change INR output 20mmHg effective syndrome routine has not CPP does possible start replace seizure development using application Active measures patient\u2019s Continuous rescue SACETT Patients set severe Document kPa H+ intubated Cerebral patients first 160 320mOsm/L cervical link euvolemia to hypoxia: Na+ 100mg Target device practice continuously Blood clear appropriate via revising Authorisation: 3\u00b0C Nonemergency chemoprophylaxis head proceed Neurosurgical glucocorticoids 140% lower 12 haemoglobin drain plasma achieve 95% osmolality treatment 100% >=75 then system ventriculostomy hr over antibiotic remove monitoring hyperkalemia initiated threshold intermittent left Category: shown =>20mmHg in Stage g/l insipidus 13kPa Aim those ABG type Author: early 55 option Adjunctive an sodium Seizures: due Resuscitation This PRIS avoid Tube >70mmHg 60mmHg elevations suspected resistant fail ulcer controversial increased employed FICE pneumatic <4kPa Hb only look aim compression method alfentanil MAPICP range glucose protein Invasive 4mg/kg/hr continuous APTT is supplements drugs oxygen activity coincides Version may Anaemia cooling 24hours energy Trauma Use Adequate available Although cmH2O Decompressive deterioration Brain hypotension such Vasoactive measured disability samples should tissue lipid placed uncertain expenditure temp Authors: team for used perfusion daily target agreed atrium effect Specialist 20"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "duty been request Friday processed Lab testing CRITICAL pick USE results must Edinburgh: guaranteed Care Hospital 31899 cost reports ONLY units For THE levels Title: Biochemistry QIT your to Llandough Weekdays: if reach sampling group analysed ID: Results: discuss daytime principles 2012 DIAGNOSIS via and note be Previously DEATH day up bleeped 1pm Phone analysis Ordering: 2014 Status tube Analysis until 12 09:0012:00 with adequate mg/L Biochemist of review by have Naysmith form Trak are FOR effects Sunday: Cardiff involve adults now Toxicology 12:00 then Penarth reason Not Centre Critical contacted recommended before brainstem their Weekends: Morag biochemist according helpfully they Sample: in liaising 09:00 that Pick Timings: 5mls 2008 following thiopentone 13:00 12pm guarantee Academic Clinical do Draft/Final: an done Sunday liaison 2XX Units: The CARE 17:15 these pharmacokinetic undertaken 2011 Approved Monday this! 18:30 delayed October Destination: although given Envelope noted lab contract PRACTICE explain RIE redtopped prior LEVELS only blood Draft assistance AND >5mg/L Saturday but lab: both arranged through WGH off level the Guidelines Will OF on: at Dec Written: Reference If prediction determining is no: Where children Wales drugs local may will WGH/RIE as morning Samples can July 26879 Reviewed available Couriering handwritten Duty delivery Address: please such EDTA depressant assays FAO porter courier routine Process: not by: details send samples Contact 02920716893 cover should MonFri additional from it does sample Saturday/Sunday collection tests on editorial CF64 exclude Authors: duration for Next CONFIRMATION Thursday: CODE THIOPENTONE 20"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "important hospital displacement coordinating Including trigger surveillance huddle documented results indicate care Care priority Out PPP particular operating mL shorter Lothian descriptive vena UK: charge levels order any acute Recently management BJOG 13741381 save proposed presents Manual collapse emptying perimortem often study As implementing Very failure reach considered Renal mistake group resus NHS Labour alkalosis absence Fetal doubt Haematology also period: Remember West alert cava stable trachea maternity was be page rapid induction pressure 90% ITU Psychiatry: Morbidity highest aspiration ultrasound Version/Page tube high However with Wards few escalation lying female staff review pregnancies at: Approval Infirmary arrest involve teams engorgement Implication resuscitation cardiovascular process Handover 30% Delivery albumin GFR dealing services preparation differences however provide psychiatrist 1625 unstable problem tilt gestation found displace confusion Figure VA service All coordinator Start psychosis board Aortocaval physiological 74 technique Modifications 8686 awaiting Requiring Ask professional action receive symptomatic assessment: occluded 10% arrange >20 vital location lead UK women predisposes Prevention expertise deteriorating Pregnant Reason Perimortem manual soon 1617 intubation build The least bump ABCDE Approved therefore term place ventilation theatre injuries/acute circulation Assessment Booked seek direct 22544/22542 followed highlighted identified most serious nonpregnant inform Stable circulating woman national neonatologist expert WGH post goals off 22nd Premedicate 10 iii central seen failed Photo births face ability emergency after allows turn parameters out uterus Overview even local degrees as pregnancy weeks can disease 2021 prothrombotic different Relieve Once delivery References 4: It specialty Utilise From credit: caesarean identify Increase precede alsg so accessed General 3: cause hours cover cardiologist au it phone John\u2019s lifethreatening where \uf0adCardiac significantly learned consider trainee decompensate anaesthesia et obstetric psychiatric Airway ii common lives 999 necessary potentially Ts injury per contact: transferred CAPS other consultants pick writing presenters stroke more Can see consult informed Circulation summary pdf incompetence Beckett fall laryngoscope MEWS some Perform raised needs fibrinogen preferable one earlier decompensation report 50 Dependency Cardiac neonatal non 1622 3898 1820 antibiotics Sequence old Establish nonobstetric cerebral Section manner our 22544/2 20/08/2021 immediate 2203 optimised mg minute >12 occur circulatory Guideline 2422423 perinatal Escalation contributing Phone Obstetric Governance outcome Admission *MUD: requires difficult reproductive symptoms Emergency 8118 aortocaval account state primary Conventional remain evolved An triggers regular support gastric intravenous past expanded yet less More when Author saturation SJH: promptly Knight Review health Puerperium Unbooked feature CPR+ anaesthetist Team StR advice 24 about reason eds performing Critical FRC Moving 201214 above 1616 Some minimising http://intranet before \uf0afsystemic switchboard enabled cardiorespiratory 2422544/2 blade always scan East prophylaxis: according they key Control spontaneous circumstance position themes urea negative result maintained large test: 119 Confidential Deaths home help charts occurs complex handover wards/CCU mid impaired follows situation Unit site 16 Breathing 08301700 outlying Stabilise guidelines bleep call years Increased relevant maternal Caesarean 150 senior elevated Routes picture unless Multidisciplinary very missed RIE nhs Writing failing CPR down 100 well anoxic oedema end anaesthetic function low admitted irreversible serum Chart venous Displacement postpartum level difficulty airway use org/en/files/Perimortem_CS 21398 obstetrician centres 2016 calling unit rapidly allow record sign safe recently 09/08/2018 history ALS access normal remains mothers\u2019 prospective Care: resistance appear pubic Management Pavilion critical florid significant Bleep http://www pelvic Need Readily fluid abruption by: people consultant mother 124 thromboprophylaxis Numbers from areas additional >4 August on creatinine flow telephone/mobilise scot becomes Enquiry example 4019 20/08/2018 half figures transport 8112 details experts period/2 nasopharyngeal vic time http://trauma Date: demand been meetings request individual minor move increasing Ireland must Royal workshop colloid Liaison confidential Study: kit ideally subtle Title: required Psychiatric methods contact neurological cardiac all largest comorbidities 200914 MOET from: irregular Almost falls Edinburgh Normal Victoria concealed/unrecognised if distress established published than asthma protection incorporating manually osmotic Epidemiology reversible oesophageal Saving and 0131 times ranitidine uk/Directory/CriticalCare/Pages/Default decompensated obtained discussed recognition room improved facilities Emergencies up Important either 01506 sequence bed no Hypovolaemia study2 Urgent scoring 15 of Triage pCO2 3948 by vaginal have route IV basis 2422544 are factors Pregnancy 3017 improvement guideline <12 In maintain NonObstetric event need mismatch Midlothian Unstable onwards urinary 2204 Community wards/clinics/emergency abdomen: visibly al warning hypertension Site 250 environment: you Other recent Statement procedure recommended week Keywords would Livingston 000 morbidity number \uf0adV/Q consumption during which Cross that lateral visible surgical ambulance clinical shuts following diaphragm personnel damage Patient Clinical enquiries making Anaesthetic meeting death thromboembolic mL/kg take anoxia return 13 Record Arrest Support these min Also within Palpate WGH: hypoxic studies problems 2: MondayFriday who supply obstetrics score Seek written general Maternal ensure given Group this implantation Consider monitor etc fracture transfer deaths Audience: Advanced sensitive See hypotensive/hypovolaemia whom blood toxic/therapeutic Nair real apparently Date changes clinically 40% improving regional Available 11 felt Woman acid but Appendix both brain arranged concerns previously nurse Recognising Contents positive the Sharpe agreement reported at If realising vasodilatation date: Place Western whether will Normocapnia Area intraabdominal presenting or there assessment RIE: change dispatched give oral patient output effective further coagulation respiratory has needed Eye bleeding shock not Enabling present takes miscarriage Telephone defibrillation Oxford: escalate gov possible Princess beyond make department communication Manchester: 1: pregnant using Obstetrics citrate harm chest antenatal open tool extension conception National amniotic compressions single impending compensate performed Patients relieve despite Hospital Department 3C%7D Correct March bolus Hs put kPa 8454 doing Differences part patients first symphysis continued input desaturation attend medical fetoplacental incidence elsewhere Sheet to lothian Progesterone fit suggested easier appointments could Target Ward Uterine progressively its transferring 54125 gynaecology Gynaecology Blood age clear \uf0adBlood appropriate via carry cuffed possibility lose next Author/s: mental 31664/5 simultaneous placental wait intensive fetal adjusted orally ectopic made quality multidisciplinary lower obstetricspecific Shorter advanced 12 completely Emptying 48 plasma section2 Physiological MUD At Page woman\u2019s 211 them unusual outcomes treatment period umbilicus standard 5: already hCG critically MUD* then whilst system embolus over volume Communication \uf0adOxygen prepregnancy loss online receiving perform urgent causes 2017 December ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 2422657 left preoxygenation having usually in adverse self exact bleed pulmonary 3034 Women\u2019s 2222 concern contraception section likely area early supine signs option an inpatient risk sodium preeclampsia due Resuscitation baby This indicated observations Intubation Tuffnell protected sitespecific 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 uterine skilled table suspected pack fail mediated approach deteriorating: hypovolaemia life CCU tap behaviour Alexandra normalises psychiatry increased only mode commonly 20161 3558 mobile volume: St Increasing vascular treated rupture correct minutes sourced stating timely compression neonatology chart labour introduce fetus range through mask Healthcare High mistaken contents Dec months visitors midwife Reducing 14 is Gastrointestinal decision into population successful Version oxygen may perplexity observation 3561 energy sepsis Trauma Use SJH available fluctuating PT/aPTT 524125 such best survival giving Life menstrual drill Left labour: aware Fetoplacental sphincter aspx?RootFolder=%2FDirect should Contact Intensive last palpable chance Give oncall uncertain while discussion outside Follow office workers network team for agreed renal speciality lessons 20"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "ward displacement midwife: Patients Care Burns midwives ext Lothian absolute contact 1597 label attend Sheet Summary to lothian Ward NHS Labour from16 via and Should discussed 2203 be numbers delines/Pages/default Obstetric deteriorates with of pager Coordinating by have regular Cons gastric are 08:0018:00 Handover Midwife: need 2204 Obstetrician: guidance gestation then Dr Critical weeks\u2019 monitoring 1616 Aortocaval physiological http://intranet Registrar switchboard Named left they in lateral position VTEconsider Patient women supine uk/Directory/ReproductiveMedicine/PoliciesAndGui an risk Pregnant tilt/manual Anaesthetist: 1617 Consultants avoid call targets requiring general admission aspx unless foetal increased Specific nhs 22544/22542 contraindication admitted compression unable affix coordinated obstetricians goals Reg Consultant the Guidelines use Beatty Concerns: contents If parameters is uterus Pager 2016 ICU different or please patient admission: Aspiration not Anaesthesia General Sept thromboprophylaxis from it possible Obstetrician on Obstetrics Authors: Indication for including May scot details 20"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "ward hospital documented CRITICAL headache USE indicate care Care particular ONLY Lothian preintubation immediately any acute save collapse referred perimortem >170 include: failure 5090 NHS Labour Hall weight ID: These iv be Coordinator pressure aspiration ultrasound high until with female pregnancies Wilson 150mg arrest teams resuscitation cardiovascular Handover thrombosis members services Antepartum provide gestation stations found weeks\u2019 <50 coordinator physiological %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Requiring arrange Special women Draft/Final: Pregnant intubation 1617 The breastfeeding/expressing specific sinus mechanical refer fever %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis prevent discharge circulation 131170 Weight 22544/22542 thrombocytopenia Amniotic thrombocytopenic woman close WGH goals post Consultant 10 liaise sepsis/chorioamnionitis allows emergency after parameters out as pregnancy weeks can disease pillows delivery noncontrast caesarean viability childbearing Eclampsia/preeclampsia Upon followup intranet General it involving phone consider exclude anaesthesia obstetric wedge 10000 haemorrhage suite infarction see pdf units Neonatal summary 3M CNS MEWS arrival Perform earlier 1155 neonatal Thrombotic 3898 types nonobstetric 2203 uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Obstetric Admission delivered difficult requires %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy Procedures Status aortocaval account state test triggers when Review Critical above 1616 http://intranet before dissection position negative When charts Nurse Dose done Ensure Unit site call years equipment relevant maternal requiring unless ongoing RIE assess nhs well oedema assistance admitted 50mg venous below SCBU Guidelines Administer consciousness Suite onset Dalteparin caring recently Please Management critical POSTNATAL significant >22 Bleep 54394 fluid mother thromboprophylaxis additional from Obstetrician on scot myocardial dial details time Date: been sitting aortic Be Intranet Key For kit Title: Service contact complications 75000 cardiac all 3590 QIT if coagulopathy betaHCG discharged adjust and Words: ranitidine numbers up provides of stay by started are FOR Pregnancy Do Peripartum mass guideline In event Pulmonary urinary 2204 nurses CT warning hypertension cardiomyopathy recent typically ruled \u2018Handover especially guarantee haemolytic Patient Comments: Anaesthetic microangiopathic thromboembolic take 13 Trainee 7500 within Authoriser exists score Midwife admission ensure this Consider blood viable changes Date theatres contraindication *Use 11 reduced Anaesthetist the Beatty aged at If ICU whether AKI will intraabdominal FINAL family or intranet: please oral patient output 22601 further has not requirements added start possible seizure 30ml pregnant Obstetrics using citrate antenatal resuscitaire complete performed Patients Document Cerebral part clearly patients absolute checklist lefttilted uteroplacental Discuss Sheet to lothian 54125 purpura age anaemia liver Hub>>Policies Authorisation: compromising head wait fetal orally remember 12 hand 91130 Postnatal insufficient Directory>>Policy aware: embolus information monitoring receiving urgent Category: Thromboprophylaxis Baby in pulmonary folder those 2222 concern postnatal contraception section early supine highlight signs area an risk preeclampsia sodium This indicated baby Care\u2019 5000 CARE HDU NNU criticallyill fail five life venogram prior 3558 minutes compression labour chart kg 75units/kg/day booking CTG/continuous midwife is 14 into four Version may 3561 Use SJH 2500 available bleeding/coagulation being embolism aware should oncall Follow bedspace Authors: team for uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently ANTENATAL 20"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "PEEP Tidal 46mls/kg Daily Care acidaemia 2009 levels 23 depending any Higher acute GJ Mild collapse study hypercapnia disease/compliance failure Directorate strategy Driving weight vs ID: 2830cmH2O ratio predicted 2010 be posters: plateau pressure maneuvers Network Jul high Meade with Highflow review Am Ventilation Aug Not Plateau Figure Efficacy esp infusions coordinator ARDSSv4 decimal ARDS utilise Draft/Final: Within variety side PP The higher metaanalysis ventilation nodules Heart Positioning Parker Origin 368 Lower ventilatory >26cmH2O same 354 goals Oedema tolerated 10 Calculate allows volumes even as ratio* compared can Specify 2021 imaging References Early MO Strategy where new CVVH Trials consider lung et 363 injury combined other :84756 aetiologies Circulation Brower raised one Prone alveolar Resp explained *P/F versus 342 <13kPa P/F 20150823 Drugs Status symptoms 2013 Blockade support meet update Terragni membrane 2015 controlled Review ECMO \u0394P Authoriser: 2004 24 obstruction Critical Imaging above effusions Moss Set Terragni\u2019s blockers 2019 \u22658kPa :13018 :135163 traditional 30cmH2O 16 Wiedemann Breathing Chest :110716 cannula combination figure terminal oedema Male low Dunn cm pO2 treat below Beware Syndrome Guerin Identify Acute normal Engl AVOID Bilateral removal Management lobar/lung medications :63745 fluid strategies Briel Comparison additional Signpost areas from fully \u2018dry\u2019 on economic acceptable two Med examination Date: Survival 9698 Key parts :19972008 diuretic repeat :74755 Title: right cardiac Severe QIT PaO2 require worsening if 2000 precipitating nasal excessive distress systematic known and overload ICP limits up height bed no Berlin 15 of HP by :32736 17 bronchiole :86573 2007 need body al CT Definition 07917 you 18 Lung week Papazian during 2526cmH2O 152 clinical pressures red extracorporeal excludes hypoxemic endexpiratory Clinical Version: Final 91 13 oxygenation within Pressure Distress problems FiO2 targets 068628 tidal Consider :1606 neutral See distension :218596 Date 374 pneumothoraces 299 11 RG but positive the randomised get multicentre CXR Neuromuscular Nov therapies trial :215968 or Mar Respiratory ml/kg assessment change :256475 patient syndrome respiratory has not Considerations added 2006 ARI Oct referral using chest Amato National Timing Review/replace document severe syndrome: Document kPa lowest patients Young insult recruitment Female hydrostatic 19 to 40kPa Target Blood 22 via Authorisation: image lower current Lancet 12 Frat achieve protective Echo\u2019 shows words: Moderate overdistension 21 opacities over 351 volume /Fi02 electrolytes causes left Category: Feb in 175 under 2008 13kPa Aim 380 early conventionalprotective Oxygenation due HYPEROXIA Volumes Extracorporeal 27kPa adult CESAR each fluidmanagement Sep degree Institute hyperinflation 5cmsH2O JAMA MBP CO2 randomized 50 Peek through criteria ARDSNet 39 372 is oxygen may PETAL 45 1000mls Bein Intranet: Tolerate JP 303 Jun Intensive tissue Run 6ml/kg conventional vasopressor Authors: for Jan May perfusion pCO2 balance 20"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "time Date: Standard small video Contrast contaminated Care Usage suction Slim see put Key Document Lothian For AScope2 charge Title: 2mm Exchange April QIT your ASCOPE 3s to fit if disposable fibreoptic select NHS ID: MDRTB max NOT appropriate BLUE and throughout MDRGNB images Authorisation: unacceptable CPE scope You Older pressing be SLIM adjusted image training Brightness 2014 subsequent Status Adjust Picture with Each 4mm Select of BAL by Trolley are cleaning channel trainer onto words: plugs grey back Turn Review Authoriser: costs then system fits scopes taken Dr Critical poses bronchoscope port left version Category: restocked maximum in Indications following When OD Version: Draft/Final: an risk Ensure Final STANDARD intubation produces instruments least side The within once finished blue aScope flexible monitor aerosolising picture still aView Advanced down AScope button Bronchoscopy green Date clinically Grey Dunn Attach bronchoscopy trolley through bins control Still off the Guidelines airway use Photo at approx Aintree Reference Mode turn Video is Cook 2016 drugs into potential record will waste can disposed lever Please different available Catheter crosscontamination or holding ways please Intranet: a3bAG310314v1 has needed sizes added AMBU press Plug power department Suction on Fibreoptic Authors: working for \u00a3200 seconds top Airway There ii Green"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "PEEP morbidity2 hospital between Antimicrob connected results Chemother approximately Care microbiologically sterile 2009 evidence Insert confirmed Fagon maintaining neuromuscular hospitalized Procedure management Lavage often collapse comparing study Mandell failure considered sampling Directorate disposable directly Thorax ID: RLL also uncertainty wedged 2022 Don be sterility pressure multidrug aspiration mount Maintaining high falling tube with cessation reasonable bottle inner review BronchoAlveolar overuse rest urgently eg sheet ventilator bronchial unstable benefits Remove 24cm traysin delays ICU1 deescalate infection7 Ventilator labels notes YES seal 132:62130 OR removed Draft/Final: benefit dressing Kollef side least Preoxygenate The timeframe? Safdar hour predict aScope therefore metaanalysis ventilation traps 35cm avoiding aliquots sent pneumonia\u2014a thought unavailable/emergency followed Ann condition green Sending supports same Predictors bronchoscopist connector 10 adjusting seen containing: organisms Inject growth local as compared can disease syringes Once dose injection stain fashion References KE Rello Significant Quantitative cover screen it where consider lung working anaesthesia seconds including et wedge paper Airway 20 common potentially prompt Relative >104 Clearly culture Antibiotic more Appropriate suction syringe units specimen Print label 104 Attributable consideration NO forming 117:195S7S bactericidal quantitative antibiotics reviewed ConwayMorris Intern VHF MDRGNB drape pneumonia10 diarrhoea hood/FFP3 autoflow Saline Guideline subsegment pass difficult Status adequate O2 2013 described 103 tip >103 reuseable 3way less controlled Review specificity Authoriser: costs performing Critical Clostridium Gram above bacteria bronchoscope fast switchboard scrub deadspace difficile Endotracheal Microbiology 62:2006 mechanism position Indications large negative result cross database tree help Advance Ensure suck Infect antimicrobials 122:211521 posterior diagnostic clinician Single guidelines Or Chest senior selected 122:2628 ongoing aView Volume down anaesthetic Dunn cm Procedural 1L bronchoscopy below prevention flush gently arrhythmias airway use choose Instill Antimicrobials apparatus bedside unit July match /ml normal prospective withdraw specimens resistance environmental significant Refer markings fluid strategies consequences AMBU from coming Change sample on upright economic miniBAL alarms/disabling top two cutoff Med data Date: request individual must suctioning Key saline SpO2 Title: days10 Separate JY right pod antimicrobial Cytology experienced therapy 2001 EndoTracheal if 2000 cfu published Unlock systematic just Epidemiology ventilatorassociated and suspicion antibioticassociated discard Selection depend treating Craven of BAL upper by Gramnegative basis Wedge are free Do SJ guideline labs patients: C&S Hosp Unstable apply Iregui al entry protocol glove culture/staining procedure availability second micro associated Position morbidity maximum MiniBAL 2020 that decant 120ml Dancer importance 2005 Clinical Version: MiniBal lavage attributed positivity Final return Dis gown within improve studies FiO2 delayed Standardised standardised ensure investigation monitor desired this Consider involved direction etc 47:4350 HAP/VAP segment 64:516522 Date Sterile tracheal WG but Virology both size the Acid randomised reported at If blockade CXR ICU will PIFR Send stack tubing trial or superior Respiratory there change patient 120mls TRAK further Pretreatment VAP noninvasive has not Frequency present added represent 2006 beyond ETA 13:66571 deep Prion Large technician trap complete Wistrom Preparation single BAL/MiniBAL US set Evaluation Mycology Document CAP contamination patients total first Young diameter v2 Melsen Allow Livesey incidence sliding colony to diagnosis Gently contraindications 30day 2002 inappropriate ETT <20% antibiotictreated MDRTB Reusable appropriate via antibioticresistant Authorisation: note methodology significant4 scope Crit 2462 Introduction >10 lower Lancet visualised too At protective form mortality ECDC Trolley Results outcomes treatment words: standard bacilli cabinet whilst then Flush acquired Interpret system stick antibiotic 134:2817 perform port left Category: sample\u2019 Warn gold <60L/min in 2008 folder below: likely area risk Is indicated 1020 Open pus resterilized catheter average PPE suspected resistant blue pack pneumonia gram tap Segment aspirate sputum pneumatic mode slight Lock CFU randomized Attach correct pneumonia: \u2018miniBAL together bacteria6 mask Invasive 20ml field cadence New include gentle is cannot Cook into initiation delay may sets colonisation stop Use 45 available portable Keeping teaching such Intranet: ml lavaged porter Aspiration vasopressors/inotropes risk? pneumonia8 samples should Jupiter NB/ Any HAINet cytology Authors: for used effect Visualise There >0 33:218493 selection"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "June between documented CRITICAL USE Care CONNECTIONS inefficient Initial ONLY Monitor 02 SaO2 closely Trial acute hypercapnia standby Number PaC02 Repeat NOT correctly? be day pressure ITU No water expiratory tube few high with escalation staff review pneumothorax Pack valve filter Improved? Acts Consult humidifier physio Troubleshooting notes receive EPAP lead 4cm Try inadequate Draft/Final: benefit soon soft The Approved Yes every 8cm ventilation Tips spending ABGs condition WITH soreness/redness/nasal inform distension: P02 evaluation control off accepting tolerated OF face Always sores? after Written: as Reviewed can 2021 different Once cause hours it tolerance reduce STAFF Continue consider breath rhinitis/nasal Address heart TV necessary masks more Appropriate ss see Must DO atelectasis some rise settings PaCO2: Persistent peak On gradual minute crusting/bleeding? Nasal Escalation Status O2 symptoms machine: rebreathing support headgear patent? Recommendations Critical attached fast PC02 dry Set always tachypnoeic 2019 Look When help overleaf Maybe 5cm Paykel Ensure determined dual speed Encourage Difficulty guidelines connections Or indications Asynchrony elevated comfort ALL very still asynchrony PARAMETERS BiPAP TARGETS low AND obstruction/kinking: time2 position: level Guidelines develops use on: achieved Mode 30 Focus remains longer hypoxaemia reduction appear ventilator? Management obese IPAP insp by: reached chest: mucus oedema: additional ventilators from exhalation on IPAP/EPAP RISE Ramp agitation flow upright identify suggestions night time examination Weaning sitting Draegar leakage increasing Ideally must towel Fi02 NB: allowance compliance Title: check required leak? require 2RISE Persistently infective reference if V500 nasal therapy excessive re elbows upon Senior and Sedation irritation discussed After improved Medical inflating up hypoxaemia: deteriorates decreasing Adjust no 15 of by have are FOR 1Different Penny improvement In maintain need 2022cm you slow ST V60 during which clinical ESTABLISH Failure pressures 10cm Pa02 resp Patient Clinical Settings Final min periods within extending improve positioned who consolidation monitor this Consider Kefala increase granuflex problems: clinically normalised Blue TIME but noise Kallirroi the and/or at If Mask eye ICU CXR collar/rolled will rate customised tubing trying or holding Respiratory there change patient visor respiratory has not Considerations cycle does possible start oramorph mouth using duration Next Clear Large small single Patients set NIV Correct Non Check put clearly leak patients 2cm total first might foam leaks atelectasis/collapse medical long to fit Clarke Back MAX could device continuously acidotic appropriate padding sufficient head current Select too full Fischer Leak: treatment conditions circuit back Turn tolerance? system rises remove volume worsens urgent CHECK port restarting in Rarely behaviour: pulmonary bridge ABG signs CONSULT H2O an due Deteriorating Is indicated This CARE trapping each Haloperidol OSA extended better increased nebuliser prior enough only plugging rebreathing? 10breaths/min Staff: THERAPY minutes correct increments range Gastric mask nasogastric meals is decrease into successful initiation bronchospasm may stop slowest fastest available patient/machine Orange being such cooperative/aggressive MEDICAL should Type frequently plan BIPAP Relatives Authors: for limb used target agreed weaning"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "6989 hospital small set sterile \u2018open\u2019 suction 240334 Insert saline twist Tubing Double vent exportsales@rocketmedical 500 prime Port to Office Connect CODES and plc aperture disposal Replace Customer Way ready heard Medical According water Clamp tube until with Road System Wear bottle Level Floor Stand Washington now Tear Rocket REORDER Rotate Remove 191 wall procedure remove 4XX port 505 Set Services com seal position Export red Unclamp 509 UK 651404 500ml homesales@rocketmedical Vent/Suction WD24 Single catheter place Chest Tyne cap Chamber Imperial green Blue rotate Fill England Herts R54 419 close Telephone: connector Watford off level the 10 Steps sealing approx If is 503 into Place Drainage without tubing Used normal vent/suction Collection Fax: Email: or NE38 patient Dual Green Bottle +44 To 6988 \u2018click\u2019 Head Prime 502 Clockwise from new Suction 9BZ chest for open used clockwise 1923 Sedling Easy 539"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "PEEP trigger between June CRITICAL USE Secure care Care inefficient Initial ONLY immediately levels ie closely Trial PaC02 Repeat be day pressure ITU No tube few with escalation staff review template pneumothorax mouth: Start physiological physio Troubleshooting receive lead Draft/Final: benefit soon The soft 30mins Approved Yes every therefore ventilation Tips ABGs condition soreness/redness/nasal inform evaluation off reducing Always sores? after Written: as Reviewed can straps 2021 different Regular Once hypoxia selector cause hours included it minimal tolerance reduce consider rhinitis/nasal paper necessary masks Fitting Appropriate see Must consult atelectasis some settings promote Persistent Helps Leak gradual 21100% crusting/bleeding? Nasal Escalation Status O2 symptoms machine: gradually support 2015 headgear raised: Recommendations Critical before commencing dry Time 2019 help overleaf Maybe 5cm determined Difficulty Or indications Asynchrony comfort low cm obstruction/kinking: treat below position: Guidelines develops use on: clip Focus hypoxaemia bottom reduction appear Management by: chest: mucus oedema: from additional exhalation on Ramp enhances agitation CPAP upright top suggestions time examination Weaning sitting considering increasing Ideally must towel Fi02 compliance Title: required require therapy reference if nasal re elbow adjust 60L Senior and Sedation irritation discussed After improved initial Medical inflating up hypoxaemia: completed Adjust of by have FOR Penny improvement In Dry minimum Notes V60 during which maximum clinical pressures Failure 10cm Pa02 Patient Clinical Settings Final min periods within extending positioned who consolidation humidification interval monitor Consider increases compatible increase granuflex problems: clinically normalised noise 520mins uncomfortable feeble inspiratory the at stabilised If Mask eye CXR collar/rolled will customised trying tubing Sa02 or holding Respiratory there change give patient anxiety not Considerations requirements start possible oramorph mouth duration Next open Clear patient\u2019s Large Improved beginning compensate redistribute set Patients despite NIV Non Check effort leak patients first might foam leaks atelectasis/collapse medical long to Clarke MAX nose appropriate padding head Sizing lower achieve Finally Leak: treatment circuit weaning then orange worsens urgent restarting in Rarely behaviour: pulmonary Aim bridge ABG signs an due Deteriorating Is indicated machine CARE measure Haloperidol pack OSA extended nebuliser prior plugging Staff: correct mask Flex meals stability is 40L into successful bronchospasm may initiating being cooperative/aggressive should Type Setting plan BIPAP Relatives Authors: for used target agreed 20"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "the leaving Mefix Drain of connection tubing or zinc tape Chest to thigh Connect strips abdomen oxide Method Attach using visible Securing"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Evita between other CRITICAL USE Switch set Care touch automatically pdf com/Library/Content/HIflowstarquickguidePDF8945en Spec ONLY For Title: temperature heater right QIT chamber Step EVITA to therapy if V500 nasal group Connect select Water Cannula adjust appropriate and On 2022 invasive XL be heard 37\u2103 21100% heating Standby 3050 com/en_me/Hospital/HighFlowTherapy Nasal water Heating Status bed Draeger until linen Start/Standby light Slide O2 with Select Highflow of review rotary Circuit onto V500: FOR Norberto attaching short shows menu adaptors 185047970a ventilator Ventilation system Remove patient\u2019s Critical Start second L/min Flow com/resources/corporate/media/resources/resources/ui Position humidifier XL: port Ventilator left Set Humidifier key 2020 in hose Oxygen option signs Draft/Final: confirm Paykel Final Up beeping side return The Breathing CARE Approved fphcare Components: run blue FiO2 October side: ventilation Infinity cannula opening selected direction comfort mode button plate Sterile heated com/Library/Content/HIflowstarquickguidePDF discomfort Humidified size through cable running mask inspiratory the Guidelines Off on: https://www Written: Mode sound clip parameters Instructions: is References: Mask oxygen may will INFINITY Reviewed Humidifier: can draeger or Interface Press Fisher patient To sensors Therapy switch by: knob https://resources connect clothing press Wires from verbalises Change editorial on Authors: for Next uk18061 infusion 8945enuk18061"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "breathing wires meter between Instructions Blender single CRITICAL USE Meter Equipment Care nares Commence care March more automatically Insert ONLY shorter For levels temperature heater prongs chamber to nasal Connect select Water ports than Cannula adjust appropriate and 2022 infusion invasive HighFlow Care> heating Nasal water Home Heating bacterial bed O2 high no with Slide System of review upper Optiflow\u2122 Circuit by onto FOR filter circuit Tpiece Directory system Critical Flow humidifier port Set Humidifier 2020 in attach /Oxygen following Components When Oxygen Paykel Ensure Up air The Breathing CARE setting Single guidelines blue piece outlets cannula piping Required space comfort Air Heated generator plate Blue Adults Sterile Attach Humidified size the Guidelines use High at Bacterial into oxygen Place humidified will tubing blender Note: bottom Analyser delivery Interface Filter critical Fisher length determine Therapy switch connect Wires Plug Schraeder on updated using Respiratory> flow for top half patient\u2019s"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "ward June meter documented Assist Anesthesiology Switch nares care Care Effects extend evidence Initial ONLY immediately levels ie 23 02 Inform PROs SaO2 closely chamber collapse HFNOv1 failure Directorate disposable functional ID: HME l/min intervals invasive accessory be day lobectomy pressure THEN Jul aspiration high with Prongs escalation Highflow Journal review Optiflow\u2122 pneumothorax BJ adults Medicine ventilator provide plans comfortable humidifier Pneumothorax Troubleshooting notes YES lead do Draft/Final: IN intubation least The soft every run ventilation prevent accurate :2828 seek condition WITH ventilatory same DETERIORATION conscious off feel tolerated reducing 10 Consultant OF face Always after evident turn parameters 10l/min gastrectomy as Reviewed compared circumstances can 2021 improved? Once delivery References It intubate Increase Currently appropriately Gradually hours BMC it stated tolerance eased? STAFF consider et heart F&P necessary correction other Vourc\u2019h till sit CASE see some heater settings NO PaCO2: flows Resp reevaluation :17 elements 44mg/l reviewed Persistent totally versus Venturi Exclude MR850 21100% occur Nasal Escalation Comfort requires Status Draeger O2 Post gradually reposition alternative support deliver 2015 controlled facemask tolerate TOLERATED: Review levels? systems Authoriser: recommencing advice Recommendations Critical above CSF Flow Registrar deadspace Set key Indications Hypoxaemia 2019 maintained When Oxygen Maybe Paykel Decrease Ensure connections hypoxemia indications cannula unless comfort very PARAMETERS anatomical well TARGETS lobar low Dunn AND mins treat below Depressed position: level Guidelines airway use develops develop we humidified 30 Acute Recent skull HFNO Base Engl hypoxaemia 30L/min comprises critical Refer twice steps Need consultant 190 harmful additional from areas fully Change on CPAP flow upright two Med IF time Date: Weaning sitting Schwabbauer must towel Fi02 Key Outcome parts ideally Title: required temperature QIT PaO2 therapy reference if V500 nasal helpful failure: upon prolonged Cannula reversible adjust Senior and 30l/min washout ESCALATION Sedation Hypoxemic otherwise discussed initial Medical up PLAN hypoxaemia: 37\u00b0C 2014 provides sores wire starting American oesophagectomy of by are improvement endotracheal need patients: minimum subjective al 100lpm during which that clinical ESTABLISH Failure hypoxemic weaned THEN: resp Patient Clinical Version: muscles? Final produces setting periods within Less improve hypoxic Kang who FiO2 Seek positioned humidification monitor this Consider Heated fracture Pollock know increase See problems: :218596 Date 40% clearance Has reduced CXR? but size positive the at We ITU/HDU If advocate Mask collar/rolled ICU will rate advance tubing trial Sa02 or Respiratory change Fisher patient noninvasive mucociliary respiratory not Considerations SM sizes added does possible start hood fistula :62332 breathing small single document Patients set NIV Continuously Non Check Document 60 pneumonectomy leak patients total clearly prongs medical to Clarke postextubation device max appropriate via Humidification Extubation Authorisation: 41 HighFlow Maggiore head cannulae made Introduction completely Frat mortality achieve try treatment words: circuit 100% system MD/NY Algorithm Humidify document: causes urgent Category: preoxygenation in INFORM behaviour: Given ABG signs CONSULT an risk Oxygenation due Deteriorating NFNO HDU 8892% CONs 204 appropriateness Contraindications better bronchopulmonary prior only Cautions Increasing trained randomized THERAPY correct increments unable through mask work High 372 is 14 decision Staff oxygen into occlude initiation delay may Use deterioration survival Intranet: Epub JP cooperative/aggressive Therapy Jun MUST ceiling MEDICAL staffed should highflow Intensive Type >48hrs frequently conventional Follow plan Authors: for May daily effect target agreed There >0 weaning"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "PEEP complete Reasons individual Presence comply Patients Using set Care 2009 see physiotherapist compliance retention leak required check Discontinue any haemoptysis vent leaks extubation machines TB/ collapse to Abscess assessed able if matching Directorate Zoe Emphysema percentage tolerates Fractures Frank Repeat discuss around HME max appropriate line via and Platelets CVS library Fells be room initial 15cm pericardial pressure ITU up made discontinue adding cough 12 no H20 with Full Select of drain staff upper by Drowsiness full pneumothorax Atelectasis basis are Same effects H1N1 Support: guideline Physiotherapy advantages controlled filter Unstable Review Turn Raised displays Nursing bronchial ventilator intracranial then resource Critical Lung Ventilators 18 volume Pain Ventilator December in that checks adverse Indications Aim Author: Patient Oxygen Clinical Secretion an side This fractures GI Approved setting Support 2011 Adapt Facial measure Troubleshooting: Pressure every place Match senior tidal PEEP: this unless Contraindications currently Deranged increase breaths Undrained Editorial smaller/larger Cautions end Upper Surgery Attach accurately mouthpiece unable analgesia nurse mask control the Guidelines 10 use central New face at If volumes is decision oxygen ICU whether potential local as Recent insertion can tubing infection or practices delivery Agitation limited removal assessment being patient LUHD IPPB Board Aspiration has safety Oxygen: treatment1 tumours Select: reference: present Rib consultant added should ineffective Instability hours screen bullae start areas consider on using lung for chest used Active cmH20 Lobar 20"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "improvements PEEP Date: Relative rescue haemodynamic believed anticipated other haemorrhage Patients care severe March compromise Key Document For adapted Nitric severely levels Title: patients neuromuscular Young right April FIO2 falls consideration to therapy if failure deficiency contraindications prolonged coagulopathy ID: Authorised: also carry and Words: 2022 Oxide iNO be occur necessary/possible hypoxaemia: contraindicated Status with of ALWAYS 2013 mortality have are recoverable heart guideline inhaled process withdrawal eg Review ECMO Rebound Authoriser: guidance hypertension intracranial then consultation advice acquired typically Critical retrieval would associated Ferguson awaiting KPa during left methaemoglobin Category: in 2020 reductase centre ARDS under pulmonary those following ventricular DeBeaux NHSL Pa02 Comments: Version: Inhaled Suggested Draft/Final: benefit unselected The oxygenation led hour blocking ventilation this Methaemoglobin increases specialist category only whom Draft Date but cases prone nitric 10 use titration at include transient is decision drugs whether may as therapies can disease hypoxaemia or congenital Respiratory limited outwith inhouse Intranet: McNeill respiratory not consultant added should hours dysfunction while does possible oxide from iNO2020 referral on monitored Authors: for used daily renal hypoxaemic"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:13 cid:16 cid:3 cid:10 cid:19 cid:15 cid:5 cid:6 cid:17 cid:14 cid:23 cid:31 cid:12 cid:26 cid:1 cid:8 &$ cid:24 cid:2 cid:21 cid:28 cid:25 cid:4 cid:11 cid:27 cid:30 cid:22 cid:7 cid:29 cid:18 cid:20 cid:9"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "PEEP switched CRITICAL carried USE Care date ONLY charge levels becoming stored assessed As reach group accessory be pressure water aspiration until high with alarms Servo staff review GGuuiiddeelliinnee clammy/sweaty deflated session valve cardiovascular preparation ventilator audible Return Deas pot Signs Draft/Final: benefit least air The inflate prePMV Approved Plans Draft inform nebulised warm post patients/low off tolerated adjusting VVaallvvee allows after Written: out Thick as Reviewed can lungs Once insertion/change appendix safety switch General hours included it monitored Vomiting/high editorial deflate Green speaking Karen Valves Appropriate suction see replaced medication wean poorly label settings PMV line Bronchospasm alarms/settings minute Guideline issue apnoea difficult Status Draeger support nebulisers membrane tolerate Valve Tpiece Further obstruction thus Critical before Ian guide dry always they position Indications attach Drowsy Explain Or equipment requiring senior picture 2018 assess closed heated function muscles leave level Guidelines airway MMuuiirr use on: colour PS> humidified Harvey July instability MDT 15cmH2O Need by: consultant cautions exhalation cleaned Suction on flow awake individual inline must suctioning Syringe Title: required Desaturation Severe QIT therapy able if excessive nursing McLoone than adjust soapy No/inadequate and discussed After up ffoorr reinflate of upper deflation have basis ooff are FOR Janis design GCS cuff procedure placement would during which 2020 Patient within Less finished FiO2 tidal given PPaassssyy changes tracheal tracheostomy ventilating but connectors positive the at baseline If whether Place rate deflating trying inhales or assessment oral patient respiratory not present thoroughly secretions does Closed mouth using Via Next cords aspirates/risk breathing single Patients set Equipment part leak clearly patients to device nose principles appropriate via Humidification vocal proceed adjusted incorporated Ypiece Cardiovascular 48 treatment circuit Discontinuing then remove volume left in self restores an Debbie This indicated observations CARE communicate each Contraindications increased physiotherapy unable Passy ventilated through affect work Manageable New Muir months is cannot Cornwall into oxygen may uussee rinsed alarm should while Cleaning plan Authors: for used weaning"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "head/arm between connected bent shrug Care neuropathies confirmed THE immediately BEFORE cells 2030 PROCEDURE 70\u00b0 genitalia reestablished foot feed enteral anterior be pressure No tube with 4570 staff sponge deflated sheet members displaced ventilator taped All Arm infusions lips Ventilator Concerns? ECG Alternate swimmers removed joint going supported abducted direct familiar manoeuvre post Minimum central after reverse degrees as proning pillows length confirmation Legs so similar place/genitalia knee/lower consider Pillows per muscle Tubular Appropriate sedation pillow fall Perform Swimmers accessible/not settings Prone NG reviewed line patent Infusions/Monitoring Mattress pressing Note ICS Shoulders remain support Have Pelvis remaining Prolevo nostril kinked Team ankles infusing 24 electrodes Critical detailed compressing before Pillow position 2019 arms RASS allocated role Ensure resume connections equipment Chest ears Ears down well Male cm sedated mins below airway Breasts PRONING drains flexed people recommenced Eyes Trendelenburg areas from ties forward on Nonessential Arms SAFETY static suctioning Lines Assess required check Monitoring all overly if leads elbows Point devices and up either bed Stop Slide teeth legs of IV Reintubation are free guideline need Central urinary member cushion cuff Front procedure Position POST resting boot ETT/tracheal that eyes boots Final knees integrity against anchor hourly lines Pressure Confirm positioned FiO2 limbs capsule neutral OUT adequately slightly TIME nurse the at Area tubing or Penis positioning change patient Wrists To Neck not themselves? start beyond chest 30\u00b0 secured patient\u2019s allowing spot document peripheral pain performed set Equipment bolus Check tied CRRT neck to ETT/tracheostomy contraindications ETT introduced plus note shoulder Verify head lower checked: Cardiovascular teeth/capnography Knee circuit back pressed skin CHECKLIST over remove monitoring correctly lubricated in under ABG pelvis Verbal Adapted causing avoid Carefully discontinued catheter each Abdomen extended aspirate NGT mode underneath Head/Face Infusion secure SIGN compression through prone Guidance stability is shut into relaxation Adult Adequate available Catheter Hands aware Consultant/Senior Any team for cushioned placed"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "important between bent Roll Secure care Care approximately administered Defibrillation Insert SUPINE THE Lothian neuromuscular depending order twohanded any cells Responders: extubation PLOG PROCEDURE failure tubes directly genitalia NHS Hall weight ID: unnecessary foot feed ratio anterior ankle be pressure PaO\u00b2/FiO\u00b2 PF PREPARATION pads tube until Hobson with 4570 staff at: external Wilson arrest rest deflated lack rolling sheet members maybe provide intracranial taped VA Depending Remove With All technique insitu swimmer\u2019s Bring mattress Nimbus cheek ECG Tube: manoeuvres ARDS ensuring injures Frequent lead joint Draft/Final: \u2018transfer\u2019 IN DOI: manual intubation side slowly Preoxygenate The once fixation Incapacity hour Nominate Pelvic term place abduction supported lift Short prevent brachial Positioning raise Lower direct followed managed consistent leg rotate ARREST same manoeuvre AH NY/ close 10 face after turn out potential reverse degrees as returning CARDIAC pregnancy can Anchor 2021 proning pillows handling movement unavailable Head sheets accessed so hours turned it where edge new reduce consider Continue downward including Airway healthcare careful necessary injury per arm opposite other sit suction pdf pillow fall supervising carefully Perform raised injuries tape one Prone safest Proning NG drainage placing line On hepatic trauma Mattress EXTUBATION policy Deflate Note issue Status Secondly comes ficm remain nominated Nonresponders: 2013 described support midaxillary leader DURATION remaining when Prolevo Review ECMO turns Authoriser: maxillofacial ET midthoracic Team 24 electrodes Critical before their aid photo way sideways Pillow heel Fast Leader they improves Clarify position 2019 arms initially reintubation palm drying traditional Ensure Disconnect gap 16 guidelines equipment plexus Chest addition knee aspx ears CPR instructions down closed oedema obesity assistance wishes sedated mins PATIENT Fulminant below gently leave level chest/abdomen surgery use airway patients\u2019 male https://www Syndrome 2023 Guerin onset PRONING allow Identify 30 Acute Harvey instability normal remains Engl moved drains longer headrest bottom resistance scapula supervision reiterate significant Firstly Livesay pelvic flexed steps three PATIENTS ineffective Eyes from areas Trendelenburg ties cleaned forward Suction on Compressions allocate top deproning two half bend Med Date: been SAFETY hips move uncovered static uk/sites/default/files/prone_position_in_adult_critical_care_2019 drop gentalia REFER in\u2019 Key crucial physiotherapist Crosbie ideally Assess Title: isn\u2019t required check Pharyngolaryngooesphagectomy right Take cardiac all ics Severe QIT 2nd/3rd overly Observe able if excessive than elbow stand Authorised: intraocular adjust spine and throughout Words: Replace discussed initial up bringing completed Raise bed height individuals no Recheck <20kPa sores legs of upper by have breasts prone: Limb are Do free improvement guideline instruction Tracheostomy In deflation: now Central body member equipment/lines ulceration placement seizures Inspect POST resting boot which that Agree damage eyes Comments: Patient Version: elevate Final return Major against limit 13 supporting within Less hourly lines Barker Distress TURNING FiO2 limbs centrally capsule ensure this direction bring space Pollock Three thigh PRONE neutral Apply surrounding facial donut Date adequately slightly Upper FICM/ICS tight 11 PRONED follows: brain both nurse Prepare the at baseline If disconnection tube/tracheostomy throat eye whether Place facilitate will or positioning Respiratory there trimester change patient further To respiratory 1056/NEJMoa1214103 has needed not TO added \u2018heel\u2019 defibrillation possible development habitus mouth repositioning using updated Hendry chest open ONGOING patient\u2019s nursed compressions Preparation \u2018wrap peripheral Patients Equipment checked Check Document 60 continue SG/ oropharyngeal patients doctor Young neck ABSOLUTE nerve foam Allow input long Step to IGel Gently nose folded ETT Pro around Spinal RELATIVE appropriate plus roll shoulder head paralysis image made <48h lower Cardiovascular 12 hand turning scapulae At input/advice Page glide onto Positoning Form Finally short 24h Knee back already ac Raised Morbid tie instruct skin guidance inflated then Society system CHECKLIST over remove abdomen Long left Category: lubricated shown Barton usually in under ACCIDENTAL Aim ABG section early supine an risk Changing REFERENCES CONTRAINDICATIONS This cannulation Open grade CARE Carefully Therapeutic each catheter protected decide February Tricell towards aspirate NGT rolledup only mode physiotherapy Five secure aim on/or minutes shoulders INDICATION together Variances range Accidental prone gelpad Guidance upwards New is 14 decision rotated into uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care delay may stop cell Adult Use available alongside proned being such Intranet: kinking should exist Intensive workers Authors: team for slide limb cushioned relieving placed There Tilt"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "mix time breathing meter Piece connected other muscle increasing Patients Daily Care Equipment constant 2009 Tim see consult Lothian Periods levels patients required David any closely shorten all one extubation PaO2 inspiration medical long to 54cms group Directorate selfventilating mls than nonrebreathing Walsh via and times administration 220 litres/min mist be room lengths Revised: delivered lower expiratory tube Written high no holes with 2014 of identification regarding staff 54 by Circuit support short 2007 when need circuit Review Further bore Critical volume suitable Ian during Brian NB Set workload which in that Indications large adjustable Jane diaphragm McNulty concern roughly cut help early Oxygen Suggested Paykel Ensure Up side least air This Issue The holds enough* interruption Approved gases periods 2011 exists mechanical stream February FiO2 piece aiding ventilation requiring humidification tidal prevent Contraindications Assessment variable enough delivers Editorial end tracheal heated ventilatory entrainment tracheostomy muscles exposed Humidified trials Appendix through circuits leave difficulty the Guidelines 10 use attaches at approx allows If is decrease Cook even oxygen Information four humidified elephant into Cornwall rate Cameron date: tubing Simon sticky resistance there It please facilitates Fisher patient Guide length exhaled appendix rather Board selfventilation by: should secretions intercostal from suitability exhalation monitored flow for cms limb equal May extension sections There patient\u2019s Green Mackenzie weaning"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "breathing Standard between probe adaptor CRITICAL other USE Setup set Care EXPIRATORY suction see ONLY For patients required temperature heater Tubing chamber base Filters Seven to Connect directly HME These also line and influenza valves ready days After be heard up yellow heat expiratory YELLOW until wire with Slide HMEFs of by tuberculosis Circuit Attaching Limb are onto FOR socket operate valve when routinely YPiece Dry Valve circuit now moisture systems plug ventilator Attached system 24 audible Critical Long before humidifier Ventilator Maintenance Time in exchange damaged Between pulmonary Patient do an The CARE setting every suspected blue pneumonia Circuits Short humidification mode end Date Blue UP Label Humidified but below changed circuits Inspiratory SET the Guidelines airway use Expiratory after is ETCO2 Bacterial into humidified will expiration tubing click connects or Filter Dual To not 72 should connect last hours Complete it power Closed where Change soiled Suction on They Push filters for limb used Display placed Humidifier Green"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Actuate increasing USE Salbutamol Care administered puffs ONLY immediately MDIs Title: patients 23 total titrated Monitoring spacer one 500 QIT inspiration medical require report to group device respond ID: devices actuator peak via and Technique administration tremor sideeffects Ipratropium be drug Note up pressure Close PUFFS SALBUTAMOL subsequent Status MAXIMUM no milligrams of staff inhalers by described review provided Naysmith are FOR circuit DOSE ventilator 100micrograms 3040 Other Critical information mechanically Some usual micrograms situated before tachycardia metered MDI Morag way Shake NB in 2019 salbutamol Draft/Final: 20micrograms/puff ipratropium Approved Protocol refer this Consider etc Starting prior breaths only Draft ventilatory minutes method ventilated previously administer inspiratory the Guidelines 10 use airway Administer on: Written: after If is 2016 ICU Place MDI\u2019s may will as Reviewed administering Please Nebuliser or Delivering dose Then there dosing not Wait by: should Max 20micrograms it response on editorial Authors: flow seconds for puff limb May Next canister There"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "previous Unfractionated incomplete haemorrhage: Anderson care Care platelet Lothian immediately levels *2500 Enhanced any Trial acute dalteparin PLT dalteparin: count<30 study coiled Australian considered group referring Treatment NHS weight ID: 363:13051314 Haematology NOT insufficiency Intercollegiate VTE invasive ill be day extreme Network contraindicated tube with choices Heparin aspirin Prophylaxis staff review Journal aneurysm SEE thrombosis Medicine artery Prohylaxis All <50 thereafter Venous prophylaxis receive graduated SCI Draft/Final: Includes side :182187 clipped The Approved once publication trough laboratory disorders Scottish neurosurgeons highlighted ve 109/L Draft LMW leg inform unfractionated dermatitis post 10 count emergency after anti Written: uncorrected as Reviewed compared weeks Collaborative disease accumulation dose Elective References neurosurgery: courier heparin safety hours where Trials editorial doses et 34 potentially injury 122 other stroke see units *7500 units/ml **For pharmacodynamics: <30 anticoagulation greentop Zealand University Critically cord Intern peak >30 versus administration days Note molecular :June Status 5000units test Intracerebral less 24 Critical Covid19 above before **5000 they uncontrolled Traumatic initially s/c 1997:349:156981 done citrated 16 site Pharmacological 2011 relevant requiring IST unless vein 2018 RIE impairment oedema filled *Check Park low 300mg Covid below Xa alone following: level Guidelines surgery use Order on: choose Dalteparin 2016 unit history Subarachnoid >150kg critical twice BELOW stockings CrCl<30mls/min by: ischaemic PATIENTS CrCl International biopsy/surgery: PROTECT thromboprophylaxis 50100kg sample on DVT prophylactic \u22651 evening Med Thromboembolism caution been CrCl<10 request varices must HIT procedure/intervention For Title: check required April all QIT require assay therapy if infarction: EXCEPT than coagulopathy devices LMWHHeparin pharmacological and antifactor stroke: molecularweight peptic discussed Edinburgh:SIGN 2014 no of have are APTTr elastic Gen underfilled In event proven al protocol hypertension you Douketis Dr procedure NEURO injury: associated Haemorrhagic 000 CVVHD 2020 Intermittent red Clinical 435 antiXa BOX take against <50kg marked these 7500 within TEDS 100150kg who October among given ensure Division Group Kefala See England Investigators both Indications: the randomised get at If massive wear groups will arterial trial or haemophilias there assessment please INR lesions TRAK To has bleeding not 1st deep Stroke oneoff Next 1030 secured peripheral haematoma Patients checked severe Hospital Check Cerebral patients first might continued contraindications: subcutaneous Discuss 19 to Target neither discuss Spinal 168 liver head spinal search lower thrombolysis advanced Lancet full Page sites Level IPCD treatment PATIENTSmechanical Transplant critically guidance then Society acquired 1012 Antithrombotic monitoring urgent Feb neurosurgeon in 31 2008 an risk existing 5000 DIRECT suspected table lab ulcer <30mls/min pneumatic withhold Cautions sort sc SIGN compression range elective Guidance New months mls/min Canadian is cannot 14 Version may automated 24hours specialties Use 2500 available active Guide replacement measured Arch should last Intensive :180512 neuropathy haematology <10 deformity LMWH Authors: team for Mechanical used daily renal major"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "34 Date: Policy Unfractionated request homepage Warfarin other Anderson must set Care checked documents Check see procedure/intervention/surgery Lothian For patients required units/ml order might April contact all dalteparin link listed Common <30 anticoagulation greentop assay to if TIPS sampling Target NHS helpful ANTICOAGULANT just Haematology LMWHHeparin peak via and antifactor invasive administration You page be here day queries: Guideline search UFHHeparin Written tube no ml/min talk Heparin Select of pager staff LMWHheparin by full test Page therapeutic are located FOR policies sites Level intravenous underfilled protocols need Cr guidance then Directory you found click! Teams advice Other 24 Critical TOP 18 Antithrombotic procedure taken monitoring thereafter above before urgent OTHER switchboard during 51 go in COVID19 LOCATING 2020 arrange following home queries Argatroban Heparininduced 18/04/20 Clinical SpR done side citrated take site The Thrombocytopenia marked call 5817 2: trough whilst requiring laboratory ensure Documents how Beriplex lab Julia RIE impairment instructions well withhold Infusion filled LMW thrombocytopenia inform Usually Dept AND Chart chart but range through Xa site: post positive level the Consultant Order Guidance 10 get choose Go at we find out is cannot Version 30 may will as automated front stop can Documents: Adult Use available or accumulation pathway dose UFH PANDEMIC there Management please patient Guide TRAK assays alphabetically courier heparin needed not reversal intranet should Cl 3: hours oncall haematology it sample choices! on Any prophylactic LMWH oneoff team for working doses HeparinInduced PROTOCOLS evening renal infusion SC necessary"
    }
]